Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-04-01
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| PTGES | -5.261183 |
| TNNI2 | -4.209869 |
| AF127577.2 | -3.690327 |
| AC253572.2 | 3.662219 |
| CKB | -3.594732 |
| PUS10 | -3.544353 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 12783 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 10269 |
| num_profile_genes_not_in_sets | 2514 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets: c5.go.v2023.2.Hs.symbols.gmt| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4888 |
| num_genesets_included | 5573 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP SEQUESTERING OF IRON ION | 5 | 0.001910 | -0.802 | 0.241 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 0.004760 | -0.729 | 0.363 |
| GOBP RESPONSE TO ZINC ION STARVATION | 5 | 0.004880 | 0.727 | 0.363 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 5 | 0.007620 | 0.689 | 0.417 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 5 | 0.008050 | -0.684 | 0.417 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 0.008370 | -0.681 | 0.417 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 0.008370 | -0.681 | 0.417 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 0.008440 | -0.680 | 0.417 |
| GOBP SEX DETERMINATION | 6 | 0.003950 | 0.679 | 0.331 |
| GOBP L SERINE TRANSPORT | 6 | 0.005080 | 0.661 | 0.363 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 0.005080 | 0.661 | 0.363 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 9 | 0.000652 | 0.656 | 0.140 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 0.011400 | -0.654 | 0.458 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 5 | 0.011600 | -0.652 | 0.462 |
| GOCC CELL POLE | 5 | 0.013300 | -0.639 | 0.467 |
| GOMF ACID PHOSPHATASE ACTIVITY | 5 | 0.013500 | 0.638 | 0.467 |
| GOBP REGULATION OF FERTILIZATION | 5 | 0.014600 | 0.630 | 0.475 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 0.015100 | 0.628 | 0.475 |
| GOBP CILIUM DISASSEMBLY | 5 | 0.015100 | 0.628 | 0.475 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 0.015100 | -0.627 | 0.475 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 0.008490 | -0.620 | 0.417 |
| GOBP COCHLEA MORPHOGENESIS | 5 | 0.016400 | 0.620 | 0.494 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 0.008960 | -0.616 | 0.419 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 0.002570 | -0.616 | 0.288 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 0.009220 | -0.614 | 0.419 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 0.001630 | 0.606 | 0.227 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 0.018900 | 0.606 | 0.514 |
| GOMF TAP BINDING | 7 | 0.005760 | 0.603 | 0.386 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 0.003200 | 0.602 | 0.312 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 0.010800 | 0.601 | 0.450 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 0.010800 | 0.601 | 0.450 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 0.020300 | -0.599 | 0.522 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 9 | 0.002040 | 0.594 | 0.249 |
| GOBP FOLIC ACID TRANSPORT | 6 | 0.012000 | 0.592 | 0.462 |
| GOBP GAS TRANSPORT | 6 | 0.012100 | 0.591 | 0.463 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 0.022500 | 0.589 | 0.534 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 0.022700 | 0.588 | 0.537 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 0.023700 | -0.584 | 0.539 |
| GOCC TORC1 COMPLEX | 6 | 0.013600 | 0.582 | 0.467 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 7 | 0.007770 | -0.581 | 0.417 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 0.026100 | 0.574 | 0.551 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 10 | 0.001740 | 0.572 | 0.229 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 10 | 0.001740 | 0.572 | 0.229 |
| GOBP LIPID IMPORT INTO CELL | 13 | 0.000366 | 0.571 | 0.103 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 0.009210 | -0.568 | 0.419 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 0.009720 | 0.564 | 0.430 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 5 | 0.029400 | 0.562 | 0.570 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 0.029600 | -0.562 | 0.571 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 0.030400 | 0.559 | 0.571 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 7 | 0.010700 | -0.557 | 0.450 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP SEQUESTERING OF IRON ION | 5 | 1.91e-03 | -8.02e-01 | 2.41e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 4.76e-03 | -7.29e-01 | 3.63e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 5 | 4.88e-03 | 7.27e-01 | 3.63e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 5 | 7.62e-03 | 6.89e-01 | 4.17e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 5 | 8.05e-03 | -6.84e-01 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 8.37e-03 | -6.81e-01 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 8.37e-03 | -6.81e-01 | 4.17e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 8.44e-03 | -6.80e-01 | 4.17e-01 |
| GOBP SEX DETERMINATION | 6 | 3.95e-03 | 6.79e-01 | 3.31e-01 |
| GOBP L SERINE TRANSPORT | 6 | 5.08e-03 | 6.61e-01 | 3.63e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.08e-03 | 6.61e-01 | 3.63e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 9 | 6.52e-04 | 6.56e-01 | 1.40e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 1.14e-02 | -6.54e-01 | 4.58e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 5 | 1.16e-02 | -6.52e-01 | 4.62e-01 |
| GOCC CELL POLE | 5 | 1.33e-02 | -6.39e-01 | 4.67e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 5 | 1.35e-02 | 6.38e-01 | 4.67e-01 |
| GOBP REGULATION OF FERTILIZATION | 5 | 1.46e-02 | 6.30e-01 | 4.75e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 1.51e-02 | 6.28e-01 | 4.75e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 1.51e-02 | 6.28e-01 | 4.75e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 1.51e-02 | -6.27e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 8.49e-03 | -6.20e-01 | 4.17e-01 |
| GOBP COCHLEA MORPHOGENESIS | 5 | 1.64e-02 | 6.20e-01 | 4.94e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 8.96e-03 | -6.16e-01 | 4.19e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 2.57e-03 | -6.16e-01 | 2.88e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 9.22e-03 | -6.14e-01 | 4.19e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 1.63e-03 | 6.06e-01 | 2.27e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 1.89e-02 | 6.06e-01 | 5.14e-01 |
| GOMF TAP BINDING | 7 | 5.76e-03 | 6.03e-01 | 3.86e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 3.20e-03 | 6.02e-01 | 3.12e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.08e-02 | 6.01e-01 | 4.50e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 1.08e-02 | 6.01e-01 | 4.50e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 2.03e-02 | -5.99e-01 | 5.22e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 9 | 2.04e-03 | 5.94e-01 | 2.49e-01 |
| GOBP FOLIC ACID TRANSPORT | 6 | 1.20e-02 | 5.92e-01 | 4.62e-01 |
| GOBP GAS TRANSPORT | 6 | 1.21e-02 | 5.91e-01 | 4.63e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 2.25e-02 | 5.89e-01 | 5.34e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.27e-02 | 5.88e-01 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 2.37e-02 | -5.84e-01 | 5.39e-01 |
| GOCC TORC1 COMPLEX | 6 | 1.36e-02 | 5.82e-01 | 4.67e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 7 | 7.77e-03 | -5.81e-01 | 4.17e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 2.61e-02 | 5.74e-01 | 5.51e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 10 | 1.74e-03 | 5.72e-01 | 2.29e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 10 | 1.74e-03 | 5.72e-01 | 2.29e-01 |
| GOBP LIPID IMPORT INTO CELL | 13 | 3.66e-04 | 5.71e-01 | 1.03e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 9.21e-03 | -5.68e-01 | 4.19e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 9.72e-03 | 5.64e-01 | 4.30e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 5 | 2.94e-02 | 5.62e-01 | 5.70e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 2.96e-02 | -5.62e-01 | 5.71e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 3.04e-02 | 5.59e-01 | 5.71e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 7 | 1.07e-02 | -5.57e-01 | 4.50e-01 |
| GOCC GID COMPLEX | 5 | 3.15e-02 | -5.56e-01 | 5.81e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 6 | 1.88e-02 | 5.54e-01 | 5.14e-01 |
| GOBP AXIS ELONGATION | 7 | 1.12e-02 | 5.54e-01 | 4.58e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 1.13e-02 | 5.53e-01 | 4.58e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 3.24e-02 | 5.52e-01 | 5.88e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 5 | 3.28e-02 | 5.51e-01 | 5.88e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 1.17e-02 | -5.50e-01 | 4.62e-01 |
| GOBP CRANIAL NERVE FORMATION | 5 | 3.34e-02 | 5.49e-01 | 5.88e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 3.39e-02 | 5.48e-01 | 5.88e-01 |
| GOBP SEGMENT SPECIFICATION | 6 | 2.15e-02 | 5.42e-01 | 5.33e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 1.38e-02 | -5.37e-01 | 4.68e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 2.30e-02 | -5.36e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 3.81e-02 | -5.35e-01 | 6.11e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 3.94e-02 | 5.32e-01 | 6.15e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 6 | 2.42e-02 | -5.32e-01 | 5.39e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 1.51e-02 | 5.30e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 2.46e-02 | -5.30e-01 | 5.39e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 9 | 6.07e-03 | -5.28e-01 | 3.89e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 4.13e-02 | 5.27e-01 | 6.19e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 7 | 1.59e-02 | -5.26e-01 | 4.86e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 5 | 4.20e-02 | -5.25e-01 | 6.21e-01 |
| GOBP OSTEOCLAST FUSION | 5 | 4.20e-02 | -5.25e-01 | 6.21e-01 |
| GOBP UREA CYCLE | 5 | 4.20e-02 | -5.25e-01 | 6.21e-01 |
| GOBP UREA METABOLIC PROCESS | 5 | 4.20e-02 | -5.25e-01 | 6.21e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 2.68e-02 | 5.22e-01 | 5.54e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.71e-02 | 5.21e-01 | 5.54e-01 |
| GOBP HEAT ACCLIMATION | 6 | 2.74e-02 | -5.20e-01 | 5.55e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 6 | 2.80e-02 | -5.18e-01 | 5.61e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 6 | 2.83e-02 | 5.17e-01 | 5.64e-01 |
| GOMF TRAIL BINDING | 5 | 4.54e-02 | 5.17e-01 | 6.34e-01 |
| GOBP LEUCINE TRANSPORT | 6 | 2.85e-02 | -5.16e-01 | 5.64e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 3.69e-11 | -5.16e-01 | 1.01e-07 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 5 | 4.60e-02 | -5.15e-01 | 6.34e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 1.17e-02 | -5.15e-01 | 4.62e-01 |
| GOBP STEROID CATABOLIC PROCESS | 8 | 1.19e-02 | 5.14e-01 | 4.62e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 4.76e-02 | -5.12e-01 | 6.42e-01 |
| GOBP OXYGEN TRANSPORT | 5 | 4.76e-02 | 5.12e-01 | 6.42e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 10 | 5.44e-03 | 5.08e-01 | 3.77e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 5 | 4.93e-02 | 5.08e-01 | 6.48e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 8 | 1.29e-02 | -5.07e-01 | 4.67e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 2.12e-02 | -5.03e-01 | 5.33e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 6 | 3.37e-02 | 5.01e-01 | 5.88e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 1.82e-03 | -5.00e-01 | 2.32e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 6 | 3.45e-02 | -4.98e-01 | 5.88e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 11 | 4.21e-03 | 4.98e-01 | 3.39e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 6 | 3.45e-02 | 4.98e-01 | 5.88e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 5 | 5.49e-02 | -4.96e-01 | 6.62e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 5 | 5.49e-02 | -4.96e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 6.66e-03 | -4.96e-01 | 4.01e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 5 | 5.54e-02 | 4.95e-01 | 6.62e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 5 | 5.56e-02 | 4.94e-01 | 6.62e-01 |
| GOCC WNT SIGNALOSOME | 8 | 1.55e-02 | 4.94e-01 | 4.79e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 5 | 5.58e-02 | 4.94e-01 | 6.62e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 5.67e-02 | -4.92e-01 | 6.62e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 3.70e-02 | 4.92e-01 | 6.08e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 1.65e-07 | -4.91e-01 | 1.94e-04 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 6 | 3.81e-02 | 4.89e-01 | 6.11e-01 |
| GOBP WNT PROTEIN SECRETION | 5 | 5.86e-02 | 4.88e-01 | 6.64e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 6 | 3.87e-02 | -4.87e-01 | 6.12e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 6 | 3.88e-02 | 4.87e-01 | 6.12e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 5 | 6.17e-02 | 4.83e-01 | 6.68e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 2.75e-02 | 4.81e-01 | 5.56e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 1.86e-02 | 4.80e-01 | 5.14e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 5 | 6.38e-02 | 4.79e-01 | 6.70e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 6.51e-02 | 4.76e-01 | 6.70e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 9 | 1.33e-02 | -4.76e-01 | 4.67e-01 |
| GOBP NEURON REMODELING | 8 | 2.00e-02 | 4.75e-01 | 5.22e-01 |
| GOBP EXCRETION | 6 | 4.48e-02 | 4.73e-01 | 6.32e-01 |
| GOMF OLIGOSACCHARIDE BINDING | 5 | 6.80e-02 | -4.71e-01 | 6.72e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 9.89e-03 | 4.71e-01 | 4.31e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 8 | 2.14e-02 | 4.70e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 7 | 3.15e-02 | 4.69e-01 | 5.82e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 6 | 4.66e-02 | -4.69e-01 | 6.37e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 4.76e-02 | -4.67e-01 | 6.42e-01 |
| GOBP GLUTAMINE TRANSPORT | 7 | 3.31e-02 | 4.65e-01 | 5.88e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.31e-02 | 4.65e-01 | 5.88e-01 |
| GOCC ZONULA ADHERENS | 6 | 4.85e-02 | 4.65e-01 | 6.48e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 7.76e-03 | 4.64e-01 | 4.17e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 6 | 4.93e-02 | 4.63e-01 | 6.48e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 5 | 7.28e-02 | -4.63e-01 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 8 | 2.34e-02 | -4.63e-01 | 5.39e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 6 | 4.96e-02 | -4.63e-01 | 6.48e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 1.13e-02 | -4.63e-01 | 4.58e-01 |
| GOMF GAMMA CATENIN BINDING | 5 | 7.32e-02 | 4.63e-01 | 6.81e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 9 | 1.63e-02 | 4.62e-01 | 4.93e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 3.42e-02 | 4.62e-01 | 5.88e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 5 | 7.41e-02 | -4.61e-01 | 6.84e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 7 | 3.46e-02 | -4.61e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 8 | 2.40e-02 | -4.61e-01 | 5.39e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 2.41e-02 | -4.60e-01 | 5.39e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 3.52e-02 | -4.60e-01 | 5.92e-01 |
| GOMF TITIN BINDING | 7 | 3.53e-02 | 4.59e-01 | 5.92e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 7 | 3.54e-02 | -4.59e-01 | 5.92e-01 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 5 | 7.59e-02 | 4.58e-01 | 6.87e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 12 | 6.05e-03 | -4.58e-01 | 3.89e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 6 | 5.32e-02 | 4.56e-01 | 6.61e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 5.32e-02 | 4.56e-01 | 6.61e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 2.61e-02 | 4.54e-01 | 5.51e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 19 | 6.22e-04 | -4.54e-01 | 1.40e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 5.53e-02 | -4.52e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 5.54e-02 | 4.52e-01 | 6.62e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 8.06e-02 | 4.51e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 8.07e-02 | -4.51e-01 | 6.95e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 8.07e-02 | 4.51e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 7 | 3.88e-02 | -4.51e-01 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 7 | 3.90e-02 | 4.51e-01 | 6.12e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 8 | 2.74e-02 | 4.50e-01 | 5.55e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 8 | 2.74e-02 | 4.50e-01 | 5.55e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 11 | 1.02e-02 | -4.47e-01 | 4.37e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 8 | 2.86e-02 | 4.47e-01 | 5.64e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 8.41e-02 | 4.46e-01 | 7.03e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 5.84e-02 | -4.46e-01 | 6.64e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 5.86e-02 | -4.46e-01 | 6.64e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 6 | 5.95e-02 | -4.44e-01 | 6.67e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 6 | 6.01e-02 | -4.43e-01 | 6.68e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 5 | 8.67e-02 | -4.42e-01 | 7.11e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 5 | 8.69e-02 | 4.42e-01 | 7.11e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 6.10e-02 | -4.42e-01 | 6.68e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 5 | 8.75e-02 | 4.41e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 9 | 2.20e-02 | 4.41e-01 | 5.33e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 12 | 8.27e-03 | 4.40e-01 | 4.17e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 6 | 6.20e-02 | 4.40e-01 | 6.68e-01 |
| GOCC POLYSOMAL RIBOSOME | 29 | 4.27e-05 | -4.39e-01 | 1.94e-02 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 7 | 4.43e-02 | -4.39e-01 | 6.27e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 8.92e-02 | 4.39e-01 | 7.11e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 10 | 1.62e-02 | -4.39e-01 | 4.93e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 6.34e-02 | -4.38e-01 | 6.70e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 7 | 4.51e-02 | 4.37e-01 | 6.33e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 5 | 9.04e-02 | 4.37e-01 | 7.14e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 12 | 8.84e-03 | 4.37e-01 | 4.19e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 12 | 8.84e-03 | 4.37e-01 | 4.19e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 1.71e-02 | 4.36e-01 | 5.00e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 6.54e-02 | 4.34e-01 | 6.70e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 8 | 3.34e-02 | -4.34e-01 | 5.88e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 1.29e-02 | 4.33e-01 | 4.67e-01 |
| GOBP MAST CELL CHEMOTAXIS | 6 | 6.66e-02 | -4.32e-01 | 6.72e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 7 | 4.81e-02 | 4.31e-01 | 6.48e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 13 | 7.10e-03 | 4.31e-01 | 4.14e-01 |
| GOMF HYALURONIC ACID BINDING | 10 | 1.84e-02 | 4.31e-01 | 5.12e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 2.54e-02 | -4.30e-01 | 5.45e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 6 | 6.82e-02 | -4.30e-01 | 6.72e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 3.53e-02 | -4.30e-01 | 5.92e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 5 | 9.75e-02 | 4.28e-01 | 7.33e-01 |
| GOBP LATE NUCLEOPHAGY | 7 | 5.02e-02 | 4.28e-01 | 6.52e-01 |
| GOBP BONE MARROW DEVELOPMENT | 6 | 6.98e-02 | 4.27e-01 | 6.73e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 6.99e-02 | -4.27e-01 | 6.73e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 9 | 2.67e-02 | 4.27e-01 | 5.54e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 5 | 9.86e-02 | 4.27e-01 | 7.33e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 9.87e-02 | 4.26e-01 | 7.33e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 9 | 2.68e-02 | 4.26e-01 | 5.54e-01 |
| GOBP AUTOCRINE SIGNALING | 5 | 9.88e-02 | 4.26e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 7 | 5.15e-02 | -4.25e-01 | 6.58e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 6 | 7.24e-02 | -4.24e-01 | 6.78e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 6 | 7.35e-02 | 4.22e-01 | 6.81e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 5 | 1.04e-01 | 4.20e-01 | 7.39e-01 |
| GOMF INSULIN BINDING | 5 | 1.04e-01 | 4.20e-01 | 7.39e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 5 | 1.06e-01 | 4.18e-01 | 7.42e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 10 | 2.22e-02 | 4.18e-01 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 9 | 3.01e-02 | -4.18e-01 | 5.71e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 5 | 1.07e-01 | 4.16e-01 | 7.42e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 5.65e-02 | 4.16e-01 | 6.62e-01 |
| GOBP L ALANINE TRANSPORT | 5 | 1.08e-01 | 4.15e-01 | 7.44e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.08e-01 | 4.15e-01 | 7.44e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 5 | 1.09e-01 | -4.14e-01 | 7.47e-01 |
| GOBP PYRUVATE TRANSPORT | 5 | 1.09e-01 | -4.14e-01 | 7.47e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 1.09e-01 | 4.13e-01 | 7.47e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 7.99e-02 | 4.13e-01 | 6.95e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.34e-02 | 4.12e-01 | 6.26e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 5 | 1.11e-01 | -4.12e-01 | 7.49e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 8.14e-02 | 4.11e-01 | 6.95e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.16e-02 | -4.11e-01 | 6.95e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 5 | 1.12e-01 | 4.10e-01 | 7.50e-01 |
| GOCC BBAF COMPLEX | 9 | 3.34e-02 | 4.09e-01 | 5.88e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 5 | 1.13e-01 | -4.09e-01 | 7.51e-01 |
| GOBP KETONE CATABOLIC PROCESS | 9 | 3.40e-02 | -4.08e-01 | 5.88e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 13 | 1.09e-02 | 4.08e-01 | 4.51e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 4.57e-02 | 4.08e-01 | 6.34e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 6.17e-02 | 4.08e-01 | 6.68e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 11 | 1.92e-02 | 4.08e-01 | 5.18e-01 |
| GOMF UBIQUINONE BINDING | 6 | 8.40e-02 | -4.07e-01 | 7.03e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 15 | 6.36e-03 | 4.07e-01 | 3.94e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 6.27e-02 | 4.06e-01 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 14 | 8.51e-03 | 4.06e-01 | 4.17e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 7 | 6.29e-02 | -4.06e-01 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 11 | 1.99e-02 | 4.05e-01 | 5.22e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 7 | 6.34e-02 | 4.05e-01 | 6.70e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 1.17e-01 | 4.05e-01 | 7.52e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 9 | 3.55e-02 | 4.05e-01 | 5.92e-01 |
| GOCC CYTOSOLIC RIBOSOME | 109 | 3.18e-13 | -4.04e-01 | 2.02e-09 |
| GOCC BRAHMA COMPLEX | 12 | 1.54e-02 | 4.04e-01 | 4.79e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 5 | 1.18e-01 | -4.04e-01 | 7.52e-01 |
| GOMF PH DOMAIN BINDING | 7 | 6.47e-02 | 4.03e-01 | 6.70e-01 |
| GOBP RETINA LAYER FORMATION | 7 | 6.51e-02 | -4.03e-01 | 6.70e-01 |
| GOCC DENDRITIC GROWTH CONE | 6 | 8.78e-02 | 4.02e-01 | 7.11e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 2.08e-02 | 4.02e-01 | 5.32e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 7 | 6.54e-02 | 4.02e-01 | 6.70e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 9 | 3.69e-02 | -4.02e-01 | 6.08e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 5 | 1.20e-01 | -4.02e-01 | 7.52e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 4.93e-02 | -4.01e-01 | 6.48e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 18 | 3.20e-03 | 4.01e-01 | 3.12e-01 |
| GOCC PINOSOME | 5 | 1.20e-01 | 4.01e-01 | 7.52e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 6.61e-02 | -4.01e-01 | 6.72e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 18 | 3.32e-03 | -4.00e-01 | 3.16e-01 |
| GOBP SIALYLATION | 5 | 1.22e-01 | -4.00e-01 | 7.53e-01 |
| GOBP GERMINAL CENTER FORMATION | 12 | 1.65e-02 | -4.00e-01 | 4.94e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 5 | 1.22e-01 | 4.00e-01 | 7.54e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 11 | 2.18e-02 | -4.00e-01 | 5.33e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 5 | 1.22e-01 | -3.99e-01 | 7.54e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 6 | 9.07e-02 | 3.99e-01 | 7.14e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 1.23e-01 | 3.98e-01 | 7.55e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 5.85e-03 | -3.98e-01 | 3.86e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 5.15e-02 | 3.98e-01 | 6.58e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.24e-01 | -3.97e-01 | 7.55e-01 |
| GOMF MYOSIN II BINDING | 5 | 1.24e-01 | 3.97e-01 | 7.55e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 8 | 5.19e-02 | 3.97e-01 | 6.60e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 1.24e-01 | -3.97e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 3.96e-02 | -3.96e-01 | 6.15e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 21 | 1.68e-03 | -3.96e-01 | 2.29e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 9.40e-02 | -3.95e-01 | 7.27e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 15 | 8.17e-03 | 3.95e-01 | 4.17e-01 |
| GOBP RENAL FILTRATION | 10 | 3.08e-02 | 3.95e-01 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 1.27e-01 | 3.94e-01 | 7.55e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 13 | 1.38e-02 | 3.94e-01 | 4.68e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 8 | 5.35e-02 | -3.94e-01 | 6.61e-01 |
| GOBP PIRNA PROCESSING | 5 | 1.27e-01 | -3.94e-01 | 7.55e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 6 | 9.46e-02 | -3.94e-01 | 7.27e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 4.09e-02 | -3.94e-01 | 6.17e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 7.15e-02 | 3.93e-01 | 6.78e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 7.16e-02 | 3.93e-01 | 6.78e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 1.28e-01 | 3.93e-01 | 7.56e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 3.96e-03 | -3.92e-01 | 3.31e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 1.29e-01 | 3.92e-01 | 7.57e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 11 | 2.44e-02 | -3.92e-01 | 5.39e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 11 | 2.45e-02 | 3.92e-01 | 5.39e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 5 | 1.30e-01 | 3.91e-01 | 7.57e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 1.48e-02 | -3.91e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 1.30e-01 | -3.91e-01 | 7.57e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 5.59e-02 | 3.90e-01 | 6.62e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 9.80e-02 | 3.90e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 5.62e-02 | -3.90e-01 | 6.62e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 5 | 1.31e-01 | 3.90e-01 | 7.57e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 6 | 9.90e-02 | -3.89e-01 | 7.33e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 4.34e-02 | 3.89e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 9 | 4.39e-02 | 3.88e-01 | 6.27e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 5.75e-02 | 3.88e-01 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 6 | 1.00e-01 | 3.88e-01 | 7.37e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 12 | 2.01e-02 | 3.88e-01 | 5.22e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 11 | 2.62e-02 | -3.87e-01 | 5.51e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 1.01e-01 | -3.87e-01 | 7.38e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 1.34e-01 | 3.87e-01 | 7.62e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 1.22e-02 | -3.87e-01 | 4.63e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 1.35e-01 | 3.86e-01 | 7.62e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 5 | 1.35e-01 | 3.86e-01 | 7.62e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 19 | 3.59e-03 | 3.86e-01 | 3.16e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 1.02e-01 | 3.86e-01 | 7.39e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 7.77e-02 | -3.85e-01 | 6.92e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 1.37e-01 | -3.85e-01 | 7.62e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 10 | 3.53e-02 | 3.84e-01 | 5.92e-01 |
| GOBP REGULATION OF T CELL EXTRAVASATION | 5 | 1.37e-01 | 3.84e-01 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 7.87e-02 | -3.84e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 23 | 1.45e-03 | 3.84e-01 | 2.16e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 1.37e-01 | 3.84e-01 | 7.62e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 1.38e-01 | -3.83e-01 | 7.62e-01 |
| GOCC GRANULAR COMPONENT | 6 | 1.04e-01 | 3.83e-01 | 7.39e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 12 | 2.17e-02 | 3.83e-01 | 5.33e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 5 | 1.39e-01 | 3.82e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 19 | 3.93e-03 | -3.82e-01 | 3.31e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 1.39e-01 | -3.82e-01 | 7.67e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 1.40e-01 | 3.81e-01 | 7.68e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 1.73e-02 | 3.81e-01 | 5.01e-01 |
| GOMF VIRION BINDING | 7 | 8.11e-02 | -3.81e-01 | 6.95e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 6 | 1.07e-01 | -3.80e-01 | 7.42e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 9 | 4.86e-02 | -3.80e-01 | 6.48e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 1.42e-01 | -3.80e-01 | 7.74e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 5 | 1.43e-01 | 3.79e-01 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 3.02e-02 | 3.77e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 6.51e-02 | -3.77e-01 | 6.70e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 13 | 1.88e-02 | -3.76e-01 | 5.14e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 6 | 1.11e-01 | -3.76e-01 | 7.49e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 8 | 6.59e-02 | 3.76e-01 | 6.72e-01 |
| GOMF PROTEOGLYCAN BINDING | 14 | 1.50e-02 | 3.76e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 12 | 2.45e-02 | 3.75e-01 | 5.39e-01 |
| GOMF T CELL RECEPTOR BINDING | 10 | 4.02e-02 | 3.75e-01 | 6.16e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 13 | 1.93e-02 | -3.75e-01 | 5.18e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 5 | 1.47e-01 | 3.75e-01 | 7.81e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 6 | 1.12e-01 | -3.75e-01 | 7.50e-01 |
| GOCC NODE OF RANVIER | 5 | 1.47e-01 | 3.74e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 8 | 6.69e-02 | -3.74e-01 | 6.72e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 7 | 8.67e-02 | 3.74e-01 | 7.11e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 9 | 5.22e-02 | -3.74e-01 | 6.61e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 21 | 3.04e-03 | 3.74e-01 | 3.11e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.14e-01 | 3.73e-01 | 7.52e-01 |
| GOMF GLUCOSE BINDING | 9 | 5.28e-02 | 3.73e-01 | 6.61e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 17 | 7.85e-03 | 3.73e-01 | 4.17e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 6 | 1.14e-01 | -3.72e-01 | 7.52e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 1.49e-01 | 3.72e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 1.50e-01 | -3.72e-01 | 7.89e-01 |
| GOBP RESPONSE TO REDOX STATE | 8 | 6.89e-02 | -3.71e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 8.90e-02 | -3.71e-01 | 7.11e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 9 | 5.39e-02 | 3.71e-01 | 6.62e-01 |
| GOBP RESPONSE TO VITAMIN A | 5 | 1.51e-01 | -3.71e-01 | 7.89e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 12 | 2.62e-02 | 3.71e-01 | 5.51e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 20 | 4.13e-03 | 3.71e-01 | 3.38e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 8.96e-02 | 3.71e-01 | 7.11e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 4.27e-02 | -3.70e-01 | 6.23e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 5.49e-02 | -3.70e-01 | 6.62e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 1.53e-01 | -3.69e-01 | 7.89e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 28 | 7.18e-04 | 3.69e-01 | 1.51e-01 |
| GOMF RDNA BINDING | 9 | 5.50e-02 | 3.69e-01 | 6.62e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 10 | 4.32e-02 | -3.69e-01 | 6.26e-01 |
| GOCC CYTOCHROME COMPLEX | 29 | 5.79e-04 | -3.69e-01 | 1.35e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 17 | 8.41e-03 | -3.69e-01 | 4.17e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 1.17e-01 | -3.69e-01 | 7.52e-01 |
| GOBP LIPID PHOSPHORYLATION | 8 | 7.06e-02 | 3.69e-01 | 6.75e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 8 | 7.06e-02 | 3.69e-01 | 6.75e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 5.56e-02 | 3.69e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 5 | 1.54e-01 | -3.68e-01 | 7.89e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 11 | 3.45e-02 | 3.68e-01 | 5.88e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 10 | 4.41e-02 | -3.68e-01 | 6.27e-01 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 1.55e-01 | -3.68e-01 | 7.89e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 4.42e-02 | -3.67e-01 | 6.27e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 16 | 1.10e-02 | -3.67e-01 | 4.53e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 5.66e-02 | -3.67e-01 | 6.62e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 1.20e-01 | 3.67e-01 | 7.52e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 5 | 1.56e-01 | -3.66e-01 | 7.89e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 7 | 9.35e-02 | -3.66e-01 | 7.25e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.57e-01 | -3.66e-01 | 7.89e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 9 | 5.74e-02 | 3.66e-01 | 6.64e-01 |
| GOBP CYTOLYSIS | 5 | 1.57e-01 | 3.65e-01 | 7.90e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 19 | 5.95e-03 | 3.65e-01 | 3.87e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 14 | 1.83e-02 | -3.64e-01 | 5.11e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 4.62e-02 | -3.64e-01 | 6.34e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 7.48e-02 | -3.64e-01 | 6.85e-01 |
| GOCC POLE PLASM | 12 | 2.92e-02 | -3.64e-01 | 5.69e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 11 | 3.69e-02 | -3.63e-01 | 6.08e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 5 | 1.59e-01 | 3.63e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 1.60e-01 | 3.63e-01 | 7.96e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 7.54e-02 | 3.63e-01 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 1.60e-01 | 3.62e-01 | 7.96e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 19 | 6.32e-03 | 3.62e-01 | 3.94e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 2.39e-02 | -3.62e-01 | 5.39e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 7.65e-02 | 3.62e-01 | 6.87e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 1.62e-01 | -3.61e-01 | 7.98e-01 |
| GOBP FAT PAD DEVELOPMENT | 7 | 9.84e-02 | -3.61e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 5 | 1.63e-01 | -3.61e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 1.28e-01 | -3.59e-01 | 7.55e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 18 | 8.34e-03 | 3.59e-01 | 4.17e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 6.23e-02 | 3.59e-01 | 6.68e-01 |
| GOBP SERINE TRANSPORT | 8 | 7.88e-02 | 3.59e-01 | 6.93e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.88e-02 | 3.59e-01 | 6.93e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.28e-01 | 3.58e-01 | 7.57e-01 |
| GOMF TAT PROTEIN BINDING | 9 | 6.28e-02 | 3.58e-01 | 6.68e-01 |
| GOCC CAVEOLA | 45 | 3.27e-05 | 3.58e-01 | 1.67e-02 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 8 | 7.98e-02 | -3.58e-01 | 6.95e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 11 | 4.00e-02 | -3.58e-01 | 6.15e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 16 | 1.33e-02 | 3.58e-01 | 4.67e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 5 | 1.66e-01 | -3.58e-01 | 8.04e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 5.04e-02 | -3.57e-01 | 6.52e-01 |
| GOBP VITAMIN TRANSPORT | 23 | 3.04e-03 | 3.57e-01 | 3.11e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 1.30e-01 | -3.57e-01 | 7.57e-01 |
| GOCC FLOTILLIN COMPLEX | 7 | 1.02e-01 | 3.57e-01 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 1.67e-01 | -3.57e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 1.67e-01 | -3.57e-01 | 8.04e-01 |
| GOBP AMELOGENESIS | 11 | 4.07e-02 | -3.56e-01 | 6.16e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 6 | 1.31e-01 | 3.56e-01 | 7.57e-01 |
| GOBP DETECTION OF CALCIUM ION | 7 | 1.03e-01 | 3.56e-01 | 7.39e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 8 | 8.11e-02 | -3.56e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 7 | 1.03e-01 | -3.56e-01 | 7.39e-01 |
| GOMF SYNTAXIN 1 BINDING | 11 | 4.10e-02 | 3.56e-01 | 6.18e-01 |
| GOCC AXOLEMMA | 8 | 8.15e-02 | -3.56e-01 | 6.95e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 20 | 5.95e-03 | 3.55e-01 | 3.87e-01 |
| GOBP EATING BEHAVIOR | 13 | 2.68e-02 | -3.55e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 5 | 1.71e-01 | 3.54e-01 | 8.05e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 8 | 8.34e-02 | 3.54e-01 | 7.02e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 33 | 4.43e-04 | 3.53e-01 | 1.17e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 7 | 1.06e-01 | 3.53e-01 | 7.42e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 1.35e-01 | -3.52e-01 | 7.62e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 6 | 1.35e-01 | 3.52e-01 | 7.62e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 8 | 8.46e-02 | 3.52e-01 | 7.03e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 1.36e-01 | 3.52e-01 | 7.62e-01 |
| GOCC TRAMP COMPLEX | 5 | 1.73e-01 | 3.52e-01 | 8.07e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 11 | 4.39e-02 | -3.51e-01 | 6.27e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 1.37e-01 | -3.50e-01 | 7.62e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 8.63e-02 | 3.50e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 1.75e-01 | 3.50e-01 | 8.07e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 5 | 1.75e-01 | -3.50e-01 | 8.07e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 7 | 1.09e-01 | 3.50e-01 | 7.47e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 144 | 4.93e-13 | -3.49e-01 | 2.02e-09 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 8.73e-02 | -3.49e-01 | 7.11e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 9 | 7.00e-02 | 3.49e-01 | 6.73e-01 |
| GOCC AXON INITIAL SEGMENT | 5 | 1.77e-01 | 3.49e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 1.77e-01 | 3.49e-01 | 8.07e-01 |
| GOCC INTEGRIN COMPLEX | 15 | 1.95e-02 | -3.48e-01 | 5.18e-01 |
| GOMF THIOESTERASE BINDING | 9 | 7.05e-02 | -3.48e-01 | 6.75e-01 |
| GOBP GANGLION DEVELOPMENT | 5 | 1.78e-01 | -3.48e-01 | 8.07e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 7 | 1.11e-01 | -3.48e-01 | 7.50e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 8.88e-02 | 3.47e-01 | 7.11e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 8 | 8.90e-02 | -3.47e-01 | 7.11e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 8.90e-02 | -3.47e-01 | 7.11e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 11 | 4.62e-02 | 3.47e-01 | 6.34e-01 |
| GOMF ALPHA ACTININ BINDING | 13 | 3.02e-02 | -3.47e-01 | 5.71e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 9 | 7.17e-02 | 3.47e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 7.18e-02 | 3.47e-01 | 6.78e-01 |
| GOMF GABA RECEPTOR BINDING | 9 | 7.21e-02 | -3.46e-01 | 6.78e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 1.13e-01 | -3.46e-01 | 7.51e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 22 | 4.99e-03 | 3.46e-01 | 3.63e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 30 | 1.05e-03 | -3.46e-01 | 1.74e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 5 | 1.81e-01 | 3.45e-01 | 8.07e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 1.82e-01 | 3.45e-01 | 8.07e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 5 | 1.82e-01 | 3.45e-01 | 8.07e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 16 | 1.72e-02 | 3.44e-01 | 5.00e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 6 | 1.44e-01 | 3.44e-01 | 7.75e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 5.96e-02 | 3.44e-01 | 6.67e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 7 | 1.15e-01 | 3.44e-01 | 7.52e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 5 | 1.83e-01 | -3.44e-01 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 6 | 1.46e-01 | 3.43e-01 | 7.77e-01 |
| GOBP STARTLE RESPONSE | 11 | 4.90e-02 | -3.43e-01 | 6.48e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 38 | 2.61e-04 | -3.42e-01 | 8.91e-02 |
| GOBP HAIR CELL DIFFERENTIATION | 22 | 5.45e-03 | 3.42e-01 | 3.77e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 19 | 9.82e-03 | 3.42e-01 | 4.30e-01 |
| GOMF PHOSPHATE ION BINDING | 7 | 1.17e-01 | 3.42e-01 | 7.52e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 8 | 9.39e-02 | 3.42e-01 | 7.27e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 16 | 1.79e-02 | -3.42e-01 | 5.05e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 9.41e-02 | -3.42e-01 | 7.27e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 12 | 4.04e-02 | 3.42e-01 | 6.16e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 8 | 9.43e-02 | 3.42e-01 | 7.27e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 9.46e-02 | -3.41e-01 | 7.27e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 9 | 7.65e-02 | 3.41e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 1.88e-01 | -3.40e-01 | 8.14e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 7 | 1.19e-01 | 3.40e-01 | 7.52e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 8 | 9.60e-02 | -3.40e-01 | 7.30e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 15 | 2.29e-02 | 3.39e-01 | 5.38e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 9 | 7.81e-02 | -3.39e-01 | 6.92e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 11 | 5.16e-02 | 3.39e-01 | 6.58e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 10 | 6.36e-02 | 3.39e-01 | 6.70e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 3.37e-03 | 3.39e-01 | 3.16e-01 |
| GOMF CERAMIDE BINDING | 12 | 4.25e-02 | -3.38e-01 | 6.23e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 9.77e-02 | -3.38e-01 | 7.33e-01 |
| GOBP LYMPHOCYTE ANERGY | 6 | 1.51e-01 | 3.38e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 12 | 4.26e-02 | 3.38e-01 | 6.23e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 8 | 9.80e-02 | 3.38e-01 | 7.33e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 12 | 4.27e-02 | 3.38e-01 | 6.23e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 6 | 1.52e-01 | 3.38e-01 | 7.89e-01 |
| GOCC B WICH COMPLEX | 7 | 1.22e-01 | 3.37e-01 | 7.54e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 6 | 1.53e-01 | 3.37e-01 | 7.89e-01 |
| GOMF DYNACTIN BINDING | 10 | 6.52e-02 | 3.37e-01 | 6.70e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 8.03e-02 | 3.37e-01 | 6.95e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 9 | 8.03e-02 | -3.37e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 1.93e-01 | -3.36e-01 | 8.17e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 1.93e-01 | -3.36e-01 | 8.17e-01 |
| GOBP SULFATION | 8 | 9.99e-02 | 3.36e-01 | 7.36e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 1.93e-01 | -3.36e-01 | 8.17e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 6 | 1.54e-01 | 3.36e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 7 | 1.24e-01 | 3.36e-01 | 7.55e-01 |
| GOBP DETECTION OF BACTERIUM | 12 | 4.42e-02 | 3.36e-01 | 6.27e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 5 | 1.94e-01 | 3.35e-01 | 8.18e-01 |
| GOBP PREPULSE INHIBITION | 7 | 1.25e-01 | -3.35e-01 | 7.55e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 1.56e-01 | 3.34e-01 | 7.89e-01 |
| GOBP HYPERSENSITIVITY | 11 | 5.49e-02 | 3.34e-01 | 6.62e-01 |
| GOBP PRENYLATION | 9 | 8.26e-02 | -3.34e-01 | 6.99e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 8 | 1.02e-01 | -3.34e-01 | 7.39e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 19 | 1.18e-02 | 3.34e-01 | 4.62e-01 |
| GOCC RIPOPTOSOME | 6 | 1.57e-01 | -3.34e-01 | 7.89e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 1.57e-01 | 3.34e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 8 | 1.03e-01 | 3.33e-01 | 7.39e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 18 | 1.45e-02 | -3.33e-01 | 4.75e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 3.77e-02 | -3.33e-01 | 6.11e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 10 | 6.86e-02 | 3.33e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 26 | 3.36e-03 | -3.32e-01 | 3.16e-01 |
| GOBP ENAMEL MINERALIZATION | 9 | 8.43e-02 | -3.32e-01 | 7.03e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 10 | 6.89e-02 | -3.32e-01 | 6.73e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 1.99e-01 | -3.32e-01 | 8.24e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 6 | 1.60e-01 | 3.32e-01 | 7.96e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 2.00e-01 | 3.31e-01 | 8.25e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.55e-02 | 3.31e-01 | 7.09e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 1.60e-01 | 3.31e-01 | 7.96e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 1.60e-01 | 3.31e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 15 | 2.67e-02 | -3.31e-01 | 5.54e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 5 | 2.01e-01 | -3.30e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 11 | 5.83e-02 | -3.30e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 7 | 1.31e-01 | 3.30e-01 | 7.57e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 13 | 3.99e-02 | -3.29e-01 | 6.15e-01 |
| GOBP GLUTATHIONE TRANSPORT | 5 | 2.03e-01 | 3.29e-01 | 8.28e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 5 | 2.03e-01 | -3.29e-01 | 8.28e-01 |
| GOBP BONE MORPHOGENESIS | 35 | 7.59e-04 | 3.29e-01 | 1.55e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 6 | 1.63e-01 | -3.29e-01 | 8.00e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 1.07e-01 | 3.29e-01 | 7.42e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 11 | 5.90e-02 | 3.29e-01 | 6.65e-01 |
| GOBP INNER EAR MORPHOGENESIS | 27 | 3.12e-03 | 3.29e-01 | 3.12e-01 |
| GOBP PEXOPHAGY | 6 | 1.63e-01 | -3.29e-01 | 8.00e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 14 | 3.35e-02 | -3.28e-01 | 5.88e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 5 | 2.04e-01 | -3.28e-01 | 8.28e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 7.24e-02 | 3.28e-01 | 6.78e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 8.88e-02 | -3.28e-01 | 7.11e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 7.29e-02 | 3.28e-01 | 6.80e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 1.33e-01 | 3.28e-01 | 7.62e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 18 | 1.62e-02 | 3.27e-01 | 4.93e-01 |
| GOMF POLY G BINDING | 8 | 1.09e-01 | -3.27e-01 | 7.47e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.65e-01 | 3.27e-01 | 8.03e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 13 | 4.15e-02 | 3.27e-01 | 6.20e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 5 | 2.06e-01 | 3.27e-01 | 8.28e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 9 | 9.05e-02 | -3.26e-01 | 7.14e-01 |
| GOBP SYNAPSE PRUNING | 9 | 9.05e-02 | 3.26e-01 | 7.14e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.49e-02 | 3.26e-01 | 5.91e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 10 | 7.46e-02 | 3.26e-01 | 6.85e-01 |
| GOBP NODAL SIGNALING PATHWAY | 7 | 1.36e-01 | -3.25e-01 | 7.62e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 4.22e-02 | 3.25e-01 | 6.23e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 11 | 6.19e-02 | 3.25e-01 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 10 | 7.51e-02 | 3.25e-01 | 6.85e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 1.36e-01 | 3.25e-01 | 7.62e-01 |
| GOMF ACTININ BINDING | 16 | 2.45e-02 | -3.25e-01 | 5.39e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 7 | 1.37e-01 | -3.25e-01 | 7.62e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 1.43e-02 | -3.25e-01 | 4.75e-01 |
| GOBP CHORION DEVELOPMENT | 5 | 2.09e-01 | 3.24e-01 | 8.30e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 2.09e-01 | -3.24e-01 | 8.30e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 6 | 1.69e-01 | -3.24e-01 | 8.04e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 9 | 9.19e-02 | -3.24e-01 | 7.17e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 2.09e-01 | 3.24e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 1.69e-01 | 3.24e-01 | 8.04e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 1.12e-01 | 3.24e-01 | 7.50e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 1.69e-01 | -3.24e-01 | 8.04e-01 |
| GOBP NK T CELL ACTIVATION | 9 | 9.24e-02 | 3.24e-01 | 7.19e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 10 | 7.61e-02 | 3.24e-01 | 6.87e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 6 | 1.70e-01 | -3.24e-01 | 8.04e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 6.29e-02 | -3.24e-01 | 6.68e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 16 | 2.49e-02 | 3.24e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 2.10e-01 | 3.24e-01 | 8.32e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 2.11e-01 | 3.23e-01 | 8.32e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 2.11e-01 | 3.23e-01 | 8.32e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 6 | 1.70e-01 | 3.23e-01 | 8.04e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 5 | 2.11e-01 | 3.23e-01 | 8.32e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 8 | 1.14e-01 | 3.23e-01 | 7.52e-01 |
| GOMF SPHINGOLIPID BINDING | 17 | 2.12e-02 | -3.23e-01 | 5.33e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 5 | 2.11e-01 | 3.23e-01 | 8.32e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 6 | 1.71e-01 | -3.23e-01 | 8.05e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 5 | 2.12e-01 | 3.23e-01 | 8.32e-01 |
| GOBP CD40 SIGNALING PATHWAY | 12 | 5.31e-02 | -3.23e-01 | 6.61e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 6 | 1.71e-01 | -3.22e-01 | 8.05e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 6 | 1.71e-01 | -3.22e-01 | 8.05e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 2.12e-01 | -3.22e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 13 | 4.42e-02 | -3.22e-01 | 6.27e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 19 | 1.51e-02 | 3.22e-01 | 4.75e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 1.72e-01 | -3.22e-01 | 8.07e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 11 | 6.51e-02 | 3.21e-01 | 6.70e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 2.14e-01 | 3.21e-01 | 8.32e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 1.74e-01 | 3.21e-01 | 8.07e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 5 | 2.14e-01 | 3.21e-01 | 8.32e-01 |
| GOBP HEART TRABECULA FORMATION | 5 | 2.15e-01 | -3.20e-01 | 8.32e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 1.74e-01 | -3.20e-01 | 8.07e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 16 | 2.66e-02 | -3.20e-01 | 5.54e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 5 | 2.15e-01 | 3.20e-01 | 8.32e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 5 | 2.15e-01 | 3.20e-01 | 8.32e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 7 | 1.43e-01 | -3.20e-01 | 7.75e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 7 | 1.44e-01 | 3.19e-01 | 7.75e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 3.88e-02 | 3.19e-01 | 6.12e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 7 | 1.44e-01 | -3.19e-01 | 7.75e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 1.18e-01 | 3.19e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 8 | 1.19e-01 | -3.18e-01 | 7.52e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 1.77e-01 | 3.18e-01 | 8.07e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 5 | 2.18e-01 | 3.18e-01 | 8.32e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 8.16e-02 | -3.18e-01 | 6.95e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 2.18e-01 | 3.18e-01 | 8.32e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 1.77e-01 | -3.18e-01 | 8.07e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 1.20e-01 | 3.18e-01 | 7.52e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 21 | 1.17e-02 | 3.18e-01 | 4.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.78e-01 | 3.17e-01 | 8.07e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 8 | 1.20e-01 | 3.17e-01 | 7.52e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 6.84e-02 | 3.17e-01 | 6.72e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 11 | 6.84e-02 | 3.17e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 2.19e-01 | -3.17e-01 | 8.32e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 8 | 1.20e-01 | -3.17e-01 | 7.52e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 1.20e-01 | 3.17e-01 | 7.52e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 6 | 1.79e-01 | 3.17e-01 | 8.07e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 6 | 1.79e-01 | 3.17e-01 | 8.07e-01 |
| GOBP RRNA METHYLATION | 21 | 1.20e-02 | 3.17e-01 | 4.62e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 1.00e-01 | 3.16e-01 | 7.38e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 6.95e-02 | 3.16e-01 | 6.73e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 8 | 1.22e-01 | -3.16e-01 | 7.54e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 1.81e-01 | -3.15e-01 | 8.07e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 1.81e-01 | -3.15e-01 | 8.07e-01 |
| GOBP WALKING BEHAVIOR | 18 | 2.07e-02 | -3.15e-01 | 5.31e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 8.47e-02 | -3.15e-01 | 7.03e-01 |
| GOBP TAURINE TRANSPORT | 6 | 1.82e-01 | -3.15e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 7 | 1.49e-01 | 3.15e-01 | 7.89e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 16 | 2.94e-02 | 3.15e-01 | 5.70e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 2.24e-01 | 3.14e-01 | 8.32e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 6 | 1.83e-01 | 3.14e-01 | 8.09e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 1.51e-01 | -3.13e-01 | 7.89e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 6 | 1.84e-01 | 3.13e-01 | 8.10e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.84e-01 | -3.13e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 12 | 6.09e-02 | -3.13e-01 | 6.68e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 21 | 1.32e-02 | -3.13e-01 | 4.67e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 5 | 2.26e-01 | 3.12e-01 | 8.32e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 8 | 1.26e-01 | 3.12e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 6 | 1.85e-01 | -3.12e-01 | 8.11e-01 |
| GOBP DOPAMINE SECRETION | 12 | 6.19e-02 | 3.11e-01 | 6.68e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 10 | 8.85e-02 | 3.11e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 17 | 2.64e-02 | -3.11e-01 | 5.53e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 8 | 1.28e-01 | -3.11e-01 | 7.55e-01 |
| GOMF COMPLEMENT BINDING | 8 | 1.28e-01 | 3.11e-01 | 7.55e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 9 | 1.06e-01 | 3.11e-01 | 7.42e-01 |
| GOCC MEIOTIC SPINDLE | 8 | 1.28e-01 | 3.11e-01 | 7.56e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 6.26e-02 | 3.10e-01 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 9 | 1.07e-01 | 3.10e-01 | 7.42e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 5 | 2.30e-01 | -3.10e-01 | 8.35e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 11 | 7.50e-02 | -3.10e-01 | 6.85e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 13 | 5.32e-02 | -3.10e-01 | 6.61e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.30e-01 | 3.09e-01 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 16 | 3.26e-02 | 3.09e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 2.32e-01 | -3.09e-01 | 8.37e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 1.10e-01 | 3.08e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 5 | 2.33e-01 | -3.08e-01 | 8.37e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 1.58e-01 | 3.08e-01 | 7.93e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 6 | 1.92e-01 | -3.08e-01 | 8.17e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 1.32e-01 | -3.08e-01 | 7.57e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 7.73e-02 | -3.08e-01 | 6.92e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 20 | 1.73e-02 | 3.08e-01 | 5.01e-01 |
| GOBP UV PROTECTION | 8 | 1.32e-01 | 3.08e-01 | 7.57e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 8 | 1.32e-01 | 3.07e-01 | 7.57e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 15 | 3.96e-02 | 3.07e-01 | 6.15e-01 |
| GOMF NARROW PORE CHANNEL ACTIVITY | 5 | 2.35e-01 | 3.07e-01 | 8.39e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 1.93e-01 | -3.07e-01 | 8.17e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 9 | 1.12e-01 | 3.06e-01 | 7.50e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 2.36e-01 | 3.06e-01 | 8.40e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 12 | 6.63e-02 | 3.06e-01 | 6.72e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 11 | 7.88e-02 | 3.06e-01 | 6.93e-01 |
| GOBP PROLINE TRANSPORT | 6 | 1.95e-01 | 3.06e-01 | 8.19e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 5 | 2.37e-01 | -3.05e-01 | 8.40e-01 |
| GOCC LAMELLAR BODY | 5 | 2.37e-01 | -3.05e-01 | 8.40e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 6.71e-02 | 3.05e-01 | 6.72e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 18 | 2.49e-02 | 3.05e-01 | 5.41e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 13 | 5.70e-02 | 3.05e-01 | 6.64e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 2.38e-01 | -3.05e-01 | 8.42e-01 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 2.38e-01 | 3.04e-01 | 8.42e-01 |
| GOBP LONG TERM MEMORY | 18 | 2.55e-02 | -3.04e-01 | 5.46e-01 |
| GOBP SELF PROTEOLYSIS | 8 | 1.36e-01 | 3.04e-01 | 7.62e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 19 | 2.18e-02 | -3.04e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 21 | 1.59e-02 | 3.04e-01 | 4.86e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 1.14e-01 | 3.04e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 13 | 5.81e-02 | -3.04e-01 | 6.64e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.98e-01 | 3.04e-01 | 8.23e-01 |
| GOBP FAT CELL PROLIFERATION | 9 | 1.15e-01 | -3.03e-01 | 7.52e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 11 | 8.15e-02 | 3.03e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 11 | 8.15e-02 | -3.03e-01 | 6.95e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 2.40e-01 | 3.03e-01 | 8.43e-01 |
| GOBP MYOBLAST MIGRATION | 7 | 1.65e-01 | -3.03e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 1.15e-01 | -3.03e-01 | 7.52e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 6.98e-02 | 3.02e-01 | 6.73e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 2.42e-01 | 3.02e-01 | 8.43e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 1.39e-01 | -3.02e-01 | 7.66e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 23 | 1.22e-02 | -3.02e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 12 | 7.02e-02 | 3.02e-01 | 6.74e-01 |
| GOBP RESPONSE TO HYPEROXIA | 13 | 5.96e-02 | -3.02e-01 | 6.67e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 9 | 1.17e-01 | 3.01e-01 | 7.52e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 9.89e-02 | 3.01e-01 | 7.33e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 6 | 2.01e-01 | -3.01e-01 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 6 | 2.01e-01 | -3.01e-01 | 8.27e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 1.68e-01 | 3.01e-01 | 8.04e-01 |
| GOBP ANIMAL ORGAN FORMATION | 21 | 1.71e-02 | 3.01e-01 | 5.00e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 2.02e-01 | 3.01e-01 | 8.28e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 5 | 2.44e-01 | 3.01e-01 | 8.48e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 2.02e-01 | 3.01e-01 | 8.28e-01 |
| GOCC UNIPLEX COMPLEX | 5 | 2.45e-01 | 3.00e-01 | 8.49e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 2.03e-01 | -3.00e-01 | 8.28e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 20 | 2.01e-02 | 3.00e-01 | 5.22e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 6 | 2.03e-01 | -3.00e-01 | 8.28e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 1.69e-01 | 3.00e-01 | 8.04e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 6 | 2.04e-01 | 3.00e-01 | 8.28e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 26 | 8.25e-03 | 2.99e-01 | 4.17e-01 |
| GOBP MAMMARY GLAND INVOLUTION | 5 | 2.46e-01 | 2.99e-01 | 8.49e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 5 | 2.46e-01 | 2.99e-01 | 8.49e-01 |
| GOBP MAST CELL MIGRATION | 8 | 1.43e-01 | -2.99e-01 | 7.75e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 6 | 2.05e-01 | -2.99e-01 | 8.28e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 2.47e-01 | -2.99e-01 | 8.49e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 13 | 6.23e-02 | 2.99e-01 | 6.68e-01 |
| GOMF BUBBLE DNA BINDING | 6 | 2.05e-01 | -2.99e-01 | 8.28e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 14 | 5.31e-02 | -2.99e-01 | 6.61e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 2.48e-01 | 2.98e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 11 | 8.69e-02 | 2.98e-01 | 7.11e-01 |
| GOCC PARASPECKLES | 8 | 1.44e-01 | -2.98e-01 | 7.75e-01 |
| GOCC NBAF COMPLEX | 13 | 6.30e-02 | 2.98e-01 | 6.68e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 2.07e-01 | 2.97e-01 | 8.29e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 5 | 2.50e-01 | -2.97e-01 | 8.50e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 12 | 7.48e-02 | -2.97e-01 | 6.85e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 6 | 2.08e-01 | -2.97e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 1.05e-01 | 2.96e-01 | 7.39e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 11 | 8.95e-02 | 2.96e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 5 | 2.52e-01 | 2.96e-01 | 8.50e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 9 | 1.25e-01 | 2.95e-01 | 7.55e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 1.06e-01 | 2.95e-01 | 7.42e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 11 | 9.02e-02 | 2.95e-01 | 7.14e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 5 | 2.53e-01 | 2.95e-01 | 8.50e-01 |
| GOBP DNA PROTECTION | 5 | 2.54e-01 | 2.95e-01 | 8.50e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 10 | 1.07e-01 | -2.95e-01 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 7 | 1.78e-01 | -2.94e-01 | 8.07e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 8 | 1.50e-01 | -2.94e-01 | 7.89e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 2.59e-10 | -2.94e-01 | 5.29e-07 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 5 | 2.56e-01 | -2.93e-01 | 8.50e-01 |
| GOBP RESPONSE TO GLUCAGON | 8 | 1.51e-01 | -2.93e-01 | 7.89e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 2.57e-01 | -2.93e-01 | 8.50e-01 |
| GOBP ADP TRANSPORT | 8 | 1.52e-01 | -2.93e-01 | 7.89e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 18 | 3.18e-02 | -2.92e-01 | 5.82e-01 |
| GOMF SPECTRIN BINDING | 14 | 5.84e-02 | 2.92e-01 | 6.64e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 15 | 5.02e-02 | 2.92e-01 | 6.52e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 9.35e-02 | 2.92e-01 | 7.25e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 2.16e-01 | 2.92e-01 | 8.32e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 2.16e-01 | 2.92e-01 | 8.32e-01 |
| GOBP GLUTAMATE SECRETION | 14 | 5.88e-02 | 2.92e-01 | 6.64e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 32 | 4.35e-03 | 2.91e-01 | 3.42e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 8 | 1.54e-01 | -2.91e-01 | 7.89e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 8 | 1.54e-01 | -2.91e-01 | 7.89e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 9 | 1.31e-01 | -2.91e-01 | 7.57e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 7 | 1.83e-01 | 2.91e-01 | 8.07e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 9.51e-02 | 2.91e-01 | 7.30e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 17 | 3.81e-02 | -2.91e-01 | 6.11e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 24 | 1.37e-02 | -2.91e-01 | 4.68e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 25 | 1.20e-02 | 2.90e-01 | 4.62e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 29 | 6.83e-03 | 2.90e-01 | 4.08e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 11 | 9.56e-02 | 2.90e-01 | 7.30e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 2.61e-01 | -2.90e-01 | 8.51e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 8 | 1.56e-01 | 2.90e-01 | 7.89e-01 |
| GOBP RESPONSE TO SALT STRESS | 15 | 5.20e-02 | 2.90e-01 | 6.60e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 6 | 2.19e-01 | -2.90e-01 | 8.32e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 2.62e-01 | 2.90e-01 | 8.51e-01 |
| GOBP MONOCYTE ACTIVATION | 7 | 1.85e-01 | 2.89e-01 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 6 | 2.20e-01 | 2.89e-01 | 8.32e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 7 | 1.85e-01 | -2.89e-01 | 8.11e-01 |
| GOBP RESPONSE TO FORSKOLIN | 5 | 2.63e-01 | -2.89e-01 | 8.52e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 1.33e-01 | -2.89e-01 | 7.62e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 2.20e-02 | 2.89e-01 | 5.33e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 19 | 2.96e-02 | 2.88e-01 | 5.71e-01 |
| GOBP CONVERGENT EXTENSION | 6 | 2.22e-01 | 2.88e-01 | 8.32e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 12 | 8.40e-02 | 2.88e-01 | 7.03e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 13 | 7.23e-02 | 2.88e-01 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 13 | 7.24e-02 | -2.88e-01 | 6.78e-01 |
| GOBP PROTEIN TRIMERIZATION | 12 | 8.44e-02 | 2.88e-01 | 7.03e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 2.65e-01 | 2.88e-01 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 22 | 1.96e-02 | -2.88e-01 | 5.19e-01 |
| GOBP NK T CELL PROLIFERATION | 7 | 1.88e-01 | 2.88e-01 | 8.14e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 1.54e-07 | -2.87e-01 | 1.94e-04 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 1.16e-01 | -2.87e-01 | 7.52e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 2.23e-01 | -2.87e-01 | 8.32e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 1.88e-01 | -2.87e-01 | 8.14e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 9 | 1.36e-01 | 2.87e-01 | 7.62e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 7 | 1.89e-01 | -2.87e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 13 | 7.32e-02 | 2.87e-01 | 6.81e-01 |
| GOBP NUCLEOBASE TRANSPORT | 6 | 2.24e-01 | -2.87e-01 | 8.32e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 8 | 1.60e-01 | 2.87e-01 | 7.96e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 22 | 1.99e-02 | 2.87e-01 | 5.22e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 7 | 1.89e-01 | -2.87e-01 | 8.14e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 8 | 1.61e-01 | 2.87e-01 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 8 | 1.61e-01 | -2.86e-01 | 7.96e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 1.90e-01 | 2.86e-01 | 8.14e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 2.68e-01 | -2.86e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 10 | 1.17e-01 | 2.86e-01 | 7.52e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 5 | 2.68e-01 | -2.86e-01 | 8.56e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 6 | 2.25e-01 | 2.86e-01 | 8.32e-01 |
| GOBP NK T CELL DIFFERENTIATION | 10 | 1.18e-01 | 2.86e-01 | 7.52e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 15 | 5.54e-02 | 2.86e-01 | 6.62e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 6 | 2.26e-01 | -2.86e-01 | 8.32e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 1.62e-01 | 2.86e-01 | 7.97e-01 |
| GOBP COCHLEA DEVELOPMENT | 12 | 8.67e-02 | 2.86e-01 | 7.11e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 1.91e-01 | -2.86e-01 | 8.16e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 8.70e-02 | -2.85e-01 | 7.11e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 7 | 1.91e-01 | 2.85e-01 | 8.17e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 2.70e-01 | -2.85e-01 | 8.58e-01 |
| GOMF C C CHEMOKINE BINDING | 8 | 1.63e-01 | 2.85e-01 | 8.00e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 2.27e-01 | 2.85e-01 | 8.33e-01 |
| GOCC POLYSOME | 61 | 1.20e-04 | -2.85e-01 | 4.93e-02 |
| GOBP GROWTH HORMONE SECRETION | 8 | 1.63e-01 | -2.85e-01 | 8.00e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 1.63e-01 | -2.85e-01 | 8.00e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 20 | 2.76e-02 | 2.85e-01 | 5.56e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 21 | 2.40e-02 | -2.85e-01 | 5.39e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 6 | 2.28e-01 | 2.84e-01 | 8.34e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 14 | 6.58e-02 | -2.84e-01 | 6.72e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 1.94e-01 | -2.84e-01 | 8.17e-01 |
| GOBP NEGATIVE T CELL SELECTION | 8 | 1.65e-01 | 2.84e-01 | 8.02e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 10 | 1.21e-01 | 2.83e-01 | 7.52e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 7 | 1.94e-01 | 2.83e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 11 | 1.04e-01 | -2.83e-01 | 7.39e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 11 | 1.04e-01 | 2.83e-01 | 7.39e-01 |
| GOBP REPLICATIVE SENESCENCE | 11 | 1.04e-01 | 2.83e-01 | 7.39e-01 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 2.74e-01 | 2.83e-01 | 8.58e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 2.74e-01 | -2.83e-01 | 8.58e-01 |
| GOBP IRIS MORPHOGENESIS | 5 | 2.74e-01 | -2.83e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 2.74e-01 | 2.83e-01 | 8.58e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 6.74e-02 | -2.82e-01 | 6.72e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 39 | 2.29e-03 | -2.82e-01 | 2.68e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 10 | 1.23e-01 | 2.82e-01 | 7.55e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 9 | 1.43e-01 | -2.82e-01 | 7.75e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 2.32e-01 | -2.82e-01 | 8.37e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 2.33e-01 | -2.81e-01 | 8.37e-01 |
| GOCC CATSPER COMPLEX | 5 | 2.76e-01 | 2.81e-01 | 8.60e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 2.33e-01 | 2.81e-01 | 8.37e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 25 | 1.50e-02 | 2.81e-01 | 4.75e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 9 | 1.44e-01 | -2.81e-01 | 7.75e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 2.77e-01 | 2.81e-01 | 8.60e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 2.34e-01 | 2.81e-01 | 8.37e-01 |
| GOBP FIBROBLAST ACTIVATION | 9 | 1.45e-01 | 2.81e-01 | 7.76e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 14 | 6.93e-02 | -2.80e-01 | 6.73e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 4.54e-02 | -2.80e-01 | 6.34e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 1.70e-01 | 2.80e-01 | 8.04e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 2.36e-01 | -2.80e-01 | 8.40e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 11 | 1.09e-01 | -2.79e-01 | 7.47e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 6 | 2.37e-01 | -2.79e-01 | 8.40e-01 |
| GOCC FILOPODIUM MEMBRANE | 10 | 1.27e-01 | 2.79e-01 | 7.55e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 13 | 8.18e-02 | -2.79e-01 | 6.95e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 2.81e-01 | -2.78e-01 | 8.63e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 2.38e-01 | 2.78e-01 | 8.42e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 5 | 2.81e-01 | -2.78e-01 | 8.64e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 1.11e-01 | 2.78e-01 | 7.49e-01 |
| GOCC BRISC COMPLEX | 6 | 2.39e-01 | -2.78e-01 | 8.42e-01 |
| GOBP EOSINOPHIL ACTIVATION | 8 | 1.74e-01 | 2.78e-01 | 8.07e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 5 | 2.83e-01 | 2.77e-01 | 8.66e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 5 | 2.83e-01 | -2.77e-01 | 8.66e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 7 | 2.04e-01 | 2.77e-01 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 16 | 5.49e-02 | -2.77e-01 | 6.62e-01 |
| GOCC U7 SNRNP | 7 | 2.04e-01 | 2.77e-01 | 8.28e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 2.83e-01 | 2.77e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.75e-01 | 2.77e-01 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 2.84e-01 | -2.77e-01 | 8.66e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 2.05e-01 | 2.77e-01 | 8.28e-01 |
| GOBP HISTONE UBIQUITINATION | 9 | 1.51e-01 | -2.76e-01 | 7.89e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 6 | 2.41e-01 | 2.76e-01 | 8.43e-01 |
| GOCC CYTOLYTIC GRANULE | 13 | 8.47e-02 | -2.76e-01 | 7.03e-01 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 2.85e-01 | 2.76e-01 | 8.67e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 6 | 2.42e-01 | -2.76e-01 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 10 | 1.31e-01 | 2.76e-01 | 7.57e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 9 | 1.52e-01 | 2.76e-01 | 7.89e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 21 | 2.86e-02 | -2.76e-01 | 5.64e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 2.06e-01 | 2.76e-01 | 8.29e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 7 | 2.06e-01 | 2.76e-01 | 8.29e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 5 | 2.86e-01 | 2.76e-01 | 8.67e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 5 | 2.86e-01 | -2.76e-01 | 8.67e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 19 | 3.76e-02 | 2.76e-01 | 6.11e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 8 | 1.77e-01 | 2.75e-01 | 8.07e-01 |
| GOBP SYNAPSE MATURATION | 15 | 6.48e-02 | 2.75e-01 | 6.70e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 5.66e-02 | 2.75e-01 | 6.62e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 18 | 4.32e-02 | 2.75e-01 | 6.26e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 6 | 2.44e-01 | 2.75e-01 | 8.47e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 14 | 7.55e-02 | 2.74e-01 | 6.85e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 7 | 2.09e-01 | -2.74e-01 | 8.30e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 31 | 8.32e-03 | -2.74e-01 | 4.17e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.89e-01 | -2.74e-01 | 8.69e-01 |
| GOCC BLOC 1 COMPLEX | 8 | 1.80e-01 | 2.74e-01 | 8.07e-01 |
| GOCC NPBAF COMPLEX | 14 | 7.64e-02 | 2.74e-01 | 6.87e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 2.46e-01 | 2.74e-01 | 8.49e-01 |
| GOMF FMN BINDING | 9 | 1.55e-01 | -2.73e-01 | 7.89e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 2.46e-01 | 2.73e-01 | 8.49e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 2.90e-01 | 2.73e-01 | 8.69e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 8 | 1.81e-01 | 2.73e-01 | 8.07e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 1.57e-01 | 2.73e-01 | 7.89e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 7 | 2.12e-01 | 2.72e-01 | 8.32e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 13 | 8.92e-02 | 2.72e-01 | 7.11e-01 |
| GOMF CARDIOLIPIN BINDING | 6 | 2.48e-01 | 2.72e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 16 | 5.97e-02 | -2.72e-01 | 6.67e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 15 | 6.83e-02 | -2.72e-01 | 6.72e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 11 | 1.19e-01 | 2.72e-01 | 7.52e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 19 | 4.04e-02 | 2.72e-01 | 6.16e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 2.49e-01 | -2.72e-01 | 8.50e-01 |
| GOBP MICROTUBULE ANCHORING | 19 | 4.06e-02 | 2.71e-01 | 6.16e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 7 | 2.14e-01 | 2.71e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 11 | 1.20e-01 | -2.71e-01 | 7.52e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 1.21e-01 | 2.70e-01 | 7.52e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 8 | 1.86e-01 | -2.70e-01 | 8.11e-01 |
| GOCC AXONAL GROWTH CONE | 16 | 6.14e-02 | 2.70e-01 | 6.68e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 2.50e-02 | -2.70e-01 | 5.41e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 8 | 1.86e-01 | -2.70e-01 | 8.12e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 42 | 2.48e-03 | 2.70e-01 | 2.82e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 6 | 2.52e-01 | -2.70e-01 | 8.50e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 2.53e-01 | 2.70e-01 | 8.50e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 22 | 2.88e-02 | 2.69e-01 | 5.65e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 16 | 6.22e-02 | 2.69e-01 | 6.68e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 8 | 1.87e-01 | 2.69e-01 | 8.14e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 8 | 1.87e-01 | 2.69e-01 | 8.14e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 6 | 2.54e-01 | -2.69e-01 | 8.50e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 2.54e-01 | -2.69e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 6 | 2.54e-01 | 2.69e-01 | 8.50e-01 |
| GOMF CAMP BINDING | 11 | 1.23e-01 | 2.69e-01 | 7.55e-01 |
| GOCC PHAGOLYSOSOME | 5 | 2.98e-01 | 2.69e-01 | 8.71e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 1.23e-01 | 2.69e-01 | 7.55e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 6 | 2.55e-01 | 2.69e-01 | 8.50e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 2.99e-01 | 2.68e-01 | 8.72e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 14 | 8.21e-02 | -2.68e-01 | 6.96e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 2.55e-01 | 2.68e-01 | 8.50e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 7 | 2.19e-01 | -2.68e-01 | 8.32e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 7 | 2.19e-01 | 2.68e-01 | 8.32e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 7 | 2.19e-01 | 2.68e-01 | 8.32e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 2.19e-01 | -2.68e-01 | 8.32e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 16 | 6.35e-02 | 2.68e-01 | 6.70e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 1.24e-01 | -2.68e-01 | 7.55e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 10 | 1.43e-01 | -2.68e-01 | 7.75e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 3.00e-01 | -2.68e-01 | 8.73e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 16 | 6.39e-02 | 2.68e-01 | 6.70e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 9 | 1.65e-01 | -2.68e-01 | 8.02e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 1.90e-01 | -2.67e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 2.57e-01 | 2.67e-01 | 8.50e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 6 | 2.57e-01 | -2.67e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 17 | 5.66e-02 | -2.67e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 16 | 6.45e-02 | 2.67e-01 | 6.70e-01 |
| GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 3.02e-01 | -2.67e-01 | 8.74e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 55 | 6.31e-04 | -2.67e-01 | 1.40e-01 |
| GOBP DNA INTEGRATION | 6 | 2.58e-01 | 2.67e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 7 | 2.22e-01 | -2.67e-01 | 8.32e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 40 | 3.55e-03 | 2.67e-01 | 3.16e-01 |
| GOCC TOR COMPLEX | 11 | 1.26e-01 | 2.66e-01 | 7.55e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 36 | 5.69e-03 | -2.66e-01 | 3.86e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 2.58e-01 | -2.66e-01 | 8.50e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 19 | 4.45e-02 | 2.66e-01 | 6.30e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 2.24e-01 | -2.65e-01 | 8.32e-01 |
| GOMF LNCRNA BINDING | 11 | 1.28e-01 | -2.65e-01 | 7.55e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 6 | 2.60e-01 | -2.65e-01 | 8.51e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 1.12e-01 | -2.65e-01 | 7.50e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 6 | 2.61e-01 | 2.65e-01 | 8.51e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 43 | 2.65e-03 | 2.65e-01 | 2.93e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 2.61e-01 | -2.65e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 2.62e-01 | 2.65e-01 | 8.51e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 17 | 5.93e-02 | -2.64e-01 | 6.67e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 5 | 3.06e-01 | -2.64e-01 | 8.75e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 9 | 1.70e-01 | 2.64e-01 | 8.04e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 2.84e-02 | -2.64e-01 | 5.64e-01 |
| GOBP REPLACEMENT OSSIFICATION | 11 | 1.30e-01 | 2.64e-01 | 7.57e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 16 | 6.78e-02 | 2.64e-01 | 6.72e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 31 | 1.11e-02 | 2.64e-01 | 4.55e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 3.07e-01 | -2.64e-01 | 8.75e-01 |
| GOBP EAR MORPHOGENESIS | 35 | 7.00e-03 | 2.64e-01 | 4.13e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 11 | 1.31e-01 | 2.63e-01 | 7.57e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 8 | 1.98e-01 | -2.63e-01 | 8.22e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 7 | 2.28e-01 | 2.63e-01 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 6 | 2.65e-01 | 2.63e-01 | 8.52e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 3.09e-01 | -2.63e-01 | 8.75e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 12 | 1.15e-01 | -2.63e-01 | 7.52e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 2.29e-01 | -2.63e-01 | 8.34e-01 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 1.32e-09 | -2.63e-01 | 2.16e-06 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 2.65e-01 | 2.63e-01 | 8.52e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 16 | 6.90e-02 | -2.63e-01 | 6.73e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 7 | 2.29e-01 | 2.63e-01 | 8.34e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 7 | 2.29e-01 | 2.63e-01 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 14 | 8.94e-02 | 2.62e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 5 | 3.10e-01 | 2.62e-01 | 8.75e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 2.66e-01 | 2.62e-01 | 8.54e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 2.66e-01 | -2.62e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 8 | 2.00e-01 | 2.62e-01 | 8.25e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 5 | 3.11e-01 | -2.62e-01 | 8.76e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 3.04e-04 | -2.61e-01 | 9.41e-02 |
| GOBP PLATELET MORPHOGENESIS | 20 | 4.32e-02 | -2.61e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 7.99e-02 | -2.61e-01 | 6.95e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 5 | 3.12e-01 | -2.61e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 16 | 7.08e-02 | -2.61e-01 | 6.77e-01 |
| GOBP BLASTODERM SEGMENTATION | 6 | 2.69e-01 | 2.61e-01 | 8.57e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 2.69e-01 | 2.61e-01 | 8.57e-01 |
| GOCC AUTOLYSOSOME | 12 | 1.18e-01 | -2.61e-01 | 7.52e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 1.34e-01 | -2.61e-01 | 7.62e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 12 | 1.18e-01 | 2.61e-01 | 7.52e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 2.33e-01 | 2.61e-01 | 8.37e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 1.18e-01 | 2.60e-01 | 7.52e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 13 | 1.04e-01 | 2.60e-01 | 7.39e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 5 | 3.14e-01 | 2.60e-01 | 8.76e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 15 | 8.13e-02 | 2.60e-01 | 6.95e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 127 | 4.40e-07 | -2.60e-01 | 4.50e-04 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 1.77e-01 | -2.60e-01 | 8.07e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 8 | 2.03e-01 | 2.60e-01 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 11 | 1.36e-01 | 2.60e-01 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 2.71e-01 | -2.60e-01 | 8.58e-01 |
| GOMF QUINONE BINDING | 13 | 1.05e-01 | -2.60e-01 | 7.42e-01 |
| GOBP REGULATION OF CELL MATURATION | 11 | 1.36e-01 | 2.60e-01 | 7.62e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 2.04e-01 | -2.59e-01 | 8.28e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 31 | 1.25e-02 | -2.59e-01 | 4.67e-01 |
| GOCC CHITOSOME | 9 | 1.78e-01 | -2.59e-01 | 8.07e-01 |
| GOBP MITOTIC RECOMBINATION | 21 | 3.98e-02 | 2.59e-01 | 6.15e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 8 | 2.04e-01 | -2.59e-01 | 8.28e-01 |
| GOBP PROSTAGLANDIN SECRETION | 10 | 1.56e-01 | 2.59e-01 | 7.89e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 2.72e-01 | -2.59e-01 | 8.58e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 2.72e-01 | 2.59e-01 | 8.58e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 9 | 1.79e-01 | 2.59e-01 | 8.07e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 7 | 2.36e-01 | 2.59e-01 | 8.40e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 17 | 6.49e-02 | 2.59e-01 | 6.70e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 3.17e-01 | -2.58e-01 | 8.76e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.73e-01 | 2.58e-01 | 8.58e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 5 | 3.17e-01 | 2.58e-01 | 8.76e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 2.74e-01 | -2.58e-01 | 8.58e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 11 | 1.39e-01 | -2.58e-01 | 7.65e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 9 | 1.81e-01 | 2.58e-01 | 8.07e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 13 | 1.08e-01 | 2.58e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 3.19e-01 | -2.58e-01 | 8.76e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 31 | 1.32e-02 | 2.57e-01 | 4.67e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 9 | 1.81e-01 | 2.57e-01 | 8.07e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 16 | 7.49e-02 | -2.57e-01 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 5 | 3.20e-01 | -2.57e-01 | 8.76e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 6 | 2.76e-01 | -2.57e-01 | 8.60e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 1.83e-01 | 2.56e-01 | 8.08e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 7 | 2.40e-01 | 2.56e-01 | 8.43e-01 |
| GOCC PLASMA MEMBRANE RAFT | 61 | 5.40e-04 | 2.56e-01 | 1.34e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 12 | 1.24e-01 | -2.56e-01 | 7.55e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.41e-01 | 2.56e-01 | 8.43e-01 |
| GOBP DAMP METABOLIC PROCESS | 5 | 3.21e-01 | -2.56e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 6 | 2.78e-01 | 2.56e-01 | 8.61e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 11 | 1.42e-01 | -2.56e-01 | 7.74e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 3.22e-01 | 2.56e-01 | 8.76e-01 |
| GOBP FEMALE MEIOSIS I | 5 | 3.22e-01 | 2.56e-01 | 8.76e-01 |
| GOCC CELL TRAILING EDGE | 14 | 9.79e-02 | 2.56e-01 | 7.33e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 2.11e-01 | 2.55e-01 | 8.32e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 2.42e-01 | -2.55e-01 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 2.79e-01 | 2.55e-01 | 8.63e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 18 | 6.09e-02 | -2.55e-01 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 6 | 2.79e-01 | 2.55e-01 | 8.63e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 3.23e-01 | 2.55e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 7 | 2.43e-01 | -2.55e-01 | 8.44e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 22 | 3.86e-02 | 2.55e-01 | 6.12e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 26 | 2.46e-02 | 2.55e-01 | 5.39e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 2.12e-01 | 2.55e-01 | 8.32e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 6 | 2.80e-01 | 2.55e-01 | 8.63e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 10 | 1.64e-01 | 2.54e-01 | 8.00e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 2.81e-01 | -2.54e-01 | 8.63e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 15 | 8.84e-02 | -2.54e-01 | 7.11e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 6 | 2.81e-01 | 2.54e-01 | 8.63e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 3.26e-01 | 2.54e-01 | 8.76e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 3.26e-01 | -2.54e-01 | 8.76e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 6 | 2.82e-01 | -2.54e-01 | 8.65e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 19 | 5.57e-02 | 2.54e-01 | 6.62e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 42 | 4.50e-03 | 2.53e-01 | 3.48e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 5 | 3.27e-01 | -2.53e-01 | 8.76e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 6 | 2.83e-01 | 2.53e-01 | 8.66e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 2.15e-01 | 2.53e-01 | 8.32e-01 |
| GOBP SPINDLE ELONGATION | 6 | 2.83e-01 | 2.53e-01 | 8.66e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 2.84e-01 | 2.53e-01 | 8.66e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 7 | 2.47e-01 | -2.53e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 3.28e-01 | 2.52e-01 | 8.76e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 3.29e-01 | -2.52e-01 | 8.77e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 2.85e-01 | -2.52e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 7 | 2.49e-01 | -2.52e-01 | 8.49e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 7.23e-02 | -2.52e-01 | 6.78e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 15 | 9.17e-02 | -2.52e-01 | 7.17e-01 |
| GOMF ALPHA TUBULIN BINDING | 31 | 1.54e-02 | 2.51e-01 | 4.79e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 3.30e-01 | -2.51e-01 | 8.79e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 1.69e-01 | 2.51e-01 | 8.04e-01 |
| GOCC LATERAL ELEMENT | 8 | 2.19e-01 | -2.51e-01 | 8.32e-01 |
| GOCC BLOC COMPLEX | 13 | 1.17e-01 | 2.51e-01 | 7.52e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 19 | 5.83e-02 | 2.51e-01 | 6.64e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 6 | 2.88e-01 | 2.50e-01 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 10 | 1.70e-01 | -2.50e-01 | 8.04e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 1.94e-01 | 2.50e-01 | 8.17e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 3.33e-01 | -2.50e-01 | 8.80e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 5 | 3.33e-01 | 2.50e-01 | 8.80e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 7 | 2.52e-01 | 2.50e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 1.19e-01 | -2.50e-01 | 7.52e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 7 | 2.53e-01 | 2.49e-01 | 8.50e-01 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 5 | 3.35e-01 | 2.49e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 3.35e-01 | 2.49e-01 | 8.82e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 13 | 1.20e-01 | 2.49e-01 | 7.52e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 7 | 2.54e-01 | -2.49e-01 | 8.50e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 33 | 1.34e-02 | 2.49e-01 | 4.67e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 1.65e-02 | 2.49e-01 | 4.94e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 8 | 2.23e-01 | 2.49e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 7 | 2.54e-01 | -2.49e-01 | 8.50e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 5 | 3.36e-01 | 2.49e-01 | 8.83e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 2.92e-01 | -2.49e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 5 | 3.36e-01 | 2.48e-01 | 8.83e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 5 | 3.36e-01 | 2.48e-01 | 8.83e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 27 | 2.55e-02 | 2.48e-01 | 5.46e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 2.55e-01 | -2.48e-01 | 8.50e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 3.36e-01 | -2.48e-01 | 8.83e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 3.36e-01 | 2.48e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 2.93e-01 | -2.48e-01 | 8.70e-01 |
| GOCC CASPASE COMPLEX | 9 | 1.97e-01 | -2.48e-01 | 8.22e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 2.56e-01 | -2.48e-01 | 8.50e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 6.85e-02 | -2.48e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 10 | 1.74e-01 | 2.48e-01 | 8.07e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 10 | 1.75e-01 | 2.48e-01 | 8.07e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 2.56e-01 | 2.48e-01 | 8.50e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 5 | 3.38e-01 | 2.48e-01 | 8.83e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 3.38e-01 | -2.48e-01 | 8.83e-01 |
| GOCC TORC2 COMPLEX | 9 | 1.99e-01 | 2.48e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 10 | 1.76e-01 | 2.47e-01 | 8.07e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 3.38e-01 | 2.47e-01 | 8.83e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 7 | 2.58e-01 | 2.47e-01 | 8.50e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 2.26e-01 | -2.47e-01 | 8.32e-01 |
| GOBP ACROSOME ASSEMBLY | 12 | 1.38e-01 | -2.47e-01 | 7.64e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 17 | 7.82e-02 | -2.47e-01 | 6.92e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 10 | 1.77e-01 | -2.47e-01 | 8.07e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 7 | 2.59e-01 | 2.47e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 9 | 2.01e-01 | 2.46e-01 | 8.26e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 20 | 5.67e-02 | -2.46e-01 | 6.62e-01 |
| GOBP THYROID HORMONE GENERATION | 8 | 2.28e-01 | 2.46e-01 | 8.34e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 13 | 1.25e-01 | -2.46e-01 | 7.55e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 6 | 2.97e-01 | -2.46e-01 | 8.71e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 6 | 2.97e-01 | -2.46e-01 | 8.71e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 15 | 9.95e-02 | 2.46e-01 | 7.35e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 2.00e-02 | 2.46e-01 | 5.22e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 18 | 7.15e-02 | -2.45e-01 | 6.78e-01 |
| GOBP AORTA DEVELOPMENT | 29 | 2.23e-02 | 2.45e-01 | 5.34e-01 |
| GOBP HEART VALVE FORMATION | 5 | 3.42e-01 | -2.45e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 3.42e-01 | -2.45e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 5 | 3.42e-01 | -2.45e-01 | 8.84e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 3.43e-01 | -2.45e-01 | 8.85e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 12 | 1.42e-01 | -2.45e-01 | 7.74e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 7 | 2.62e-01 | -2.45e-01 | 8.51e-01 |
| GOBP TRNA METHYLATION | 40 | 7.47e-03 | 2.45e-01 | 4.17e-01 |
| GOCC RESPIRASOME | 87 | 8.22e-05 | -2.45e-01 | 3.54e-02 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 12 | 1.43e-01 | -2.45e-01 | 7.75e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 3.00e-01 | -2.44e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 19 | 6.52e-02 | 2.44e-01 | 6.70e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 16 | 9.11e-02 | 2.44e-01 | 7.14e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 14 | 1.14e-01 | 2.44e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 12 | 1.44e-01 | 2.44e-01 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 13 | 1.28e-01 | 2.44e-01 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 3.45e-01 | -2.44e-01 | 8.87e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 15 | 1.02e-01 | 2.44e-01 | 7.39e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 2.64e-01 | -2.44e-01 | 8.52e-01 |
| GOMF SNRNP BINDING | 9 | 2.06e-01 | -2.44e-01 | 8.28e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 3.47e-01 | 2.43e-01 | 8.87e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 14 | 1.16e-01 | -2.43e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 13 | 1.30e-01 | 2.43e-01 | 7.57e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 3.47e-01 | 2.43e-01 | 8.87e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 3.47e-01 | 2.43e-01 | 8.87e-01 |
| GOCC CELL BODY MEMBRANE | 9 | 2.07e-01 | 2.43e-01 | 8.29e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 15 | 1.04e-01 | 2.43e-01 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 20 | 6.04e-02 | 2.43e-01 | 6.68e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 19 | 6.73e-02 | 2.42e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 29 | 2.39e-02 | 2.42e-01 | 5.39e-01 |
| GOBP MRNA METHYLATION | 18 | 7.50e-02 | 2.42e-01 | 6.85e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 9 | 2.08e-01 | 2.42e-01 | 8.30e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 9 | 2.08e-01 | 2.42e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 30 | 2.17e-02 | 2.42e-01 | 5.33e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 1.31e-01 | -2.42e-01 | 7.57e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 7 | 2.68e-01 | -2.42e-01 | 8.56e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 16 | 9.43e-02 | -2.42e-01 | 7.27e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 10 | 1.86e-01 | -2.42e-01 | 8.12e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 110 | 1.25e-05 | -2.41e-01 | 8.51e-03 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 2.10e-01 | 2.41e-01 | 8.32e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 7 | 2.69e-01 | -2.41e-01 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 15 | 1.06e-01 | 2.41e-01 | 7.42e-01 |
| GOBP COBALAMIN TRANSPORT | 5 | 3.51e-01 | 2.41e-01 | 8.88e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 3.51e-01 | 2.41e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT | 5 | 3.51e-01 | 2.41e-01 | 8.88e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 2.39e-01 | -2.41e-01 | 8.42e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 9 | 2.12e-01 | -2.40e-01 | 8.32e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 2.71e-01 | 2.40e-01 | 8.58e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 14 | 1.20e-01 | 2.40e-01 | 7.52e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 2.71e-01 | -2.40e-01 | 8.58e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 5 | 3.53e-01 | 2.40e-01 | 8.88e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 3.09e-01 | -2.40e-01 | 8.75e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 58 | 1.59e-03 | 2.40e-01 | 2.27e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 3.53e-01 | -2.40e-01 | 8.88e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 2.72e-01 | 2.40e-01 | 8.58e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 2.73e-01 | -2.40e-01 | 8.58e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 2.41e-01 | 2.39e-01 | 8.43e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 2.41e-01 | 2.39e-01 | 8.43e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 1.09e-01 | -2.39e-01 | 7.47e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 1.52e-01 | -2.39e-01 | 7.89e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 16 | 9.81e-02 | 2.39e-01 | 7.33e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 2.74e-01 | 2.39e-01 | 8.58e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 7 | 2.74e-01 | 2.39e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 18 | 7.98e-02 | 2.39e-01 | 6.95e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 15 | 1.10e-01 | 2.39e-01 | 7.49e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 3.56e-01 | 2.39e-01 | 8.88e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 8 | 2.43e-01 | -2.38e-01 | 8.44e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 1.71e-01 | -2.38e-01 | 8.05e-01 |
| GOBP INSULIN METABOLIC PROCESS | 9 | 2.16e-01 | -2.38e-01 | 8.32e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 3.12e-01 | -2.38e-01 | 8.76e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 6 | 3.12e-01 | 2.38e-01 | 8.76e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 2.16e-01 | 2.38e-01 | 8.32e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 10 | 1.93e-01 | 2.38e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 1.38e-01 | 2.38e-01 | 7.63e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 2.45e-01 | 2.38e-01 | 8.49e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 7 | 2.77e-01 | -2.37e-01 | 8.60e-01 |
| GOCC DENSE CORE GRANULE | 11 | 1.73e-01 | 2.37e-01 | 8.07e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 1.55e-01 | -2.37e-01 | 7.89e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 12 | 1.55e-01 | 2.37e-01 | 7.89e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 22 | 5.43e-02 | 2.37e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 7 | 2.78e-01 | -2.37e-01 | 8.61e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 3.59e-01 | -2.37e-01 | 8.90e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 5 | 3.59e-01 | 2.37e-01 | 8.90e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 6 | 3.15e-01 | 2.37e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 4.05e-02 | -2.37e-01 | 6.16e-01 |
| GOBP SUCKLING BEHAVIOR | 7 | 2.78e-01 | 2.37e-01 | 8.62e-01 |
| GOBP PROTEIN REPAIR | 6 | 3.16e-01 | 2.37e-01 | 8.76e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 9 | 2.19e-01 | 2.36e-01 | 8.32e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 1.96e-01 | 2.36e-01 | 8.20e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 3.16e-01 | -2.36e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 3.17e-01 | 2.36e-01 | 8.76e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 8 | 2.48e-01 | 2.36e-01 | 8.49e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 9 | 2.20e-01 | -2.36e-01 | 8.32e-01 |
| GOBP GASTRIC ACID SECRETION | 6 | 3.17e-01 | -2.36e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 3.17e-01 | 2.36e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 25 | 4.13e-02 | -2.36e-01 | 6.19e-01 |
| GOCC SMN COMPLEX | 10 | 1.97e-01 | 2.36e-01 | 8.22e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 2.21e-01 | 2.36e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 11 | 1.76e-01 | -2.35e-01 | 8.07e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 11 | 1.77e-01 | 2.35e-01 | 8.07e-01 |
| GOMF MRNA 5 UTR BINDING | 23 | 5.08e-02 | -2.35e-01 | 6.56e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 11 | 1.77e-01 | 2.35e-01 | 8.07e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 6 | 3.19e-01 | -2.35e-01 | 8.76e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 7 | 2.81e-01 | -2.35e-01 | 8.64e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 23 | 5.12e-02 | 2.35e-01 | 6.58e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 11 | 1.77e-01 | 2.35e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 15 | 1.15e-01 | -2.35e-01 | 7.52e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 5.75e-04 | -2.35e-01 | 1.35e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 2.23e-01 | 2.35e-01 | 8.32e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 6 | 3.19e-01 | 2.35e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.50e-01 | -2.35e-01 | 8.50e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 6 | 3.19e-01 | -2.35e-01 | 8.76e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 6 | 3.19e-01 | -2.35e-01 | 8.76e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 6 | 3.19e-01 | -2.35e-01 | 8.76e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 6 | 3.19e-01 | -2.35e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 19 | 7.66e-02 | 2.35e-01 | 6.87e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 37 | 1.36e-02 | -2.34e-01 | 4.67e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 3.64e-01 | -2.34e-01 | 8.92e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 17 | 9.43e-02 | 2.34e-01 | 7.27e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 3.20e-01 | -2.34e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 7 | 2.83e-01 | 2.34e-01 | 8.66e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 8 | 2.51e-01 | 2.34e-01 | 8.50e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 1.60e-01 | 2.34e-01 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 3.21e-01 | 2.34e-01 | 8.76e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 3.21e-01 | -2.34e-01 | 8.76e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 13 | 1.45e-01 | 2.34e-01 | 7.75e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 6 | 3.21e-01 | 2.34e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 1.80e-01 | -2.34e-01 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 18 | 8.64e-02 | 2.33e-01 | 7.11e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 39 | 1.17e-02 | 2.33e-01 | 4.62e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 3.22e-01 | 2.33e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 17 | 9.59e-02 | 2.33e-01 | 7.30e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 6 | 3.22e-01 | -2.33e-01 | 8.76e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 13 | 1.45e-01 | 2.33e-01 | 7.77e-01 |
| GOMF FOLIC ACID BINDING | 8 | 2.54e-01 | 2.33e-01 | 8.50e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 14 | 1.31e-01 | 2.33e-01 | 7.57e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 26 | 3.97e-02 | -2.33e-01 | 6.15e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 23 | 5.31e-02 | 2.33e-01 | 6.61e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 2.86e-01 | -2.33e-01 | 8.67e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 7 | 2.86e-01 | 2.33e-01 | 8.67e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 14 | 1.31e-01 | -2.33e-01 | 7.57e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 2.26e-01 | -2.33e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 8 | 2.54e-01 | -2.33e-01 | 8.50e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 11 | 1.81e-01 | 2.33e-01 | 8.07e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 14 | 1.32e-01 | 2.33e-01 | 7.57e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 3.68e-01 | 2.33e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 2.55e-01 | 2.33e-01 | 8.50e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 11 | 1.82e-01 | 2.33e-01 | 8.07e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 18 | 8.79e-02 | -2.32e-01 | 7.11e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 24 | 4.88e-02 | 2.32e-01 | 6.48e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 5 | 3.68e-01 | 2.32e-01 | 8.92e-01 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 8.80e-02 | -2.32e-01 | 7.11e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 6 | 3.24e-01 | -2.32e-01 | 8.76e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 2.87e-01 | 2.32e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 2.28e-01 | -2.32e-01 | 8.34e-01 |
| GOBP PLASMINOGEN ACTIVATION | 10 | 2.04e-01 | -2.32e-01 | 8.28e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 5 | 3.70e-01 | 2.31e-01 | 8.92e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 42 | 9.48e-03 | 2.31e-01 | 4.24e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 2.89e-01 | -2.31e-01 | 8.69e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 3.27e-01 | 2.31e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 9 | 2.30e-01 | -2.31e-01 | 8.35e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 9 | 2.30e-01 | 2.31e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 18 | 8.96e-02 | 2.31e-01 | 7.11e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 1.34e-01 | -2.31e-01 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 25 | 4.55e-02 | 2.31e-01 | 6.34e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 6 | 3.27e-01 | -2.31e-01 | 8.76e-01 |
| GOBP HYPOTONIC RESPONSE | 6 | 3.27e-01 | -2.31e-01 | 8.76e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 2.90e-01 | 2.31e-01 | 8.69e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 12 | 1.66e-01 | -2.31e-01 | 8.04e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 23 | 5.53e-02 | 2.31e-01 | 6.62e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 16 | 1.10e-01 | 2.31e-01 | 7.49e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 12 | 1.66e-01 | -2.31e-01 | 8.04e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 88 | 1.86e-04 | -2.31e-01 | 6.94e-02 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 6.11e-02 | -2.31e-01 | 6.68e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 17 | 9.98e-02 | -2.31e-01 | 7.36e-01 |
| GOCC POLAR MICROTUBULE | 5 | 3.72e-01 | 2.30e-01 | 8.95e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 2.07e-01 | -2.30e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 1.11e-01 | 2.30e-01 | 7.49e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 13 | 1.51e-01 | -2.30e-01 | 7.89e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 12 | 1.68e-01 | -2.30e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 9 | 2.32e-01 | -2.30e-01 | 8.37e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 2.32e-01 | -2.30e-01 | 8.37e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 13 | 1.51e-01 | -2.30e-01 | 7.89e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 1.87e-01 | -2.30e-01 | 8.14e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 5 | 3.74e-01 | 2.29e-01 | 8.96e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 2.93e-01 | -2.29e-01 | 8.71e-01 |
| GOMF U3 SNORNA BINDING | 10 | 2.09e-01 | 2.29e-01 | 8.30e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 8 | 2.62e-01 | 2.29e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 5 | 3.75e-01 | -2.29e-01 | 8.97e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 32 | 2.52e-02 | 2.29e-01 | 5.43e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 1.13e-01 | -2.29e-01 | 7.52e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 10 | 2.11e-01 | 2.29e-01 | 8.32e-01 |
| GOCC NSL COMPLEX | 11 | 1.89e-01 | 2.29e-01 | 8.14e-01 |
| GOBP RESPONSE TO INACTIVITY | 5 | 3.77e-01 | 2.28e-01 | 8.97e-01 |
| GOCC GBAF COMPLEX | 13 | 1.55e-01 | 2.28e-01 | 7.89e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 45 | 8.25e-03 | -2.28e-01 | 4.17e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 10 | 2.13e-01 | -2.28e-01 | 8.32e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 29 | 3.39e-02 | 2.28e-01 | 5.88e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 5 | 3.78e-01 | 2.28e-01 | 8.97e-01 |
| GOMF U1 SNRNA BINDING | 8 | 2.65e-01 | 2.28e-01 | 8.52e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 13 | 1.56e-01 | 2.28e-01 | 7.89e-01 |
| GOCC THO COMPLEX | 6 | 3.35e-01 | 2.27e-01 | 8.82e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 13 | 1.56e-01 | -2.27e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 8 | 2.66e-01 | 2.27e-01 | 8.53e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 7 | 2.98e-01 | 2.27e-01 | 8.71e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 7 | 2.98e-01 | 2.27e-01 | 8.71e-01 |
| GOCC 90S PRERIBOSOME | 25 | 4.95e-02 | 2.27e-01 | 6.48e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 9 | 2.39e-01 | -2.27e-01 | 8.42e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 35 | 2.03e-02 | -2.27e-01 | 5.22e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 10 | 2.15e-01 | -2.27e-01 | 8.32e-01 |
| GOCC SWI SNF COMPLEX | 28 | 3.80e-02 | 2.27e-01 | 6.11e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 7 | 2.99e-01 | 2.27e-01 | 8.73e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 10 | 2.15e-01 | -2.26e-01 | 8.32e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 3.00e-01 | -2.26e-01 | 8.73e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 13 | 1.58e-01 | 2.26e-01 | 7.90e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 2.40e-01 | 2.26e-01 | 8.43e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 6 | 3.37e-01 | -2.26e-01 | 8.83e-01 |
| GOBP MUCUS SECRETION | 11 | 1.94e-01 | -2.26e-01 | 8.18e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 8 | 2.68e-01 | -2.26e-01 | 8.57e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 2.69e-01 | -2.26e-01 | 8.57e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 9.73e-02 | -2.26e-01 | 7.33e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 9 | 2.41e-01 | 2.26e-01 | 8.43e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 13 | 1.59e-01 | -2.26e-01 | 7.96e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 15 | 1.31e-01 | -2.25e-01 | 7.57e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 3.83e-01 | 2.25e-01 | 8.97e-01 |
| GOBP CGMP METABOLIC PROCESS | 5 | 3.83e-01 | -2.25e-01 | 8.97e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 20 | 8.12e-02 | 2.25e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 1.60e-01 | -2.25e-01 | 7.96e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 16 | 1.19e-01 | -2.25e-01 | 7.52e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 10 | 2.18e-01 | 2.25e-01 | 8.32e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 5 | 3.84e-01 | 2.25e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 7 | 3.03e-01 | 2.25e-01 | 8.75e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 13 | 1.61e-01 | 2.25e-01 | 7.96e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 13 | 1.61e-01 | -2.24e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 3.42e-01 | 2.24e-01 | 8.84e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 72 | 1.02e-03 | -2.24e-01 | 1.74e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 8 | 2.73e-01 | 2.24e-01 | 8.58e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 3.86e-01 | -2.24e-01 | 8.97e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 5 | 3.86e-01 | 2.24e-01 | 8.97e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 5 | 3.87e-01 | 2.24e-01 | 8.97e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 22 | 6.98e-02 | -2.23e-01 | 6.73e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 3.06e-01 | -2.23e-01 | 8.75e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 11 | 2.00e-01 | 2.23e-01 | 8.25e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 16 | 1.22e-01 | -2.23e-01 | 7.54e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 1.81e-01 | 2.23e-01 | 8.07e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 7 | 3.08e-01 | 2.23e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 46 | 9.03e-03 | -2.23e-01 | 4.19e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 8 | 2.76e-01 | 2.22e-01 | 8.60e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 18 | 1.03e-01 | 2.22e-01 | 7.39e-01 |
| GOMF 7S RNA BINDING | 7 | 3.09e-01 | -2.22e-01 | 8.75e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 10 | 2.25e-01 | -2.22e-01 | 8.32e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 7.88e-02 | 2.22e-01 | 6.93e-01 |
| GOBP DETECTION OF CELL DENSITY | 6 | 3.48e-01 | 2.21e-01 | 8.87e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 13 | 1.67e-01 | -2.21e-01 | 8.04e-01 |
| GOBP ALANINE TRANSPORT | 9 | 2.51e-01 | 2.21e-01 | 8.50e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 3.92e-01 | -2.21e-01 | 8.97e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 32 | 3.06e-02 | 2.21e-01 | 5.72e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 12 | 1.85e-01 | 2.21e-01 | 8.11e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 13 | 1.68e-01 | 2.21e-01 | 8.04e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 3.12e-01 | 2.21e-01 | 8.76e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 30 | 3.65e-02 | 2.21e-01 | 6.04e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 5 | 3.93e-01 | -2.21e-01 | 8.97e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 11 | 2.05e-01 | -2.21e-01 | 8.28e-01 |
| GOBP LACTATE METABOLIC PROCESS | 13 | 1.69e-01 | -2.20e-01 | 8.04e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 3.93e-01 | -2.20e-01 | 8.97e-01 |
| GOCC COPII VESICLE COAT | 16 | 1.27e-01 | -2.20e-01 | 7.55e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 96 | 1.96e-04 | -2.20e-01 | 6.96e-02 |
| GOCC IKAPPAB KINASE COMPLEX | 5 | 3.94e-01 | 2.20e-01 | 8.97e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 3.94e-01 | 2.20e-01 | 8.97e-01 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 3.14e-01 | -2.20e-01 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 25 | 5.72e-02 | -2.20e-01 | 6.64e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 3.52e-01 | 2.20e-01 | 8.88e-01 |
| GOBP STRIATUM DEVELOPMENT | 13 | 1.71e-01 | 2.20e-01 | 8.04e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 13 | 1.71e-01 | 2.20e-01 | 8.04e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 25 | 5.76e-02 | -2.19e-01 | 6.64e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 3.52e-01 | -2.19e-01 | 8.88e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 18 | 1.07e-01 | -2.19e-01 | 7.42e-01 |
| GOCC XY BODY | 11 | 2.09e-01 | -2.19e-01 | 8.30e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 23 | 6.93e-02 | 2.19e-01 | 6.73e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 19 | 9.88e-02 | 2.19e-01 | 7.33e-01 |
| GOBP POLYAMINE TRANSPORT | 8 | 2.84e-01 | -2.19e-01 | 8.66e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 5 | 3.97e-01 | -2.19e-01 | 8.98e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 13 | 1.72e-01 | 2.19e-01 | 8.07e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 5 | 3.97e-01 | -2.19e-01 | 8.98e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 8 | 2.84e-01 | 2.19e-01 | 8.67e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 14 | 1.57e-01 | -2.19e-01 | 7.89e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 52 | 6.52e-03 | 2.18e-01 | 3.95e-01 |
| GOBP NEURAL TUBE PATTERNING | 21 | 8.35e-02 | 2.18e-01 | 7.03e-01 |
| GOBP CELL FATE DETERMINATION | 12 | 1.91e-01 | 2.18e-01 | 8.16e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 7 | 3.18e-01 | 2.18e-01 | 8.76e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 7 | 3.18e-01 | 2.18e-01 | 8.76e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 6 | 3.56e-01 | -2.18e-01 | 8.88e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 3.56e-01 | -2.18e-01 | 8.88e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 15 | 1.45e-01 | 2.17e-01 | 7.76e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 2.13e-01 | 2.17e-01 | 8.32e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 2.88e-01 | 2.17e-01 | 8.68e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 24 | 6.58e-02 | -2.17e-01 | 6.72e-01 |
| GOBP TRANSCYTOSIS | 15 | 1.46e-01 | -2.17e-01 | 7.77e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 3.21e-01 | -2.17e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 1.46e-01 | -2.17e-01 | 7.79e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 18 | 1.12e-01 | -2.17e-01 | 7.50e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 7 | 3.21e-01 | 2.17e-01 | 8.76e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 40 | 1.79e-02 | 2.17e-01 | 5.05e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 16 | 1.34e-01 | -2.16e-01 | 7.62e-01 |
| GOMF FK506 BINDING | 6 | 3.59e-01 | 2.16e-01 | 8.90e-01 |
| GOMF MACROLIDE BINDING | 6 | 3.59e-01 | 2.16e-01 | 8.90e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 6 | 3.59e-01 | 2.16e-01 | 8.90e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 4.03e-01 | -2.16e-01 | 8.99e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 3.22e-01 | -2.16e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 7 | 3.22e-01 | 2.16e-01 | 8.76e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 18 | 1.13e-01 | 2.16e-01 | 7.50e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 6 | 3.59e-01 | -2.16e-01 | 8.90e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 6.16e-02 | 2.16e-01 | 6.68e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 35 | 2.72e-02 | 2.16e-01 | 5.54e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 18 | 1.13e-01 | -2.16e-01 | 7.51e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 8 | 2.91e-01 | 2.15e-01 | 8.69e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 2.38e-01 | 2.15e-01 | 8.42e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 21 | 8.75e-02 | 2.15e-01 | 7.11e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 2.63e-01 | -2.15e-01 | 8.52e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 6 | 3.61e-01 | -2.15e-01 | 8.91e-01 |
| GOBP LEUKOCYTE AGGREGATION | 10 | 2.38e-01 | -2.15e-01 | 8.42e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 2.16e-01 | -2.15e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 10 | 2.39e-01 | -2.15e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 28 | 4.88e-02 | -2.15e-01 | 6.48e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 25 | 6.26e-02 | 2.15e-01 | 6.68e-01 |
| GOCC DENDRITE TERMINUS | 9 | 2.64e-01 | 2.15e-01 | 8.52e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 9 | 2.64e-01 | -2.15e-01 | 8.52e-01 |
| GOCC EXOCYST | 12 | 1.98e-01 | 2.15e-01 | 8.22e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 2.93e-01 | 2.15e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 3.25e-01 | 2.15e-01 | 8.76e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 12 | 1.98e-01 | 2.14e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 5 | 4.06e-01 | -2.14e-01 | 8.99e-01 |
| GOBP AEROBIC RESPIRATION | 168 | 1.74e-06 | -2.14e-01 | 1.30e-03 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 3.64e-01 | 2.14e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 16 | 1.38e-01 | -2.14e-01 | 7.64e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 15 | 1.51e-01 | 2.14e-01 | 7.89e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 18 | 1.16e-01 | -2.14e-01 | 7.52e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 50 | 8.92e-03 | 2.14e-01 | 4.19e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 30 | 4.27e-02 | 2.14e-01 | 6.23e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 18 | 1.16e-01 | 2.14e-01 | 7.52e-01 |
| GOMF 7SK SNRNA BINDING | 8 | 2.95e-01 | 2.14e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 1.07e-01 | -2.14e-01 | 7.42e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 2.96e-01 | 2.14e-01 | 8.71e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 3.65e-01 | -2.14e-01 | 8.92e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 16 | 1.40e-01 | -2.13e-01 | 7.67e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 2.21e-01 | -2.13e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 29 | 4.71e-02 | 2.13e-01 | 6.40e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 2.97e-01 | -2.13e-01 | 8.71e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 11 | 2.22e-01 | -2.13e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 34 | 3.18e-02 | -2.13e-01 | 5.82e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 4.10e-01 | -2.13e-01 | 9.03e-01 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 1.84e-01 | 2.13e-01 | 8.10e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 7.76e-02 | 2.13e-01 | 6.92e-01 |
| GOBP RESPONSE TO UV B | 14 | 1.69e-01 | 2.13e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 11 | 2.22e-01 | 2.12e-01 | 8.32e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 2.70e-01 | 2.12e-01 | 8.58e-01 |
| GOCC REPLISOME | 15 | 1.54e-01 | 2.12e-01 | 7.89e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 6 | 3.68e-01 | 2.12e-01 | 8.92e-01 |
| GOBP MACROPINOCYTOSIS | 8 | 2.99e-01 | 2.12e-01 | 8.72e-01 |
| GOCC FILAMENTOUS ACTIN | 13 | 1.86e-01 | -2.12e-01 | 8.11e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 3.69e-01 | -2.12e-01 | 8.92e-01 |
| GOCC SARCOPLASM | 46 | 1.29e-02 | 2.12e-01 | 4.67e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 2.46e-01 | 2.12e-01 | 8.49e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 2.04e-01 | -2.12e-01 | 8.28e-01 |
| GOBP RETINAL METABOLIC PROCESS | 9 | 2.71e-01 | -2.12e-01 | 8.58e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.72e-01 | -2.12e-01 | 8.58e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 1.02e-01 | 2.12e-01 | 7.39e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 5 | 4.13e-01 | 2.11e-01 | 9.05e-01 |
| GOBP REGULATION OF LIPID STORAGE | 38 | 2.42e-02 | -2.11e-01 | 5.39e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 19 | 1.11e-01 | 2.11e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 17 | 1.32e-01 | 2.11e-01 | 7.57e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 2.72e-01 | 2.11e-01 | 8.58e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 18 | 1.21e-01 | 2.11e-01 | 7.52e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 15 | 1.57e-01 | -2.11e-01 | 7.89e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 18 | 1.21e-01 | -2.11e-01 | 7.53e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 11 | 2.26e-01 | -2.11e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 3.34e-01 | 2.11e-01 | 8.82e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 16 | 1.45e-01 | -2.11e-01 | 7.75e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 11 | 2.26e-01 | 2.11e-01 | 8.32e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 12 | 2.06e-01 | 2.11e-01 | 8.29e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 13 | 1.89e-01 | 2.11e-01 | 8.14e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 51 | 9.37e-03 | 2.10e-01 | 4.24e-01 |
| GOCC LATERAL PART OF CELL | 5 | 4.15e-01 | 2.10e-01 | 9.08e-01 |
| GOBP ADP METABOLIC PROCESS | 5 | 4.16e-01 | -2.10e-01 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 8 | 3.04e-01 | 2.10e-01 | 8.75e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 14 | 1.74e-01 | 2.10e-01 | 8.07e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 20 | 1.04e-01 | -2.10e-01 | 7.39e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 9 | 2.76e-01 | -2.10e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 5 | 4.17e-01 | 2.10e-01 | 9.08e-01 |
| GOMF NOTCH BINDING | 14 | 1.75e-01 | -2.10e-01 | 8.07e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 7 | 3.37e-01 | 2.10e-01 | 8.83e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 1.14e-01 | 2.09e-01 | 7.52e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 14 | 1.75e-01 | 2.09e-01 | 8.07e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 7 | 3.37e-01 | -2.09e-01 | 8.83e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 27 | 5.98e-02 | -2.09e-01 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 7 | 3.38e-01 | -2.09e-01 | 8.83e-01 |
| GOMF GPI ANCHOR BINDING | 5 | 4.18e-01 | -2.09e-01 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 3.75e-01 | 2.09e-01 | 8.97e-01 |
| GOBP VESICLE COATING | 36 | 3.02e-02 | -2.09e-01 | 5.71e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 11 | 2.30e-01 | -2.09e-01 | 8.36e-01 |
| GOBP STEM CELL DIVISION | 19 | 1.16e-01 | 2.08e-01 | 7.52e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 1.49e-01 | 2.08e-01 | 7.89e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 22 | 9.10e-02 | 2.08e-01 | 7.14e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 31 | 4.50e-02 | 2.08e-01 | 6.33e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 6 | 3.77e-01 | 2.08e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 9 | 2.80e-01 | -2.08e-01 | 8.63e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 9 | 2.80e-01 | 2.08e-01 | 8.63e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.41e-01 | -2.08e-01 | 8.84e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 6 | 3.79e-01 | 2.08e-01 | 8.97e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 18 | 1.27e-01 | 2.08e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 8 | 3.09e-01 | 2.08e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 10 | 2.56e-01 | -2.07e-01 | 8.50e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 73 | 2.20e-03 | 2.07e-01 | 2.62e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 3.42e-01 | 2.07e-01 | 8.84e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 44 | 1.74e-02 | 2.07e-01 | 5.01e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 53 | 9.07e-03 | 2.07e-01 | 4.19e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 22 | 9.26e-02 | 2.07e-01 | 7.20e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 16 | 1.52e-01 | -2.07e-01 | 7.89e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 26 | 6.77e-02 | 2.07e-01 | 6.72e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 7 | 3.43e-01 | -2.07e-01 | 8.85e-01 |
| GOCC EMC COMPLEX | 10 | 2.57e-01 | -2.07e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 8 | 3.11e-01 | -2.07e-01 | 8.76e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 2.58e-01 | -2.07e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 18 | 1.29e-01 | -2.07e-01 | 7.57e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 44 | 1.79e-02 | -2.06e-01 | 5.05e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 62 | 4.98e-03 | -2.06e-01 | 3.63e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 4.24e-01 | 2.06e-01 | 9.13e-01 |
| GOCC CATENIN COMPLEX | 8 | 3.12e-01 | 2.06e-01 | 8.76e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 7 | 3.44e-01 | -2.06e-01 | 8.86e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 5 | 4.25e-01 | 2.06e-01 | 9.13e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 20 | 1.10e-01 | -2.06e-01 | 7.49e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 13 | 1.98e-01 | -2.06e-01 | 8.23e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 8 | 3.13e-01 | 2.06e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 3.13e-01 | 2.06e-01 | 8.76e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 18 | 1.30e-01 | 2.06e-01 | 7.57e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 3.13e-01 | -2.06e-01 | 8.76e-01 |
| GOMF ISOPRENOID BINDING | 9 | 2.85e-01 | -2.06e-01 | 8.67e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 5 | 4.26e-01 | -2.06e-01 | 9.13e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 5 | 4.26e-01 | 2.06e-01 | 9.13e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 3.14e-01 | -2.06e-01 | 8.76e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 12 | 2.17e-01 | -2.06e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 2.18e-01 | -2.06e-01 | 8.32e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 8 | 3.14e-01 | -2.05e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 7 | 3.47e-01 | -2.05e-01 | 8.87e-01 |
| GOCC MHC PROTEIN COMPLEX | 23 | 8.83e-02 | 2.05e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 14 | 1.84e-01 | -2.05e-01 | 8.10e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 3.47e-01 | 2.05e-01 | 8.87e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 33 | 4.14e-02 | 2.05e-01 | 6.20e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 4.27e-01 | -2.05e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 7 | 3.48e-01 | -2.05e-01 | 8.87e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 4.27e-01 | -2.05e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 7 | 3.48e-01 | 2.05e-01 | 8.87e-01 |
| GOMF DNA HELICASE ACTIVITY | 48 | 1.41e-02 | 2.05e-01 | 4.74e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 14 | 1.85e-01 | 2.05e-01 | 8.11e-01 |
| GOBP RRNA MODIFICATION | 30 | 5.26e-02 | 2.05e-01 | 6.61e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 19 | 1.23e-01 | 2.04e-01 | 7.55e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 15 | 1.71e-01 | -2.04e-01 | 8.04e-01 |
| GOMF CUPROUS ION BINDING | 6 | 3.86e-01 | -2.04e-01 | 8.97e-01 |
| GOMF RRNA BINDING | 62 | 5.48e-03 | -2.04e-01 | 3.77e-01 |
| GOBP FUCOSYLATION | 10 | 2.64e-01 | 2.04e-01 | 8.52e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 9 | 2.89e-01 | -2.04e-01 | 8.69e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 32 | 4.58e-02 | -2.04e-01 | 6.34e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 8 | 3.18e-01 | 2.04e-01 | 8.76e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 3.18e-01 | -2.04e-01 | 8.76e-01 |
| GOBP CELLULAR RESPIRATION | 202 | 6.50e-07 | -2.04e-01 | 5.48e-04 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 5 | 4.30e-01 | 2.04e-01 | 9.14e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 8 | 3.19e-01 | -2.04e-01 | 8.76e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 13 | 2.04e-01 | 2.04e-01 | 8.28e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 6 | 3.88e-01 | 2.04e-01 | 8.97e-01 |
| GOCC CHROMOCENTER | 8 | 3.19e-01 | 2.04e-01 | 8.76e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 35 | 3.73e-02 | 2.04e-01 | 6.08e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 7 | 3.52e-01 | 2.03e-01 | 8.88e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 106 | 3.08e-04 | -2.03e-01 | 9.41e-02 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 3.89e-01 | -2.03e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 20 | 1.16e-01 | 2.03e-01 | 7.52e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 3.90e-01 | 2.03e-01 | 8.97e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 6 | 3.90e-01 | 2.03e-01 | 8.97e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 1.89e-01 | 2.03e-01 | 8.14e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 45 | 1.89e-02 | -2.02e-01 | 5.14e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 7 | 3.55e-01 | 2.02e-01 | 8.88e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 7 | 3.55e-01 | 2.02e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 14 | 1.91e-01 | 2.02e-01 | 8.16e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 14 | 1.91e-01 | 2.02e-01 | 8.16e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 6 | 3.92e-01 | 2.02e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 6 | 3.92e-01 | 2.02e-01 | 8.97e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 6 | 3.92e-01 | -2.02e-01 | 8.97e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 6 | 3.92e-01 | -2.02e-01 | 8.97e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 5 | 4.35e-01 | 2.02e-01 | 9.14e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 18 | 1.39e-01 | 2.02e-01 | 7.65e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 11 | 2.47e-01 | 2.02e-01 | 8.49e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 3.24e-01 | -2.02e-01 | 8.76e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 11 | 2.47e-01 | -2.01e-01 | 8.49e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 6 | 3.93e-01 | -2.01e-01 | 8.97e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 12 | 2.27e-01 | 2.01e-01 | 8.34e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 7 | 3.57e-01 | 2.01e-01 | 8.88e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 140 | 4.13e-05 | -2.01e-01 | 1.94e-02 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 65 | 5.10e-03 | -2.01e-01 | 3.63e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 15 | 1.78e-01 | -2.01e-01 | 8.07e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 2.96e-01 | -2.01e-01 | 8.71e-01 |
| GOMF TROPOMYOSIN BINDING | 9 | 2.97e-01 | 2.01e-01 | 8.71e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 8 | 3.25e-01 | 2.01e-01 | 8.76e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 2.97e-01 | -2.01e-01 | 8.71e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 6 | 3.94e-01 | 2.01e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 16 | 1.64e-01 | -2.01e-01 | 8.02e-01 |
| GOBP CALCIUM ION IMPORT | 19 | 1.30e-01 | 2.01e-01 | 7.57e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 8.25e-02 | 2.01e-01 | 6.99e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 33 | 4.61e-02 | 2.01e-01 | 6.34e-01 |
| GOBP POSTREPLICATION REPAIR | 30 | 5.73e-02 | -2.01e-01 | 6.64e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 21 | 1.12e-01 | -2.01e-01 | 7.50e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 22 | 1.04e-01 | 2.01e-01 | 7.39e-01 |
| GOBP R LOOP PROCESSING | 6 | 3.95e-01 | 2.00e-01 | 8.98e-01 |
| GOCC EXCITATORY SYNAPSE | 20 | 1.21e-01 | 2.00e-01 | 7.52e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 24 | 8.94e-02 | 2.00e-01 | 7.11e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 4.38e-01 | 2.00e-01 | 9.15e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 17 | 1.53e-01 | 2.00e-01 | 7.89e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 18 | 1.41e-01 | 2.00e-01 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 6 | 3.96e-01 | 2.00e-01 | 8.98e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 27 | 7.19e-02 | -2.00e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 5 | 4.38e-01 | -2.00e-01 | 9.15e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 17 | 1.53e-01 | -2.00e-01 | 7.89e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 16 | 1.66e-01 | 2.00e-01 | 8.04e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 4.39e-01 | -2.00e-01 | 9.15e-01 |
| GOMF SIALIC ACID BINDING | 10 | 2.74e-01 | 2.00e-01 | 8.58e-01 |
| GOMF LRR DOMAIN BINDING | 14 | 1.96e-01 | 2.00e-01 | 8.20e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 17 | 1.54e-01 | 2.00e-01 | 7.89e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 1.67e-01 | -2.00e-01 | 8.04e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 3.97e-01 | -2.00e-01 | 8.98e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 27 | 7.26e-02 | 2.00e-01 | 6.80e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 16 | 1.67e-01 | -2.00e-01 | 8.04e-01 |
| GOBP ZINC ION TRANSPORT | 17 | 1.54e-01 | 2.00e-01 | 7.89e-01 |
| GOMF WNT PROTEIN BINDING | 9 | 3.00e-01 | 1.99e-01 | 8.73e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 18 | 1.44e-01 | 1.99e-01 | 7.75e-01 |
| GOMF DEATH RECEPTOR BINDING | 13 | 2.14e-01 | -1.99e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 7 | 3.62e-01 | -1.99e-01 | 8.92e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 41 | 2.76e-02 | 1.99e-01 | 5.56e-01 |
| GOBP BICARBONATE TRANSPORT | 16 | 1.69e-01 | 1.99e-01 | 8.04e-01 |
| GOBP RNA METHYLATION | 83 | 1.76e-03 | 1.99e-01 | 2.29e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 5 | 4.41e-01 | 1.99e-01 | 9.16e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 14 | 1.99e-01 | -1.98e-01 | 8.23e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 1.99e-01 | 1.98e-01 | 8.23e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 6 | 4.00e-01 | -1.98e-01 | 8.99e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 20 | 1.25e-01 | -1.98e-01 | 7.55e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 8 | 3.31e-01 | 1.98e-01 | 8.79e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 12 | 2.35e-01 | -1.98e-01 | 8.39e-01 |
| GOBP DENDRITE EXTENSION | 20 | 1.25e-01 | 1.98e-01 | 7.55e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 40 | 3.04e-02 | 1.98e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 4.02e-01 | -1.98e-01 | 8.99e-01 |
| GOMF PROTEASE BINDING | 88 | 1.36e-03 | -1.98e-01 | 2.07e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 12 | 2.36e-01 | -1.98e-01 | 8.40e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 20 | 1.26e-01 | 1.98e-01 | 7.55e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 1.85e-01 | 1.98e-01 | 8.11e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 12 | 2.36e-01 | -1.98e-01 | 8.40e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 3.05e-01 | 1.98e-01 | 8.75e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 7 | 3.65e-01 | 1.98e-01 | 8.92e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 6 | 4.02e-01 | -1.98e-01 | 8.99e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 2.80e-01 | 1.98e-01 | 8.63e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 11 | 2.57e-01 | 1.97e-01 | 8.50e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 2.36e-01 | -1.97e-01 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 3.05e-01 | -1.97e-01 | 8.75e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 9 | 3.06e-01 | 1.97e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 3.34e-01 | 1.97e-01 | 8.82e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 10 | 2.80e-01 | -1.97e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 2.80e-01 | 1.97e-01 | 8.63e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 1.60e-01 | -1.97e-01 | 7.96e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 32 | 5.38e-02 | 1.97e-01 | 6.62e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 9 | 3.06e-01 | 1.97e-01 | 8.75e-01 |
| GOMF FILAMIN BINDING | 6 | 4.04e-01 | -1.97e-01 | 8.99e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 3.67e-01 | -1.97e-01 | 8.92e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 13 | 2.19e-01 | 1.97e-01 | 8.32e-01 |
| GOBP REGULATION OF NEURON MATURATION | 5 | 4.47e-01 | 1.97e-01 | 9.18e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 3.68e-01 | 1.97e-01 | 8.92e-01 |
| GOBP NEURON CELL CELL ADHESION | 6 | 4.05e-01 | -1.96e-01 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 13 | 2.20e-01 | 1.96e-01 | 8.32e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 7 | 3.68e-01 | -1.96e-01 | 8.92e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 5 | 4.47e-01 | 1.96e-01 | 9.19e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 5 | 4.47e-01 | 1.96e-01 | 9.19e-01 |
| GOMF U1 SNRNP BINDING | 6 | 4.05e-01 | -1.96e-01 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 15 | 1.89e-01 | 1.96e-01 | 8.14e-01 |
| GOBP RESPONSE TO LEAD ION | 16 | 1.75e-01 | -1.96e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 9 | 3.09e-01 | -1.96e-01 | 8.75e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 3.70e-01 | -1.96e-01 | 8.92e-01 |
| GOMF PROTEIN KINASE C BINDING | 34 | 4.82e-02 | -1.96e-01 | 6.48e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 5 | 4.48e-01 | 1.96e-01 | 9.19e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 4.48e-01 | -1.96e-01 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 4.06e-01 | 1.96e-01 | 8.99e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 3.38e-01 | 1.96e-01 | 8.83e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 7 | 3.70e-01 | 1.96e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 7 | 3.70e-01 | 1.96e-01 | 8.92e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 14 | 2.06e-01 | 1.95e-01 | 8.28e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 3.39e-01 | 1.95e-01 | 8.83e-01 |
| GOMF TRNA BINDING | 63 | 7.47e-03 | 1.95e-01 | 4.17e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 4.50e-01 | 1.95e-01 | 9.21e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 29 | 6.93e-02 | -1.95e-01 | 6.73e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 2.24e-01 | 1.95e-01 | 8.32e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 2.86e-01 | -1.95e-01 | 8.67e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 8 | 3.40e-01 | -1.95e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 6 | 4.09e-01 | 1.95e-01 | 9.02e-01 |
| GOCC RIBOSOME | 221 | 6.69e-07 | -1.95e-01 | 5.48e-04 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 28 | 7.49e-02 | 1.95e-01 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 13 | 2.26e-01 | 1.94e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 5 | 4.52e-01 | 1.94e-01 | 9.21e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 4.53e-01 | -1.94e-01 | 9.21e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 26 | 8.70e-02 | -1.94e-01 | 7.11e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 51 | 1.67e-02 | 1.94e-01 | 4.95e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 4.53e-01 | 1.94e-01 | 9.21e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 21 | 1.25e-01 | 1.94e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 6 | 4.12e-01 | 1.94e-01 | 9.04e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 2.67e-01 | 1.93e-01 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 18 | 1.56e-01 | 1.93e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 4.54e-01 | 1.93e-01 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 4.54e-01 | 1.93e-01 | 9.22e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 4.54e-01 | 1.93e-01 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 3.44e-01 | 1.93e-01 | 8.86e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 33 | 5.50e-02 | 1.93e-01 | 6.62e-01 |
| GOBP WATER TRANSPORT | 8 | 3.44e-01 | -1.93e-01 | 8.86e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 12 | 2.47e-01 | 1.93e-01 | 8.49e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 11 | 2.68e-01 | -1.93e-01 | 8.56e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 20 | 1.36e-01 | 1.93e-01 | 7.62e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 24 | 1.02e-01 | -1.93e-01 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 5 | 4.55e-01 | 1.93e-01 | 9.23e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 24 | 1.02e-01 | 1.93e-01 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 4.56e-01 | -1.93e-01 | 9.23e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 35 | 4.87e-02 | -1.93e-01 | 6.48e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 28 | 7.79e-02 | 1.93e-01 | 6.92e-01 |
| GOBP HEART FORMATION | 12 | 2.48e-01 | 1.93e-01 | 8.49e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 26 | 8.94e-02 | 1.93e-01 | 7.11e-01 |
| GOCC AMPHISOME MEMBRANE | 10 | 2.92e-01 | -1.92e-01 | 8.70e-01 |
| GOCC DENDRITIC SHAFT | 20 | 1.36e-01 | 1.92e-01 | 7.62e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 24 | 1.03e-01 | 1.92e-01 | 7.39e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 31 | 6.41e-02 | 1.92e-01 | 6.70e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 60 | 1.01e-02 | 1.92e-01 | 4.37e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 4.57e-01 | -1.92e-01 | 9.23e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 13 | 2.31e-01 | -1.92e-01 | 8.37e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 57 | 1.24e-02 | 1.92e-01 | 4.65e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 7 | 3.80e-01 | -1.92e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 25 | 9.73e-02 | 1.92e-01 | 7.33e-01 |
| GOCC SEPTIN CYTOSKELETON | 10 | 2.94e-01 | 1.92e-01 | 8.71e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 4.59e-01 | -1.91e-01 | 9.24e-01 |
| GOBP RRNA TRANSCRIPTION | 31 | 6.53e-02 | 1.91e-01 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 10 | 2.95e-01 | 1.91e-01 | 8.71e-01 |
| GOBP PEROXISOMAL TRANSPORT | 21 | 1.29e-01 | -1.91e-01 | 7.57e-01 |
| GOBP SPERM DNA CONDENSATION | 6 | 4.17e-01 | -1.91e-01 | 9.08e-01 |
| GOMF PROFILIN BINDING | 6 | 4.18e-01 | -1.91e-01 | 9.08e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 8 | 3.50e-01 | 1.91e-01 | 8.87e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 40 | 3.67e-02 | 1.91e-01 | 6.07e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 10 | 2.96e-01 | 1.91e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 4.18e-01 | 1.91e-01 | 9.08e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 23 | 1.13e-01 | -1.91e-01 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 34 | 5.42e-02 | 1.91e-01 | 6.62e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 48 | 2.23e-02 | -1.91e-01 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 16 | 1.87e-01 | 1.91e-01 | 8.14e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 3.82e-01 | -1.91e-01 | 8.97e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 9 | 3.22e-01 | 1.91e-01 | 8.76e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 8 | 3.51e-01 | -1.90e-01 | 8.88e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 23 | 1.14e-01 | 1.90e-01 | 7.52e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 3.23e-01 | -1.90e-01 | 8.76e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 2.54e-01 | 1.90e-01 | 8.50e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 15 | 2.03e-01 | 1.90e-01 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 14 | 2.19e-01 | -1.90e-01 | 8.32e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 5 | 4.62e-01 | -1.90e-01 | 9.25e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 2.55e-01 | -1.90e-01 | 8.50e-01 |
| GOCC HAUS COMPLEX | 8 | 3.53e-01 | -1.90e-01 | 8.88e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 13 | 2.37e-01 | 1.90e-01 | 8.40e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 9 | 3.25e-01 | 1.90e-01 | 8.76e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 5 | 4.63e-01 | 1.89e-01 | 9.25e-01 |
| GOBP HEART VALVE DEVELOPMENT | 34 | 5.60e-02 | 1.89e-01 | 6.62e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 49 | 2.19e-02 | 1.89e-01 | 5.33e-01 |
| GOBP TELOMERE CAPPING | 36 | 4.94e-02 | 1.89e-01 | 6.48e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 4.22e-01 | -1.89e-01 | 9.11e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 5 | 4.64e-01 | 1.89e-01 | 9.25e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 23 | 1.16e-01 | 1.89e-01 | 7.52e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 25 | 1.02e-01 | 1.89e-01 | 7.39e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 4.64e-01 | -1.89e-01 | 9.25e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 8 | 3.55e-01 | -1.89e-01 | 8.88e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 3.87e-01 | 1.89e-01 | 8.97e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 29 | 7.85e-02 | 1.89e-01 | 6.93e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 2.58e-01 | -1.89e-01 | 8.50e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 3.87e-01 | 1.89e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 6 | 4.24e-01 | 1.89e-01 | 9.13e-01 |
| GOMF NADPLUS BINDING | 16 | 1.92e-01 | 1.89e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 8 | 3.56e-01 | -1.89e-01 | 8.88e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 6 | 4.24e-01 | 1.89e-01 | 9.13e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 3.88e-01 | -1.88e-01 | 8.97e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 33 | 6.11e-02 | -1.88e-01 | 6.68e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 17 | 1.79e-01 | 1.88e-01 | 8.07e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 12 | 2.59e-01 | 1.88e-01 | 8.50e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 30 | 7.45e-02 | -1.88e-01 | 6.85e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 24 | 1.11e-01 | 1.88e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 44 | 3.09e-02 | 1.88e-01 | 5.75e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 5 | 4.66e-01 | 1.88e-01 | 9.25e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 4.66e-01 | -1.88e-01 | 9.25e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 90 | 2.06e-03 | -1.88e-01 | 2.49e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 13 | 2.40e-01 | -1.88e-01 | 8.43e-01 |
| GOBP COPII COATED VESICLE BUDDING | 41 | 3.73e-02 | -1.88e-01 | 6.08e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 99 | 1.25e-03 | -1.88e-01 | 1.93e-01 |
| GOMF NUCLEOSOME BINDING | 51 | 2.03e-02 | 1.88e-01 | 5.22e-01 |
| GOBP REGULATION OF COAGULATION | 27 | 9.11e-02 | 1.88e-01 | 7.14e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 3.89e-01 | -1.88e-01 | 8.97e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 5 | 4.67e-01 | 1.88e-01 | 9.25e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 23 | 1.19e-01 | 1.88e-01 | 7.52e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 30 | 7.53e-02 | -1.88e-01 | 6.85e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 1.28e-01 | -1.88e-01 | 7.55e-01 |
| GOBP BONE DEVELOPMENT | 102 | 1.07e-03 | 1.88e-01 | 1.74e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 29 | 8.04e-02 | 1.88e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 14 | 2.24e-01 | 1.88e-01 | 8.32e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 9 | 3.30e-01 | -1.88e-01 | 8.78e-01 |
| GOCC CILIARY MEMBRANE | 32 | 6.66e-02 | -1.87e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 9 | 3.30e-01 | 1.87e-01 | 8.79e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 38 | 4.58e-02 | -1.87e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 6 | 4.28e-01 | -1.87e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 4.69e-01 | 1.87e-01 | 9.26e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 14 | 2.26e-01 | 1.87e-01 | 8.32e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 13 | 2.44e-01 | 1.87e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 6 | 4.28e-01 | 1.87e-01 | 9.14e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 6.79e-02 | 1.87e-01 | 6.72e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 3.61e-01 | -1.87e-01 | 8.91e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 10 | 3.07e-01 | 1.87e-01 | 8.75e-01 |
| GOCC CALYX OF HELD | 8 | 3.61e-01 | 1.87e-01 | 8.91e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 2.63e-01 | 1.86e-01 | 8.52e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 28 | 8.78e-02 | -1.86e-01 | 7.11e-01 |
| GOBP NUCLEOSIDE SALVAGE | 9 | 3.33e-01 | 1.86e-01 | 8.80e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 4.29e-01 | -1.86e-01 | 9.14e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 16 | 1.97e-01 | 1.86e-01 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 4.71e-01 | 1.86e-01 | 9.26e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 3.08e-01 | -1.86e-01 | 8.75e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 17 | 1.84e-01 | 1.86e-01 | 8.10e-01 |
| GOBP UTP METABOLIC PROCESS | 10 | 3.08e-01 | -1.86e-01 | 8.75e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 10 | 3.09e-01 | 1.86e-01 | 8.75e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 74 | 5.79e-03 | -1.86e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 2.87e-01 | 1.86e-01 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 7 | 3.95e-01 | 1.86e-01 | 8.98e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 15 | 2.14e-01 | 1.85e-01 | 8.32e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 5 | 4.73e-01 | -1.85e-01 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 20 | 1.52e-01 | -1.85e-01 | 7.89e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.32e-01 | -1.85e-01 | 9.14e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 4.73e-01 | 1.85e-01 | 9.26e-01 |
| GOMF TAU PROTEIN BINDING | 35 | 5.84e-02 | 1.85e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 11 | 2.88e-01 | -1.85e-01 | 8.68e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 8 | 3.65e-01 | -1.85e-01 | 8.92e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 9 | 3.37e-01 | -1.85e-01 | 8.83e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 7 | 3.97e-01 | 1.85e-01 | 8.98e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 28 | 9.08e-02 | 1.85e-01 | 7.14e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 8 | 3.66e-01 | 1.85e-01 | 8.92e-01 |
| GOBP NEURON MATURATION | 24 | 1.18e-01 | 1.85e-01 | 7.52e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 2.33e-01 | -1.84e-01 | 8.37e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 17 | 1.89e-01 | 1.84e-01 | 8.14e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 7 | 3.99e-01 | -1.84e-01 | 8.99e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 29 | 8.62e-02 | 1.84e-01 | 7.11e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 17 | 1.89e-01 | -1.84e-01 | 8.14e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 6 | 4.35e-01 | 1.84e-01 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 20 | 1.55e-01 | 1.84e-01 | 7.89e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 11 | 2.91e-01 | 1.84e-01 | 8.69e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 41 | 4.17e-02 | 1.84e-01 | 6.21e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 26 | 1.05e-01 | 1.84e-01 | 7.40e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 59 | 1.47e-02 | -1.84e-01 | 4.75e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 11 | 2.91e-01 | 1.84e-01 | 8.69e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 3.68e-01 | -1.84e-01 | 8.92e-01 |
| GOBP MEMBRANE DISASSEMBLY | 10 | 3.14e-01 | 1.84e-01 | 8.76e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 4.00e-01 | -1.84e-01 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 38 | 5.03e-02 | -1.84e-01 | 6.52e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 4.00e-01 | 1.84e-01 | 8.99e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 4.36e-01 | 1.84e-01 | 9.14e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 4.78e-01 | 1.83e-01 | 9.26e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 10 | 3.16e-01 | 1.83e-01 | 8.76e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 29 | 8.77e-02 | 1.83e-01 | 7.11e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 2.19e-01 | -1.83e-01 | 8.32e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 21 | 1.46e-01 | -1.83e-01 | 7.79e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 3.70e-01 | -1.83e-01 | 8.92e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 4.37e-01 | -1.83e-01 | 9.14e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 24 | 1.21e-01 | -1.83e-01 | 7.52e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 7 | 4.02e-01 | -1.83e-01 | 8.99e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 8 | 3.70e-01 | -1.83e-01 | 8.92e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 23 | 1.29e-01 | 1.83e-01 | 7.57e-01 |
| GOCC SARCOPLASMIC RETICULUM | 34 | 6.52e-02 | 1.83e-01 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 7 | 4.03e-01 | -1.83e-01 | 8.99e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 5 | 4.79e-01 | 1.83e-01 | 9.26e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 18 | 1.80e-01 | 1.82e-01 | 8.07e-01 |
| GOBP MELANIN METABOLIC PROCESS | 13 | 2.55e-01 | -1.82e-01 | 8.50e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 11 | 2.95e-01 | 1.82e-01 | 8.71e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 1.81e-01 | -1.82e-01 | 8.07e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 8 | 3.72e-01 | -1.82e-01 | 8.95e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 19 | 1.69e-01 | 1.82e-01 | 8.04e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 4.81e-01 | 1.82e-01 | 9.26e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 3.73e-01 | 1.82e-01 | 8.95e-01 |
| GOCC BORC COMPLEX | 8 | 3.73e-01 | 1.82e-01 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 40 | 4.64e-02 | -1.82e-01 | 6.36e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 28 | 9.57e-02 | 1.82e-01 | 7.30e-01 |
| GOMF VITAMIN B6 BINDING | 28 | 9.58e-02 | 1.82e-01 | 7.30e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 15 | 2.23e-01 | 1.82e-01 | 8.32e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 22 | 1.40e-01 | -1.82e-01 | 7.68e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 8 | 3.73e-01 | -1.82e-01 | 8.96e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 24 | 1.24e-01 | 1.82e-01 | 7.55e-01 |
| GOCC HOPS COMPLEX | 9 | 3.46e-01 | 1.82e-01 | 8.87e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 5 | 4.82e-01 | 1.82e-01 | 9.27e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 6 | 4.42e-01 | -1.81e-01 | 9.16e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 3.46e-01 | 1.81e-01 | 8.87e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 46 | 3.37e-02 | -1.81e-01 | 5.88e-01 |
| GOBP AMINO ACID ACTIVATION | 24 | 1.25e-01 | 1.81e-01 | 7.55e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 6 | 4.43e-01 | 1.81e-01 | 9.16e-01 |
| GOBP TYPE II HYPERSENSITIVITY | 5 | 4.84e-01 | 1.81e-01 | 9.28e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 9 | 3.48e-01 | 1.81e-01 | 8.87e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 2.11e-01 | 1.81e-01 | 8.32e-01 |
| GOMF DEAMINASE ACTIVITY | 23 | 1.34e-01 | 1.81e-01 | 7.62e-01 |
| GOBP RESPONSE TO ACIDIC PH | 11 | 3.00e-01 | -1.81e-01 | 8.73e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 13 | 2.60e-01 | 1.81e-01 | 8.51e-01 |
| GOCC U2 SNRNP | 25 | 1.18e-01 | -1.81e-01 | 7.52e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 24 | 1.26e-01 | -1.80e-01 | 7.55e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 16 | 2.11e-01 | 1.80e-01 | 8.32e-01 |
| GOCC BBSOME | 7 | 4.08e-01 | 1.80e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 12 | 2.79e-01 | -1.80e-01 | 8.63e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 26 | 1.12e-01 | -1.80e-01 | 7.50e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 9 | 3.49e-01 | -1.80e-01 | 8.87e-01 |
| GOBP VACUOLE FUSION | 11 | 3.01e-01 | -1.80e-01 | 8.73e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 5 | 4.85e-01 | 1.80e-01 | 9.29e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 6 | 4.45e-01 | 1.80e-01 | 9.17e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 4.85e-01 | -1.80e-01 | 9.29e-01 |
| GOBP VASCULAR TRANSPORT | 42 | 4.35e-02 | 1.80e-01 | 6.26e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 12 | 2.80e-01 | -1.80e-01 | 8.63e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 1.75e-01 | -1.80e-01 | 8.07e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 69 | 9.80e-03 | 1.80e-01 | 4.30e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 4.45e-01 | 1.80e-01 | 9.17e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 13 | 2.61e-01 | 1.80e-01 | 8.51e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 24 | 1.28e-01 | 1.80e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 5 | 4.87e-01 | 1.80e-01 | 9.30e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 8 | 3.79e-01 | 1.80e-01 | 8.97e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 12 | 2.82e-01 | 1.79e-01 | 8.65e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 12 | 2.82e-01 | 1.79e-01 | 8.65e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 4.12e-01 | -1.79e-01 | 9.04e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 3.81e-01 | -1.79e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 4.88e-01 | 1.79e-01 | 9.30e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 9 | 3.53e-01 | 1.79e-01 | 8.88e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 6 | 4.48e-01 | 1.79e-01 | 9.19e-01 |
| GOBP DOPAMINE TRANSPORT | 16 | 2.16e-01 | 1.79e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 13 | 2.64e-01 | 1.79e-01 | 8.52e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 2.84e-01 | 1.79e-01 | 8.66e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 10 | 3.28e-01 | 1.79e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 4.89e-01 | 1.79e-01 | 9.30e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 11 | 3.05e-01 | 1.78e-01 | 8.75e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 16 | 2.17e-01 | 1.78e-01 | 8.32e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 27 | 1.09e-01 | -1.78e-01 | 7.47e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 3.83e-01 | 1.78e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 42 | 4.58e-02 | -1.78e-01 | 6.34e-01 |
| GOCC MYOSIN FILAMENT | 7 | 4.15e-01 | 1.78e-01 | 9.08e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 2.86e-01 | 1.78e-01 | 8.67e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 4.91e-01 | 1.78e-01 | 9.31e-01 |
| GOMF PROTEASOME BINDING | 15 | 2.33e-01 | -1.78e-01 | 8.37e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 98 | 2.41e-03 | 1.78e-01 | 2.78e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 6 | 4.51e-01 | 1.78e-01 | 9.21e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 7 | 4.16e-01 | -1.78e-01 | 9.08e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 2.87e-01 | 1.78e-01 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 13 | 2.68e-01 | 1.77e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 4.16e-01 | 1.77e-01 | 9.08e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 4.16e-01 | 1.77e-01 | 9.08e-01 |
| GOMF PEPTIDE HORMONE BINDING | 14 | 2.50e-01 | 1.77e-01 | 8.50e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 14 | 2.51e-01 | 1.77e-01 | 8.50e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 11 | 3.09e-01 | 1.77e-01 | 8.75e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 6 | 4.52e-01 | -1.77e-01 | 9.21e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 35 | 6.99e-02 | 1.77e-01 | 6.73e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 13 | 2.69e-01 | 1.77e-01 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 4.93e-01 | 1.77e-01 | 9.31e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 4.93e-01 | 1.77e-01 | 9.31e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 4.93e-01 | 1.77e-01 | 9.31e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 11 | 3.10e-01 | 1.77e-01 | 8.75e-01 |
| GOMF HORMONE RECEPTOR BINDING | 7 | 4.18e-01 | -1.77e-01 | 9.08e-01 |
| GOCC GTPASE COMPLEX | 26 | 1.19e-01 | -1.77e-01 | 7.52e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 11 | 3.11e-01 | 1.77e-01 | 8.76e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 5 | 4.94e-01 | -1.77e-01 | 9.31e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 9 | 3.59e-01 | -1.76e-01 | 8.90e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 11 | 3.11e-01 | 1.76e-01 | 8.76e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 14 | 2.54e-01 | -1.76e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 14 | 2.54e-01 | -1.76e-01 | 8.50e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 4.95e-01 | 1.76e-01 | 9.31e-01 |
| GOBP SLEEP | 9 | 3.61e-01 | -1.76e-01 | 8.91e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 4.20e-01 | 1.76e-01 | 9.09e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 36 | 6.83e-02 | 1.76e-01 | 6.72e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 3.13e-01 | 1.76e-01 | 8.76e-01 |
| GOCC MITOTIC SPINDLE POLE | 30 | 9.60e-02 | 1.76e-01 | 7.30e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 42 | 4.92e-02 | -1.76e-01 | 6.48e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 11 | 3.14e-01 | -1.75e-01 | 8.76e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 5 | 4.97e-01 | -1.75e-01 | 9.31e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 8 | 3.91e-01 | 1.75e-01 | 8.97e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 2.25e-01 | 1.75e-01 | 8.32e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 16 | 2.25e-01 | 1.75e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 8 | 3.91e-01 | 1.75e-01 | 8.97e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 8 | 3.92e-01 | 1.75e-01 | 8.97e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 18 | 1.99e-01 | -1.75e-01 | 8.24e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 4.58e-01 | 1.75e-01 | 9.24e-01 |
| GOBP CAMP METABOLIC PROCESS | 12 | 2.95e-01 | -1.75e-01 | 8.71e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 23 | 1.47e-01 | 1.75e-01 | 7.82e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 3.65e-01 | -1.75e-01 | 8.92e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 2.95e-01 | -1.74e-01 | 8.71e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 2.76e-01 | -1.74e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 7 | 4.24e-01 | 1.74e-01 | 9.13e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 5.00e-01 | 1.74e-01 | 9.31e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 3.93e-01 | 1.74e-01 | 8.97e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 18 | 2.01e-01 | -1.74e-01 | 8.26e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 3.94e-01 | 1.74e-01 | 8.97e-01 |
| GOMF LIPASE ACTIVITY | 73 | 1.02e-02 | -1.74e-01 | 4.37e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 20 | 1.78e-01 | 1.74e-01 | 8.07e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 32 | 8.85e-02 | -1.74e-01 | 7.11e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 5 | 5.01e-01 | -1.74e-01 | 9.31e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 41 | 5.41e-02 | -1.74e-01 | 6.62e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 4.26e-01 | 1.74e-01 | 9.13e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 12 | 2.97e-01 | 1.74e-01 | 8.71e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 2.61e-01 | 1.74e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 10 | 3.42e-01 | 1.74e-01 | 8.84e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.27e-01 | -1.74e-01 | 9.13e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 6 | 4.62e-01 | 1.73e-01 | 9.25e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 10 | 3.42e-01 | 1.73e-01 | 8.84e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 1.91e-01 | -1.73e-01 | 8.16e-01 |
| GOCC COPI VESICLE COAT | 13 | 2.79e-01 | 1.73e-01 | 8.63e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 40 | 5.80e-02 | 1.73e-01 | 6.64e-01 |
| GOBP ASTROCYTE ACTIVATION | 16 | 2.30e-01 | -1.73e-01 | 8.36e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 4.63e-01 | -1.73e-01 | 9.25e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 8 | 3.97e-01 | 1.73e-01 | 8.98e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 26 | 1.27e-01 | -1.73e-01 | 7.55e-01 |
| GOBP PROTEIN DESTABILIZATION | 43 | 4.99e-02 | 1.73e-01 | 6.49e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 26 | 1.27e-01 | -1.73e-01 | 7.55e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 5.03e-01 | -1.73e-01 | 9.31e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 13 | 2.80e-01 | -1.73e-01 | 8.63e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 20 | 1.81e-01 | -1.73e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 4.64e-01 | 1.73e-01 | 9.25e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 9 | 3.70e-01 | 1.73e-01 | 8.92e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 12 | 3.01e-01 | -1.73e-01 | 8.73e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 20 | 1.82e-01 | 1.73e-01 | 8.07e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 17 | 2.18e-01 | 1.73e-01 | 8.32e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 7 | 4.30e-01 | 1.72e-01 | 9.14e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 7 | 4.30e-01 | 1.72e-01 | 9.14e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 1.44e-01 | 1.72e-01 | 7.75e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 12 | 3.02e-01 | 1.72e-01 | 8.74e-01 |
| GOCC SWR1 COMPLEX | 13 | 2.82e-01 | 1.72e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 18 | 2.06e-01 | 1.72e-01 | 8.28e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 9 | 3.71e-01 | -1.72e-01 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 25 | 1.37e-01 | 1.72e-01 | 7.62e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 10 | 3.46e-01 | 1.72e-01 | 8.87e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 25 | 1.37e-01 | 1.72e-01 | 7.62e-01 |
| GOCC NURF COMPLEX | 6 | 4.66e-01 | 1.72e-01 | 9.25e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 3.24e-01 | -1.72e-01 | 8.76e-01 |
| GOBP ENDODERM FORMATION | 21 | 1.73e-01 | -1.72e-01 | 8.07e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 17 | 2.20e-01 | 1.72e-01 | 8.32e-01 |
| GOMF ALPHA CATENIN BINDING | 6 | 4.66e-01 | 1.72e-01 | 9.25e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 3.24e-01 | 1.72e-01 | 8.76e-01 |
| GOBP OPSONIZATION | 5 | 5.06e-01 | -1.72e-01 | 9.31e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 2.50e-01 | 1.72e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 32 | 9.31e-02 | -1.72e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 27 | 1.23e-01 | -1.72e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 12 | 3.04e-01 | -1.71e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 27 | 1.23e-01 | -1.71e-01 | 7.55e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 38 | 6.76e-02 | -1.71e-01 | 6.72e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 7 | 4.32e-01 | 1.71e-01 | 9.14e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 3.74e-01 | 1.71e-01 | 8.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 16 | 2.36e-01 | 1.71e-01 | 8.40e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 2.51e-01 | -1.71e-01 | 8.50e-01 |
| GOBP MEMBRANE REPOLARIZATION | 16 | 2.36e-01 | 1.71e-01 | 8.40e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 17 | 2.22e-01 | -1.71e-01 | 8.32e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 19 | 1.97e-01 | -1.71e-01 | 8.22e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 6 | 4.69e-01 | 1.71e-01 | 9.26e-01 |
| GOMF OPSONIN BINDING | 8 | 4.03e-01 | 1.71e-01 | 8.99e-01 |
| GOCC MYOFILAMENT | 11 | 3.27e-01 | 1.71e-01 | 8.76e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 7 | 4.35e-01 | 1.70e-01 | 9.14e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 5 | 5.10e-01 | -1.70e-01 | 9.32e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 16 | 2.38e-01 | 1.70e-01 | 8.42e-01 |
| GOBP AXIS SPECIFICATION | 35 | 8.14e-02 | 1.70e-01 | 6.95e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 88 | 5.83e-03 | 1.70e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 30 | 1.07e-01 | 1.70e-01 | 7.42e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 14 | 2.70e-01 | -1.70e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 9 | 3.77e-01 | 1.70e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 10 | 3.52e-01 | -1.70e-01 | 8.88e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 3.77e-01 | 1.70e-01 | 8.97e-01 |
| GOBP RESPONSE TO LITHIUM ION | 7 | 4.36e-01 | 1.70e-01 | 9.14e-01 |
| GOBP SIRNA PROCESSING | 8 | 4.06e-01 | 1.70e-01 | 8.99e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 28 | 1.20e-01 | -1.70e-01 | 7.52e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 6 | 4.72e-01 | -1.70e-01 | 9.26e-01 |
| GOCC FEMALE PRONUCLEUS | 7 | 4.37e-01 | 1.70e-01 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 10 | 3.53e-01 | -1.70e-01 | 8.88e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 16 | 2.40e-01 | -1.70e-01 | 8.43e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 25 | 1.42e-01 | -1.70e-01 | 7.75e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 5 | 5.11e-01 | -1.70e-01 | 9.32e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 27 | 1.28e-01 | 1.70e-01 | 7.55e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 8 | 4.06e-01 | 1.70e-01 | 8.99e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 4.73e-01 | -1.69e-01 | 9.26e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 11 | 3.31e-01 | -1.69e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 10 | 3.54e-01 | 1.69e-01 | 8.88e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 26 | 1.35e-01 | -1.69e-01 | 7.62e-01 |
| GOBP TOOTH MINERALIZATION | 13 | 2.91e-01 | -1.69e-01 | 8.69e-01 |
| GOMF SIRNA BINDING | 10 | 3.55e-01 | -1.69e-01 | 8.88e-01 |
| GOBP CERAMIDE TRANSPORT | 9 | 3.80e-01 | -1.69e-01 | 8.97e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 23 | 1.61e-01 | 1.69e-01 | 7.96e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 21 | 1.80e-01 | 1.69e-01 | 8.07e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 16 | 2.42e-01 | 1.69e-01 | 8.43e-01 |
| GOCC STEREOCILIUM TIP | 7 | 4.39e-01 | 1.69e-01 | 9.15e-01 |
| GOBP THALAMUS DEVELOPMENT | 5 | 5.13e-01 | -1.69e-01 | 9.33e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 44 | 5.27e-02 | 1.69e-01 | 6.61e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 25 | 1.44e-01 | 1.69e-01 | 7.75e-01 |
| GOBP RESPONSE TO VITAMIN D | 17 | 2.28e-01 | 1.69e-01 | 8.34e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 28 | 1.22e-01 | 1.69e-01 | 7.54e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 54 | 3.21e-02 | 1.69e-01 | 5.85e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 30 | 1.10e-01 | 1.69e-01 | 7.49e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 20 | 1.92e-01 | -1.69e-01 | 8.17e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 19 | 2.04e-01 | -1.69e-01 | 8.28e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 5 | 5.14e-01 | 1.69e-01 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 46 | 4.85e-02 | 1.68e-01 | 6.48e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 5.15e-01 | -1.68e-01 | 9.34e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 15 | 2.59e-01 | 1.68e-01 | 8.51e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 11 | 3.34e-01 | 1.68e-01 | 8.82e-01 |
| GOCC CILIARY BASE | 24 | 1.54e-01 | 1.68e-01 | 7.89e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 5 | 5.15e-01 | 1.68e-01 | 9.34e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 11 | 3.34e-01 | 1.68e-01 | 8.82e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 41 | 6.27e-02 | -1.68e-01 | 6.68e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 16 | 2.45e-01 | 1.68e-01 | 8.49e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 42 | 6.02e-02 | 1.68e-01 | 6.68e-01 |
| GOBP AXONEME ASSEMBLY | 32 | 1.01e-01 | 1.68e-01 | 7.39e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 10 | 3.59e-01 | 1.68e-01 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 23 | 1.65e-01 | -1.67e-01 | 8.02e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 6 | 4.78e-01 | -1.67e-01 | 9.26e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 2.96e-01 | -1.67e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 6 | 4.78e-01 | 1.67e-01 | 9.26e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 17 | 2.33e-01 | -1.67e-01 | 8.37e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 26 | 1.40e-01 | 1.67e-01 | 7.68e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 21 | 1.85e-01 | 1.67e-01 | 8.11e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 5 | 5.18e-01 | 1.67e-01 | 9.35e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 2.33e-01 | 1.67e-01 | 8.37e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 3.86e-01 | 1.67e-01 | 8.97e-01 |
| GOBP THYMIC T CELL SELECTION | 16 | 2.48e-01 | 1.67e-01 | 8.49e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 5.18e-01 | -1.67e-01 | 9.35e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 5.18e-01 | 1.67e-01 | 9.35e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 6 | 4.79e-01 | 1.67e-01 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 17 | 2.34e-01 | 1.67e-01 | 8.38e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 5.19e-01 | -1.67e-01 | 9.35e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 2.09e-01 | 1.67e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 4.46e-01 | 1.67e-01 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 7 | 4.46e-01 | 1.67e-01 | 9.17e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 7 | 4.46e-01 | 1.66e-01 | 9.17e-01 |
| GOBP SNRNA PROCESSING | 26 | 1.42e-01 | 1.66e-01 | 7.74e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 17 | 2.35e-01 | 1.66e-01 | 8.40e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 4.16e-01 | -1.66e-01 | 9.08e-01 |
| GOCC PERIKARYON | 58 | 2.87e-02 | 1.66e-01 | 5.64e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 60 | 2.62e-02 | 1.66e-01 | 5.51e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 11 | 3.40e-01 | 1.66e-01 | 8.84e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 14 | 2.82e-01 | -1.66e-01 | 8.65e-01 |
| GOCC INTERCALATED DISC | 25 | 1.51e-01 | 1.66e-01 | 7.89e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 10 | 3.64e-01 | -1.66e-01 | 8.92e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 17 | 2.37e-01 | 1.66e-01 | 8.40e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 23 | 1.69e-01 | -1.66e-01 | 8.04e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 5 | 5.21e-01 | 1.66e-01 | 9.35e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 16 | 2.51e-01 | -1.66e-01 | 8.50e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 52 | 3.89e-02 | -1.66e-01 | 6.12e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 32 | 1.05e-01 | 1.66e-01 | 7.42e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 4.18e-01 | 1.66e-01 | 9.08e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 4.18e-01 | -1.65e-01 | 9.08e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 10 | 3.65e-01 | -1.65e-01 | 8.92e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 55 | 3.42e-02 | 1.65e-01 | 5.88e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 2.85e-01 | -1.65e-01 | 8.67e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 11 | 3.43e-01 | 1.65e-01 | 8.85e-01 |
| GOBP INTESTINAL ABSORPTION | 16 | 2.53e-01 | 1.65e-01 | 8.50e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 19 | 2.13e-01 | 1.65e-01 | 8.32e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 19 | 2.13e-01 | -1.65e-01 | 8.32e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 6 | 4.84e-01 | -1.65e-01 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 13 | 3.04e-01 | -1.65e-01 | 8.75e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 36 | 8.75e-02 | 1.65e-01 | 7.11e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 4.20e-01 | -1.65e-01 | 9.09e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 36 | 8.80e-02 | 1.64e-01 | 7.11e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 32 | 1.08e-01 | 1.64e-01 | 7.43e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 4.21e-01 | -1.64e-01 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 4.86e-01 | -1.64e-01 | 9.29e-01 |
| GOBP CHOLESTEROL STORAGE | 20 | 2.04e-01 | -1.64e-01 | 8.28e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 3.94e-01 | -1.64e-01 | 8.97e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 14 | 2.88e-01 | -1.64e-01 | 8.68e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 44 | 6.01e-02 | 1.64e-01 | 6.68e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 4.75e-02 | -1.64e-01 | 6.42e-01 |
| GOBP GERM CELL PROLIFERATION | 8 | 4.23e-01 | -1.64e-01 | 9.13e-01 |
| GOBP CDP CHOLINE PATHWAY | 5 | 5.27e-01 | -1.63e-01 | 9.36e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 11 | 3.48e-01 | -1.63e-01 | 8.87e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 7 | 4.54e-01 | -1.63e-01 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 8 | 4.24e-01 | 1.63e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 16 | 2.58e-01 | -1.63e-01 | 8.50e-01 |
| GOBP ARTERY DEVELOPMENT | 45 | 5.81e-02 | 1.63e-01 | 6.64e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 14 | 2.90e-01 | 1.63e-01 | 8.69e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 3.08e-01 | 1.63e-01 | 8.75e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 111 | 3.00e-03 | -1.63e-01 | 3.11e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 5.27e-01 | 1.63e-01 | 9.36e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 11 | 3.49e-01 | -1.63e-01 | 8.87e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 14 | 2.91e-01 | -1.63e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 20 | 2.07e-01 | 1.63e-01 | 8.29e-01 |
| GOCC PSEUDOPODIUM | 11 | 3.49e-01 | -1.63e-01 | 8.87e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 12 | 3.28e-01 | -1.63e-01 | 8.76e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 6 | 4.89e-01 | -1.63e-01 | 9.30e-01 |
| GOBP BONE MATURATION | 13 | 3.09e-01 | 1.63e-01 | 8.75e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 19 | 2.19e-01 | -1.63e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 41 | 7.12e-02 | -1.63e-01 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 4.25e-01 | -1.63e-01 | 9.13e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 14 | 2.91e-01 | -1.63e-01 | 8.69e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 9 | 3.98e-01 | -1.63e-01 | 8.98e-01 |
| GOBP NEUROBLAST DIVISION | 7 | 4.56e-01 | 1.63e-01 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 8 | 4.26e-01 | 1.63e-01 | 9.13e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 5.29e-01 | -1.63e-01 | 9.37e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 8 | 4.26e-01 | 1.63e-01 | 9.13e-01 |
| GOCC TIGHT JUNCTION | 54 | 3.89e-02 | 1.63e-01 | 6.12e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 142 | 8.49e-04 | -1.63e-01 | 1.63e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 92 | 7.13e-03 | -1.63e-01 | 4.14e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 14 | 2.93e-01 | -1.63e-01 | 8.70e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 8 | 4.26e-01 | -1.62e-01 | 9.13e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 9 | 3.99e-01 | 1.62e-01 | 8.99e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 1.69e-01 | -1.62e-01 | 8.04e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 4.57e-01 | 1.62e-01 | 9.23e-01 |
| GOMF GLUTATHIONE BINDING | 6 | 4.91e-01 | -1.62e-01 | 9.31e-01 |
| GOCC FLEMMING BODY | 28 | 1.37e-01 | 1.62e-01 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 9 | 3.99e-01 | -1.62e-01 | 8.99e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 7 | 4.57e-01 | -1.62e-01 | 9.23e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 26 | 1.52e-01 | -1.62e-01 | 7.89e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 7 | 4.57e-01 | -1.62e-01 | 9.23e-01 |
| GOCC COMPACT MYELIN | 5 | 5.30e-01 | -1.62e-01 | 9.38e-01 |
| GOBP PROTEIN SUMOYLATION | 59 | 3.14e-02 | 1.62e-01 | 5.81e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 3.52e-01 | -1.62e-01 | 8.88e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 4.58e-01 | -1.62e-01 | 9.23e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 4.58e-01 | -1.62e-01 | 9.23e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 4.00e-01 | 1.62e-01 | 8.99e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 17 | 2.48e-01 | 1.62e-01 | 8.49e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 41 | 7.29e-02 | 1.62e-01 | 6.80e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 40 | 7.66e-02 | 1.62e-01 | 6.87e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 4.92e-01 | 1.62e-01 | 9.31e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 25 | 1.61e-01 | 1.62e-01 | 7.97e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 23 | 1.79e-01 | 1.62e-01 | 8.07e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 10 | 3.76e-01 | 1.62e-01 | 8.97e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 2.63e-01 | -1.62e-01 | 8.52e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 6 | 4.93e-01 | 1.62e-01 | 9.31e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 4.59e-01 | -1.62e-01 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 14 | 2.95e-01 | -1.62e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 12 | 3.33e-01 | -1.62e-01 | 8.80e-01 |
| GOBP REGULATION OF APPETITE | 9 | 4.01e-01 | -1.62e-01 | 8.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 8 | 4.29e-01 | -1.61e-01 | 9.14e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 27 | 1.47e-01 | 1.61e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 4.94e-01 | 1.61e-01 | 9.31e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 34 | 1.04e-01 | -1.61e-01 | 7.39e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 4.03e-01 | 1.61e-01 | 8.99e-01 |
| GOBP REGULATION OF GASTRULATION | 7 | 4.61e-01 | -1.61e-01 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 4.61e-01 | -1.61e-01 | 9.25e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 24 | 1.73e-01 | -1.61e-01 | 8.07e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 3.16e-01 | 1.61e-01 | 8.76e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 19 | 2.25e-01 | 1.61e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 4.31e-01 | -1.61e-01 | 9.14e-01 |
| GOMF OXIDIZED DNA BINDING | 10 | 3.79e-01 | -1.61e-01 | 8.97e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 5.34e-01 | -1.61e-01 | 9.40e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 4.96e-01 | -1.61e-01 | 9.31e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 7 | 4.62e-01 | 1.61e-01 | 9.25e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 20 | 2.14e-01 | -1.61e-01 | 8.32e-01 |
| GOBP NEUTROPHIL CLEARANCE | 5 | 5.34e-01 | 1.61e-01 | 9.40e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 103 | 4.95e-03 | 1.61e-01 | 3.63e-01 |
| GOBP PROTEIN OXIDATION | 7 | 4.62e-01 | -1.60e-01 | 9.25e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 9 | 4.05e-01 | 1.60e-01 | 8.99e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 3.17e-01 | 1.60e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 17 | 2.53e-01 | -1.60e-01 | 8.50e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 17 | 2.53e-01 | 1.60e-01 | 8.50e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 10 | 3.81e-01 | 1.60e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 9 | 4.05e-01 | -1.60e-01 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 32 | 1.17e-01 | 1.60e-01 | 7.52e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 5.36e-01 | 1.60e-01 | 9.40e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 34 | 1.07e-01 | 1.60e-01 | 7.42e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 5.36e-01 | -1.60e-01 | 9.40e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 3.38e-01 | 1.60e-01 | 8.83e-01 |
| GOBP GLYCOLIPID TRANSPORT | 7 | 4.64e-01 | -1.60e-01 | 9.25e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 11 | 3.59e-01 | 1.60e-01 | 8.90e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 4.98e-01 | -1.60e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 6 | 4.98e-01 | -1.60e-01 | 9.31e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 20 | 2.17e-01 | 1.60e-01 | 8.32e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 72 | 1.93e-02 | 1.60e-01 | 5.18e-01 |
| GOMF METHYL CPG BINDING | 19 | 2.29e-01 | -1.60e-01 | 8.34e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 45 | 6.45e-02 | -1.59e-01 | 6.70e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 11 | 3.60e-01 | 1.59e-01 | 8.91e-01 |
| GOBP PEROXISOME ORGANIZATION | 31 | 1.25e-01 | -1.59e-01 | 7.55e-01 |
| GOBP PEPTIDE CROSS LINKING | 7 | 4.66e-01 | -1.59e-01 | 9.25e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 5.93e-02 | -1.59e-01 | 6.67e-01 |
| GOCC CHROMATOID BODY | 5 | 5.38e-01 | -1.59e-01 | 9.40e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 44 | 6.81e-02 | 1.59e-01 | 6.72e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 12 | 3.40e-01 | 1.59e-01 | 8.84e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 22 | 1.97e-01 | -1.59e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 3.85e-01 | 1.59e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 12 | 3.41e-01 | 1.59e-01 | 8.84e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 10 | 3.85e-01 | 1.59e-01 | 8.97e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 3.85e-01 | -1.59e-01 | 8.97e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 10 | 3.85e-01 | 1.59e-01 | 8.97e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 16 | 2.72e-01 | -1.59e-01 | 8.58e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 3.86e-01 | 1.59e-01 | 8.97e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 6 | 5.02e-01 | -1.58e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 3.86e-01 | 1.58e-01 | 8.97e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 38 | 9.15e-02 | -1.58e-01 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 23 | 1.89e-01 | 1.58e-01 | 8.14e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 1.80e-01 | -1.58e-01 | 8.07e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 8 | 4.39e-01 | -1.58e-01 | 9.15e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 10 | 3.87e-01 | -1.58e-01 | 8.97e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 19 | 2.33e-01 | 1.58e-01 | 8.37e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 9.21e-02 | 1.58e-01 | 7.17e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 4.39e-01 | -1.58e-01 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 5.41e-01 | 1.58e-01 | 9.40e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 9 | 4.12e-01 | 1.58e-01 | 9.04e-01 |
| GOCC NUCLEAR REPLICATION FORK | 30 | 1.35e-01 | 1.58e-01 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 14 | 3.07e-01 | 1.58e-01 | 8.75e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 5.41e-01 | 1.58e-01 | 9.40e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 22 | 2.00e-01 | 1.58e-01 | 8.26e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 27 | 1.57e-01 | -1.58e-01 | 7.89e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 45 | 6.78e-02 | 1.57e-01 | 6.72e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 3.66e-01 | -1.57e-01 | 8.92e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 22 | 2.01e-01 | 1.57e-01 | 8.27e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 7 | 4.71e-01 | 1.57e-01 | 9.26e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 8 | 4.41e-01 | 1.57e-01 | 9.16e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 24 | 1.83e-01 | 1.57e-01 | 8.07e-01 |
| GOMF SNORNA BINDING | 31 | 1.30e-01 | 1.57e-01 | 7.57e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 2.92e-01 | 1.57e-01 | 8.70e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 20 | 2.24e-01 | 1.57e-01 | 8.32e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 20 | 2.24e-01 | -1.57e-01 | 8.32e-01 |
| GOBP EAR DEVELOPMENT | 74 | 1.97e-02 | 1.57e-01 | 5.20e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 18 | 2.49e-01 | -1.57e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 3.47e-01 | -1.57e-01 | 8.87e-01 |
| GOCC PRONUCLEUS | 9 | 4.15e-01 | 1.57e-01 | 9.08e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 3.90e-01 | -1.57e-01 | 8.97e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 92 | 9.43e-03 | 1.57e-01 | 4.24e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 33 | 1.19e-01 | -1.57e-01 | 7.52e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 3.28e-01 | 1.57e-01 | 8.76e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 5 | 5.44e-01 | -1.57e-01 | 9.40e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 3.91e-01 | 1.57e-01 | 8.97e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 11 | 3.69e-01 | 1.56e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 17 | 2.64e-01 | -1.56e-01 | 8.52e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 16 | 2.79e-01 | -1.56e-01 | 8.63e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 6 | 5.07e-01 | 1.56e-01 | 9.31e-01 |
| GOBP CHROMOSOME SEPARATION | 53 | 4.92e-02 | 1.56e-01 | 6.48e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 7 | 4.74e-01 | 1.56e-01 | 9.26e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 7 | 4.74e-01 | 1.56e-01 | 9.26e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 45 | 7.00e-02 | -1.56e-01 | 6.73e-01 |
| GOBP DNA DEAMINATION | 10 | 3.92e-01 | 1.56e-01 | 8.97e-01 |
| GOCC CHROMAFFIN GRANULE | 8 | 4.44e-01 | -1.56e-01 | 9.17e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 39 | 9.18e-02 | 1.56e-01 | 7.17e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 5 | 5.46e-01 | 1.56e-01 | 9.40e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 84 | 1.36e-02 | -1.56e-01 | 4.67e-01 |
| GOBP PROTEIN DENEDDYLATION | 10 | 3.93e-01 | -1.56e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 3.13e-01 | 1.56e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 7 | 4.75e-01 | -1.56e-01 | 9.26e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 4.75e-01 | -1.56e-01 | 9.26e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 4.45e-01 | 1.56e-01 | 9.17e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 5 | 5.47e-01 | -1.56e-01 | 9.40e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 65 | 3.02e-02 | 1.56e-01 | 5.71e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 4.46e-01 | -1.56e-01 | 9.18e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 4.76e-01 | 1.56e-01 | 9.26e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 12 | 3.51e-01 | -1.56e-01 | 8.88e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 19 | 2.41e-01 | -1.55e-01 | 8.43e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 5 | 5.47e-01 | 1.55e-01 | 9.40e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 11 | 3.72e-01 | 1.55e-01 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 20 | 2.29e-01 | 1.55e-01 | 8.35e-01 |
| GOBP HEART FIELD SPECIFICATION | 5 | 5.48e-01 | 1.55e-01 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 3.95e-01 | 1.55e-01 | 8.98e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 3.52e-01 | -1.55e-01 | 8.88e-01 |
| GOBP URETER DEVELOPMENT | 5 | 5.48e-01 | -1.55e-01 | 9.40e-01 |
| GOCC CILIARY TIP | 31 | 1.35e-01 | 1.55e-01 | 7.62e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 8 | 4.48e-01 | 1.55e-01 | 9.19e-01 |
| GOBP SNRNA MODIFICATION | 7 | 4.78e-01 | 1.55e-01 | 9.26e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 29 | 1.49e-01 | 1.55e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 6 | 5.11e-01 | -1.55e-01 | 9.32e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 7 | 4.78e-01 | 1.55e-01 | 9.26e-01 |
| GOBP AGGREPHAGY | 8 | 4.48e-01 | -1.55e-01 | 9.19e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 3.53e-01 | -1.55e-01 | 8.88e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 4.78e-01 | 1.55e-01 | 9.26e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 44 | 7.61e-02 | -1.55e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 1.81e-01 | -1.55e-01 | 8.07e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 6 | 5.12e-01 | -1.55e-01 | 9.33e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 257 | 2.17e-05 | -1.54e-01 | 1.27e-02 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 3.98e-01 | 1.54e-01 | 8.98e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 10 | 3.98e-01 | -1.54e-01 | 8.98e-01 |
| GOCC MKS COMPLEX | 10 | 3.98e-01 | 1.54e-01 | 8.98e-01 |
| GOCC KATANIN COMPLEX | 5 | 5.50e-01 | -1.54e-01 | 9.40e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 25 | 1.82e-01 | 1.54e-01 | 8.07e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 21 | 2.21e-01 | -1.54e-01 | 8.32e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 5 | 5.51e-01 | -1.54e-01 | 9.40e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 96 | 9.21e-03 | 1.54e-01 | 4.19e-01 |
| GOBP SEROTONIN TRANSPORT | 8 | 4.51e-01 | 1.54e-01 | 9.21e-01 |
| GOCC TERMINAL BOUTON | 20 | 2.33e-01 | 1.54e-01 | 8.37e-01 |
| GOCC AMPHISOME | 12 | 3.56e-01 | -1.54e-01 | 8.88e-01 |
| GOCC ESC E Z COMPLEX | 9 | 4.25e-01 | -1.54e-01 | 9.13e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 21 | 2.23e-01 | 1.54e-01 | 8.32e-01 |
| GOBP RESPONSE TO NICOTINE | 22 | 2.12e-01 | -1.54e-01 | 8.32e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 21 | 2.23e-01 | 1.54e-01 | 8.32e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 29 | 1.52e-01 | 1.54e-01 | 7.89e-01 |
| GOBP RESPONSE TO ESTROGEN | 34 | 1.21e-01 | 1.54e-01 | 7.52e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 7 | 4.82e-01 | 1.54e-01 | 9.27e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 11 | 3.78e-01 | 1.54e-01 | 8.97e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 9 | 4.25e-01 | 1.54e-01 | 9.13e-01 |
| GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX | 5 | 5.52e-01 | 1.53e-01 | 9.41e-01 |
| GOBP REGULATION OF GTP BINDING | 7 | 4.82e-01 | -1.53e-01 | 9.27e-01 |
| GOMF FLOPPASE ACTIVITY | 12 | 3.58e-01 | -1.53e-01 | 8.89e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 6 | 5.15e-01 | -1.53e-01 | 9.34e-01 |
| GOBP ATP TRANSPORT | 12 | 3.58e-01 | -1.53e-01 | 8.90e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 162 | 7.80e-04 | -1.53e-01 | 1.56e-01 |
| GOBP TRABECULA MORPHOGENESIS | 24 | 1.94e-01 | -1.53e-01 | 8.17e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 2.60e-01 | 1.53e-01 | 8.51e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 27 | 1.68e-01 | 1.53e-01 | 8.04e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 52 | 5.61e-02 | 1.53e-01 | 6.62e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 35 | 1.17e-01 | 1.53e-01 | 7.52e-01 |
| GOBP TRANSLESION SYNTHESIS | 21 | 2.24e-01 | -1.53e-01 | 8.32e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 19 | 2.48e-01 | 1.53e-01 | 8.49e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 3.05e-01 | -1.53e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 15 | 3.05e-01 | 1.53e-01 | 8.75e-01 |
| GOBP GLUCOSE IMPORT | 45 | 7.63e-02 | 1.53e-01 | 6.87e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 22 | 2.15e-01 | 1.53e-01 | 8.32e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 5 | 5.54e-01 | 1.53e-01 | 9.42e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 3.06e-01 | 1.53e-01 | 8.75e-01 |
| GOMF CD4 RECEPTOR BINDING | 7 | 4.84e-01 | 1.53e-01 | 9.29e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 10 | 4.04e-01 | 1.53e-01 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 3.61e-01 | -1.52e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 88 | 1.36e-02 | -1.52e-01 | 4.67e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 2.77e-01 | 1.52e-01 | 8.60e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 5 | 5.56e-01 | 1.52e-01 | 9.43e-01 |
| GOBP NEURON RECOGNITION | 18 | 2.64e-01 | 1.52e-01 | 8.52e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 12 | 3.62e-01 | -1.52e-01 | 8.91e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 22 | 2.17e-01 | -1.52e-01 | 8.32e-01 |
| GOBP MYELIN ASSEMBLY | 11 | 3.83e-01 | 1.52e-01 | 8.97e-01 |
| GOBP CHOLESTEROL IMPORT | 6 | 5.19e-01 | 1.52e-01 | 9.35e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 33 | 1.31e-01 | 1.52e-01 | 7.57e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 9 | 4.30e-01 | -1.52e-01 | 9.14e-01 |
| GOMF DENEDDYLASE ACTIVITY | 5 | 5.57e-01 | -1.52e-01 | 9.44e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 7 | 4.87e-01 | 1.52e-01 | 9.30e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 75 | 2.34e-02 | -1.52e-01 | 5.39e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 7 | 4.87e-01 | -1.52e-01 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 5.58e-01 | 1.51e-01 | 9.44e-01 |
| GOBP ACUTE PHASE RESPONSE | 19 | 2.53e-01 | 1.51e-01 | 8.50e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 19 | 2.54e-01 | -1.51e-01 | 8.50e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 3.85e-01 | 1.51e-01 | 8.97e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 19 | 2.54e-01 | 1.51e-01 | 8.50e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 6 | 5.21e-01 | -1.51e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 20 | 2.42e-01 | -1.51e-01 | 8.43e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 6 | 5.21e-01 | -1.51e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 6 | 5.21e-01 | 1.51e-01 | 9.35e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 14 | 3.28e-01 | 1.51e-01 | 8.76e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 18 | 2.68e-01 | -1.51e-01 | 8.56e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 26 | 1.83e-01 | -1.51e-01 | 8.08e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 16 | 2.96e-01 | -1.51e-01 | 8.71e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 61 | 4.19e-02 | 1.51e-01 | 6.21e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 31 | 1.47e-01 | -1.51e-01 | 7.80e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 9 | 4.34e-01 | 1.51e-01 | 9.14e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 16 | 2.97e-01 | 1.51e-01 | 8.71e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 2.97e-01 | 1.51e-01 | 8.71e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 2.97e-01 | 1.51e-01 | 8.71e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 4.11e-01 | -1.50e-01 | 9.04e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 5.61e-01 | -1.50e-01 | 9.44e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 21 | 2.33e-01 | -1.50e-01 | 8.37e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 6 | 5.24e-01 | 1.50e-01 | 9.35e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 3.14e-01 | 1.50e-01 | 8.76e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 13 | 3.49e-01 | -1.50e-01 | 8.87e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 78 | 2.21e-02 | 1.50e-01 | 5.33e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 5.61e-01 | 1.50e-01 | 9.44e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 3.31e-01 | -1.50e-01 | 8.79e-01 |
| GOBP POSITIVE CHEMOTAXIS | 25 | 1.95e-01 | -1.50e-01 | 8.19e-01 |
| GOMF HYDRO LYASE ACTIVITY | 37 | 1.15e-01 | 1.50e-01 | 7.52e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 3.69e-01 | 1.50e-01 | 8.92e-01 |
| GOBP HAIR FOLLICLE MATURATION | 7 | 4.93e-01 | 1.50e-01 | 9.31e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 5 | 5.62e-01 | -1.50e-01 | 9.44e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 8 | 4.64e-01 | 1.50e-01 | 9.25e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 3.90e-01 | 1.50e-01 | 8.97e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 18 | 2.72e-01 | 1.50e-01 | 8.58e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 8 | 4.64e-01 | -1.50e-01 | 9.25e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 67 | 3.45e-02 | 1.50e-01 | 5.88e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 77 | 2.35e-02 | 1.49e-01 | 5.39e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 11 | 3.91e-01 | -1.49e-01 | 8.97e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 5.63e-01 | 1.49e-01 | 9.44e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 4.94e-01 | -1.49e-01 | 9.31e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 24 | 2.06e-01 | -1.49e-01 | 8.28e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 33 | 1.38e-01 | -1.49e-01 | 7.64e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 18 | 2.73e-01 | 1.49e-01 | 8.58e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 26 | 1.88e-01 | 1.49e-01 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 5 | 5.64e-01 | -1.49e-01 | 9.44e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.95e-01 | 1.49e-01 | 9.31e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 36 | 1.22e-01 | -1.49e-01 | 7.54e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 4.66e-01 | -1.49e-01 | 9.25e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 26 | 1.90e-01 | 1.49e-01 | 8.14e-01 |
| GOCC ZYMOGEN GRANULE | 8 | 4.66e-01 | 1.49e-01 | 9.25e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 5 | 5.65e-01 | 1.49e-01 | 9.44e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 19 | 2.62e-01 | -1.49e-01 | 8.52e-01 |
| GOCC SAGA COMPLEX | 23 | 2.18e-01 | 1.48e-01 | 8.32e-01 |
| GOBP KINETOCHORE ASSEMBLY | 15 | 3.20e-01 | 1.48e-01 | 8.76e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 23 | 2.18e-01 | -1.48e-01 | 8.32e-01 |
| GOBP SARCOMERE ORGANIZATION | 15 | 3.20e-01 | -1.48e-01 | 8.76e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 22 | 2.29e-01 | -1.48e-01 | 8.34e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 5 | 5.66e-01 | 1.48e-01 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 31 | 1.54e-01 | 1.48e-01 | 7.89e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 18 | 2.77e-01 | 1.48e-01 | 8.60e-01 |
| GOCC ACTOMYOSIN | 48 | 7.60e-02 | 1.48e-01 | 6.87e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 3.96e-01 | 1.48e-01 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 7 | 4.98e-01 | 1.48e-01 | 9.31e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 9 | 4.42e-01 | -1.48e-01 | 9.16e-01 |
| GOBP REGULATION OF BEHAVIOR | 31 | 1.54e-01 | -1.48e-01 | 7.89e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 4.18e-01 | 1.48e-01 | 9.08e-01 |
| GOBP LIVER REGENERATION | 17 | 2.91e-01 | -1.48e-01 | 8.69e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 3.38e-01 | 1.48e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 17 | 2.92e-01 | -1.48e-01 | 8.69e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 5.67e-01 | -1.48e-01 | 9.44e-01 |
| GOCC RUFFLE MEMBRANE | 72 | 3.03e-02 | -1.48e-01 | 5.71e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 2.31e-01 | 1.48e-01 | 8.36e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 3.39e-01 | -1.48e-01 | 8.83e-01 |
| GOBP PRE MIRNA PROCESSING | 14 | 3.39e-01 | 1.48e-01 | 8.83e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 4.99e-01 | 1.48e-01 | 9.31e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 156 | 1.50e-03 | -1.48e-01 | 2.20e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 5.31e-01 | 1.48e-01 | 9.39e-01 |
| GOMF MHC PROTEIN BINDING | 26 | 1.93e-01 | -1.48e-01 | 8.17e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 24 | 2.11e-01 | -1.47e-01 | 8.32e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 5.00e-01 | -1.47e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 61 | 4.68e-02 | -1.47e-01 | 6.37e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 42 | 9.88e-02 | -1.47e-01 | 7.33e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 3.98e-01 | 1.47e-01 | 8.98e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 46 | 8.42e-02 | 1.47e-01 | 7.03e-01 |
| GOCC SCAR COMPLEX | 9 | 4.44e-01 | 1.47e-01 | 9.17e-01 |
| GOMF ACYL COA BINDING | 16 | 3.08e-01 | 1.47e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 12 | 3.78e-01 | 1.47e-01 | 8.97e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 5.69e-01 | 1.47e-01 | 9.44e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 5.01e-01 | 1.47e-01 | 9.31e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 3.24e-01 | -1.47e-01 | 8.76e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 9 | 4.45e-01 | -1.47e-01 | 9.17e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 3.25e-01 | 1.47e-01 | 8.76e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 77 | 2.62e-02 | 1.47e-01 | 5.51e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 5 | 5.70e-01 | 1.47e-01 | 9.44e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 83 | 2.11e-02 | 1.47e-01 | 5.33e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 3.79e-01 | 1.47e-01 | 8.97e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 5.34e-01 | -1.46e-01 | 9.40e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 5 | 5.71e-01 | -1.46e-01 | 9.44e-01 |
| GOBP P BODY ASSEMBLY | 21 | 2.46e-01 | 1.46e-01 | 8.49e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 31 | 1.59e-01 | -1.46e-01 | 7.94e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 5.35e-01 | 1.46e-01 | 9.40e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 3.62e-01 | 1.46e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 5.03e-01 | 1.46e-01 | 9.31e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 5.36e-01 | 1.46e-01 | 9.40e-01 |
| GOBP ATP METABOLIC PROCESS | 113 | 7.40e-03 | -1.46e-01 | 4.17e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 7 | 5.03e-01 | -1.46e-01 | 9.31e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 6 | 5.36e-01 | 1.46e-01 | 9.40e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 5 | 5.72e-01 | 1.46e-01 | 9.44e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 10 | 4.24e-01 | 1.46e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 5.04e-01 | 1.46e-01 | 9.31e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 25 | 2.07e-01 | 1.46e-01 | 8.29e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 5.04e-01 | 1.46e-01 | 9.31e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 2.98e-01 | 1.46e-01 | 8.71e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 18 | 2.84e-01 | -1.46e-01 | 8.67e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 7 | 5.04e-01 | -1.46e-01 | 9.31e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 5.05e-01 | -1.46e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 27 | 1.90e-01 | -1.46e-01 | 8.15e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 30 | 1.68e-01 | 1.46e-01 | 8.04e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 18 | 2.85e-01 | 1.46e-01 | 8.67e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 14 | 3.46e-01 | 1.46e-01 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 6 | 5.37e-01 | -1.45e-01 | 9.40e-01 |
| GOBP REGULATION OF HEAT GENERATION | 7 | 5.05e-01 | -1.45e-01 | 9.31e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 5.73e-01 | 1.45e-01 | 9.44e-01 |
| GOCC U6 SNRNP | 8 | 4.77e-01 | -1.45e-01 | 9.26e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 6 | 5.38e-01 | -1.45e-01 | 9.40e-01 |
| GOCC MICROVILLUS MEMBRANE | 13 | 3.65e-01 | -1.45e-01 | 8.92e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 11 | 4.05e-01 | -1.45e-01 | 8.99e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 29 | 1.76e-01 | -1.45e-01 | 8.07e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 30 | 1.69e-01 | 1.45e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 22 | 2.39e-01 | -1.45e-01 | 8.42e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 41 | 1.08e-01 | 1.45e-01 | 7.44e-01 |
| GOBP DNA REPLICATION INITIATION | 26 | 2.01e-01 | 1.45e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 7 | 5.07e-01 | -1.45e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 49 | 7.95e-02 | -1.45e-01 | 6.95e-01 |
| GOMF COBALAMIN BINDING | 7 | 5.07e-01 | -1.45e-01 | 9.31e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 19 | 2.74e-01 | 1.45e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 19 | 2.75e-01 | -1.45e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 5.39e-01 | -1.45e-01 | 9.40e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 3.32e-01 | 1.45e-01 | 8.80e-01 |
| GOCC BLEB | 8 | 4.78e-01 | 1.45e-01 | 9.26e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 12 | 3.86e-01 | 1.45e-01 | 8.97e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 17 | 3.02e-01 | -1.45e-01 | 8.74e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 14 | 3.49e-01 | -1.44e-01 | 8.87e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 26 | 2.03e-01 | 1.44e-01 | 8.28e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 60 | 5.34e-02 | -1.44e-01 | 6.61e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 82 | 2.41e-02 | -1.44e-01 | 5.39e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 13 | 3.68e-01 | -1.44e-01 | 8.92e-01 |
| GOBP RESPONSE TO COPPER ION | 18 | 2.90e-01 | -1.44e-01 | 8.69e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 4.80e-01 | 1.44e-01 | 9.26e-01 |
| GOBP COPULATION | 6 | 5.41e-01 | -1.44e-01 | 9.40e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 4.80e-01 | 1.44e-01 | 9.26e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 14 | 3.51e-01 | -1.44e-01 | 8.88e-01 |
| GOMF DIACYLGLYCEROL BINDING | 8 | 4.81e-01 | 1.44e-01 | 9.26e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 38 | 1.25e-01 | -1.44e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 7 | 5.10e-01 | -1.44e-01 | 9.32e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 4.55e-01 | 1.44e-01 | 9.23e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 7 | 5.10e-01 | 1.44e-01 | 9.32e-01 |
| GOBP AXONAL FASCICULATION | 7 | 5.11e-01 | 1.44e-01 | 9.32e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 41 | 1.12e-01 | 1.44e-01 | 7.50e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 5.78e-01 | -1.43e-01 | 9.47e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 39 | 1.21e-01 | -1.43e-01 | 7.53e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 5 | 5.79e-01 | -1.43e-01 | 9.48e-01 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 2.80e-01 | 1.43e-01 | 8.63e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 5 | 5.79e-01 | 1.43e-01 | 9.48e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 1.49e-01 | 1.43e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 33 | 1.55e-01 | -1.43e-01 | 7.89e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 77 | 3.03e-02 | 1.43e-01 | 5.71e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 3.91e-01 | -1.43e-01 | 8.97e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 10 | 4.34e-01 | 1.43e-01 | 9.14e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 7 | 5.13e-01 | 1.43e-01 | 9.33e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 9 | 4.58e-01 | 1.43e-01 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 3.55e-01 | 1.43e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 69 | 4.04e-02 | -1.43e-01 | 6.16e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 7 | 5.13e-01 | 1.43e-01 | 9.33e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 5 | 5.81e-01 | 1.43e-01 | 9.48e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 10 | 4.35e-01 | -1.42e-01 | 9.14e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 10 | 4.35e-01 | -1.42e-01 | 9.14e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 5 | 5.81e-01 | 1.42e-01 | 9.48e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 21 | 2.59e-01 | 1.42e-01 | 8.50e-01 |
| GOBP OTOLITH DEVELOPMENT | 5 | 5.82e-01 | 1.42e-01 | 9.48e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 16 | 3.26e-01 | -1.42e-01 | 8.76e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 117 | 8.16e-03 | -1.42e-01 | 4.17e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 7 | 5.16e-01 | -1.42e-01 | 9.34e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 4.16e-01 | -1.42e-01 | 9.08e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 5.83e-01 | 1.42e-01 | 9.48e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 5 | 5.84e-01 | 1.42e-01 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 46 | 9.69e-02 | 1.42e-01 | 7.33e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 5.84e-01 | 1.42e-01 | 9.48e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 15 | 3.43e-01 | 1.42e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 3.77e-01 | -1.42e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 4.88e-01 | 1.42e-01 | 9.30e-01 |
| GOBP SULFATE TRANSPORT | 8 | 4.88e-01 | 1.42e-01 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 39 | 1.26e-01 | 1.41e-01 | 7.55e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 5.49e-01 | 1.41e-01 | 9.40e-01 |
| GOCC NEURON SPINE | 96 | 1.69e-02 | 1.41e-01 | 5.00e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 56 | 6.78e-02 | 1.41e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 10 | 4.39e-01 | 1.41e-01 | 9.15e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 36 | 1.43e-01 | 1.41e-01 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 8 | 4.89e-01 | 1.41e-01 | 9.30e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 6 | 5.49e-01 | -1.41e-01 | 9.40e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 5.50e-01 | 1.41e-01 | 9.40e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 30 | 1.82e-01 | -1.41e-01 | 8.07e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 55 | 7.10e-02 | -1.41e-01 | 6.77e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 27 | 2.05e-01 | -1.41e-01 | 8.28e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 5.86e-01 | -1.41e-01 | 9.49e-01 |
| GOMF RNA CAP BINDING | 19 | 2.88e-01 | 1.41e-01 | 8.68e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 3.62e-01 | -1.41e-01 | 8.92e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 8 | 4.91e-01 | -1.41e-01 | 9.31e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 18 | 3.01e-01 | 1.41e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 6 | 5.51e-01 | -1.41e-01 | 9.40e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 73 | 3.79e-02 | -1.41e-01 | 6.11e-01 |
| GOCC PROTEASOME COMPLEX | 58 | 6.45e-02 | -1.40e-01 | 6.70e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 41 | 1.20e-01 | 1.40e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 4.20e-01 | -1.40e-01 | 9.09e-01 |
| GOBP SEGMENTATION | 41 | 1.20e-01 | 1.40e-01 | 7.52e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 39 | 1.30e-01 | 1.40e-01 | 7.57e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 3.82e-01 | -1.40e-01 | 8.97e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 12 | 4.01e-01 | 1.40e-01 | 8.99e-01 |
| GOBP COPPER ION HOMEOSTASIS | 16 | 3.32e-01 | -1.40e-01 | 8.80e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 16 | 3.32e-01 | 1.40e-01 | 8.80e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 5.88e-01 | -1.40e-01 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 5.53e-01 | 1.40e-01 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 4.68e-01 | 1.40e-01 | 9.25e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 4.68e-01 | -1.40e-01 | 9.25e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 18 | 3.05e-01 | -1.40e-01 | 8.75e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 13 | 3.83e-01 | 1.40e-01 | 8.97e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 2.18e-01 | -1.40e-01 | 8.32e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 6 | 5.53e-01 | -1.40e-01 | 9.41e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 5.22e-01 | 1.40e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 5.54e-01 | -1.40e-01 | 9.41e-01 |
| GOBP TRNA MODIFICATION | 89 | 2.29e-02 | 1.40e-01 | 5.38e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 17 | 3.19e-01 | -1.40e-01 | 8.76e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 15 | 3.49e-01 | 1.40e-01 | 8.87e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 35 | 1.53e-01 | 1.40e-01 | 7.89e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 20 | 2.80e-01 | -1.39e-01 | 8.63e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 47 | 9.85e-02 | 1.39e-01 | 7.33e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 5.90e-01 | -1.39e-01 | 9.51e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 12 | 4.04e-01 | -1.39e-01 | 8.99e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 2.19e-01 | -1.39e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 95 | 1.92e-02 | 1.39e-01 | 5.18e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 10 | 4.46e-01 | -1.39e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 32 | 1.73e-01 | 1.39e-01 | 8.07e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 32 | 1.74e-01 | -1.39e-01 | 8.07e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 9 | 4.71e-01 | -1.39e-01 | 9.26e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 4.47e-01 | 1.39e-01 | 9.19e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 12 | 4.05e-01 | 1.39e-01 | 8.99e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 5 | 5.91e-01 | 1.39e-01 | 9.51e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 28 | 2.04e-01 | 1.39e-01 | 8.28e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 11 | 4.26e-01 | -1.39e-01 | 9.13e-01 |
| GOBP PLASMA MEMBRANE FUSION | 8 | 4.98e-01 | 1.38e-01 | 9.31e-01 |
| GOBP TRANSFERRIN TRANSPORT | 7 | 5.26e-01 | 1.38e-01 | 9.36e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 8 | 4.98e-01 | 1.38e-01 | 9.31e-01 |
| GOMF HELICASE ACTIVITY | 132 | 6.15e-03 | 1.38e-01 | 3.91e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 5 | 5.92e-01 | 1.38e-01 | 9.51e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 5 | 5.92e-01 | 1.38e-01 | 9.51e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 106 | 1.40e-02 | -1.38e-01 | 4.72e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 33 | 1.69e-01 | 1.38e-01 | 8.04e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 146 | 4.02e-03 | 1.38e-01 | 3.32e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 5 | 5.93e-01 | -1.38e-01 | 9.51e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 29 | 1.98e-01 | 1.38e-01 | 8.23e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 4.99e-01 | 1.38e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 5.93e-01 | -1.38e-01 | 9.51e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 12 | 4.08e-01 | -1.38e-01 | 9.01e-01 |
| GOBP L SERINE METABOLIC PROCESS | 8 | 4.99e-01 | 1.38e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 16 | 3.39e-01 | -1.38e-01 | 8.83e-01 |
| GOCC COP9 SIGNALOSOME | 15 | 3.55e-01 | -1.38e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 5.58e-01 | 1.38e-01 | 9.44e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 4.08e-01 | 1.38e-01 | 9.01e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 5 | 5.94e-01 | -1.38e-01 | 9.51e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 14 | 3.72e-01 | -1.38e-01 | 8.95e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 2.64e-01 | -1.38e-01 | 8.52e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 58 | 7.00e-02 | -1.38e-01 | 6.73e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 10 | 4.51e-01 | 1.38e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 20 | 2.87e-01 | 1.38e-01 | 8.68e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 28 | 2.08e-01 | -1.37e-01 | 8.30e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 4.75e-01 | 1.37e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 9 | 4.75e-01 | 1.37e-01 | 9.26e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 3.42e-01 | -1.37e-01 | 8.84e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 13 | 3.91e-01 | -1.37e-01 | 8.97e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 37 | 1.49e-01 | 1.37e-01 | 7.88e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 8 | 5.01e-01 | 1.37e-01 | 9.31e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 17 | 3.27e-01 | 1.37e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 11 | 4.31e-01 | -1.37e-01 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 9 | 4.76e-01 | -1.37e-01 | 9.26e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 4.31e-01 | 1.37e-01 | 9.14e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 3.93e-01 | -1.37e-01 | 8.97e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 9 | 4.77e-01 | -1.37e-01 | 9.26e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 3.59e-01 | -1.37e-01 | 8.90e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 31 | 1.87e-01 | 1.37e-01 | 8.14e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 12 | 4.12e-01 | 1.37e-01 | 9.04e-01 |
| GOBP PEROXISOME FISSION | 7 | 5.31e-01 | -1.37e-01 | 9.38e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 17 | 3.29e-01 | 1.37e-01 | 8.77e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 10 | 4.54e-01 | 1.37e-01 | 9.22e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 4.33e-01 | -1.37e-01 | 9.14e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 23 | 2.57e-01 | 1.37e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 9 | 4.78e-01 | 1.36e-01 | 9.26e-01 |
| GOMF DYNEIN COMPLEX BINDING | 18 | 3.16e-01 | 1.36e-01 | 8.76e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 4.55e-01 | -1.36e-01 | 9.23e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 8 | 5.05e-01 | 1.36e-01 | 9.31e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 5.98e-01 | 1.36e-01 | 9.52e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 12 | 4.14e-01 | -1.36e-01 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 4.79e-01 | 1.36e-01 | 9.26e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 47 | 1.06e-01 | -1.36e-01 | 7.42e-01 |
| GOCC ESCRT COMPLEX | 25 | 2.39e-01 | -1.36e-01 | 8.42e-01 |
| GOCC SITE OF DNA DAMAGE | 104 | 1.66e-02 | 1.36e-01 | 4.94e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.98e-01 | 1.36e-01 | 9.52e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 5.34e-01 | -1.36e-01 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 11 | 4.35e-01 | 1.36e-01 | 9.14e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 25 | 2.40e-01 | 1.36e-01 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 21 | 2.81e-01 | 1.36e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 12 | 4.15e-01 | 1.36e-01 | 9.08e-01 |
| GOBP RESPONSE TO INSULIN | 182 | 1.64e-03 | 1.36e-01 | 2.27e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 25 | 2.40e-01 | -1.36e-01 | 8.43e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 5.65e-01 | -1.36e-01 | 9.44e-01 |
| GOBP EXPLORATION BEHAVIOR | 10 | 4.58e-01 | 1.36e-01 | 9.23e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 26 | 2.32e-01 | 1.36e-01 | 8.37e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 5 | 6.00e-01 | 1.36e-01 | 9.52e-01 |
| GOCC TRAPP COMPLEX | 15 | 3.64e-01 | -1.35e-01 | 8.92e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 103 | 1.78e-02 | 1.35e-01 | 5.05e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 14 | 3.81e-01 | -1.35e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 16 | 3.49e-01 | -1.35e-01 | 8.87e-01 |
| GOMF HORMONE ACTIVITY | 12 | 4.17e-01 | -1.35e-01 | 9.08e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 7 | 5.35e-01 | -1.35e-01 | 9.40e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 8 | 5.08e-01 | -1.35e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 4.83e-01 | -1.35e-01 | 9.28e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 18 | 3.21e-01 | 1.35e-01 | 8.76e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 6.01e-01 | 1.35e-01 | 9.52e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 6.01e-01 | 1.35e-01 | 9.52e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 5 | 6.01e-01 | -1.35e-01 | 9.52e-01 |
| GOBP GENITALIA DEVELOPMENT | 15 | 3.66e-01 | 1.35e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 27 | 2.25e-01 | 1.35e-01 | 8.32e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 6 | 5.67e-01 | -1.35e-01 | 9.44e-01 |
| GOMF CTPASE ACTIVITY | 5 | 6.01e-01 | -1.35e-01 | 9.52e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 11 | 4.39e-01 | 1.35e-01 | 9.15e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 5 | 6.02e-01 | -1.35e-01 | 9.52e-01 |
| GOBP SECRETION BY TISSUE | 21 | 2.85e-01 | -1.35e-01 | 8.67e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 24 | 2.53e-01 | 1.35e-01 | 8.50e-01 |
| GOBP DEMETHYLATION | 37 | 1.56e-01 | 1.35e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 12 | 4.19e-01 | 1.35e-01 | 9.09e-01 |
| GOBP FATTY ACID ELONGATION | 8 | 5.10e-01 | 1.35e-01 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 44 | 1.23e-01 | -1.35e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 18 | 3.23e-01 | 1.35e-01 | 8.76e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 13 | 4.01e-01 | -1.35e-01 | 8.99e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 7 | 5.38e-01 | -1.34e-01 | 9.40e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 6.03e-01 | -1.34e-01 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 11 | 4.40e-01 | 1.34e-01 | 9.15e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 13 | 4.02e-01 | 1.34e-01 | 8.99e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 51 | 9.72e-02 | -1.34e-01 | 7.33e-01 |
| GOBP MEIOTIC CYTOKINESIS | 5 | 6.03e-01 | 1.34e-01 | 9.52e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 25 | 2.45e-01 | -1.34e-01 | 8.49e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 15 | 3.68e-01 | 1.34e-01 | 8.92e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 10 | 4.62e-01 | 1.34e-01 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 20 | 2.99e-01 | 1.34e-01 | 8.72e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 4.21e-01 | 1.34e-01 | 9.10e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 25 | 2.46e-01 | -1.34e-01 | 8.49e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 64 | 6.38e-02 | 1.34e-01 | 6.70e-01 |
| GOMF HISTONE KINASE ACTIVITY | 14 | 3.85e-01 | 1.34e-01 | 8.97e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 25 | 2.46e-01 | -1.34e-01 | 8.49e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 6 | 5.70e-01 | -1.34e-01 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 7 | 5.39e-01 | -1.34e-01 | 9.40e-01 |
| GOBP CELL FATE SPECIFICATION | 31 | 1.97e-01 | 1.34e-01 | 8.22e-01 |
| GOBP DIAPEDESIS | 6 | 5.70e-01 | -1.34e-01 | 9.44e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 5.70e-01 | -1.34e-01 | 9.44e-01 |
| GOBP PROTEIN NEDDYLATION | 27 | 2.29e-01 | -1.34e-01 | 8.34e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 11 | 4.42e-01 | 1.34e-01 | 9.16e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 16 | 3.54e-01 | 1.34e-01 | 8.88e-01 |
| GOBP FACE DEVELOPMENT | 31 | 1.98e-01 | -1.34e-01 | 8.22e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 5.70e-01 | 1.34e-01 | 9.44e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 5.13e-01 | 1.34e-01 | 9.33e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 5.41e-01 | 1.34e-01 | 9.40e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 8 | 5.13e-01 | 1.33e-01 | 9.33e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 14 | 3.87e-01 | -1.33e-01 | 8.97e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 3.27e-01 | -1.33e-01 | 8.76e-01 |
| GOCC INNER KINETOCHORE | 14 | 3.88e-01 | 1.33e-01 | 8.97e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 5.72e-01 | 1.33e-01 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 5 | 6.06e-01 | -1.33e-01 | 9.52e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 5.72e-01 | 1.33e-01 | 9.44e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 37 | 1.61e-01 | 1.33e-01 | 7.96e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 24 | 2.59e-01 | -1.33e-01 | 8.50e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 60 | 7.45e-02 | 1.33e-01 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 4.25e-01 | 1.33e-01 | 9.13e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 8 | 5.15e-01 | 1.33e-01 | 9.33e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 16 | 3.57e-01 | 1.33e-01 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 21 | 2.91e-01 | 1.33e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 16 | 3.57e-01 | 1.33e-01 | 8.88e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 34 | 1.80e-01 | 1.33e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 13 | 4.06e-01 | 1.33e-01 | 8.99e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 36 | 1.68e-01 | -1.33e-01 | 8.04e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 19 | 3.16e-01 | 1.33e-01 | 8.76e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 6.07e-01 | 1.33e-01 | 9.54e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 4.46e-01 | 1.33e-01 | 9.18e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 6.07e-01 | 1.33e-01 | 9.54e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 18 | 3.30e-01 | -1.33e-01 | 8.78e-01 |
| GOCC APICAL JUNCTION COMPLEX | 65 | 6.45e-02 | 1.33e-01 | 6.70e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 14 | 3.90e-01 | 1.33e-01 | 8.97e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 13 | 4.08e-01 | 1.33e-01 | 9.01e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 6 | 5.74e-01 | -1.33e-01 | 9.44e-01 |
| GOMF R SMAD BINDING | 19 | 3.17e-01 | 1.33e-01 | 8.76e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 5 | 6.08e-01 | 1.33e-01 | 9.54e-01 |
| GOCC DYNEIN COMPLEX | 25 | 2.52e-01 | 1.33e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 5.74e-01 | 1.33e-01 | 9.44e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 3.91e-01 | -1.32e-01 | 8.97e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 51 | 1.02e-01 | -1.32e-01 | 7.39e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 24 | 2.62e-01 | -1.32e-01 | 8.51e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 34 | 1.82e-01 | -1.32e-01 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 7 | 5.44e-01 | 1.32e-01 | 9.40e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 32 | 1.95e-01 | 1.32e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 3.75e-01 | 1.32e-01 | 8.97e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 5.45e-01 | 1.32e-01 | 9.40e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 29 | 2.18e-01 | -1.32e-01 | 8.32e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 28 | 2.26e-01 | -1.32e-01 | 8.32e-01 |
| GOBP VESICLE CARGO LOADING | 27 | 2.35e-01 | -1.32e-01 | 8.40e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 14 | 3.92e-01 | 1.32e-01 | 8.97e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 2.35e-01 | -1.32e-01 | 8.40e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 7 | 5.45e-01 | -1.32e-01 | 9.40e-01 |
| GOBP SNRNA TRANSCRIPTION | 17 | 3.46e-01 | -1.32e-01 | 8.87e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 14 | 3.93e-01 | 1.32e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 5 | 6.10e-01 | 1.32e-01 | 9.55e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 102 | 2.16e-02 | 1.32e-01 | 5.33e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 21 | 2.96e-01 | 1.32e-01 | 8.71e-01 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 6.10e-01 | 1.32e-01 | 9.55e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 39 | 1.55e-01 | -1.32e-01 | 7.89e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 60 | 7.82e-02 | 1.32e-01 | 6.92e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 62 | 7.34e-02 | 1.32e-01 | 6.81e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 2.97e-01 | 1.31e-01 | 8.71e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 7 | 5.47e-01 | 1.31e-01 | 9.40e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 7 | 5.47e-01 | 1.31e-01 | 9.40e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 35 | 1.79e-01 | 1.31e-01 | 8.07e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 12 | 4.31e-01 | -1.31e-01 | 9.14e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 48 | 1.16e-01 | 1.31e-01 | 7.52e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 5.78e-01 | 1.31e-01 | 9.47e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 12 | 4.31e-01 | 1.31e-01 | 9.14e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 21 | 2.98e-01 | 1.31e-01 | 8.71e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 16 | 3.64e-01 | -1.31e-01 | 8.92e-01 |
| GOBP T CELL MIGRATION | 48 | 1.16e-01 | -1.31e-01 | 7.52e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 7 | 5.48e-01 | 1.31e-01 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 6.12e-01 | -1.31e-01 | 9.55e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 37 | 1.68e-01 | -1.31e-01 | 8.04e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 5 | 6.12e-01 | 1.31e-01 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 3.23e-01 | -1.31e-01 | 8.76e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 6.12e-01 | -1.31e-01 | 9.55e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 18 | 3.36e-01 | 1.31e-01 | 8.83e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 11 | 4.52e-01 | -1.31e-01 | 9.21e-01 |
| GOBP AMP SALVAGE | 5 | 6.12e-01 | -1.31e-01 | 9.55e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 7 | 5.49e-01 | -1.31e-01 | 9.40e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 36 | 1.75e-01 | -1.31e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 8 | 5.22e-01 | -1.31e-01 | 9.35e-01 |
| GOMF ACTIVIN BINDING | 9 | 4.97e-01 | -1.31e-01 | 9.31e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 2.89e-01 | -1.31e-01 | 8.69e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 7 | 5.50e-01 | 1.31e-01 | 9.40e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 29 | 2.24e-01 | -1.31e-01 | 8.32e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 12 | 4.34e-01 | 1.31e-01 | 9.14e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.13e-01 | -1.31e-01 | 9.55e-01 |
| GOBP TRABECULA FORMATION | 10 | 4.75e-01 | -1.30e-01 | 9.26e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 18 | 3.38e-01 | -1.30e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 15 | 3.82e-01 | -1.30e-01 | 8.97e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 4.75e-01 | -1.30e-01 | 9.26e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 10 | 4.76e-01 | -1.30e-01 | 9.26e-01 |
| GOMF IGG BINDING | 7 | 5.51e-01 | 1.30e-01 | 9.40e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 22 | 2.91e-01 | -1.30e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 6.15e-01 | -1.30e-01 | 9.55e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 5.82e-01 | -1.30e-01 | 9.48e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 5.00e-01 | 1.30e-01 | 9.31e-01 |
| GOBP CYTOPLASM ORGANIZATION | 9 | 5.00e-01 | -1.30e-01 | 9.31e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 4.18e-01 | 1.30e-01 | 9.08e-01 |
| GOBP SPERMATID DIFFERENTIATION | 82 | 4.25e-02 | -1.30e-01 | 6.23e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 5.01e-01 | -1.30e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 5.82e-01 | 1.30e-01 | 9.48e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 6 | 5.82e-01 | -1.30e-01 | 9.48e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 13 | 4.19e-01 | -1.30e-01 | 9.08e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 6 | 5.83e-01 | 1.29e-01 | 9.48e-01 |
| GOCC X CHROMOSOME | 6 | 5.83e-01 | 1.29e-01 | 9.48e-01 |
| GOCC RIBBON SYNAPSE | 9 | 5.02e-01 | -1.29e-01 | 9.31e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 25 | 2.63e-01 | 1.29e-01 | 8.52e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 12 | 4.38e-01 | 1.29e-01 | 9.15e-01 |
| GOBP EPITHELIAL CELL MATURATION | 10 | 4.79e-01 | -1.29e-01 | 9.26e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 41 | 1.52e-01 | -1.29e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 4.58e-01 | 1.29e-01 | 9.23e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 6 | 5.83e-01 | -1.29e-01 | 9.48e-01 |
| GOMF FAD BINDING | 28 | 2.37e-01 | 1.29e-01 | 8.40e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 27 | 2.45e-01 | -1.29e-01 | 8.49e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 6.17e-01 | -1.29e-01 | 9.55e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 30 | 2.21e-01 | 1.29e-01 | 8.32e-01 |
| GOBP MISMATCH REPAIR | 24 | 2.73e-01 | 1.29e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 13 | 4.20e-01 | -1.29e-01 | 9.09e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 14 | 4.03e-01 | 1.29e-01 | 8.99e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 15 | 3.87e-01 | -1.29e-01 | 8.97e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 6.18e-01 | 1.29e-01 | 9.55e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 10 | 4.81e-01 | -1.29e-01 | 9.26e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 379 | 1.88e-05 | -1.29e-01 | 1.18e-02 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 15 | 3.88e-01 | -1.29e-01 | 8.97e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 91 | 3.41e-02 | 1.29e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 5.04e-01 | -1.29e-01 | 9.31e-01 |
| GOCC NEURON PROJECTION TERMINUS | 51 | 1.12e-01 | 1.29e-01 | 7.50e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 16 | 3.73e-01 | 1.29e-01 | 8.95e-01 |
| GOBP VASCULOGENESIS | 38 | 1.70e-01 | 1.29e-01 | 8.04e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 8 | 5.29e-01 | 1.29e-01 | 9.37e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 5 | 6.18e-01 | -1.29e-01 | 9.55e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 15 | 3.88e-01 | 1.29e-01 | 8.97e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 35 | 1.88e-01 | 1.29e-01 | 8.14e-01 |
| GOBP CAMP CATABOLIC PROCESS | 7 | 5.56e-01 | -1.28e-01 | 9.43e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 6 | 5.86e-01 | -1.28e-01 | 9.49e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 2.24e-01 | -1.28e-01 | 8.32e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 6 | 5.86e-01 | 1.28e-01 | 9.49e-01 |
| GOBP CGMP MEDIATED SIGNALING | 11 | 4.61e-01 | -1.28e-01 | 9.25e-01 |
| GOBP LIPID STORAGE | 65 | 7.38e-02 | -1.28e-01 | 6.82e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 11 | 4.61e-01 | 1.28e-01 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 12 | 4.42e-01 | -1.28e-01 | 9.16e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 5 | 6.19e-01 | 1.28e-01 | 9.55e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 105 | 2.34e-02 | -1.28e-01 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 23 | 2.87e-01 | -1.28e-01 | 8.68e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 21 | 3.09e-01 | 1.28e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 11 | 4.62e-01 | -1.28e-01 | 9.25e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 13 | 4.25e-01 | 1.28e-01 | 9.13e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 136 | 1.02e-02 | -1.28e-01 | 4.37e-01 |
| GOMF BH DOMAIN BINDING | 7 | 5.58e-01 | -1.28e-01 | 9.44e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 34 | 1.97e-01 | 1.28e-01 | 8.22e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 4.85e-01 | -1.28e-01 | 9.29e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 9 | 5.07e-01 | -1.28e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 4.64e-01 | -1.28e-01 | 9.25e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 3.77e-01 | -1.28e-01 | 8.97e-01 |
| GOBP CHEMOKINE PRODUCTION | 62 | 8.28e-02 | -1.28e-01 | 6.99e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 32 | 2.12e-01 | -1.28e-01 | 8.32e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 5 | 6.22e-01 | 1.28e-01 | 9.55e-01 |
| GOBP MOTOR BEHAVIOR | 15 | 3.93e-01 | 1.27e-01 | 8.97e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 20 | 3.24e-01 | 1.27e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 5.89e-01 | 1.27e-01 | 9.51e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 127 | 1.34e-02 | -1.27e-01 | 4.67e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 5.60e-01 | 1.27e-01 | 9.44e-01 |
| GOCC LIPID DROPLET | 78 | 5.23e-02 | -1.27e-01 | 6.61e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 30 | 2.28e-01 | 1.27e-01 | 8.34e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 23 | 2.91e-01 | 1.27e-01 | 8.69e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 3.94e-01 | -1.27e-01 | 8.97e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 8 | 5.34e-01 | 1.27e-01 | 9.40e-01 |
| GOBP NEURON PROJECTION REGENERATION | 28 | 2.45e-01 | 1.27e-01 | 8.49e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 23 | 2.93e-01 | -1.27e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 4.88e-01 | 1.27e-01 | 9.30e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 5.91e-01 | -1.27e-01 | 9.51e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 11 | 4.67e-01 | -1.27e-01 | 9.25e-01 |
| GOBP NEPHRON DEVELOPMENT | 58 | 9.54e-02 | 1.27e-01 | 7.30e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 5.91e-01 | -1.27e-01 | 9.51e-01 |
| GOBP SOMITE DEVELOPMENT | 35 | 1.95e-01 | 1.27e-01 | 8.19e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 15 | 3.96e-01 | -1.27e-01 | 8.98e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 9 | 5.11e-01 | 1.27e-01 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 6.24e-01 | 1.26e-01 | 9.57e-01 |
| GOBP SKIN MORPHOGENESIS | 6 | 5.92e-01 | -1.26e-01 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 97 | 3.17e-02 | -1.26e-01 | 5.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 109 | 2.29e-02 | -1.26e-01 | 5.38e-01 |
| GOCC INTERCELLULAR BRIDGE | 51 | 1.19e-01 | -1.26e-01 | 7.52e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 17 | 3.68e-01 | -1.26e-01 | 8.92e-01 |
| GOBP VIRAL GENOME REPLICATION | 106 | 2.50e-02 | 1.26e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 28 | 2.48e-01 | -1.26e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 10 | 4.90e-01 | 1.26e-01 | 9.30e-01 |
| GOBP DECIDUALIZATION | 15 | 3.98e-01 | 1.26e-01 | 8.98e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 17 | 3.68e-01 | 1.26e-01 | 8.92e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 19 | 3.42e-01 | 1.26e-01 | 8.84e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 6 | 5.93e-01 | 1.26e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 20 | 3.30e-01 | -1.26e-01 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 19 | 3.42e-01 | -1.26e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 5.64e-01 | -1.26e-01 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 39 | 1.75e-01 | -1.26e-01 | 8.07e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 29 | 2.42e-01 | -1.26e-01 | 8.43e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 66 | 7.78e-02 | -1.26e-01 | 6.92e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 5.38e-01 | 1.26e-01 | 9.40e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 53 | 1.14e-01 | -1.26e-01 | 7.52e-01 |
| GOBP ADULT BEHAVIOR | 66 | 7.81e-02 | -1.26e-01 | 6.92e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 2.87e-01 | 1.26e-01 | 8.68e-01 |
| GOBP MYOBLAST PROLIFERATION | 13 | 4.33e-01 | -1.25e-01 | 9.14e-01 |
| GOBP REGULATION OF URINE VOLUME | 8 | 5.39e-01 | 1.25e-01 | 9.40e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 33 | 2.13e-01 | 1.25e-01 | 8.32e-01 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 1.93e-01 | 1.25e-01 | 8.17e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 131 | 1.35e-02 | 1.25e-01 | 4.67e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 11 | 4.72e-01 | -1.25e-01 | 9.26e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 5.40e-01 | -1.25e-01 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 33 | 2.14e-01 | 1.25e-01 | 8.32e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 4.35e-01 | 1.25e-01 | 9.14e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 5 | 6.28e-01 | 1.25e-01 | 9.58e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 8 | 5.40e-01 | -1.25e-01 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 10 | 4.94e-01 | 1.25e-01 | 9.31e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 10 | 4.94e-01 | 1.25e-01 | 9.31e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 7 | 5.67e-01 | 1.25e-01 | 9.44e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 7 | 5.68e-01 | -1.25e-01 | 9.44e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 5.97e-01 | 1.25e-01 | 9.51e-01 |
| GOMF MRNA 3 UTR BINDING | 82 | 5.11e-02 | -1.25e-01 | 6.58e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 5 | 6.29e-01 | -1.25e-01 | 9.58e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 21 | 3.23e-01 | 1.25e-01 | 8.76e-01 |
| GOCC CELL CELL CONTACT ZONE | 39 | 1.78e-01 | 1.25e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 6.30e-01 | 1.25e-01 | 9.58e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 26 | 2.72e-01 | 1.25e-01 | 8.58e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 7 | 5.68e-01 | -1.25e-01 | 9.44e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 96 | 3.54e-02 | 1.24e-01 | 5.92e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 65 | 8.32e-02 | 1.24e-01 | 7.01e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 60 | 9.60e-02 | 1.24e-01 | 7.30e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 9 | 5.18e-01 | 1.24e-01 | 9.35e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 28 | 2.55e-01 | 1.24e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 21 | 3.25e-01 | -1.24e-01 | 8.76e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 7 | 5.69e-01 | -1.24e-01 | 9.44e-01 |
| GOBP STRESS FIBER ASSEMBLY | 73 | 6.70e-02 | -1.24e-01 | 6.72e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 33 | 2.17e-01 | -1.24e-01 | 8.32e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 13 | 4.39e-01 | 1.24e-01 | 9.15e-01 |
| GOBP APPENDAGE DEVELOPMENT | 84 | 4.96e-02 | 1.24e-01 | 6.48e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 4.97e-01 | 1.24e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 76 | 6.18e-02 | -1.24e-01 | 6.68e-01 |
| GOCC PRP19 COMPLEX | 12 | 4.57e-01 | -1.24e-01 | 9.23e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 5.44e-01 | -1.24e-01 | 9.40e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 5 | 6.32e-01 | -1.24e-01 | 9.58e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 23 | 3.04e-01 | -1.24e-01 | 8.75e-01 |
| GOBP RESPONSE TO FOOD | 17 | 3.77e-01 | -1.24e-01 | 8.97e-01 |
| GOBP PARTURITION | 6 | 6.00e-01 | -1.24e-01 | 9.52e-01 |
| GOBP REGULATION OF MITOPHAGY | 12 | 4.59e-01 | -1.24e-01 | 9.24e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 26 | 2.76e-01 | -1.24e-01 | 8.60e-01 |
| GOBP MALATE METABOLIC PROCESS | 6 | 6.00e-01 | 1.24e-01 | 9.52e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 9 | 5.21e-01 | -1.23e-01 | 9.35e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 10 | 4.99e-01 | -1.23e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 97 | 3.59e-02 | 1.23e-01 | 5.97e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 9 | 5.22e-01 | -1.23e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 19 | 3.52e-01 | 1.23e-01 | 8.88e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 6 | 6.01e-01 | -1.23e-01 | 9.52e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 240 | 1.04e-03 | 1.23e-01 | 1.74e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 4.60e-01 | -1.23e-01 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 22 | 3.17e-01 | 1.23e-01 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 8 | 5.46e-01 | 1.23e-01 | 9.40e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 6.33e-01 | -1.23e-01 | 9.59e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 6.33e-01 | -1.23e-01 | 9.59e-01 |
| GOMF PRERIBOSOME BINDING | 8 | 5.46e-01 | 1.23e-01 | 9.40e-01 |
| GOBP PROTEIN HEXAMERIZATION | 8 | 5.47e-01 | -1.23e-01 | 9.40e-01 |
| GOMF GLYCOLIPID BINDING | 18 | 3.67e-01 | -1.23e-01 | 8.92e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 5 | 6.34e-01 | 1.23e-01 | 9.59e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 9 | 5.23e-01 | -1.23e-01 | 9.35e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 47 | 1.45e-01 | -1.23e-01 | 7.77e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 5 | 6.34e-01 | -1.23e-01 | 9.59e-01 |
| GOBP TRNA 5 END PROCESSING | 16 | 3.95e-01 | 1.23e-01 | 8.98e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 5 | 6.35e-01 | -1.23e-01 | 9.59e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 5 | 6.35e-01 | -1.23e-01 | 9.59e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 29 | 2.53e-01 | 1.23e-01 | 8.50e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 27 | 2.70e-01 | -1.23e-01 | 8.58e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 3.55e-01 | -1.23e-01 | 8.88e-01 |
| GOCC MICOS COMPLEX | 8 | 5.48e-01 | -1.23e-01 | 9.40e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 132 | 1.52e-02 | 1.23e-01 | 4.75e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 49 | 1.38e-01 | -1.23e-01 | 7.63e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 16 | 3.96e-01 | 1.23e-01 | 8.98e-01 |
| GOMF DNA BINDING BENDING | 9 | 5.25e-01 | -1.23e-01 | 9.36e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 80 | 5.87e-02 | 1.22e-01 | 6.64e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.04e-01 | 1.22e-01 | 9.52e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 10 | 5.03e-01 | -1.22e-01 | 9.31e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 7 | 5.75e-01 | -1.22e-01 | 9.45e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 23 | 3.10e-01 | -1.22e-01 | 8.75e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 10 | 5.03e-01 | -1.22e-01 | 9.31e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 38 | 1.93e-01 | 1.22e-01 | 8.17e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 11 | 4.83e-01 | -1.22e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 16 | 3.98e-01 | -1.22e-01 | 8.98e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 5 | 6.37e-01 | 1.22e-01 | 9.59e-01 |
| GOBP ENDOCRINE PROCESS | 34 | 2.18e-01 | -1.22e-01 | 8.32e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 33 | 2.25e-01 | -1.22e-01 | 8.32e-01 |
| GOCC CORNIFIED ENVELOPE | 12 | 4.64e-01 | 1.22e-01 | 9.25e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 8 | 5.50e-01 | 1.22e-01 | 9.40e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 21 | 3.34e-01 | -1.22e-01 | 8.81e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 5.27e-01 | 1.22e-01 | 9.36e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 297 | 3.22e-04 | 1.22e-01 | 9.41e-02 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 53 | 1.25e-01 | 1.22e-01 | 7.55e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 33 | 2.26e-01 | 1.22e-01 | 8.32e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 12 | 4.65e-01 | 1.22e-01 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 6 | 6.05e-01 | -1.22e-01 | 9.52e-01 |
| GOCC RETROMER COMPLEX | 12 | 4.65e-01 | -1.22e-01 | 9.25e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 3.85e-01 | 1.22e-01 | 8.97e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 16 | 3.99e-01 | 1.22e-01 | 8.99e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 169 | 6.48e-03 | 1.22e-01 | 3.95e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 36 | 2.07e-01 | -1.22e-01 | 8.29e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 195 | 3.56e-03 | 1.21e-01 | 3.16e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 7 | 5.78e-01 | 1.21e-01 | 9.47e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 3.73e-01 | 1.21e-01 | 8.95e-01 |
| GOBP KIDNEY MORPHOGENESIS | 34 | 2.21e-01 | 1.21e-01 | 8.32e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 15 | 4.16e-01 | 1.21e-01 | 9.08e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 20 | 3.48e-01 | 1.21e-01 | 8.87e-01 |
| GOBP PROTEIN TETRAMERIZATION | 61 | 1.02e-01 | 1.21e-01 | 7.39e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 22 | 3.25e-01 | 1.21e-01 | 8.76e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 21 | 3.37e-01 | -1.21e-01 | 8.83e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 17 | 3.88e-01 | 1.21e-01 | 8.97e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 11 | 4.87e-01 | -1.21e-01 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 5.30e-01 | 1.21e-01 | 9.38e-01 |
| GOBP REGULATION OF HAIR CYCLE | 9 | 5.30e-01 | 1.21e-01 | 9.38e-01 |
| GOBP OXALATE TRANSPORT | 5 | 6.40e-01 | 1.21e-01 | 9.59e-01 |
| GOBP HEME TRANSPORT | 6 | 6.08e-01 | 1.21e-01 | 9.54e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 6 | 6.08e-01 | 1.21e-01 | 9.54e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.08e-01 | 1.21e-01 | 9.54e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 154 | 9.80e-03 | -1.21e-01 | 4.30e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 252 | 9.99e-04 | 1.21e-01 | 1.74e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 7 | 5.80e-01 | 1.21e-01 | 9.48e-01 |
| GOBP DENDRITE MORPHOGENESIS | 80 | 6.24e-02 | 1.21e-01 | 6.68e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 71 | 7.92e-02 | 1.21e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 23 | 3.17e-01 | -1.21e-01 | 8.76e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 9 | 5.31e-01 | 1.21e-01 | 9.39e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 20 | 3.51e-01 | 1.20e-01 | 8.88e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 51 | 1.37e-01 | -1.20e-01 | 7.62e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 9 | 5.32e-01 | 1.20e-01 | 9.39e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 7 | 5.81e-01 | 1.20e-01 | 9.48e-01 |
| GOBP RNA MODIFICATION | 160 | 8.77e-03 | 1.20e-01 | 4.19e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 6.10e-01 | -1.20e-01 | 9.55e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 17 | 3.90e-01 | -1.20e-01 | 8.97e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 43 | 1.73e-01 | -1.20e-01 | 8.07e-01 |
| GOCC LEADING EDGE MEMBRANE | 101 | 3.71e-02 | -1.20e-01 | 6.08e-01 |
| GOBP NEURON FATE COMMITMENT | 16 | 4.05e-01 | -1.20e-01 | 8.99e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 17 | 3.91e-01 | 1.20e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 21 | 3.41e-01 | -1.20e-01 | 8.84e-01 |
| GOBP UBIQUITIN RECYCLING | 10 | 5.11e-01 | -1.20e-01 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 12 | 4.72e-01 | -1.20e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 18 | 3.78e-01 | -1.20e-01 | 8.97e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 9 | 5.33e-01 | -1.20e-01 | 9.40e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 55 | 1.24e-01 | 1.20e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 30 | 2.56e-01 | 1.20e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 6.43e-01 | -1.20e-01 | 9.59e-01 |
| GOCC HOST CELLULAR COMPONENT | 7 | 5.83e-01 | 1.20e-01 | 9.48e-01 |
| GOBP ZYMOGEN ACTIVATION | 29 | 2.65e-01 | -1.20e-01 | 8.52e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 46 | 1.61e-01 | -1.20e-01 | 7.96e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 3.80e-01 | -1.20e-01 | 8.97e-01 |
| GOMF L ASCORBIC ACID BINDING | 15 | 4.23e-01 | 1.20e-01 | 9.12e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 11 | 4.93e-01 | 1.20e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 62 | 1.04e-01 | -1.19e-01 | 7.39e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 14 | 4.39e-01 | 1.19e-01 | 9.15e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 5.84e-01 | -1.19e-01 | 9.49e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 18 | 3.81e-01 | 1.19e-01 | 8.97e-01 |
| GOBP ASSOCIATIVE LEARNING | 36 | 2.16e-01 | -1.19e-01 | 8.32e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 30 | 2.59e-01 | 1.19e-01 | 8.50e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 6.13e-01 | 1.19e-01 | 9.55e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 4.94e-01 | 1.19e-01 | 9.31e-01 |
| GOCC REPLICATION FORK | 59 | 1.14e-01 | 1.19e-01 | 7.52e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 81 | 6.43e-02 | 1.19e-01 | 6.70e-01 |
| GOBP SPLEEN DEVELOPMENT | 26 | 2.94e-01 | -1.19e-01 | 8.71e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 23 | 3.23e-01 | -1.19e-01 | 8.76e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 16 | 4.10e-01 | -1.19e-01 | 9.03e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 43 | 1.77e-01 | -1.19e-01 | 8.07e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 39 | 1.99e-01 | 1.19e-01 | 8.24e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 38 | 2.05e-01 | -1.19e-01 | 8.28e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.86e-01 | 1.19e-01 | 9.49e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 8 | 5.61e-01 | 1.19e-01 | 9.44e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 8 | 5.61e-01 | 1.19e-01 | 9.44e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 54 | 1.31e-01 | 1.19e-01 | 7.57e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 5.37e-01 | 1.19e-01 | 9.40e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 13 | 4.59e-01 | -1.19e-01 | 9.24e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 6 | 6.15e-01 | -1.19e-01 | 9.55e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 4.43e-01 | -1.19e-01 | 9.16e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 10 | 5.17e-01 | -1.18e-01 | 9.34e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 16 | 4.12e-01 | 1.18e-01 | 9.04e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 68 | 9.16e-02 | 1.18e-01 | 7.16e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 62 | 1.07e-01 | 1.18e-01 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 5.88e-01 | 1.18e-01 | 9.50e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 8 | 5.62e-01 | 1.18e-01 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 6 | 6.16e-01 | 1.18e-01 | 9.55e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 31 | 2.55e-01 | -1.18e-01 | 8.50e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 29 | 2.71e-01 | 1.18e-01 | 8.58e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 5.63e-01 | -1.18e-01 | 9.44e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 133 | 1.88e-02 | -1.18e-01 | 5.14e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 20 | 3.60e-01 | 1.18e-01 | 8.91e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 10 | 5.18e-01 | 1.18e-01 | 9.35e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 6.48e-01 | 1.18e-01 | 9.60e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 9 | 5.40e-01 | -1.18e-01 | 9.40e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 5.89e-01 | -1.18e-01 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 18 | 3.86e-01 | -1.18e-01 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 5 | 6.48e-01 | 1.18e-01 | 9.60e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 36 | 2.21e-01 | 1.18e-01 | 8.32e-01 |
| GOMF I SMAD BINDING | 12 | 4.79e-01 | -1.18e-01 | 9.26e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 4.80e-01 | 1.18e-01 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 9 | 5.41e-01 | -1.18e-01 | 9.40e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 10 | 5.19e-01 | 1.18e-01 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 41 | 1.93e-01 | 1.18e-01 | 8.17e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 9 | 5.41e-01 | 1.18e-01 | 9.40e-01 |
| GOMF FERROUS IRON BINDING | 19 | 3.75e-01 | -1.18e-01 | 8.97e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 24 | 3.20e-01 | -1.17e-01 | 8.76e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 65 | 1.02e-01 | -1.17e-01 | 7.39e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 20 | 3.64e-01 | -1.17e-01 | 8.92e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 6.19e-01 | 1.17e-01 | 9.55e-01 |
| GOBP TUBE FORMATION | 85 | 6.20e-02 | 1.17e-01 | 6.68e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 37 | 2.17e-01 | 1.17e-01 | 8.32e-01 |
| GOCC TERTIARY GRANULE LUMEN | 42 | 1.89e-01 | -1.17e-01 | 8.14e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 9 | 5.43e-01 | -1.17e-01 | 9.40e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 12 | 4.82e-01 | -1.17e-01 | 9.27e-01 |
| GOBP RESPONSE TO ZINC ION | 23 | 3.31e-01 | 1.17e-01 | 8.79e-01 |
| GOMF CO SMAD BINDING | 7 | 5.92e-01 | 1.17e-01 | 9.51e-01 |
| GOCC NON MOTILE CILIUM | 76 | 7.82e-02 | 1.17e-01 | 6.92e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 3.78e-01 | -1.17e-01 | 8.97e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 86 | 6.12e-02 | 1.17e-01 | 6.68e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 112 | 3.29e-02 | 1.17e-01 | 5.88e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 5.44e-01 | 1.17e-01 | 9.40e-01 |
| GOBP DUMP METABOLIC PROCESS | 5 | 6.51e-01 | -1.17e-01 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 22 | 3.43e-01 | -1.17e-01 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 23 | 3.33e-01 | 1.17e-01 | 8.80e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 7 | 5.93e-01 | -1.17e-01 | 9.51e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 6.21e-01 | -1.17e-01 | 9.55e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 11 | 5.03e-01 | -1.17e-01 | 9.31e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 6.52e-01 | 1.17e-01 | 9.61e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 11 | 5.04e-01 | 1.17e-01 | 9.31e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 7 | 5.94e-01 | 1.16e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 15 | 4.35e-01 | 1.16e-01 | 9.14e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 56 | 1.32e-01 | 1.16e-01 | 7.57e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 5.69e-01 | -1.16e-01 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 6.52e-01 | -1.16e-01 | 9.61e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 19 | 3.80e-01 | -1.16e-01 | 8.97e-01 |
| GOBP ZYMOGEN INHIBITION | 6 | 6.22e-01 | 1.16e-01 | 9.55e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 9 | 5.46e-01 | 1.16e-01 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 6.52e-01 | -1.16e-01 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 7 | 5.94e-01 | -1.16e-01 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 15 | 4.36e-01 | -1.16e-01 | 9.14e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 47 | 1.68e-01 | -1.16e-01 | 8.04e-01 |
| GOBP MRNA 3 END PROCESSING | 48 | 1.64e-01 | 1.16e-01 | 8.02e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 5.69e-01 | -1.16e-01 | 9.44e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 64 | 1.09e-01 | 1.16e-01 | 7.47e-01 |
| GOMF VINCULIN BINDING | 9 | 5.47e-01 | 1.16e-01 | 9.40e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 3.95e-01 | 1.16e-01 | 8.98e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 8 | 5.70e-01 | 1.16e-01 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 37 | 2.23e-01 | 1.16e-01 | 8.32e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 50 | 1.57e-01 | 1.16e-01 | 7.89e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 11 | 5.06e-01 | -1.16e-01 | 9.31e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 6.54e-01 | 1.16e-01 | 9.62e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 6.54e-01 | 1.16e-01 | 9.62e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 77 | 7.94e-02 | -1.16e-01 | 6.95e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 10 | 5.26e-01 | -1.16e-01 | 9.36e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 332 | 3.13e-04 | -1.16e-01 | 9.41e-02 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 25 | 3.17e-01 | 1.16e-01 | 8.76e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 5.27e-01 | 1.16e-01 | 9.36e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 8 | 5.71e-01 | 1.16e-01 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 9 | 5.48e-01 | -1.16e-01 | 9.40e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 8 | 5.72e-01 | -1.16e-01 | 9.44e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 5.72e-01 | -1.16e-01 | 9.44e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 4.71e-01 | -1.16e-01 | 9.26e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 8 | 5.72e-01 | -1.15e-01 | 9.44e-01 |
| GOBP AXON GUIDANCE | 85 | 6.61e-02 | 1.15e-01 | 6.72e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 46 | 1.76e-01 | 1.15e-01 | 8.07e-01 |
| GOBP ENDOSOME ORGANIZATION | 83 | 6.96e-02 | -1.15e-01 | 6.73e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 8 | 5.72e-01 | 1.15e-01 | 9.44e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 7 | 5.97e-01 | 1.15e-01 | 9.52e-01 |
| GOBP TISSUE REGENERATION | 38 | 2.19e-01 | -1.15e-01 | 8.32e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 59 | 1.26e-01 | 1.15e-01 | 7.55e-01 |
| GOMF G PROTEIN ACTIVITY | 34 | 2.45e-01 | -1.15e-01 | 8.49e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 4.11e-01 | 1.15e-01 | 9.04e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 11 | 5.09e-01 | -1.15e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 23 | 3.40e-01 | -1.15e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 5.98e-01 | 1.15e-01 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 2.33e-01 | 1.15e-01 | 8.37e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 40 | 2.08e-01 | 1.15e-01 | 8.30e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 5.50e-01 | -1.15e-01 | 9.40e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 32 | 2.61e-01 | -1.15e-01 | 8.51e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 18 | 3.99e-01 | 1.15e-01 | 8.99e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 109 | 3.86e-02 | 1.15e-01 | 6.12e-01 |
| GOBP MACROMOLECULE METHYLATION | 176 | 8.80e-03 | 1.15e-01 | 4.19e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 20 | 3.74e-01 | -1.15e-01 | 8.96e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 15 | 4.42e-01 | 1.15e-01 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 15 | 4.42e-01 | 1.15e-01 | 9.16e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 6.57e-01 | 1.15e-01 | 9.62e-01 |
| GOCC SPINDLE MICROTUBULE | 63 | 1.16e-01 | -1.15e-01 | 7.52e-01 |
| GOBP COLLATERAL SPROUTING | 13 | 4.74e-01 | 1.15e-01 | 9.26e-01 |
| GOMF JUN KINASE BINDING | 10 | 5.30e-01 | 1.15e-01 | 9.38e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 7 | 6.00e-01 | 1.15e-01 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 32 | 2.62e-01 | 1.15e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 5.11e-01 | 1.15e-01 | 9.32e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 27 | 3.03e-01 | 1.14e-01 | 8.75e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 6.00e-01 | -1.14e-01 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 6 | 6.27e-01 | 1.14e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 12 | 4.93e-01 | 1.14e-01 | 9.31e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 7 | 6.00e-01 | -1.14e-01 | 9.52e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 15 | 4.44e-01 | 1.14e-01 | 9.17e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 42 | 2.00e-01 | -1.14e-01 | 8.26e-01 |
| GOBP MOLTING CYCLE | 44 | 1.90e-01 | 1.14e-01 | 8.15e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 13 | 4.77e-01 | -1.14e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 68 | 1.04e-01 | 1.14e-01 | 7.39e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 15 | 4.45e-01 | 1.14e-01 | 9.17e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 17 | 4.16e-01 | -1.14e-01 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 21 | 3.66e-01 | -1.14e-01 | 8.92e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 39 | 2.19e-01 | 1.14e-01 | 8.32e-01 |
| GOCC SUPER ELONGATION COMPLEX | 5 | 6.59e-01 | -1.14e-01 | 9.62e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 21 | 3.66e-01 | 1.14e-01 | 8.92e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 9 | 5.54e-01 | 1.14e-01 | 9.42e-01 |
| GOCC KINETOCHORE MICROTUBULE | 18 | 4.03e-01 | -1.14e-01 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 25 | 3.25e-01 | 1.14e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 38 | 2.25e-01 | -1.14e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 19 | 3.91e-01 | -1.14e-01 | 8.97e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 6.60e-01 | 1.14e-01 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 19 | 3.91e-01 | 1.14e-01 | 8.97e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 12 | 4.96e-01 | -1.14e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 21 | 3.68e-01 | -1.14e-01 | 8.92e-01 |
| GOBP OOGENESIS | 50 | 1.65e-01 | 1.14e-01 | 8.03e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 12 | 4.96e-01 | -1.14e-01 | 9.31e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 39 | 2.20e-01 | 1.14e-01 | 8.32e-01 |
| GOCC T TUBULE | 24 | 3.36e-01 | 1.14e-01 | 8.83e-01 |
| GOCC NADPH OXIDASE COMPLEX | 9 | 5.56e-01 | 1.13e-01 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 5 | 6.61e-01 | -1.13e-01 | 9.62e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 9 | 5.56e-01 | 1.13e-01 | 9.43e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 6.31e-01 | 1.13e-01 | 9.58e-01 |
| GOBP VACUOLAR ACIDIFICATION | 31 | 2.75e-01 | -1.13e-01 | 8.59e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 119 | 3.32e-02 | 1.13e-01 | 5.88e-01 |
| GOMF CARD DOMAIN BINDING | 12 | 4.97e-01 | 1.13e-01 | 9.31e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 47 | 1.80e-01 | -1.13e-01 | 8.07e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 4.20e-01 | -1.13e-01 | 9.09e-01 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 6 | 6.31e-01 | -1.13e-01 | 9.58e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 62 | 1.24e-01 | 1.13e-01 | 7.55e-01 |
| GOCC PEPTIDASE COMPLEX | 104 | 4.67e-02 | -1.13e-01 | 6.37e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 23 | 3.48e-01 | 1.13e-01 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 20 | 3.82e-01 | 1.13e-01 | 8.97e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 24 | 3.38e-01 | 1.13e-01 | 8.83e-01 |
| GOBP HISTONE METHYLATION | 33 | 2.62e-01 | 1.13e-01 | 8.51e-01 |
| GOBP NEURAL CREST FORMATION | 8 | 5.81e-01 | 1.13e-01 | 9.48e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 34 | 2.56e-01 | 1.13e-01 | 8.50e-01 |
| GOBP RESPONSE TO NUTRIENT | 83 | 7.63e-02 | 1.13e-01 | 6.87e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 31 | 2.78e-01 | -1.13e-01 | 8.61e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 115 | 3.73e-02 | -1.13e-01 | 6.08e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 6.63e-01 | -1.13e-01 | 9.62e-01 |
| GOCC MYOSIN II COMPLEX | 9 | 5.59e-01 | -1.13e-01 | 9.44e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 6.33e-01 | 1.13e-01 | 9.59e-01 |
| GOBP REGULATION OF DNA BINDING | 60 | 1.32e-01 | -1.13e-01 | 7.57e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 14 | 4.66e-01 | -1.13e-01 | 9.25e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 4.82e-01 | -1.13e-01 | 9.27e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 8 | 5.82e-01 | -1.12e-01 | 9.48e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 239 | 2.86e-03 | -1.12e-01 | 3.04e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 24 | 3.41e-01 | -1.12e-01 | 8.84e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 6 | 6.34e-01 | 1.12e-01 | 9.59e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 5.01e-01 | -1.12e-01 | 9.31e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 19 | 3.97e-01 | 1.12e-01 | 8.98e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 74 | 9.53e-02 | 1.12e-01 | 7.30e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 41 | 2.14e-01 | -1.12e-01 | 8.32e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 5.60e-01 | -1.12e-01 | 9.44e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 54 | 1.54e-01 | -1.12e-01 | 7.89e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 11 | 5.19e-01 | -1.12e-01 | 9.35e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 6 | 6.34e-01 | -1.12e-01 | 9.59e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 29 | 2.96e-01 | -1.12e-01 | 8.71e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 15 | 4.52e-01 | -1.12e-01 | 9.21e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 17 | 4.24e-01 | 1.12e-01 | 9.13e-01 |
| GOBP RESPONSE TO UV A | 5 | 6.64e-01 | -1.12e-01 | 9.63e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 77 | 8.94e-02 | 1.12e-01 | 7.11e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 109 | 4.38e-02 | -1.12e-01 | 6.27e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 29 | 2.97e-01 | 1.12e-01 | 8.71e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 27 | 3.15e-01 | -1.12e-01 | 8.76e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 72 | 1.01e-01 | 1.12e-01 | 7.39e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 19 | 3.99e-01 | 1.12e-01 | 8.99e-01 |
| GOCC ESCRT I COMPLEX | 10 | 5.41e-01 | -1.12e-01 | 9.40e-01 |
| GOCC SET1C COMPASS COMPLEX | 12 | 5.03e-01 | -1.12e-01 | 9.31e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 5.03e-01 | 1.12e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 10 | 5.41e-01 | -1.12e-01 | 9.40e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 5.85e-01 | 1.12e-01 | 9.49e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 23 | 3.55e-01 | -1.12e-01 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 46 | 1.91e-01 | 1.11e-01 | 8.16e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 6.66e-01 | -1.11e-01 | 9.63e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 5.85e-01 | -1.11e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 29 | 2.99e-01 | 1.11e-01 | 8.73e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 22 | 3.66e-01 | 1.11e-01 | 8.92e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 15 | 4.55e-01 | 1.11e-01 | 9.23e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 5.04e-01 | -1.11e-01 | 9.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 6.10e-01 | -1.11e-01 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 7 | 6.10e-01 | -1.11e-01 | 9.55e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 13 | 4.88e-01 | -1.11e-01 | 9.30e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 10 | 5.43e-01 | 1.11e-01 | 9.40e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 332 | 5.34e-04 | 1.11e-01 | 1.34e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 6.37e-01 | 1.11e-01 | 9.59e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 16 | 4.42e-01 | 1.11e-01 | 9.16e-01 |
| GOBP TRNA METABOLIC PROCESS | 169 | 1.30e-02 | 1.11e-01 | 4.67e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 5 | 6.67e-01 | -1.11e-01 | 9.63e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 34 | 2.63e-01 | -1.11e-01 | 8.52e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 33 | 2.70e-01 | -1.11e-01 | 8.58e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 8 | 5.87e-01 | 1.11e-01 | 9.50e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 16 | 4.43e-01 | 1.11e-01 | 9.16e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 205 | 6.40e-03 | 1.11e-01 | 3.94e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 6.68e-01 | -1.11e-01 | 9.63e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 6 | 6.38e-01 | 1.11e-01 | 9.59e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 123 | 3.42e-02 | -1.11e-01 | 5.88e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 5 | 6.68e-01 | -1.11e-01 | 9.63e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 50 | 1.76e-01 | 1.11e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 5.45e-01 | 1.11e-01 | 9.40e-01 |
| GOBP NECROPTOTIC PROCESS | 34 | 2.64e-01 | -1.11e-01 | 8.52e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 34 | 2.65e-01 | 1.11e-01 | 8.52e-01 |
| GOBP STEM CELL PROLIFERATION | 52 | 1.68e-01 | -1.11e-01 | 8.04e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 8 | 5.88e-01 | -1.10e-01 | 9.50e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 28 | 3.12e-01 | 1.10e-01 | 8.76e-01 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 6.69e-01 | -1.10e-01 | 9.64e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 14 | 4.75e-01 | -1.10e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 12 | 5.08e-01 | 1.10e-01 | 9.31e-01 |
| GOBP ENTRY INTO HOST | 102 | 5.47e-02 | -1.10e-01 | 6.62e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 8 | 5.89e-01 | 1.10e-01 | 9.51e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 201 | 7.28e-03 | 1.10e-01 | 4.17e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 8 | 5.90e-01 | 1.10e-01 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 6 | 6.41e-01 | -1.10e-01 | 9.59e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 175 | 1.23e-02 | 1.10e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 21 | 3.83e-01 | 1.10e-01 | 8.97e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 21 | 3.83e-01 | -1.10e-01 | 8.97e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 25 | 3.42e-01 | 1.10e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 20 | 3.95e-01 | 1.10e-01 | 8.98e-01 |
| GOBP NEURAL TUBE FORMATION | 71 | 1.10e-01 | 1.10e-01 | 7.49e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 3.96e-01 | 1.10e-01 | 8.98e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 6.15e-01 | 1.10e-01 | 9.55e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 7 | 6.15e-01 | -1.10e-01 | 9.55e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 6.15e-01 | -1.10e-01 | 9.55e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 23 | 3.63e-01 | 1.10e-01 | 8.92e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 29 | 3.07e-01 | 1.10e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 26 | 3.34e-01 | 1.10e-01 | 8.82e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 5.70e-01 | -1.09e-01 | 9.44e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 15 | 4.63e-01 | 1.09e-01 | 9.25e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 6.72e-01 | 1.09e-01 | 9.64e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 41 | 2.26e-01 | -1.09e-01 | 8.32e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 6 | 6.43e-01 | -1.09e-01 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 9 | 5.70e-01 | 1.09e-01 | 9.44e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 8 | 5.92e-01 | -1.09e-01 | 9.51e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 27 | 3.26e-01 | 1.09e-01 | 8.76e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 5.31e-01 | -1.09e-01 | 9.38e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 17 | 4.36e-01 | -1.09e-01 | 9.14e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 21 | 3.87e-01 | -1.09e-01 | 8.97e-01 |
| GOBP NUCLEOPHAGY | 17 | 4.36e-01 | 1.09e-01 | 9.14e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 6.44e-01 | -1.09e-01 | 9.59e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 34 | 2.71e-01 | -1.09e-01 | 8.58e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 8 | 5.93e-01 | 1.09e-01 | 9.51e-01 |
| GOMF VITAMIN BINDING | 79 | 9.45e-02 | 1.09e-01 | 7.27e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 6.44e-01 | -1.09e-01 | 9.60e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 91 | 7.29e-02 | 1.09e-01 | 6.80e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 5.51e-01 | -1.09e-01 | 9.40e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 5.51e-01 | -1.09e-01 | 9.40e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 17 | 4.37e-01 | 1.09e-01 | 9.14e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 34 | 2.72e-01 | 1.09e-01 | 8.58e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 139 | 2.71e-02 | -1.09e-01 | 5.54e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 103 | 5.69e-02 | -1.09e-01 | 6.64e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 5.52e-01 | 1.09e-01 | 9.40e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 27 | 3.28e-01 | -1.09e-01 | 8.76e-01 |
| GOBP CHROMOSOME CONDENSATION | 22 | 3.78e-01 | 1.09e-01 | 8.97e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 75 | 1.04e-01 | -1.09e-01 | 7.39e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 5.33e-01 | 1.09e-01 | 9.40e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 5.95e-01 | -1.09e-01 | 9.51e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 6.45e-01 | 1.09e-01 | 9.60e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 6.19e-01 | -1.09e-01 | 9.55e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 13 | 4.98e-01 | 1.09e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 16 | 4.52e-01 | -1.09e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 50 | 1.85e-01 | -1.08e-01 | 8.11e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 19 | 4.14e-01 | -1.08e-01 | 9.06e-01 |
| GOBP ERYTHROCYTE MATURATION | 13 | 4.99e-01 | 1.08e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 34 | 2.75e-01 | -1.08e-01 | 8.58e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 5.96e-01 | -1.08e-01 | 9.51e-01 |
| GOBP DNA DEALKYLATION | 28 | 3.22e-01 | 1.08e-01 | 8.76e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 10 | 5.54e-01 | -1.08e-01 | 9.41e-01 |
| GOMF PRE MIRNA BINDING | 8 | 5.96e-01 | 1.08e-01 | 9.51e-01 |
| GOMF DIOXYGENASE ACTIVITY | 67 | 1.26e-01 | 1.08e-01 | 7.55e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 7 | 6.20e-01 | 1.08e-01 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 15 | 4.69e-01 | -1.08e-01 | 9.26e-01 |
| GOBP MACROPHAGE PROLIFERATION | 6 | 6.47e-01 | 1.08e-01 | 9.60e-01 |
| GOBP SYNCYTIUM FORMATION | 31 | 2.98e-01 | -1.08e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 30 | 3.06e-01 | 1.08e-01 | 8.75e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 53 | 1.74e-01 | 1.08e-01 | 8.07e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 23 | 3.70e-01 | 1.08e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 12 | 5.17e-01 | -1.08e-01 | 9.35e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 25 | 3.50e-01 | -1.08e-01 | 8.88e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 37 | 2.56e-01 | 1.08e-01 | 8.50e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 49 | 1.92e-01 | 1.08e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 96 | 6.83e-02 | -1.08e-01 | 6.72e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 6.21e-01 | 1.08e-01 | 9.55e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 6.76e-01 | -1.08e-01 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 6.77e-01 | 1.08e-01 | 9.64e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 279 | 2.06e-03 | 1.08e-01 | 2.49e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 6.22e-01 | -1.08e-01 | 9.56e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 4.71e-01 | 1.08e-01 | 9.26e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 11 | 5.38e-01 | 1.07e-01 | 9.40e-01 |
| GOBP PROTEIN NITROSYLATION | 9 | 5.77e-01 | 1.07e-01 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 5 | 6.78e-01 | 1.07e-01 | 9.64e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 6.78e-01 | 1.07e-01 | 9.64e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 6.24e-01 | -1.07e-01 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 68 | 1.27e-01 | 1.07e-01 | 7.55e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 29 | 3.18e-01 | 1.07e-01 | 8.76e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 98 | 6.73e-02 | 1.07e-01 | 6.72e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 8 | 6.00e-01 | 1.07e-01 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 8 | 6.00e-01 | 1.07e-01 | 9.52e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 7 | 6.24e-01 | 1.07e-01 | 9.57e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 6.50e-01 | -1.07e-01 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 6.79e-01 | 1.07e-01 | 9.64e-01 |
| GOCC GROWTH CONE MEMBRANE | 5 | 6.79e-01 | -1.07e-01 | 9.64e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 12 | 5.22e-01 | 1.07e-01 | 9.35e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 9 | 5.79e-01 | -1.07e-01 | 9.48e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 12 | 5.22e-01 | -1.07e-01 | 9.35e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 6.79e-01 | -1.07e-01 | 9.64e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 23 | 3.76e-01 | 1.07e-01 | 8.97e-01 |
| GOCC ENDOLYSOSOME | 23 | 3.76e-01 | 1.07e-01 | 8.97e-01 |
| GOBP LIPID GLYCOSYLATION | 6 | 6.51e-01 | 1.07e-01 | 9.61e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 39 | 2.49e-01 | -1.07e-01 | 8.50e-01 |
| GOBP AMINE CATABOLIC PROCESS | 9 | 5.80e-01 | 1.07e-01 | 9.48e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 25 | 3.56e-01 | -1.07e-01 | 8.88e-01 |
| GOBP PROTEIN REFOLDING | 19 | 4.21e-01 | 1.07e-01 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 6.80e-01 | -1.07e-01 | 9.64e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 5 | 6.80e-01 | -1.07e-01 | 9.64e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 32 | 2.98e-01 | 1.06e-01 | 8.71e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 23 | 3.77e-01 | 1.06e-01 | 8.97e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 17 | 4.48e-01 | -1.06e-01 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 33 | 2.90e-01 | 1.06e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 5.23e-01 | -1.06e-01 | 9.35e-01 |
| GOBP G0 TO G1 TRANSITION | 32 | 2.98e-01 | 1.06e-01 | 8.71e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 10 | 5.60e-01 | 1.06e-01 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 7 | 6.26e-01 | -1.06e-01 | 9.58e-01 |
| GOBP MICROVILLUS ASSEMBLY | 15 | 4.76e-01 | 1.06e-01 | 9.26e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 31 | 3.06e-01 | 1.06e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 16 | 4.62e-01 | 1.06e-01 | 9.25e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 6 | 6.52e-01 | 1.06e-01 | 9.61e-01 |
| GOBP PLATELET DEGRANULATION | 6 | 6.53e-01 | -1.06e-01 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 74 | 1.15e-01 | 1.06e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 9 | 5.82e-01 | -1.06e-01 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 54 | 1.78e-01 | 1.06e-01 | 8.07e-01 |
| GOCC FIBRILLAR CENTER | 125 | 4.10e-02 | 1.06e-01 | 6.18e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 24 | 3.69e-01 | 1.06e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 39 | 2.52e-01 | 1.06e-01 | 8.50e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 10 | 5.62e-01 | 1.06e-01 | 9.44e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 6.27e-01 | 1.06e-01 | 9.58e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 13 | 5.09e-01 | 1.06e-01 | 9.31e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 47 | 2.09e-01 | -1.06e-01 | 8.30e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 7 | 6.28e-01 | 1.06e-01 | 9.58e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 4.25e-01 | 1.06e-01 | 9.13e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 9 | 5.83e-01 | -1.06e-01 | 9.48e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 11 | 5.44e-01 | 1.06e-01 | 9.40e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 4.94e-01 | -1.06e-01 | 9.31e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 22 | 3.92e-01 | 1.06e-01 | 8.97e-01 |
| GOBP MRNA MODIFICATION | 31 | 3.10e-01 | 1.06e-01 | 8.75e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 14 | 4.95e-01 | 1.05e-01 | 9.31e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 7 | 6.29e-01 | 1.05e-01 | 9.58e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 5.64e-01 | -1.05e-01 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 82 | 9.95e-02 | 1.05e-01 | 7.35e-01 |
| GOMF U2 SNRNA BINDING | 6 | 6.55e-01 | 1.05e-01 | 9.62e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 36 | 2.75e-01 | -1.05e-01 | 8.59e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 96 | 7.55e-02 | -1.05e-01 | 6.85e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 20 | 4.16e-01 | -1.05e-01 | 9.08e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 70 | 1.29e-01 | 1.05e-01 | 7.57e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 5.66e-01 | 1.05e-01 | 9.44e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 79 | 1.07e-01 | -1.05e-01 | 7.42e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 26 | 3.55e-01 | 1.05e-01 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 13 | 5.13e-01 | -1.05e-01 | 9.33e-01 |
| GOBP RESPONSE TO CALCIUM ION | 75 | 1.17e-01 | 1.05e-01 | 7.52e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 6 | 6.57e-01 | 1.05e-01 | 9.62e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 6.85e-01 | -1.05e-01 | 9.64e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 7 | 6.31e-01 | -1.05e-01 | 9.58e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 9 | 5.87e-01 | 1.05e-01 | 9.50e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 94 | 8.04e-02 | 1.05e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 6.32e-01 | -1.04e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 3.57e-01 | -1.04e-01 | 8.88e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 21 | 4.08e-01 | 1.04e-01 | 9.01e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 29 | 3.31e-01 | 1.04e-01 | 8.79e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 5 | 6.86e-01 | 1.04e-01 | 9.64e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 50 | 2.02e-01 | 1.04e-01 | 8.28e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 261 | 3.85e-03 | 1.04e-01 | 3.31e-01 |
| GOMF GTPASE BINDING | 256 | 4.22e-03 | 1.04e-01 | 3.39e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 6.87e-01 | 1.04e-01 | 9.64e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 32 | 3.08e-01 | 1.04e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 9 | 5.89e-01 | 1.04e-01 | 9.50e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 14 | 5.00e-01 | 1.04e-01 | 9.31e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 33 | 3.01e-01 | 1.04e-01 | 8.74e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 6.87e-01 | -1.04e-01 | 9.64e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 400 | 3.99e-04 | 1.04e-01 | 1.09e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 5 | 6.88e-01 | -1.04e-01 | 9.64e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 91 | 8.75e-02 | -1.04e-01 | 7.11e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 75 | 1.21e-01 | -1.04e-01 | 7.52e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 9 | 5.91e-01 | 1.04e-01 | 9.51e-01 |
| GOBP EXIT FROM MITOSIS | 25 | 3.70e-01 | -1.04e-01 | 8.92e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 5.18e-01 | 1.03e-01 | 9.35e-01 |
| GOBP MEMBRANE BIOGENESIS | 43 | 2.41e-01 | -1.03e-01 | 8.43e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 90 | 9.07e-02 | 1.03e-01 | 7.14e-01 |
| GOBP RESPONSE TO CORTISOL | 5 | 6.89e-01 | 1.03e-01 | 9.64e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 188 | 1.50e-02 | -1.03e-01 | 4.75e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 120 | 5.15e-02 | 1.03e-01 | 6.58e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 10 | 5.72e-01 | 1.03e-01 | 9.44e-01 |
| GOBP RRNA TRANSPORT | 5 | 6.90e-01 | 1.03e-01 | 9.64e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 144 | 3.31e-02 | 1.03e-01 | 5.88e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 6.62e-01 | 1.03e-01 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 14 | 5.05e-01 | 1.03e-01 | 9.31e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 16 | 4.76e-01 | -1.03e-01 | 9.26e-01 |
| GOCC NUCLEAR PORE | 85 | 1.02e-01 | 1.03e-01 | 7.39e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 131 | 4.25e-02 | 1.03e-01 | 6.23e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 85 | 1.02e-01 | 1.03e-01 | 7.39e-01 |
| GOCC U1 SNRNP | 19 | 4.38e-01 | -1.03e-01 | 9.15e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 8 | 6.15e-01 | 1.03e-01 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 99 | 7.78e-02 | 1.03e-01 | 6.92e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 26 | 3.65e-01 | 1.03e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 47 | 2.24e-01 | -1.03e-01 | 8.32e-01 |
| GOMF E BOX BINDING | 24 | 3.84e-01 | -1.03e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 44 | 2.39e-01 | -1.03e-01 | 8.42e-01 |
| GOBP BILE ACID SECRETION | 5 | 6.91e-01 | -1.03e-01 | 9.64e-01 |
| GOMF REGULATORY RNA BINDING | 40 | 2.62e-01 | -1.03e-01 | 8.51e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 30 | 3.31e-01 | -1.03e-01 | 8.79e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 5.22e-01 | -1.03e-01 | 9.35e-01 |
| GOBP RECOMBINATIONAL REPAIR | 151 | 3.01e-02 | 1.03e-01 | 5.71e-01 |
| GOBP STEROL METABOLIC PROCESS | 87 | 9.89e-02 | -1.03e-01 | 7.33e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 6 | 6.64e-01 | -1.02e-01 | 9.63e-01 |
| GOBP L LYSINE TRANSPORT | 5 | 6.92e-01 | 1.02e-01 | 9.64e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.92e-01 | 1.02e-01 | 9.64e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 5 | 6.92e-01 | 1.02e-01 | 9.64e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 7 | 6.39e-01 | 1.02e-01 | 9.59e-01 |
| GOBP CILIUM MOVEMENT | 65 | 1.54e-01 | 1.02e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 14 | 5.08e-01 | -1.02e-01 | 9.31e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 6 | 6.65e-01 | 1.02e-01 | 9.63e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 87 | 1.00e-01 | 1.02e-01 | 7.37e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 7 | 6.40e-01 | 1.02e-01 | 9.59e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 17 | 4.67e-01 | -1.02e-01 | 9.25e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 9 | 5.97e-01 | 1.02e-01 | 9.51e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 8 | 6.18e-01 | 1.02e-01 | 9.55e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 29 | 3.43e-01 | -1.02e-01 | 8.84e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 8 | 6.19e-01 | 1.02e-01 | 9.55e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 6.19e-01 | 1.02e-01 | 9.55e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 75 | 1.29e-01 | -1.02e-01 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 13 | 5.26e-01 | 1.02e-01 | 9.36e-01 |
| GOBP IMPORT INTO NUCLEUS | 133 | 4.36e-02 | 1.02e-01 | 6.27e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.19e-01 | -1.02e-01 | 9.55e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 9 | 5.98e-01 | -1.01e-01 | 9.52e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 28 | 3.53e-01 | -1.01e-01 | 8.88e-01 |
| GOCC U5 SNRNP | 19 | 4.45e-01 | 1.01e-01 | 9.17e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 20 | 4.33e-01 | -1.01e-01 | 9.14e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 63 | 1.65e-01 | 1.01e-01 | 8.03e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 119 | 5.72e-02 | 1.01e-01 | 6.64e-01 |
| GOBP ACTIN NUCLEATION | 40 | 2.69e-01 | 1.01e-01 | 8.57e-01 |
| GOBP BLASTOCYST FORMATION | 30 | 3.38e-01 | 1.01e-01 | 8.83e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 17 | 4.71e-01 | 1.01e-01 | 9.26e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 17 | 4.71e-01 | 1.01e-01 | 9.26e-01 |
| GOBP INNERVATION | 11 | 5.62e-01 | -1.01e-01 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 41 | 2.64e-01 | 1.01e-01 | 8.52e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 8 | 6.21e-01 | -1.01e-01 | 9.55e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 23 | 4.02e-01 | -1.01e-01 | 8.99e-01 |
| GOCC GLIAL CELL PROJECTION | 16 | 4.85e-01 | -1.01e-01 | 9.29e-01 |
| GOBP VISUAL BEHAVIOR | 26 | 3.74e-01 | -1.01e-01 | 8.96e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 203 | 1.36e-02 | -1.01e-01 | 4.67e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 37 | 2.89e-01 | -1.01e-01 | 8.69e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 15 | 5.00e-01 | -1.01e-01 | 9.31e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 17 | 4.72e-01 | -1.01e-01 | 9.26e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 5.81e-01 | -1.01e-01 | 9.48e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 21 | 4.25e-01 | 1.01e-01 | 9.13e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 23 | 4.04e-01 | -1.01e-01 | 8.99e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 5.63e-01 | 1.01e-01 | 9.44e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 101 | 8.10e-02 | -1.01e-01 | 6.95e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 3.33e-01 | -1.01e-01 | 8.80e-01 |
| GOBP ICOSANOID SECRETION | 15 | 5.00e-01 | 1.01e-01 | 9.31e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 77 | 1.28e-01 | 1.00e-01 | 7.56e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 42 | 2.60e-01 | 1.00e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 39 | 2.79e-01 | -1.00e-01 | 8.63e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 27 | 3.67e-01 | 1.00e-01 | 8.92e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 23 | 4.05e-01 | -1.00e-01 | 8.99e-01 |
| GOBP XENOPHAGY | 13 | 5.32e-01 | 1.00e-01 | 9.39e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 14 | 5.17e-01 | 1.00e-01 | 9.35e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 25 | 3.87e-01 | 1.00e-01 | 8.97e-01 |
| GOBP TRANSLATIONAL ELONGATION | 60 | 1.81e-01 | -1.00e-01 | 8.07e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 59 | 1.85e-01 | 1.00e-01 | 8.11e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 92 | 9.80e-02 | 1.00e-01 | 7.33e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 18 | 4.63e-01 | 1.00e-01 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 161 | 2.91e-02 | -9.99e-02 | 5.69e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 58 | 1.89e-01 | -9.98e-02 | 8.14e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 3.21e-01 | -9.98e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 5 | 6.99e-01 | 9.98e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 7 | 6.48e-01 | -9.98e-02 | 9.60e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 21 | 4.29e-01 | 9.98e-02 | 9.14e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 6.72e-01 | -9.97e-02 | 9.64e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 8 | 6.26e-01 | -9.97e-02 | 9.58e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 6.26e-01 | 9.96e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 32 | 3.30e-01 | 9.96e-02 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 6.26e-01 | 9.96e-02 | 9.58e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 6.73e-01 | -9.96e-02 | 9.64e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 6.48e-01 | -9.96e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 55 | 2.02e-01 | 9.95e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 5 | 7.00e-01 | 9.95e-02 | 9.65e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 5 | 7.00e-01 | 9.95e-02 | 9.65e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 5 | 7.00e-01 | -9.94e-02 | 9.65e-01 |
| GOBP VESICLE UNCOATING | 5 | 7.00e-01 | -9.94e-02 | 9.65e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 38 | 2.90e-01 | 9.93e-02 | 8.69e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 5 | 7.01e-01 | -9.93e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 40 | 2.78e-01 | -9.92e-02 | 8.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 5.69e-01 | -9.92e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 15 | 5.06e-01 | 9.92e-02 | 9.31e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 9 | 6.07e-01 | -9.91e-02 | 9.53e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 14 | 5.21e-01 | -9.91e-02 | 9.35e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 58 | 1.92e-01 | 9.91e-02 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 63 | 1.74e-01 | 9.91e-02 | 8.07e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 5.52e-01 | 9.91e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 16 | 4.93e-01 | 9.90e-02 | 9.31e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 23 | 4.11e-01 | 9.90e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 128 | 5.36e-02 | 9.90e-02 | 6.61e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 511 | 1.47e-04 | 9.89e-02 | 5.73e-02 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 32 | 3.33e-01 | -9.89e-02 | 8.81e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 38 | 2.92e-01 | 9.89e-02 | 8.69e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 95 | 9.63e-02 | -9.89e-02 | 7.30e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 9 | 6.08e-01 | -9.89e-02 | 9.54e-01 |
| GOMF CARBOHYDRATE BINDING | 150 | 3.71e-02 | 9.88e-02 | 6.08e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 166 | 2.85e-02 | -9.88e-02 | 5.64e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 18 | 4.68e-01 | -9.88e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 26 | 3.84e-01 | 9.88e-02 | 8.97e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 6.75e-01 | -9.87e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 6 | 6.76e-01 | -9.87e-02 | 9.64e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 6 | 6.76e-01 | -9.87e-02 | 9.64e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 5.23e-01 | -9.87e-02 | 9.35e-01 |
| GOBP LIVER MORPHOGENESIS | 14 | 5.23e-01 | 9.86e-02 | 9.35e-01 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 7.03e-01 | -9.86e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 5.89e-01 | 9.86e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 34 | 3.20e-01 | 9.86e-02 | 8.76e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 4.95e-01 | -9.86e-02 | 9.31e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 7 | 6.52e-01 | 9.85e-02 | 9.61e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 34 | 3.20e-01 | 9.85e-02 | 8.76e-01 |
| GOCC KINESIN COMPLEX | 26 | 3.85e-01 | 9.85e-02 | 8.97e-01 |
| GOCC RNA POLYMERASE COMPLEX | 95 | 9.78e-02 | 9.84e-02 | 7.33e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 6.76e-01 | -9.84e-02 | 9.64e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 6.30e-01 | -9.84e-02 | 9.58e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 8 | 6.31e-01 | 9.82e-02 | 9.58e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 50 | 2.30e-01 | 9.82e-02 | 8.36e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 11 | 5.73e-01 | -9.81e-02 | 9.44e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 278 | 5.07e-03 | -9.81e-02 | 3.63e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 10 | 5.91e-01 | -9.81e-02 | 9.51e-01 |
| GOBP MESODERM MORPHOGENESIS | 29 | 3.61e-01 | 9.81e-02 | 8.91e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 5.41e-01 | 9.80e-02 | 9.40e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 19 | 4.60e-01 | 9.80e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 25 | 3.97e-01 | 9.80e-02 | 8.98e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 6.11e-01 | 9.80e-02 | 9.55e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 6.78e-01 | 9.78e-02 | 9.64e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 9 | 6.11e-01 | -9.78e-02 | 9.55e-01 |
| GOBP RESPONSE TO DSRNA | 32 | 3.39e-01 | 9.78e-02 | 8.83e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 7 | 6.54e-01 | -9.78e-02 | 9.62e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 102 | 8.84e-02 | -9.78e-02 | 7.11e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 67 | 1.67e-01 | 9.78e-02 | 8.04e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 48 | 2.42e-01 | -9.77e-02 | 8.43e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 14 | 5.27e-01 | 9.77e-02 | 9.36e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 17 | 4.86e-01 | -9.77e-02 | 9.29e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 7.05e-01 | -9.77e-02 | 9.66e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 7 | 6.55e-01 | -9.77e-02 | 9.62e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 4.99e-01 | 9.77e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 18 | 4.74e-01 | -9.76e-02 | 9.26e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 58 | 1.99e-01 | 9.75e-02 | 8.24e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 6.55e-01 | -9.75e-02 | 9.62e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 3.25e-01 | 9.75e-02 | 8.76e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 5.28e-01 | -9.74e-02 | 9.37e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 19 | 4.62e-01 | 9.74e-02 | 9.25e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 6.56e-01 | 9.73e-02 | 9.62e-01 |
| GOBP REGULATION OF CYTOKINESIS | 61 | 1.89e-01 | 9.73e-02 | 8.14e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 15 | 5.14e-01 | 9.73e-02 | 9.33e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 42 | 2.76e-01 | 9.73e-02 | 8.60e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 18 | 4.75e-01 | 9.73e-02 | 9.26e-01 |
| GOBP QUINONE METABOLIC PROCESS | 29 | 3.65e-01 | -9.73e-02 | 8.92e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 15 | 5.14e-01 | 9.73e-02 | 9.33e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 27 | 3.82e-01 | -9.72e-02 | 8.97e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 49 | 2.40e-01 | 9.72e-02 | 8.43e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 36 | 3.13e-01 | 9.72e-02 | 8.76e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 9 | 6.14e-01 | 9.71e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 73 | 1.52e-01 | 9.71e-02 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 6.81e-01 | -9.70e-02 | 9.64e-01 |
| GOBP LIPID OXIDATION | 79 | 1.37e-01 | 9.69e-02 | 7.62e-01 |
| GOMF HISTONE READER ACTIVITY | 10 | 5.96e-01 | 9.69e-02 | 9.51e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 6 | 6.81e-01 | -9.69e-02 | 9.64e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 10 | 5.96e-01 | 9.69e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 12 | 5.61e-01 | -9.68e-02 | 9.44e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 7.08e-01 | -9.68e-02 | 9.66e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 7.08e-01 | -9.68e-02 | 9.66e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 9 | 6.15e-01 | 9.68e-02 | 9.55e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 8 | 6.36e-01 | 9.68e-02 | 9.59e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 7 | 6.57e-01 | 9.68e-02 | 9.62e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 5.96e-01 | 9.67e-02 | 9.51e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 6.82e-01 | 9.67e-02 | 9.64e-01 |
| GOBP NEURON PROJECTION EXTENSION | 98 | 9.88e-02 | 9.66e-02 | 7.33e-01 |
| GOCC CELL PROJECTION MEMBRANE | 177 | 2.71e-02 | -9.66e-02 | 5.54e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 63 | 1.85e-01 | -9.66e-02 | 8.11e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 103 | 9.09e-02 | -9.66e-02 | 7.14e-01 |
| GOBP RENAL SYSTEM PROCESS | 47 | 2.52e-01 | 9.66e-02 | 8.50e-01 |
| GOBP RNA 5 END PROCESSING | 22 | 4.33e-01 | 9.66e-02 | 9.14e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 24 | 4.13e-01 | 9.65e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 22 | 4.33e-01 | 9.65e-02 | 9.14e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 6.16e-01 | -9.65e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 104 | 8.97e-02 | 9.65e-02 | 7.11e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 10 | 5.97e-01 | -9.65e-02 | 9.52e-01 |
| GOBP RESPONSE TO COCAINE | 22 | 4.34e-01 | -9.65e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 8 | 6.37e-01 | 9.64e-02 | 9.59e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 75 | 1.50e-01 | 9.64e-02 | 7.89e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 7 | 6.59e-01 | 9.63e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 5 | 7.09e-01 | -9.63e-02 | 9.68e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 670 | 2.62e-05 | -9.63e-02 | 1.43e-02 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 20 | 4.56e-01 | 9.63e-02 | 9.23e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 124 | 6.46e-02 | 9.63e-02 | 6.70e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 38 | 3.05e-01 | -9.63e-02 | 8.75e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 5 | 7.09e-01 | -9.63e-02 | 9.68e-01 |
| GOBP LIPID DIGESTION | 5 | 7.09e-01 | -9.63e-02 | 9.68e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 8 | 6.37e-01 | 9.62e-02 | 9.59e-01 |
| GOBP PROTEIN STABILIZATION | 168 | 3.19e-02 | -9.62e-02 | 5.82e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 58 | 2.05e-01 | 9.62e-02 | 8.28e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 21 | 4.46e-01 | -9.62e-02 | 9.17e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 166 | 3.30e-02 | 9.62e-02 | 5.88e-01 |
| GOCC CHROMOSOMAL REGION | 310 | 3.76e-03 | 9.62e-02 | 3.28e-01 |
| GOCC STEREOCILIUM BUNDLE | 28 | 3.79e-01 | 9.62e-02 | 8.97e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 18 | 4.80e-01 | 9.62e-02 | 9.26e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.38e-01 | 9.62e-02 | 9.59e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 5.48e-01 | -9.62e-02 | 9.40e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 137 | 5.27e-02 | 9.61e-02 | 6.61e-01 |
| GOBP RNA 3 END PROCESSING | 89 | 1.18e-01 | 9.61e-02 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 156 | 3.89e-02 | 9.61e-02 | 6.12e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 9 | 6.18e-01 | 9.60e-02 | 9.55e-01 |
| GOBP NEUROBLAST PROLIFERATION | 34 | 3.33e-01 | 9.59e-02 | 8.81e-01 |
| GOBP EPIBOLY | 23 | 4.26e-01 | 9.59e-02 | 9.13e-01 |
| GOCC ASTER | 7 | 6.60e-01 | -9.59e-02 | 9.62e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 5.65e-01 | -9.59e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 12 | 5.66e-01 | 9.58e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 36 | 3.20e-01 | 9.58e-02 | 8.76e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 22 | 4.37e-01 | -9.57e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 53 | 2.29e-01 | 9.57e-02 | 8.34e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 9 | 6.19e-01 | -9.57e-02 | 9.55e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 70 | 1.67e-01 | -9.57e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 21 | 4.48e-01 | -9.56e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 12 | 5.66e-01 | -9.56e-02 | 9.44e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 6.40e-01 | 9.56e-02 | 9.59e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 7 | 6.62e-01 | 9.55e-02 | 9.62e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 20 | 4.60e-01 | 9.55e-02 | 9.25e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 5 | 7.12e-01 | -9.54e-02 | 9.68e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 7.12e-01 | -9.54e-02 | 9.68e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 32 | 3.51e-01 | -9.54e-02 | 8.88e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 403 | 1.10e-03 | 9.53e-02 | 1.74e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 74 | 1.57e-01 | -9.53e-02 | 7.89e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 114 | 7.93e-02 | 9.53e-02 | 6.95e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 91 | 1.17e-01 | 9.53e-02 | 7.52e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 7 | 6.63e-01 | -9.53e-02 | 9.62e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 21 | 4.50e-01 | -9.52e-02 | 9.21e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 26 | 4.01e-01 | -9.52e-02 | 8.99e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 11 | 5.85e-01 | 9.52e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 5 | 7.13e-01 | -9.52e-02 | 9.68e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 6.03e-01 | 9.51e-02 | 9.52e-01 |
| GOBP LYMPHOCYTE MIGRATION | 67 | 1.79e-01 | -9.51e-02 | 8.07e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 7.13e-01 | 9.51e-02 | 9.68e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 5 | 7.13e-01 | 9.51e-02 | 9.68e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 30 | 3.68e-01 | 9.50e-02 | 8.92e-01 |
| GOBP MITOTIC DNA REPLICATION | 10 | 6.03e-01 | 9.50e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 6.42e-01 | -9.50e-02 | 9.59e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 63 | 1.93e-01 | -9.50e-02 | 8.17e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 5.85e-01 | 9.50e-02 | 9.49e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 6.03e-01 | -9.50e-02 | 9.52e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 21 | 4.51e-01 | -9.50e-02 | 9.21e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 5.39e-01 | -9.50e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 27 | 3.93e-01 | 9.49e-02 | 8.97e-01 |
| GOBP IMP METABOLIC PROCESS | 13 | 5.54e-01 | 9.49e-02 | 9.41e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 17 | 4.98e-01 | -9.49e-02 | 9.31e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 6.64e-01 | 9.49e-02 | 9.63e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 6.42e-01 | -9.48e-02 | 9.59e-01 |
| GOBP DNA LIGATION | 14 | 5.39e-01 | 9.48e-02 | 9.40e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 7.14e-01 | 9.48e-02 | 9.68e-01 |
| GOBP RUFFLE ASSEMBLY | 29 | 3.77e-01 | -9.48e-02 | 8.97e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 77 | 1.51e-01 | -9.48e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 6 | 6.88e-01 | 9.48e-02 | 9.64e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 6.88e-01 | 9.48e-02 | 9.64e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 20 | 4.63e-01 | 9.47e-02 | 9.25e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 189 | 2.52e-02 | 9.47e-02 | 5.43e-01 |
| GOBP RHYTHMIC BEHAVIOR | 24 | 4.22e-01 | -9.47e-02 | 9.12e-01 |
| GOMF SUMO BINDING | 16 | 5.12e-01 | 9.46e-02 | 9.33e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 19 | 4.76e-01 | 9.46e-02 | 9.26e-01 |
| GOBP CILIUM ORGANIZATION | 277 | 6.99e-03 | 9.46e-02 | 4.13e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 19 | 4.76e-01 | -9.46e-02 | 9.26e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 6.89e-01 | 9.45e-02 | 9.64e-01 |
| GOCC ISWI TYPE COMPLEX | 12 | 5.71e-01 | 9.45e-02 | 9.44e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 84 | 1.35e-01 | 9.45e-02 | 7.62e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 31 | 3.63e-01 | 9.45e-02 | 8.92e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 11 | 5.88e-01 | 9.44e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 11 | 5.88e-01 | 9.43e-02 | 9.50e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 16 | 5.14e-01 | -9.43e-02 | 9.33e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 45 | 2.74e-01 | -9.43e-02 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 52 | 2.40e-01 | 9.43e-02 | 8.43e-01 |
| GOCC ENDONUCLEASE COMPLEX | 36 | 3.28e-01 | 9.43e-02 | 8.76e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 6.24e-01 | 9.43e-02 | 9.57e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 44 | 2.80e-01 | -9.42e-02 | 8.63e-01 |
| GOCC CIS GOLGI NETWORK | 48 | 2.59e-01 | -9.42e-02 | 8.50e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 5.72e-01 | 9.42e-02 | 9.44e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 4.66e-01 | -9.42e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 7.15e-01 | -9.42e-02 | 9.69e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 21 | 4.55e-01 | 9.42e-02 | 9.23e-01 |
| GOBP SPERM CAPACITATION | 8 | 6.45e-01 | -9.41e-02 | 9.60e-01 |
| GOBP RESPONSE TO ESTRADIOL | 58 | 2.16e-01 | -9.41e-02 | 8.32e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 29 | 3.81e-01 | -9.40e-02 | 8.97e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 35 | 3.36e-01 | -9.39e-02 | 8.83e-01 |
| GOCC TRANSPORTER COMPLEX | 182 | 2.93e-02 | -9.39e-02 | 5.70e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 69 | 1.78e-01 | 9.39e-02 | 8.07e-01 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 7.16e-01 | -9.39e-02 | 9.69e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 15 | 5.29e-01 | -9.38e-02 | 9.38e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 5 | 7.17e-01 | -9.38e-02 | 9.69e-01 |
| GOMF TELOMERIC DNA BINDING | 37 | 3.24e-01 | 9.38e-02 | 8.76e-01 |
| GOMF FATTY ACID BINDING | 22 | 4.47e-01 | -9.37e-02 | 9.19e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 3.91e-01 | -9.37e-02 | 8.97e-01 |
| GOMF NADP BINDING | 34 | 3.45e-01 | -9.37e-02 | 8.86e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 232 | 1.43e-02 | 9.37e-02 | 4.75e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 42 | 2.94e-01 | -9.37e-02 | 8.71e-01 |
| GOBP RETINA HOMEOSTASIS | 33 | 3.52e-01 | 9.37e-02 | 8.88e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 6.08e-01 | -9.37e-02 | 9.54e-01 |
| GOCC NUCLEOSOME | 34 | 3.45e-01 | 9.36e-02 | 8.87e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 25 | 4.19e-01 | -9.35e-02 | 9.08e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 57 | 2.23e-01 | 9.34e-02 | 8.32e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 16 | 5.18e-01 | 9.33e-02 | 9.35e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 56 | 2.28e-01 | -9.32e-02 | 8.34e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 205 | 2.18e-02 | 9.32e-02 | 5.33e-01 |
| GOCC GOLGI LUMEN | 23 | 4.39e-01 | 9.32e-02 | 9.15e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 59 | 2.16e-01 | 9.32e-02 | 8.32e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 47 | 2.70e-01 | 9.31e-02 | 8.58e-01 |
| GOMF DEMETHYLASE ACTIVITY | 34 | 3.48e-01 | 9.31e-02 | 8.87e-01 |
| GOBP METANEPHROS DEVELOPMENT | 24 | 4.30e-01 | 9.31e-02 | 9.14e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 10 | 6.10e-01 | 9.31e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 9 | 6.29e-01 | -9.31e-02 | 9.58e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 47 | 2.70e-01 | -9.31e-02 | 8.58e-01 |
| GOMF MANNOSIDASE ACTIVITY | 14 | 5.47e-01 | 9.30e-02 | 9.40e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 16 | 5.19e-01 | -9.30e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 59 | 2.17e-01 | -9.30e-02 | 8.32e-01 |
| GOMF CENTROMERIC DNA BINDING | 5 | 7.19e-01 | -9.30e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 10 | 6.11e-01 | 9.30e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 4.72e-01 | -9.29e-02 | 9.26e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 18 | 4.95e-01 | 9.29e-02 | 9.31e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 15 | 5.33e-01 | 9.29e-02 | 9.40e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 14 | 5.48e-01 | -9.28e-02 | 9.40e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 269 | 9.07e-03 | -9.28e-02 | 4.19e-01 |
| GOBP VESICLE TARGETING | 60 | 2.14e-01 | -9.28e-02 | 8.32e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 9 | 6.30e-01 | 9.28e-02 | 9.58e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 115 | 8.61e-02 | 9.28e-02 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 20 | 4.73e-01 | -9.28e-02 | 9.26e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 7 | 6.71e-01 | 9.28e-02 | 9.64e-01 |
| GOMF BETA TUBULIN BINDING | 32 | 3.64e-01 | 9.28e-02 | 8.92e-01 |
| GOBP MOLTING CYCLE PROCESS | 38 | 3.23e-01 | 9.28e-02 | 8.76e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 4.84e-01 | 9.27e-02 | 9.29e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 7.20e-01 | 9.27e-02 | 9.69e-01 |
| GOBP P38MAPK CASCADE | 41 | 3.05e-01 | -9.26e-02 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 6.71e-01 | -9.26e-02 | 9.64e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 34 | 3.51e-01 | 9.26e-02 | 8.88e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 11 | 5.95e-01 | -9.25e-02 | 9.51e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 23 | 4.43e-01 | 9.25e-02 | 9.16e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 6.72e-01 | 9.24e-02 | 9.64e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 80 | 1.54e-01 | 9.24e-02 | 7.89e-01 |
| GOBP AMYLOID BETA CLEARANCE | 27 | 4.06e-01 | -9.23e-02 | 8.99e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 31 | 3.74e-01 | -9.23e-02 | 8.96e-01 |
| GOBP REGULATION OF RNA SPLICING | 148 | 5.31e-02 | -9.23e-02 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 6 | 6.96e-01 | 9.23e-02 | 9.65e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 6.32e-01 | -9.22e-02 | 9.58e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 4.76e-01 | 9.21e-02 | 9.26e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 29 | 3.91e-01 | 9.21e-02 | 8.97e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 6.14e-01 | -9.21e-02 | 9.55e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 8 | 6.52e-01 | 9.20e-02 | 9.61e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 6.96e-01 | 9.20e-02 | 9.65e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 5.81e-01 | 9.20e-02 | 9.48e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 5.38e-01 | -9.20e-02 | 9.40e-01 |
| GOMF S100 PROTEIN BINDING | 11 | 5.98e-01 | -9.19e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 78 | 1.62e-01 | 9.17e-02 | 7.97e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 24 | 4.37e-01 | -9.17e-02 | 9.14e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 5 | 7.23e-01 | -9.16e-02 | 9.69e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 5 | 7.23e-01 | -9.16e-02 | 9.69e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 6 | 6.98e-01 | 9.16e-02 | 9.65e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 4.79e-01 | 9.15e-02 | 9.26e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 6.98e-01 | -9.15e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 6 | 6.98e-01 | -9.14e-02 | 9.65e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 51 | 2.59e-01 | -9.14e-02 | 8.50e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 9 | 6.35e-01 | -9.14e-02 | 9.59e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 9 | 6.35e-01 | -9.14e-02 | 9.59e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 73 | 1.77e-01 | -9.14e-02 | 8.07e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 6.54e-01 | 9.14e-02 | 9.62e-01 |
| GOCC MALE PRONUCLEUS | 6 | 6.98e-01 | 9.14e-02 | 9.65e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 34 | 3.57e-01 | 9.13e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 25 | 4.30e-01 | 9.13e-02 | 9.14e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 95 | 1.25e-01 | 9.12e-02 | 7.55e-01 |
| GOBP REGULATION OF TUBE SIZE | 59 | 2.26e-01 | 9.12e-02 | 8.32e-01 |
| GOMF CHROMATIN DNA BINDING | 79 | 1.61e-01 | -9.12e-02 | 7.97e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 7.24e-01 | 9.12e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 16 | 5.28e-01 | -9.12e-02 | 9.37e-01 |
| GOBP AORTA MORPHOGENESIS | 13 | 5.69e-01 | -9.12e-02 | 9.44e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 6.55e-01 | 9.12e-02 | 9.62e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 12 | 5.85e-01 | -9.12e-02 | 9.49e-01 |
| GOBP PINOCYTOSIS | 16 | 5.28e-01 | 9.12e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 5 | 7.24e-01 | 9.11e-02 | 9.69e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 74 | 1.76e-01 | -9.11e-02 | 8.07e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 189 | 3.14e-02 | -9.10e-02 | 5.81e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 20 | 4.82e-01 | -9.10e-02 | 9.27e-01 |
| GOCC CONTRACTILE RING | 8 | 6.56e-01 | 9.09e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 20 | 4.82e-01 | -9.09e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 64 | 2.09e-01 | 9.08e-02 | 8.30e-01 |
| GOBP GLUCOCORTICOID SECRETION | 8 | 6.57e-01 | -9.08e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 65 | 2.06e-01 | 9.08e-02 | 8.28e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 24 | 4.42e-01 | 9.08e-02 | 9.16e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 9 | 6.37e-01 | -9.07e-02 | 9.59e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 8 | 6.57e-01 | -9.07e-02 | 9.62e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 459 | 9.57e-04 | -9.06e-02 | 1.74e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 5.31e-01 | -9.06e-02 | 9.38e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 13 | 5.72e-01 | 9.05e-02 | 9.44e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 8 | 6.58e-01 | 9.05e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 34 | 3.62e-01 | -9.04e-02 | 8.92e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 7 | 6.79e-01 | -9.03e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 7 | 6.79e-01 | 9.03e-02 | 9.64e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 91 | 1.37e-01 | 9.02e-02 | 7.62e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 217 | 2.25e-02 | 9.02e-02 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 25 | 4.35e-01 | 9.02e-02 | 9.14e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 7 | 6.79e-01 | 9.02e-02 | 9.64e-01 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 7.27e-01 | -9.02e-02 | 9.69e-01 |
| GOCC MANCHETTE | 9 | 6.40e-01 | 9.02e-02 | 9.59e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 12 | 5.89e-01 | 9.02e-02 | 9.50e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 6.59e-01 | 9.01e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 21 | 4.75e-01 | -9.01e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 101 | 1.19e-01 | -9.00e-02 | 7.52e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 6.05e-01 | 9.00e-02 | 9.52e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 6.05e-01 | 9.00e-02 | 9.52e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 43 | 3.08e-01 | 9.00e-02 | 8.75e-01 |
| GOCC EUCHROMATIN | 40 | 3.25e-01 | 8.99e-02 | 8.76e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 3.51e-01 | -8.99e-02 | 8.88e-01 |
| GOBP MALE MEIOSIS I | 11 | 6.06e-01 | -8.99e-02 | 9.52e-01 |
| GOMF BH3 DOMAIN BINDING | 5 | 7.28e-01 | -8.99e-02 | 9.69e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 6.60e-01 | -8.98e-02 | 9.62e-01 |
| GOCC CILIARY TRANSITION ZONE | 47 | 2.87e-01 | 8.98e-02 | 8.68e-01 |
| GOBP UTERUS DEVELOPMENT | 9 | 6.41e-01 | 8.98e-02 | 9.59e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 8 | 6.60e-01 | 8.97e-02 | 9.62e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 74 | 1.83e-01 | 8.97e-02 | 8.07e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 20 | 4.88e-01 | 8.97e-02 | 9.30e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 40 | 3.27e-01 | 8.97e-02 | 8.76e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 27 | 4.20e-01 | 8.97e-02 | 9.09e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 70 | 1.96e-01 | 8.95e-02 | 8.20e-01 |
| GOBP V D J RECOMBINATION | 17 | 5.23e-01 | 8.95e-02 | 9.35e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 202 | 2.89e-02 | 8.95e-02 | 5.65e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 8 | 6.62e-01 | 8.93e-02 | 9.62e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 26 | 4.31e-01 | -8.93e-02 | 9.14e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 16 | 5.36e-01 | -8.93e-02 | 9.40e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 163 | 4.98e-02 | 8.93e-02 | 6.49e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 29 | 4.06e-01 | -8.92e-02 | 8.99e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 95 | 1.34e-01 | -8.91e-02 | 7.62e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 17 | 5.25e-01 | -8.91e-02 | 9.36e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 35 | 3.62e-01 | 8.90e-02 | 8.92e-01 |
| GOBP METHYLATION | 225 | 2.19e-02 | 8.90e-02 | 5.33e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 18 | 5.14e-01 | -8.90e-02 | 9.33e-01 |
| GOBP OVULATION | 6 | 7.06e-01 | -8.89e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 12 | 5.94e-01 | -8.89e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 23 | 4.61e-01 | 8.89e-02 | 9.25e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 5.94e-01 | -8.88e-02 | 9.51e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 15 | 5.52e-01 | -8.88e-02 | 9.40e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 6 | 7.06e-01 | -8.88e-02 | 9.66e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 44 | 3.08e-01 | 8.88e-02 | 8.75e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 23 | 4.61e-01 | -8.88e-02 | 9.25e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 9 | 6.45e-01 | -8.87e-02 | 9.60e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 7 | 6.84e-01 | -8.87e-02 | 9.64e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 23 | 4.62e-01 | -8.87e-02 | 9.25e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 48 | 2.88e-01 | -8.87e-02 | 8.68e-01 |
| GOBP BODY FLUID SECRETION | 47 | 2.93e-01 | -8.87e-02 | 8.70e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 5 | 7.32e-01 | 8.86e-02 | 9.70e-01 |
| GOBP RNA CAPPING | 36 | 3.58e-01 | 8.86e-02 | 8.90e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 20 | 4.93e-01 | -8.86e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 43 | 3.15e-01 | -8.86e-02 | 8.76e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 9 | 6.46e-01 | -8.85e-02 | 9.60e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 14 | 5.67e-01 | -8.85e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 5.96e-01 | -8.85e-02 | 9.51e-01 |
| GOBP ORGANIC CATION TRANSPORT | 27 | 4.27e-01 | 8.84e-02 | 9.13e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 19 | 5.05e-01 | 8.84e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 77 | 1.81e-01 | 8.84e-02 | 8.07e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 109 | 1.12e-01 | 8.84e-02 | 7.50e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 5.05e-01 | -8.84e-02 | 9.31e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 9 | 6.46e-01 | 8.83e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 5 | 7.32e-01 | 8.83e-02 | 9.70e-01 |
| GOBP RESPONSE TO BMP | 70 | 2.02e-01 | 8.83e-02 | 8.28e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 27 | 4.28e-01 | 8.82e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 6.66e-01 | -8.82e-02 | 9.63e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 5.06e-01 | 8.82e-02 | 9.31e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 79 | 1.76e-01 | -8.82e-02 | 8.07e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 19 | 5.06e-01 | 8.81e-02 | 9.31e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 65 | 2.20e-01 | 8.81e-02 | 8.32e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 34 | 3.75e-01 | 8.80e-02 | 8.97e-01 |
| GOCC LEWY BODY | 7 | 6.87e-01 | -8.80e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 21 | 4.85e-01 | 8.80e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 7.34e-01 | -8.79e-02 | 9.70e-01 |
| GOMF GATED CHANNEL ACTIVITY | 87 | 1.57e-01 | 8.79e-02 | 7.89e-01 |
| GOBP FIBRINOLYSIS | 6 | 7.09e-01 | 8.79e-02 | 9.68e-01 |
| GOBP POSITIVE T CELL SELECTION | 33 | 3.83e-01 | 8.79e-02 | 8.97e-01 |
| GOBP TELOMERE MAINTENANCE | 140 | 7.33e-02 | 8.79e-02 | 6.81e-01 |
| GOBP CHROMATIN LOOPING | 11 | 6.14e-01 | 8.79e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 65 | 2.21e-01 | -8.78e-02 | 8.32e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 10 | 6.31e-01 | 8.78e-02 | 9.58e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 6.31e-01 | 8.78e-02 | 9.58e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 8 | 6.67e-01 | -8.77e-02 | 9.63e-01 |
| GOBP T CELL EXTRAVASATION | 11 | 6.15e-01 | -8.77e-02 | 9.55e-01 |
| GOCC COLLAGEN TRIMER | 19 | 5.08e-01 | 8.77e-02 | 9.31e-01 |
| GOBP SODIUM ION TRANSPORT | 89 | 1.53e-01 | 8.77e-02 | 7.89e-01 |
| GOMF MONOSACCHARIDE BINDING | 53 | 2.70e-01 | 8.76e-02 | 8.58e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 65 | 2.23e-01 | -8.76e-02 | 8.32e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 14 | 5.71e-01 | 8.75e-02 | 9.44e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 24 | 4.58e-01 | 8.75e-02 | 9.24e-01 |
| GOBP HEART GROWTH | 40 | 3.39e-01 | 8.75e-02 | 8.83e-01 |
| GOCC ENDOCYTIC VESICLE | 249 | 1.79e-02 | 8.75e-02 | 5.05e-01 |
| GOBP NUCLEUS LOCALIZATION | 26 | 4.40e-01 | 8.74e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 99 | 1.34e-01 | 8.74e-02 | 7.62e-01 |
| GOMF TETRAPYRROLE BINDING | 63 | 2.31e-01 | -8.74e-02 | 8.37e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 7.35e-01 | 8.74e-02 | 9.70e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 4.99e-01 | -8.73e-02 | 9.31e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 42 | 3.28e-01 | -8.73e-02 | 8.76e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 9 | 6.50e-01 | -8.73e-02 | 9.61e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 19 | 5.10e-01 | -8.73e-02 | 9.32e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 20 | 4.99e-01 | -8.73e-02 | 9.31e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 15 | 5.59e-01 | 8.72e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 6.90e-01 | -8.71e-02 | 9.64e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 32 | 3.94e-01 | 8.71e-02 | 8.97e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 6.51e-01 | -8.71e-02 | 9.61e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 6 | 7.12e-01 | 8.71e-02 | 9.68e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 41 | 3.35e-01 | -8.71e-02 | 8.82e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 21 | 4.90e-01 | 8.70e-02 | 9.30e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 27 | 4.34e-01 | -8.70e-02 | 9.14e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 56 | 2.61e-01 | -8.70e-02 | 8.51e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 17 | 5.35e-01 | -8.70e-02 | 9.40e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 21 | 4.91e-01 | -8.69e-02 | 9.31e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 5 | 7.37e-01 | -8.69e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 5 | 7.37e-01 | 8.69e-02 | 9.70e-01 |
| GOBP INTRACILIARY TRANSPORT | 33 | 3.88e-01 | 8.68e-02 | 8.97e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 63 | 2.34e-01 | 8.68e-02 | 8.37e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 57 | 2.57e-01 | -8.68e-02 | 8.50e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 252 | 1.82e-02 | 8.68e-02 | 5.10e-01 |
| GOCC DENDRITE MEMBRANE | 9 | 6.52e-01 | 8.67e-02 | 9.61e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 7.37e-01 | -8.67e-02 | 9.70e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 7.13e-01 | -8.67e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 9 | 6.53e-01 | 8.67e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 31 | 4.04e-01 | 8.66e-02 | 8.99e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 20 | 5.03e-01 | -8.66e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 35 | 3.76e-01 | 8.65e-02 | 8.97e-01 |
| GOBP RESPONSE TO AMINE | 21 | 4.93e-01 | 8.65e-02 | 9.31e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 27 | 4.37e-01 | 8.64e-02 | 9.14e-01 |
| GOMF ALKALI METAL ION BINDING | 10 | 6.36e-01 | 8.64e-02 | 9.59e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 58 | 2.56e-01 | 8.64e-02 | 8.50e-01 |
| GOBP RESPONSE TO MANGANESE ION | 15 | 5.63e-01 | 8.63e-02 | 9.44e-01 |
| GOMF FLIPPASE ACTIVITY | 11 | 6.20e-01 | 8.63e-02 | 9.55e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 5 | 7.38e-01 | -8.63e-02 | 9.70e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 7.14e-01 | 8.63e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 27 | 4.38e-01 | 8.63e-02 | 9.15e-01 |
| GOCC AXON | 325 | 7.85e-03 | 8.62e-02 | 4.17e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 30 | 4.14e-01 | 8.62e-02 | 9.07e-01 |
| GOBP L AMINO ACID TRANSPORT | 51 | 2.87e-01 | 8.62e-02 | 8.68e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 9 | 6.55e-01 | -8.61e-02 | 9.62e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 5.91e-01 | 8.61e-02 | 9.51e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 71 | 2.10e-01 | 8.61e-02 | 8.32e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 6 | 7.15e-01 | -8.60e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 33 | 3.93e-01 | -8.59e-02 | 8.97e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 24 | 4.67e-01 | 8.59e-02 | 9.25e-01 |
| GOBP O GLYCAN PROCESSING | 26 | 4.49e-01 | -8.59e-02 | 9.19e-01 |
| GOBP FATTY ACID BETA OXIDATION | 61 | 2.47e-01 | 8.58e-02 | 8.49e-01 |
| GOBP REGULATION OF AXONOGENESIS | 82 | 1.80e-01 | 8.58e-02 | 8.07e-01 |
| GOCC SPERM PRINCIPAL PIECE | 15 | 5.65e-01 | -8.58e-02 | 9.44e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 56 | 2.67e-01 | 8.58e-02 | 8.56e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 9 | 6.56e-01 | 8.57e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 68 | 2.23e-01 | 8.56e-02 | 8.32e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 94 | 1.52e-01 | -8.56e-02 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 8 | 6.75e-01 | 8.56e-02 | 9.64e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 4.25e-01 | 8.56e-02 | 9.13e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 68 | 2.23e-01 | -8.56e-02 | 8.32e-01 |
| GOBP PHOTOTRANSDUCTION | 15 | 5.66e-01 | 8.56e-02 | 9.44e-01 |
| GOCC BASEMENT MEMBRANE | 23 | 4.78e-01 | -8.56e-02 | 9.26e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 120 | 1.06e-01 | -8.56e-02 | 7.42e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 3.62e-01 | 8.56e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 5 | 7.40e-01 | 8.56e-02 | 9.70e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 5 | 7.41e-01 | 8.55e-02 | 9.70e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 23 | 4.78e-01 | 8.55e-02 | 9.26e-01 |
| GOCC CATION CHANNEL COMPLEX | 58 | 2.61e-01 | 8.55e-02 | 8.51e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 103 | 1.35e-01 | 8.55e-02 | 7.62e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 29 | 4.26e-01 | -8.55e-02 | 9.13e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 51 | 2.92e-01 | -8.54e-02 | 8.69e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 181 | 4.82e-02 | 8.54e-02 | 6.48e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 9 | 6.57e-01 | -8.54e-02 | 9.62e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 8 | 6.76e-01 | 8.54e-02 | 9.64e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 5.42e-01 | 8.54e-02 | 9.40e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 7.41e-01 | 8.53e-02 | 9.70e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 7.41e-01 | 8.53e-02 | 9.70e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 39 | 3.57e-01 | -8.53e-02 | 8.88e-01 |
| GOBP RESPONSE TO FUNGUS | 35 | 3.83e-01 | 8.53e-02 | 8.97e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 89 | 1.65e-01 | -8.52e-02 | 8.03e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 6.25e-01 | 8.52e-02 | 9.57e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 5 | 7.41e-01 | -8.52e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 15 | 5.68e-01 | -8.52e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 64 | 2.39e-01 | 8.52e-02 | 8.42e-01 |
| GOBP VASOCONSTRICTION | 32 | 4.04e-01 | 8.52e-02 | 8.99e-01 |
| GOCC ADHERENS JUNCTION | 105 | 1.32e-01 | 8.52e-02 | 7.57e-01 |
| GOBP RESPONSE TO DOPAMINE | 31 | 4.12e-01 | 8.52e-02 | 9.04e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 114 | 1.17e-01 | 8.52e-02 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 7.42e-01 | -8.51e-02 | 9.70e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 100 | 1.42e-01 | -8.51e-02 | 7.74e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 8 | 6.77e-01 | 8.51e-02 | 9.64e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 23 | 4.81e-01 | -8.50e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 45 | 3.25e-01 | 8.49e-02 | 8.76e-01 |
| GOCC APICAL DENDRITE | 11 | 6.26e-01 | -8.48e-02 | 9.58e-01 |
| GOBP INSULIN SECRETION | 105 | 1.34e-01 | -8.48e-02 | 7.62e-01 |
| GOCC BASAL PART OF CELL | 149 | 7.47e-02 | 8.48e-02 | 6.85e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 5.01e-01 | 8.48e-02 | 9.31e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 15 | 5.70e-01 | -8.48e-02 | 9.44e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 6.78e-01 | 8.47e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 7.20e-01 | 8.47e-02 | 9.69e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 5.23e-01 | -8.46e-02 | 9.35e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 25 | 4.64e-01 | 8.46e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 104 | 1.37e-01 | -8.46e-02 | 7.62e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 12 | 6.12e-01 | 8.46e-02 | 9.55e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 5.13e-01 | 8.45e-02 | 9.33e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 41 | 3.49e-01 | 8.45e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 82 | 1.87e-01 | -8.45e-02 | 8.13e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 40 | 3.56e-01 | -8.45e-02 | 8.88e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 6.79e-01 | 8.45e-02 | 9.64e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 7.44e-01 | -8.44e-02 | 9.70e-01 |
| GOBP G1 TO G0 TRANSITION | 13 | 5.98e-01 | -8.44e-02 | 9.52e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 10 | 6.44e-01 | 8.44e-02 | 9.60e-01 |
| GOBP MITOCHONDRIAL FISSION | 34 | 3.95e-01 | 8.43e-02 | 8.98e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 12 | 6.13e-01 | -8.43e-02 | 9.55e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 50 | 3.03e-01 | -8.43e-02 | 8.75e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 21 | 5.04e-01 | -8.43e-02 | 9.31e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 59 | 2.63e-01 | -8.43e-02 | 8.52e-01 |
| GOBP CELL FATE COMMITMENT | 101 | 1.44e-01 | 8.42e-02 | 7.75e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 7.21e-01 | 8.42e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 24 | 4.75e-01 | 8.42e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 8 | 6.80e-01 | 8.42e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 7.21e-01 | 8.42e-02 | 9.69e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 2.94e-01 | -8.42e-02 | 8.71e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 13 | 6.00e-01 | 8.41e-02 | 9.52e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 7.21e-01 | -8.41e-02 | 9.69e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 23 | 4.85e-01 | 8.41e-02 | 9.29e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 12 | 6.14e-01 | -8.41e-02 | 9.55e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 7.21e-01 | -8.41e-02 | 9.69e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 7 | 7.00e-01 | 8.40e-02 | 9.65e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 49 | 3.10e-01 | 8.39e-02 | 8.75e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 45 | 3.30e-01 | 8.39e-02 | 8.79e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 9 | 6.63e-01 | 8.39e-02 | 9.62e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 5 | 7.45e-01 | -8.39e-02 | 9.70e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 11 | 6.30e-01 | 8.38e-02 | 9.58e-01 |
| GOBP LOCOMOTOR RHYTHM | 10 | 6.46e-01 | -8.38e-02 | 9.60e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 71 | 2.23e-01 | 8.38e-02 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 51 | 3.01e-01 | 8.37e-02 | 8.74e-01 |
| GOMF SYNTAXIN BINDING | 44 | 3.37e-01 | 8.37e-02 | 8.83e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 7.46e-01 | 8.37e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 25 | 4.69e-01 | -8.36e-02 | 9.26e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 37 | 3.79e-01 | 8.36e-02 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 16 | 5.63e-01 | 8.35e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 7 | 7.02e-01 | 8.35e-02 | 9.65e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 13 | 6.02e-01 | -8.35e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 8 | 6.83e-01 | -8.35e-02 | 9.64e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 7.47e-01 | -8.35e-02 | 9.71e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 12 | 6.17e-01 | -8.34e-02 | 9.55e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 30 | 4.29e-01 | 8.34e-02 | 9.14e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 10 | 6.48e-01 | -8.34e-02 | 9.60e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 5.76e-01 | 8.34e-02 | 9.46e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 13 | 6.03e-01 | 8.34e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 11 | 6.32e-01 | 8.34e-02 | 9.58e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 33 | 4.08e-01 | 8.34e-02 | 9.01e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 27 | 4.54e-01 | -8.34e-02 | 9.22e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 2.46e-01 | -8.33e-02 | 8.49e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 13 | 6.03e-01 | 8.33e-02 | 9.52e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 22 | 4.99e-01 | -8.33e-02 | 9.31e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 101 | 1.49e-01 | 8.33e-02 | 7.88e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 269 | 1.93e-02 | -8.32e-02 | 5.18e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 95 | 1.62e-01 | 8.32e-02 | 7.97e-01 |
| GOMF KINETOCHORE BINDING | 5 | 7.47e-01 | 8.32e-02 | 9.71e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 7.24e-01 | 8.32e-02 | 9.69e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 5.78e-01 | -8.31e-02 | 9.47e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 50 | 3.10e-01 | 8.30e-02 | 8.75e-01 |
| GOBP ORGANELLE INHERITANCE | 13 | 6.04e-01 | 8.30e-02 | 9.52e-01 |
| GOMF ANKYRIN BINDING | 6 | 7.25e-01 | 8.30e-02 | 9.69e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 45 | 3.36e-01 | -8.30e-02 | 8.83e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 32 | 4.17e-01 | -8.30e-02 | 9.08e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 12 | 6.19e-01 | 8.30e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 52 | 3.02e-01 | 8.28e-02 | 8.74e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 25 | 4.74e-01 | -8.28e-02 | 9.26e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 89 | 1.78e-01 | -8.27e-02 | 8.07e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 6.20e-01 | 8.26e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 32 | 4.19e-01 | 8.25e-02 | 9.09e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 17 | 5.56e-01 | 8.25e-02 | 9.43e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 10 | 6.52e-01 | 8.24e-02 | 9.61e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 7.27e-01 | 8.24e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 28 | 4.51e-01 | 8.24e-02 | 9.21e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 5.81e-01 | -8.23e-02 | 9.48e-01 |
| GOMF COPPER ION BINDING | 34 | 4.06e-01 | -8.23e-02 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 47 | 3.29e-01 | -8.23e-02 | 8.78e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 51 | 3.10e-01 | -8.23e-02 | 8.75e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 51 | 3.10e-01 | -8.22e-02 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 23 | 4.95e-01 | 8.22e-02 | 9.31e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 51 | 3.10e-01 | 8.22e-02 | 8.75e-01 |
| GOBP TRNA PROCESSING | 126 | 1.12e-01 | 8.22e-02 | 7.50e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 18 | 5.47e-01 | 8.19e-02 | 9.40e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 16 | 5.71e-01 | 8.19e-02 | 9.44e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 28 | 4.54e-01 | -8.19e-02 | 9.22e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 7.51e-01 | -8.18e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 7.08e-01 | -8.18e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 133 | 1.04e-01 | -8.18e-02 | 7.39e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 31 | 4.31e-01 | 8.17e-02 | 9.14e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 9 | 6.71e-01 | -8.17e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 238 | 3.06e-02 | 8.17e-02 | 5.72e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 10 | 6.55e-01 | -8.17e-02 | 9.62e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 17 | 5.60e-01 | 8.16e-02 | 9.44e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 95 | 1.70e-01 | -8.16e-02 | 8.04e-01 |
| GOBP MITOPHAGY | 33 | 4.18e-01 | -8.15e-02 | 9.08e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 466 | 2.79e-03 | 8.15e-02 | 3.04e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 43 | 3.56e-01 | 8.15e-02 | 8.88e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 51 | 3.15e-01 | 8.14e-02 | 8.76e-01 |
| GOBP LIPID DROPLET FORMATION | 9 | 6.72e-01 | 8.14e-02 | 9.64e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 38 | 3.86e-01 | -8.14e-02 | 8.97e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 7.30e-01 | -8.14e-02 | 9.70e-01 |
| GOBP DNA REPLICATION | 221 | 3.78e-02 | 8.14e-02 | 6.11e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 27 | 4.64e-01 | -8.14e-02 | 9.25e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 108 | 1.45e-01 | 8.14e-02 | 7.75e-01 |
| GOBP MUSCLE HYPERTROPHY | 51 | 3.15e-01 | -8.13e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 11 | 6.41e-01 | -8.13e-02 | 9.59e-01 |
| GOBP STEROID HORMONE SECRETION | 11 | 6.41e-01 | -8.13e-02 | 9.59e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 81 | 2.07e-01 | -8.12e-02 | 8.29e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 41 | 3.69e-01 | 8.12e-02 | 8.92e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 8 | 6.91e-01 | -8.12e-02 | 9.64e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 14 | 5.99e-01 | 8.12e-02 | 9.52e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 6.74e-01 | -8.11e-02 | 9.64e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 63 | 2.66e-01 | 8.11e-02 | 8.54e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 6.91e-01 | -8.11e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 7.10e-01 | 8.11e-02 | 9.68e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 6.42e-01 | 8.11e-02 | 9.59e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 7.10e-01 | 8.11e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 52 | 3.13e-01 | 8.10e-02 | 8.76e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 7.11e-01 | -8.10e-02 | 9.68e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 7.11e-01 | -8.10e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 50 | 3.22e-01 | -8.10e-02 | 8.76e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 6.92e-01 | 8.10e-02 | 9.64e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 22 | 5.11e-01 | -8.09e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 21 | 5.21e-01 | -8.09e-02 | 9.35e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 53 | 3.09e-01 | 8.09e-02 | 8.75e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 52 | 3.14e-01 | 8.08e-02 | 8.76e-01 |
| GOBP VESICLE ORGANIZATION | 278 | 2.10e-02 | -8.08e-02 | 5.33e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 69 | 2.46e-01 | 8.08e-02 | 8.49e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 13 | 6.14e-01 | 8.08e-02 | 9.55e-01 |
| GOBP PONS DEVELOPMENT | 7 | 7.11e-01 | 8.08e-02 | 9.68e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 5 | 7.55e-01 | 8.07e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 33 | 4.23e-01 | 8.07e-02 | 9.12e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 2.93e-01 | -8.06e-02 | 8.70e-01 |
| GOCC MICROBODY LUMEN | 36 | 4.03e-01 | 8.06e-02 | 8.99e-01 |
| GOMF NAD BINDING | 47 | 3.39e-01 | 8.06e-02 | 8.83e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 63 | 2.69e-01 | -8.05e-02 | 8.58e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 50 | 3.25e-01 | -8.05e-02 | 8.76e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 81 | 2.11e-01 | 8.05e-02 | 8.32e-01 |
| GOMF RIBOSOME BINDING | 102 | 1.61e-01 | -8.05e-02 | 7.96e-01 |
| GOBP FACE MORPHOGENESIS | 17 | 5.66e-01 | -8.05e-02 | 9.44e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 223 | 3.91e-02 | -8.05e-02 | 6.12e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 25 | 4.87e-01 | 8.04e-02 | 9.30e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 44 | 3.56e-01 | -8.04e-02 | 8.88e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 5.06e-01 | 8.02e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 11 | 6.45e-01 | 8.02e-02 | 9.60e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 6.61e-01 | 8.01e-02 | 9.62e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 42 | 3.69e-01 | -8.01e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 27 | 4.72e-01 | 8.00e-02 | 9.26e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 16 | 5.80e-01 | -8.00e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 21 | 5.26e-01 | 8.00e-02 | 9.36e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 43 | 3.65e-01 | -8.00e-02 | 8.92e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 8 | 6.96e-01 | -7.99e-02 | 9.65e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 11 | 6.47e-01 | -7.99e-02 | 9.60e-01 |
| GOBP LUTEINIZATION | 6 | 7.35e-01 | -7.99e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 12 | 6.32e-01 | -7.98e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 5 | 7.57e-01 | -7.98e-02 | 9.72e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 6.62e-01 | 7.98e-02 | 9.62e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 16 | 5.81e-01 | 7.98e-02 | 9.48e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 15 | 5.93e-01 | -7.98e-02 | 9.51e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 135 | 1.10e-01 | 7.98e-02 | 7.49e-01 |
| GOBP RESPONSE TO PEPTIDE | 317 | 1.52e-02 | 7.97e-02 | 4.75e-01 |
| GOCC OUTER KINETOCHORE | 9 | 6.79e-01 | 7.96e-02 | 9.64e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 18 | 5.59e-01 | 7.96e-02 | 9.44e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 102 | 1.66e-01 | -7.96e-02 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 9 | 6.79e-01 | -7.96e-02 | 9.64e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 15 | 5.94e-01 | 7.96e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 6.80e-01 | 7.95e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 19 | 5.49e-01 | 7.95e-02 | 9.40e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 13 | 6.20e-01 | -7.95e-02 | 9.55e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 36 | 4.10e-01 | 7.95e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 7.58e-01 | 7.94e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 7.16e-01 | 7.94e-02 | 9.69e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 6 | 7.37e-01 | 7.93e-02 | 9.70e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.49e-01 | -7.93e-02 | 9.61e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 120 | 1.35e-01 | 7.92e-02 | 7.62e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 37 | 4.05e-01 | 7.92e-02 | 8.99e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 89 | 1.97e-01 | 7.92e-02 | 8.22e-01 |
| GOMF LIGASE ACTIVITY | 116 | 1.42e-01 | 7.91e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 8 | 6.98e-01 | -7.91e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 68 | 2.60e-01 | 7.91e-02 | 8.51e-01 |
| GOMF FRIZZLED BINDING | 12 | 6.35e-01 | -7.91e-02 | 9.59e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 6 | 7.37e-01 | -7.91e-02 | 9.70e-01 |
| GOBP GLYCOLYTIC PROCESS | 65 | 2.71e-01 | -7.90e-02 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 9 | 6.81e-01 | -7.90e-02 | 9.64e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 52 | 3.25e-01 | -7.90e-02 | 8.76e-01 |
| GOCC GERM CELL NUCLEUS | 40 | 3.88e-01 | 7.90e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 84 | 2.12e-01 | 7.89e-02 | 8.32e-01 |
| GOCC LAMELLIPODIUM | 142 | 1.05e-01 | 7.89e-02 | 7.42e-01 |
| GOBP RETINOL METABOLIC PROCESS | 22 | 5.22e-01 | -7.89e-02 | 9.35e-01 |
| GOBP AXON DEVELOPMENT | 230 | 4.00e-02 | 7.89e-02 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 48 | 3.45e-01 | -7.88e-02 | 8.87e-01 |
| GOBP ARGININE METABOLIC PROCESS | 10 | 6.66e-01 | -7.88e-02 | 9.63e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 7 | 7.18e-01 | 7.87e-02 | 9.69e-01 |
| GOMF CGMP BINDING | 5 | 7.61e-01 | 7.87e-02 | 9.72e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 13 | 6.23e-01 | -7.87e-02 | 9.57e-01 |
| GOCC SPERM HEAD | 5 | 7.61e-01 | -7.86e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 20 | 5.43e-01 | -7.86e-02 | 9.40e-01 |
| GOBP DEPYRIMIDINATION | 7 | 7.19e-01 | -7.85e-02 | 9.69e-01 |
| GOBP RESPIRATORY BURST | 28 | 4.72e-01 | 7.85e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 8 | 7.01e-01 | -7.85e-02 | 9.65e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 6 | 7.40e-01 | 7.84e-02 | 9.70e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 78 | 2.32e-01 | 7.84e-02 | 8.37e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 44 | 3.69e-01 | -7.83e-02 | 8.92e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 7 | 7.20e-01 | -7.83e-02 | 9.69e-01 |
| GOBP T CELL SELECTION | 41 | 3.86e-01 | 7.83e-02 | 8.97e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 6 | 7.40e-01 | -7.82e-02 | 9.70e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 180 | 7.12e-02 | 7.82e-02 | 6.78e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 6 | 7.40e-01 | 7.82e-02 | 9.70e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 17 | 5.77e-01 | -7.81e-02 | 9.47e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 13 | 6.26e-01 | -7.81e-02 | 9.58e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 39 | 3.99e-01 | 7.80e-02 | 8.99e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 15 | 6.01e-01 | -7.80e-02 | 9.52e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 38 | 4.06e-01 | -7.80e-02 | 8.99e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 4.06e-01 | 7.80e-02 | 8.99e-01 |
| GOCC MYELIN SHEATH | 24 | 5.09e-01 | 7.80e-02 | 9.31e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 12 | 6.40e-01 | 7.80e-02 | 9.59e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 80 | 2.29e-01 | 7.79e-02 | 8.34e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 10 | 6.70e-01 | 7.79e-02 | 9.64e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 6.70e-01 | 7.79e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 16 | 5.90e-01 | -7.79e-02 | 9.51e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 39 | 4.00e-01 | -7.79e-02 | 8.99e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 154 | 9.62e-02 | 7.79e-02 | 7.30e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 27 | 4.84e-01 | -7.79e-02 | 9.28e-01 |
| GOMF HISTONE BINDING | 209 | 5.32e-02 | 7.79e-02 | 6.61e-01 |
| GOBP HORMONE TRANSPORT | 155 | 9.53e-02 | -7.78e-02 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 6.55e-01 | 7.78e-02 | 9.62e-01 |
| GOBP FATTY ACID TRANSPORT | 50 | 3.41e-01 | 7.78e-02 | 8.84e-01 |
| GOBP DENDRITE DEVELOPMENT | 142 | 1.10e-01 | 7.78e-02 | 7.49e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 12 | 6.41e-01 | 7.78e-02 | 9.59e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 20 | 5.47e-01 | -7.78e-02 | 9.40e-01 |
| GOCC MOTILE CILIUM | 112 | 1.56e-01 | 7.78e-02 | 7.89e-01 |
| GOMF GDP BINDING | 54 | 3.23e-01 | -7.78e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 39 | 4.01e-01 | 7.78e-02 | 8.99e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 12 | 6.41e-01 | 7.77e-02 | 9.59e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 6.28e-01 | 7.77e-02 | 9.58e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 6 | 7.42e-01 | -7.77e-02 | 9.70e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.42e-01 | -7.77e-02 | 9.70e-01 |
| GOBP DENDRITIC TRANSPORT | 10 | 6.71e-01 | 7.77e-02 | 9.64e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 6 | 7.42e-01 | -7.76e-02 | 9.70e-01 |
| GOBP ACTIN FILAMENT SEVERING | 14 | 6.15e-01 | 7.76e-02 | 9.55e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 96 | 1.90e-01 | 7.76e-02 | 8.15e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 6.29e-01 | -7.75e-02 | 9.58e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 57 | 3.12e-01 | -7.75e-02 | 8.76e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 8 | 7.04e-01 | -7.75e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 6 | 7.42e-01 | 7.75e-02 | 9.70e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 8 | 7.04e-01 | -7.75e-02 | 9.66e-01 |
| GOCC NEURON PROJECTION | 651 | 8.54e-04 | 7.74e-02 | 1.63e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 55 | 3.21e-01 | 7.74e-02 | 8.76e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 34 | 4.36e-01 | 7.72e-02 | 9.14e-01 |
| GOBP LIPID MODIFICATION | 131 | 1.28e-01 | 7.72e-02 | 7.55e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 7.05e-01 | 7.72e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 19 | 5.60e-01 | -7.72e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 27 | 4.88e-01 | 7.71e-02 | 9.30e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 19 | 5.61e-01 | 7.71e-02 | 9.44e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 25 | 5.05e-01 | 7.70e-02 | 9.31e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 9 | 6.89e-01 | 7.70e-02 | 9.64e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 7.44e-01 | -7.69e-02 | 9.70e-01 |
| GOBP HEAD MORPHOGENESIS | 21 | 5.42e-01 | -7.68e-02 | 9.40e-01 |
| GOMF MRNA BINDING | 260 | 3.37e-02 | -7.68e-02 | 5.88e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 118 | 1.50e-01 | -7.68e-02 | 7.89e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 60 | 3.04e-01 | -7.68e-02 | 8.75e-01 |
| GOMF COA HYDROLASE ACTIVITY | 14 | 6.19e-01 | 7.67e-02 | 9.55e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 5.84e-01 | -7.66e-02 | 9.49e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 129 | 1.34e-01 | 7.66e-02 | 7.62e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 8 | 7.08e-01 | -7.64e-02 | 9.67e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 6.21e-01 | -7.64e-02 | 9.55e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 7.26e-01 | -7.64e-02 | 9.69e-01 |
| GOBP DNA CATABOLIC PROCESS | 22 | 5.35e-01 | -7.63e-02 | 9.40e-01 |
| GOBP DNA CONFORMATION CHANGE | 73 | 2.60e-01 | 7.63e-02 | 8.51e-01 |
| GOBP VESICLE DOCKING | 47 | 3.66e-01 | 7.63e-02 | 8.92e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 61 | 3.03e-01 | -7.63e-02 | 8.75e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 12 | 6.47e-01 | 7.63e-02 | 9.60e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 6.76e-01 | 7.63e-02 | 9.64e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 7 | 7.27e-01 | 7.62e-02 | 9.69e-01 |
| GOMF 5S RRNA BINDING | 9 | 6.92e-01 | -7.62e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 5 | 7.68e-01 | 7.62e-02 | 9.72e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 46 | 3.71e-01 | 7.62e-02 | 8.94e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 47 | 3.66e-01 | -7.62e-02 | 8.92e-01 |
| GOBP TRANSLATIONAL INITIATION | 111 | 1.67e-01 | -7.61e-02 | 8.04e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 7.47e-01 | -7.61e-02 | 9.71e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 12 | 6.48e-01 | -7.61e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 31 | 4.64e-01 | -7.61e-02 | 9.25e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 156 | 1.02e-01 | 7.60e-02 | 7.39e-01 |
| GOBP SNRNA TRANSPORT | 6 | 7.47e-01 | 7.59e-02 | 9.71e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 7.69e-01 | -7.58e-02 | 9.72e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 5 | 7.69e-01 | 7.57e-02 | 9.72e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 5 | 7.69e-01 | 7.57e-02 | 9.72e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 25 | 5.12e-01 | 7.57e-02 | 9.33e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 7.29e-01 | 7.57e-02 | 9.70e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 13 | 6.37e-01 | 7.57e-02 | 9.59e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 28 | 4.89e-01 | -7.56e-02 | 9.30e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 26 | 5.05e-01 | 7.56e-02 | 9.31e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 7.29e-01 | -7.56e-02 | 9.70e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 12 | 6.50e-01 | 7.56e-02 | 9.61e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 7.11e-01 | 7.56e-02 | 9.68e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 66 | 2.89e-01 | 7.55e-02 | 8.69e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 10 | 6.79e-01 | 7.55e-02 | 9.64e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 6 | 7.49e-01 | 7.54e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 37 | 4.27e-01 | 7.54e-02 | 9.13e-01 |
| GOBP RESPONSE TO WATER | 7 | 7.30e-01 | 7.54e-02 | 9.70e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 48 | 3.67e-01 | -7.53e-02 | 8.92e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 67 | 2.87e-01 | 7.53e-02 | 8.68e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 87 | 2.25e-01 | -7.53e-02 | 8.32e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 49 | 3.62e-01 | 7.53e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 199 | 6.80e-02 | 7.53e-02 | 6.72e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 53 | 3.44e-01 | -7.52e-02 | 8.85e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 6.81e-01 | -7.52e-02 | 9.64e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 21 | 5.51e-01 | 7.52e-02 | 9.40e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 11 | 6.66e-01 | 7.52e-02 | 9.63e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 44 | 3.89e-01 | 7.51e-02 | 8.97e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 53 | 3.45e-01 | -7.51e-02 | 8.86e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 15 | 6.15e-01 | 7.51e-02 | 9.55e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 7.50e-01 | -7.51e-02 | 9.71e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 9 | 6.97e-01 | -7.50e-02 | 9.65e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 12 | 6.53e-01 | -7.50e-02 | 9.61e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 19 | 5.71e-01 | 7.50e-02 | 9.44e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 8 | 7.14e-01 | 7.50e-02 | 9.68e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 7.14e-01 | 7.50e-02 | 9.68e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 46 | 3.79e-01 | -7.50e-02 | 8.97e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 9 | 6.97e-01 | -7.49e-02 | 9.65e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 23 | 5.34e-01 | 7.49e-02 | 9.40e-01 |
| GOBP MYELIN MAINTENANCE | 11 | 6.67e-01 | 7.49e-02 | 9.63e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 45 | 3.85e-01 | -7.48e-02 | 8.97e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 33 | 4.57e-01 | -7.48e-02 | 9.23e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 10 | 6.82e-01 | 7.47e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 8 | 7.14e-01 | 7.47e-02 | 9.69e-01 |
| GOBP NUCLEAR TRANSPORT | 279 | 3.26e-02 | 7.47e-02 | 5.88e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 230 | 5.19e-02 | 7.47e-02 | 6.60e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 14 | 6.29e-01 | 7.47e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 34 | 4.51e-01 | -7.47e-02 | 9.21e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 28 | 4.94e-01 | -7.47e-02 | 9.31e-01 |
| GOBP ETHER METABOLIC PROCESS | 21 | 5.54e-01 | 7.47e-02 | 9.41e-01 |
| GOCC CILIARY BASAL BODY | 115 | 1.68e-01 | 7.46e-02 | 8.04e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 6.99e-01 | 7.46e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 19 | 5.74e-01 | 7.46e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 22 | 5.45e-01 | 7.45e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 36 | 4.39e-01 | 7.45e-02 | 9.15e-01 |
| GOBP NUCLEAR MIGRATION | 20 | 5.64e-01 | 7.45e-02 | 9.44e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 34 | 4.53e-01 | -7.44e-02 | 9.21e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 105 | 1.89e-01 | -7.44e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 31 | 4.74e-01 | -7.44e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 91 | 2.21e-01 | 7.43e-02 | 8.32e-01 |
| GOCC PIGMENT GRANULE | 91 | 2.21e-01 | -7.43e-02 | 8.32e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 7.74e-01 | -7.43e-02 | 9.73e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.53e-01 | 7.42e-02 | 9.71e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 23 | 5.38e-01 | 7.42e-02 | 9.40e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 12 | 6.57e-01 | 7.41e-02 | 9.62e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 29 | 4.90e-01 | 7.41e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 68 | 2.91e-01 | -7.41e-02 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 155 | 1.12e-01 | 7.41e-02 | 7.50e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 46 | 3.85e-01 | -7.41e-02 | 8.97e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 41 | 4.12e-01 | 7.41e-02 | 9.04e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 432 | 8.82e-03 | 7.40e-02 | 4.19e-01 |
| GOBP REGULATION OF WOUND HEALING | 51 | 3.61e-01 | 7.40e-02 | 8.91e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 7 | 7.35e-01 | -7.40e-02 | 9.70e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 7.17e-01 | 7.39e-02 | 9.69e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 101 | 2.00e-01 | 7.39e-02 | 8.26e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 25 | 5.23e-01 | 7.39e-02 | 9.35e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 10 | 6.86e-01 | 7.39e-02 | 9.64e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 201 | 7.22e-02 | 7.38e-02 | 6.78e-01 |
| GOBP HISTONE DEACETYLATION | 20 | 5.68e-01 | 7.38e-02 | 9.44e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 22 | 5.50e-01 | -7.37e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 32 | 4.71e-01 | -7.37e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 6 | 7.55e-01 | -7.37e-02 | 9.72e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 27 | 5.08e-01 | -7.37e-02 | 9.31e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 6.46e-01 | -7.36e-02 | 9.60e-01 |
| GOBP RESPONSE TO ETHANOL | 62 | 3.16e-01 | 7.36e-02 | 8.76e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 10 | 6.87e-01 | 7.36e-02 | 9.64e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 7.36e-01 | 7.36e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 60 | 3.25e-01 | -7.35e-02 | 8.76e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 7.55e-01 | 7.35e-02 | 9.72e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 6.22e-01 | 7.35e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 179 | 9.11e-02 | 7.34e-02 | 7.14e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 32 | 4.73e-01 | 7.34e-02 | 9.26e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 67 | 3.00e-01 | -7.34e-02 | 8.73e-01 |
| GOBP ENDODERM DEVELOPMENT | 35 | 4.53e-01 | -7.34e-02 | 9.21e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 20 | 5.70e-01 | -7.33e-02 | 9.44e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 17 | 6.01e-01 | 7.33e-02 | 9.52e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 164 | 1.06e-01 | 7.33e-02 | 7.42e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 43 | 4.06e-01 | -7.33e-02 | 8.99e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 10 | 6.88e-01 | -7.33e-02 | 9.64e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 55 | 3.48e-01 | 7.33e-02 | 8.87e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 10 | 6.88e-01 | -7.32e-02 | 9.64e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 84 | 2.47e-01 | -7.32e-02 | 8.49e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 242 | 5.08e-02 | -7.32e-02 | 6.56e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 11 | 6.75e-01 | -7.31e-02 | 9.64e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 6 | 7.57e-01 | -7.31e-02 | 9.72e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 108 | 1.90e-01 | -7.31e-02 | 8.15e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 58 | 3.36e-01 | 7.31e-02 | 8.83e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 9 | 7.04e-01 | 7.30e-02 | 9.66e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 23 | 5.45e-01 | -7.30e-02 | 9.40e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 45 | 3.98e-01 | -7.29e-02 | 8.98e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 7.05e-01 | 7.29e-02 | 9.66e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 17 | 6.03e-01 | 7.29e-02 | 9.52e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 10 | 6.90e-01 | -7.28e-02 | 9.64e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 7.78e-01 | -7.28e-02 | 9.73e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 17 | 6.04e-01 | -7.28e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 55 | 3.51e-01 | 7.28e-02 | 8.88e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 231 | 5.78e-02 | 7.27e-02 | 6.64e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 36 | 4.50e-01 | -7.27e-02 | 9.21e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 73 | 2.83e-01 | -7.27e-02 | 8.66e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 4.77e-01 | -7.27e-02 | 9.26e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 23 | 5.47e-01 | 7.26e-02 | 9.40e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 61 | 3.27e-01 | 7.26e-02 | 8.76e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 70 | 2.94e-01 | -7.26e-02 | 8.71e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 37 | 4.45e-01 | -7.25e-02 | 9.17e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 34 | 4.65e-01 | 7.25e-02 | 9.25e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 192 | 8.43e-02 | 7.25e-02 | 7.03e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 51 | 3.71e-01 | -7.25e-02 | 8.94e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 10 | 6.92e-01 | 7.24e-02 | 9.64e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 207 | 7.37e-02 | -7.24e-02 | 6.82e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 9 | 7.07e-01 | 7.24e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 542 | 4.31e-03 | -7.23e-02 | 3.42e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 6.06e-01 | 7.23e-02 | 9.52e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 121 | 1.70e-01 | 7.23e-02 | 8.04e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 48 | 3.86e-01 | 7.23e-02 | 8.97e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 262 | 4.48e-02 | -7.23e-02 | 6.32e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 41 | 4.24e-01 | -7.23e-02 | 9.13e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 7.08e-01 | 7.22e-02 | 9.66e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 6.93e-01 | -7.22e-02 | 9.64e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 47 | 3.93e-01 | -7.21e-02 | 8.97e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 751 | 8.93e-04 | -7.21e-02 | 1.66e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 8 | 7.24e-01 | 7.21e-02 | 9.69e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 118 | 1.77e-01 | -7.21e-02 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 238 | 5.64e-02 | 7.21e-02 | 6.62e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 14 | 6.41e-01 | 7.21e-02 | 9.59e-01 |
| GOBP LIPID EXPORT FROM CELL | 22 | 5.59e-01 | 7.21e-02 | 9.44e-01 |
| GOBP NEURON DEVELOPMENT | 586 | 3.20e-03 | 7.20e-02 | 3.12e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 262 | 4.59e-02 | 7.20e-02 | 6.34e-01 |
| GOCC BLOOD MICROPARTICLE | 47 | 3.94e-01 | 7.19e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 78 | 2.73e-01 | 7.19e-02 | 8.58e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 6 | 7.60e-01 | 7.19e-02 | 9.72e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 57 | 3.48e-01 | 7.19e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 7.25e-01 | -7.18e-02 | 9.69e-01 |
| GOBP REGULATION OF HEART GROWTH | 27 | 5.19e-01 | 7.18e-02 | 9.35e-01 |
| GOBP RNA DESTABILIZATION | 95 | 2.28e-01 | 7.18e-02 | 8.34e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 11 | 6.81e-01 | 7.16e-02 | 9.64e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 7.10e-01 | -7.16e-02 | 9.68e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 140 | 1.45e-01 | -7.16e-02 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 39 | 4.40e-01 | -7.15e-02 | 9.15e-01 |
| GOBP AXON EXTENSION | 68 | 3.09e-01 | 7.14e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 201 | 8.21e-02 | 7.14e-02 | 6.96e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 11 | 6.82e-01 | -7.13e-02 | 9.64e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 85 | 2.57e-01 | 7.13e-02 | 8.50e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 7.44e-01 | -7.12e-02 | 9.70e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 7.44e-01 | -7.12e-02 | 9.70e-01 |
| GOBP RNA LOCALIZATION | 178 | 1.02e-01 | 7.12e-02 | 7.39e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 32 | 4.87e-01 | 7.11e-02 | 9.30e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 51 | 3.81e-01 | 7.10e-02 | 8.97e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 7.63e-01 | 7.10e-02 | 9.72e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 129 | 1.65e-01 | -7.10e-02 | 8.02e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 6.84e-01 | -7.10e-02 | 9.64e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 154 | 1.29e-01 | -7.10e-02 | 7.57e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 156 | 1.27e-01 | 7.09e-02 | 7.55e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 4.33e-01 | 7.09e-02 | 9.14e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 6 | 7.64e-01 | 7.09e-02 | 9.72e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 10 | 6.98e-01 | 7.08e-02 | 9.65e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 6 | 7.64e-01 | -7.08e-02 | 9.72e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 6.98e-01 | -7.08e-02 | 9.65e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 6.99e-01 | -7.07e-02 | 9.65e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 5 | 7.84e-01 | -7.07e-02 | 9.73e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 8 | 7.29e-01 | 7.07e-02 | 9.70e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 42 | 4.29e-01 | 7.06e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 29 | 5.11e-01 | 7.06e-02 | 9.32e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 24 | 5.50e-01 | 7.06e-02 | 9.40e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 76 | 2.88e-01 | 7.06e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 7.85e-01 | -7.06e-02 | 9.73e-01 |
| GOBP RNA DECAPPING | 18 | 6.04e-01 | 7.05e-02 | 9.52e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 147 | 1.41e-01 | 7.05e-02 | 7.72e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 8 | 7.30e-01 | 7.05e-02 | 9.70e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 7.85e-01 | -7.05e-02 | 9.73e-01 |
| GOMF UBIQUITIN BINDING | 95 | 2.36e-01 | -7.05e-02 | 8.40e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 12 | 6.73e-01 | 7.04e-02 | 9.64e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 8 | 7.30e-01 | 7.04e-02 | 9.70e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 70 | 3.09e-01 | -7.04e-02 | 8.75e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 7.65e-01 | 7.03e-02 | 9.72e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 11 | 6.86e-01 | 7.03e-02 | 9.64e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 7.66e-01 | 7.03e-02 | 9.72e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 37 | 4.60e-01 | -7.03e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 58 | 3.55e-01 | 7.02e-02 | 8.88e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 46 | 4.10e-01 | 7.02e-02 | 9.04e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 160 | 1.26e-01 | 7.02e-02 | 7.55e-01 |
| GOBP KERATINIZATION | 6 | 7.66e-01 | -7.02e-02 | 9.72e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 7.01e-01 | -7.02e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 7.31e-01 | 7.02e-02 | 9.70e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 6.61e-01 | 7.02e-02 | 9.62e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 5 | 7.86e-01 | -7.02e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 22 | 5.69e-01 | -7.02e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 30 | 5.06e-01 | -7.01e-02 | 9.31e-01 |
| GOBP DETECTION OF STIMULUS | 91 | 2.49e-01 | 7.01e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 6 | 7.67e-01 | 7.00e-02 | 9.72e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 42 | 4.33e-01 | -7.00e-02 | 9.14e-01 |
| GOBP DENDRITIC CELL MIGRATION | 21 | 5.79e-01 | 7.00e-02 | 9.48e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 25 | 5.45e-01 | 6.99e-02 | 9.40e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 5 | 7.87e-01 | 6.99e-02 | 9.73e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 8 | 7.32e-01 | 6.98e-02 | 9.70e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 6.89e-01 | -6.98e-02 | 9.64e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 58 | 3.58e-01 | 6.98e-02 | 8.90e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 15 | 6.40e-01 | 6.97e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 7.67e-01 | -6.97e-02 | 9.72e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 11 | 6.89e-01 | -6.97e-02 | 9.64e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 19 | 5.99e-01 | 6.97e-02 | 9.52e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 32 | 4.95e-01 | -6.97e-02 | 9.31e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.33e-01 | -6.96e-02 | 9.70e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 15 | 6.41e-01 | -6.96e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 16 | 6.30e-01 | -6.96e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 6.30e-01 | -6.95e-02 | 9.58e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 213 | 8.14e-02 | -6.95e-02 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 5 | 7.88e-01 | -6.95e-02 | 9.73e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 19 | 6.01e-01 | 6.94e-02 | 9.52e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 7.04e-01 | 6.94e-02 | 9.66e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 28 | 5.25e-01 | 6.94e-02 | 9.36e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 125 | 1.82e-01 | 6.93e-02 | 8.07e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 5.41e-01 | 6.93e-02 | 9.40e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 27 | 5.33e-01 | -6.93e-02 | 9.40e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 84 | 2.73e-01 | 6.93e-02 | 8.58e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 247 | 6.22e-02 | 6.92e-02 | 6.68e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 6.66e-01 | 6.92e-02 | 9.63e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 5 | 7.89e-01 | -6.91e-02 | 9.73e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 28 | 5.27e-01 | 6.91e-02 | 9.36e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 9 | 7.20e-01 | 6.90e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 94 | 2.48e-01 | 6.90e-02 | 8.49e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 43 | 4.34e-01 | -6.90e-02 | 9.14e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 7.06e-01 | -6.89e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 20 | 5.94e-01 | -6.89e-02 | 9.51e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 437 | 1.42e-02 | -6.89e-02 | 4.75e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 5 | 7.90e-01 | 6.89e-02 | 9.73e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 6 | 7.70e-01 | -6.88e-02 | 9.73e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 413 | 1.72e-02 | 6.88e-02 | 5.00e-01 |
| GOBP CARTILAGE CONDENSATION | 5 | 7.90e-01 | 6.88e-02 | 9.73e-01 |
| GOBP CELL AGGREGATION | 5 | 7.90e-01 | 6.88e-02 | 9.73e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 11 | 6.93e-01 | -6.87e-02 | 9.64e-01 |
| GOBP NERVE DEVELOPMENT | 40 | 4.52e-01 | -6.87e-02 | 9.21e-01 |
| GOCC COSTAMERE | 11 | 6.93e-01 | -6.87e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 19 | 6.04e-01 | -6.87e-02 | 9.52e-01 |
| GOBP CELLULAR RESPONSE TO UV | 69 | 3.25e-01 | 6.87e-02 | 8.76e-01 |
| GOCC CILIUM | 373 | 2.37e-02 | 6.86e-02 | 5.39e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 8 | 7.37e-01 | -6.86e-02 | 9.70e-01 |
| GOBP RESPONSE TO METAL ION | 200 | 9.57e-02 | 6.86e-02 | 7.30e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 16 | 6.35e-01 | 6.85e-02 | 9.59e-01 |
| GOCC APICAL PART OF CELL | 190 | 1.04e-01 | 6.85e-02 | 7.39e-01 |
| GOBP TELOMERE ORGANIZATION | 145 | 1.55e-01 | 6.85e-02 | 7.89e-01 |
| GOMF NADPH BINDING | 14 | 6.57e-01 | -6.85e-02 | 9.62e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 7.22e-01 | 6.85e-02 | 9.69e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 49 | 4.08e-01 | -6.84e-02 | 9.01e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 179 | 1.16e-01 | 6.83e-02 | 7.52e-01 |
| GOMF SH2 DOMAIN BINDING | 31 | 5.11e-01 | 6.83e-02 | 9.32e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 6 | 7.72e-01 | -6.83e-02 | 9.73e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 11 | 6.95e-01 | 6.82e-02 | 9.65e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 32 | 5.04e-01 | -6.82e-02 | 9.31e-01 |
| GOBP DESMOSOME ORGANIZATION | 5 | 7.92e-01 | 6.81e-02 | 9.73e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 7.55e-01 | -6.81e-02 | 9.72e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 214 | 8.70e-02 | -6.81e-02 | 7.11e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 18 | 6.17e-01 | 6.81e-02 | 9.55e-01 |
| GOBP DNA RECOMBINATION | 254 | 6.28e-02 | 6.81e-02 | 6.68e-01 |
| GOCC SPECIFIC GRANULE | 126 | 1.88e-01 | 6.80e-02 | 8.14e-01 |
| GOCC MICROVILLUS | 44 | 4.35e-01 | -6.80e-02 | 9.14e-01 |
| GOBP RRNA METABOLIC PROCESS | 242 | 6.95e-02 | 6.80e-02 | 6.73e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 6.60e-01 | -6.80e-02 | 9.62e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 5 | 7.92e-01 | -6.80e-02 | 9.73e-01 |
| GOBP PROTEIN PALMITOYLATION | 23 | 5.73e-01 | -6.79e-02 | 9.44e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 19 | 6.08e-01 | 6.79e-02 | 9.54e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 91 | 2.64e-01 | -6.79e-02 | 8.52e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 22 | 5.82e-01 | 6.79e-02 | 9.48e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 7.56e-01 | 6.79e-02 | 9.72e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 77 | 3.04e-01 | 6.78e-02 | 8.75e-01 |
| GOCC GOLGI CISTERNA | 77 | 3.05e-01 | 6.78e-02 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 17 | 6.29e-01 | 6.78e-02 | 9.58e-01 |
| GOBP RESPONSE TO SALT | 195 | 1.04e-01 | 6.77e-02 | 7.39e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 6.98e-01 | -6.77e-02 | 9.65e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 5.74e-01 | 6.77e-02 | 9.44e-01 |
| GOBP MALE SEX DIFFERENTIATION | 84 | 2.85e-01 | 6.76e-02 | 8.67e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 124 | 1.95e-01 | 6.75e-02 | 8.19e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 24 | 5.67e-01 | 6.75e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 18 | 6.20e-01 | 6.75e-02 | 9.55e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 119 | 2.04e-01 | 6.75e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 8 | 7.41e-01 | 6.74e-02 | 9.70e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 173 | 1.27e-01 | 6.74e-02 | 7.55e-01 |
| GOCC AXONEMAL MICROTUBULE | 11 | 6.99e-01 | -6.74e-02 | 9.65e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 30 | 5.23e-01 | -6.74e-02 | 9.35e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 159 | 1.44e-01 | -6.73e-02 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 27 | 5.45e-01 | 6.73e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 7.27e-01 | 6.73e-02 | 9.69e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 7.42e-01 | 6.73e-02 | 9.70e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 118 | 2.07e-01 | 6.73e-02 | 8.29e-01 |
| GOBP ORGANIC ACID TRANSPORT | 167 | 1.35e-01 | 6.73e-02 | 7.62e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 7.94e-01 | 6.73e-02 | 9.73e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 663 | 3.48e-03 | -6.73e-02 | 3.16e-01 |
| GOCC PLATELET DENSE GRANULE | 11 | 6.99e-01 | 6.73e-02 | 9.65e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 44 | 4.41e-01 | -6.72e-02 | 9.15e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 15 | 6.52e-01 | 6.72e-02 | 9.61e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 6.63e-01 | -6.72e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 72 | 3.25e-01 | 6.72e-02 | 8.76e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 5 | 7.95e-01 | -6.71e-02 | 9.73e-01 |
| GOBP BLEB ASSEMBLY | 6 | 7.76e-01 | -6.71e-02 | 9.73e-01 |
| GOMF CALCIUM ION BINDING | 279 | 5.51e-02 | 6.70e-02 | 6.62e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 7.95e-01 | 6.70e-02 | 9.73e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 4.81e-01 | 6.70e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 7.95e-01 | 6.70e-02 | 9.73e-01 |
| GOCC PLATELET ALPHA GRANULE | 52 | 4.04e-01 | -6.69e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 9 | 7.28e-01 | -6.69e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 22 | 5.87e-01 | -6.68e-02 | 9.50e-01 |
| GOBP SOMITOGENESIS | 28 | 5.41e-01 | 6.68e-02 | 9.40e-01 |
| GOBP TRNA TRANSPORT | 5 | 7.96e-01 | -6.68e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 6 | 7.77e-01 | 6.68e-02 | 9.73e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 19 | 6.15e-01 | 6.68e-02 | 9.55e-01 |
| GOMF PHOSPHOLIPASE BINDING | 18 | 6.24e-01 | 6.67e-02 | 9.57e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 142 | 1.71e-01 | 6.67e-02 | 8.05e-01 |
| GOBP ENDOCYTIC RECYCLING | 69 | 3.39e-01 | -6.67e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 43 | 4.50e-01 | 6.67e-02 | 9.21e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 7 | 7.60e-01 | -6.67e-02 | 9.72e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 5.56e-01 | 6.67e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 157 | 1.51e-01 | -6.67e-02 | 7.89e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 109 | 2.30e-01 | 6.66e-02 | 8.36e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 7.29e-01 | -6.66e-02 | 9.70e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 43 | 4.50e-01 | 6.66e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 7 | 7.60e-01 | -6.66e-02 | 9.72e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 7.97e-01 | 6.66e-02 | 9.73e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 3.54e-01 | 6.65e-02 | 8.88e-01 |
| GOBP RNA SPLICING | 398 | 2.37e-02 | -6.65e-02 | 5.39e-01 |
| GOBP SPINDLE LOCALIZATION | 36 | 4.90e-01 | 6.65e-02 | 9.30e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 274 | 5.94e-02 | 6.65e-02 | 6.67e-01 |
| GOMF DNA POLYMERASE BINDING | 19 | 6.16e-01 | 6.64e-02 | 9.55e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 62 | 3.66e-01 | 6.64e-02 | 8.92e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 7.61e-01 | -6.64e-02 | 9.72e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 19 | 6.17e-01 | 6.63e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 17 | 6.36e-01 | -6.63e-02 | 9.59e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 52 | 4.09e-01 | -6.63e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 7.61e-01 | 6.63e-02 | 9.72e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 7.31e-01 | -6.62e-02 | 9.70e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 68 | 3.46e-01 | 6.62e-02 | 8.87e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 13 | 6.80e-01 | -6.62e-02 | 9.64e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 98 | 2.58e-01 | -6.62e-02 | 8.50e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 17 | 6.37e-01 | 6.62e-02 | 9.59e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.17e-01 | 6.62e-02 | 9.69e-01 |
| GOMF MAP KINASE ACTIVITY | 11 | 7.04e-01 | 6.61e-02 | 9.66e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 16 | 6.47e-01 | -6.61e-02 | 9.60e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 6.58e-01 | 6.61e-02 | 9.62e-01 |
| GOBP COMPLEMENT ACTIVATION | 24 | 5.75e-01 | 6.61e-02 | 9.45e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 45 | 4.43e-01 | -6.61e-02 | 9.17e-01 |
| GOBP GMP METABOLIC PROCESS | 24 | 5.75e-01 | 6.61e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 34 | 5.05e-01 | -6.60e-02 | 9.31e-01 |
| GOBP CRISTAE FORMATION | 17 | 6.38e-01 | -6.60e-02 | 9.59e-01 |
| GOCC CYTOSOLIC REGION | 17 | 6.38e-01 | -6.59e-02 | 9.59e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 13 | 6.81e-01 | 6.59e-02 | 9.64e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 25 | 5.69e-01 | 6.59e-02 | 9.44e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 88 | 2.86e-01 | -6.59e-02 | 8.68e-01 |
| GOBP TISSUE MORPHOGENESIS | 286 | 5.66e-02 | 6.58e-02 | 6.62e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 7.19e-01 | -6.58e-02 | 9.69e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 6 | 7.80e-01 | 6.58e-02 | 9.73e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 55 | 3.99e-01 | 6.58e-02 | 8.99e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 18 | 6.29e-01 | -6.58e-02 | 9.58e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 81 | 3.07e-01 | -6.58e-02 | 8.75e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 6.39e-01 | 6.58e-02 | 9.59e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 57 | 3.91e-01 | 6.58e-02 | 8.97e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 10 | 7.19e-01 | -6.57e-02 | 9.69e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 38 | 4.84e-01 | 6.57e-02 | 9.28e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 41 | 4.67e-01 | 6.56e-02 | 9.25e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 7.81e-01 | 6.56e-02 | 9.73e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 5 | 8.00e-01 | -6.56e-02 | 9.73e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 81 | 3.09e-01 | 6.55e-02 | 8.75e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 81 | 3.09e-01 | 6.54e-02 | 8.75e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 123 | 2.11e-01 | -6.54e-02 | 8.32e-01 |
| GOBP TORC1 SIGNALING | 88 | 2.90e-01 | -6.54e-02 | 8.69e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 20 | 6.13e-01 | 6.54e-02 | 9.55e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 27 | 5.57e-01 | 6.54e-02 | 9.44e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 79 | 3.16e-01 | -6.53e-02 | 8.76e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 40 | 4.75e-01 | -6.53e-02 | 9.26e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 7 | 7.65e-01 | -6.53e-02 | 9.72e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 21 | 6.05e-01 | 6.52e-02 | 9.52e-01 |
| GOCC GOLGI STACK | 102 | 2.56e-01 | 6.52e-02 | 8.50e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 709 | 3.49e-03 | -6.52e-02 | 3.16e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 20 | 6.14e-01 | 6.51e-02 | 9.55e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 7.65e-01 | 6.51e-02 | 9.72e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 36 | 4.99e-01 | 6.51e-02 | 9.31e-01 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 5 | 8.01e-01 | 6.51e-02 | 9.73e-01 |
| GOMF CYCLOSPORIN A BINDING | 16 | 6.52e-01 | 6.51e-02 | 9.61e-01 |
| GOBP MRNA CATABOLIC PROCESS | 209 | 1.06e-01 | 6.50e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 212 | 1.04e-01 | 6.50e-02 | 7.39e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 137 | 1.90e-01 | 6.50e-02 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 19 | 6.24e-01 | 6.50e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 5 | 8.01e-01 | -6.50e-02 | 9.73e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 128 | 2.05e-01 | -6.50e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 63 | 3.73e-01 | -6.49e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 27 | 5.59e-01 | 6.49e-02 | 9.44e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 5 | 8.02e-01 | -6.49e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 21 | 6.07e-01 | -6.49e-02 | 9.54e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 32 | 5.26e-01 | 6.49e-02 | 9.36e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 6.44e-01 | -6.49e-02 | 9.59e-01 |
| GOBP RUFFLE ORGANIZATION | 39 | 4.84e-01 | -6.48e-02 | 9.28e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 70 | 3.49e-01 | -6.48e-02 | 8.87e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 45 | 4.52e-01 | -6.48e-02 | 9.21e-01 |
| GOBP CHROMOSOME ORGANIZATION | 455 | 1.87e-02 | 6.48e-02 | 5.14e-01 |
| GOBP DEVELOPMENTAL MATURATION | 162 | 1.56e-01 | 6.48e-02 | 7.89e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 44 | 4.58e-01 | 6.47e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 62 | 3.79e-01 | -6.47e-02 | 8.97e-01 |
| GOBP MACROPHAGE MIGRATION | 32 | 5.27e-01 | 6.47e-02 | 9.36e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 58 | 3.95e-01 | -6.47e-02 | 8.98e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 7 | 7.67e-01 | -6.46e-02 | 9.72e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 83 | 3.10e-01 | 6.46e-02 | 8.75e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 8 | 7.52e-01 | -6.46e-02 | 9.71e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 9 | 7.38e-01 | -6.45e-02 | 9.70e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 8.03e-01 | 6.45e-02 | 9.73e-01 |
| GOMF SNARE BINDING | 73 | 3.42e-01 | 6.44e-02 | 8.84e-01 |
| GOBP NADH METABOLIC PROCESS | 7 | 7.68e-01 | -6.44e-02 | 9.72e-01 |
| GOCC COPI COATED VESICLE | 23 | 5.93e-01 | 6.44e-02 | 9.51e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 50 | 4.31e-01 | 6.44e-02 | 9.14e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 69 | 3.56e-01 | 6.43e-02 | 8.88e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 7.53e-01 | 6.43e-02 | 9.71e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 89 | 2.95e-01 | 6.43e-02 | 8.71e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 21 | 6.10e-01 | 6.43e-02 | 9.55e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 6.66e-01 | 6.43e-02 | 9.63e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 161 | 1.60e-01 | 6.43e-02 | 7.96e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 29 | 5.50e-01 | -6.42e-02 | 9.40e-01 |
| GOBP EMBRYO IMPLANTATION | 28 | 5.57e-01 | -6.42e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 18 | 6.38e-01 | 6.42e-02 | 9.59e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 15 | 6.67e-01 | -6.41e-02 | 9.63e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 9 | 7.39e-01 | -6.41e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 18 | 6.38e-01 | 6.41e-02 | 9.59e-01 |
| GOBP GENERATION OF NEURONS | 738 | 3.44e-03 | 6.40e-02 | 3.16e-01 |
| GOMF ORGANIC ACID BINDING | 96 | 2.79e-01 | 6.40e-02 | 8.63e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 88 | 3.00e-01 | -6.40e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 6.79e-01 | 6.40e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 13 | 6.90e-01 | 6.40e-02 | 9.64e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 23 | 5.96e-01 | 6.40e-02 | 9.51e-01 |
| GOBP TRACHEA FORMATION | 6 | 7.86e-01 | 6.40e-02 | 9.73e-01 |
| GOBP TRACHEA MORPHOGENESIS | 6 | 7.86e-01 | 6.40e-02 | 9.73e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 16 | 6.58e-01 | -6.40e-02 | 9.62e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 125 | 2.18e-01 | 6.39e-02 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 121 | 2.25e-01 | -6.39e-02 | 8.32e-01 |
| GOCC FILOPODIUM | 62 | 3.85e-01 | -6.39e-02 | 8.97e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 28 | 5.59e-01 | -6.38e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 81 | 3.21e-01 | 6.38e-02 | 8.76e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 12 | 7.02e-01 | 6.38e-02 | 9.65e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 18 | 6.39e-01 | -6.38e-02 | 9.59e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 49 | 4.40e-01 | 6.38e-02 | 9.15e-01 |
| GOCC CELL CORTEX REGION | 19 | 6.30e-01 | 6.38e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 41 | 4.80e-01 | 6.38e-02 | 9.26e-01 |
| GOBP PROTEIN FOLDING | 171 | 1.51e-01 | 6.38e-02 | 7.89e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 7.27e-01 | 6.38e-02 | 9.69e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 40 | 4.86e-01 | 6.37e-02 | 9.29e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 12 | 7.02e-01 | -6.37e-02 | 9.65e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 27 | 5.67e-01 | -6.37e-02 | 9.44e-01 |
| GOBP NCRNA PROCESSING | 390 | 3.20e-02 | 6.37e-02 | 5.84e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 31 | 5.40e-01 | 6.36e-02 | 9.40e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 26 | 5.75e-01 | 6.36e-02 | 9.44e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 7.88e-01 | -6.36e-02 | 9.73e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 11 | 7.15e-01 | 6.35e-02 | 9.69e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 7.88e-01 | 6.35e-02 | 9.73e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 40 | 4.87e-01 | 6.35e-02 | 9.30e-01 |
| GOBP REGULATION OF DNA REPLICATION | 96 | 2.83e-01 | 6.35e-02 | 8.66e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 100 | 2.74e-01 | 6.35e-02 | 8.58e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 37 | 5.04e-01 | -6.35e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 110 | 2.51e-01 | -6.34e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 7 | 7.71e-01 | 6.34e-02 | 9.73e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 8.06e-01 | 6.34e-02 | 9.74e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 66 | 3.74e-01 | 6.34e-02 | 8.96e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 40 | 4.88e-01 | -6.33e-02 | 9.30e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 70 | 3.60e-01 | 6.33e-02 | 8.91e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 32 | 5.36e-01 | 6.33e-02 | 9.40e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 7.72e-01 | -6.33e-02 | 9.73e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 21 | 6.16e-01 | -6.33e-02 | 9.55e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 83 | 3.20e-01 | -6.33e-02 | 8.76e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 13 | 6.93e-01 | 6.33e-02 | 9.64e-01 |
| GOCC U4 SNRNP | 10 | 7.29e-01 | -6.33e-02 | 9.70e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 10 | 7.29e-01 | 6.33e-02 | 9.70e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 21 | 6.16e-01 | -6.33e-02 | 9.55e-01 |
| GOBP GLAND MORPHOGENESIS | 52 | 4.31e-01 | 6.32e-02 | 9.14e-01 |
| GOMF RNA POLYMERASE BINDING | 53 | 4.27e-01 | 6.32e-02 | 9.13e-01 |
| GOBP RNA STABILIZATION | 53 | 4.27e-01 | -6.31e-02 | 9.13e-01 |
| GOBP HEART MORPHOGENESIS | 116 | 2.41e-01 | 6.31e-02 | 8.43e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 17 | 6.53e-01 | -6.31e-02 | 9.61e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 28 | 5.64e-01 | -6.31e-02 | 9.44e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 47 | 4.55e-01 | -6.31e-02 | 9.23e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 35 | 5.19e-01 | -6.31e-02 | 9.35e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 6 | 7.89e-01 | 6.30e-02 | 9.73e-01 |
| GOCC EARLY PHAGOSOME | 10 | 7.30e-01 | 6.30e-02 | 9.70e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 61 | 3.96e-01 | 6.29e-02 | 8.98e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 7.73e-01 | -6.29e-02 | 9.73e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 617 | 8.29e-03 | -6.29e-02 | 4.17e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 56 | 4.16e-01 | -6.28e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 51 | 4.38e-01 | -6.28e-02 | 9.15e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 7.44e-01 | -6.27e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 9 | 7.44e-01 | 6.27e-02 | 9.70e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 7.44e-01 | -6.27e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 7.45e-01 | 6.27e-02 | 9.70e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 7.90e-01 | 6.27e-02 | 9.73e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 9 | 7.45e-01 | 6.27e-02 | 9.70e-01 |
| GOBP PROTEIN AUTOPROCESSING | 15 | 6.74e-01 | -6.27e-02 | 9.64e-01 |
| GOBP BLOOD VESSEL MATURATION | 6 | 7.90e-01 | -6.27e-02 | 9.73e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 6 | 7.90e-01 | 6.27e-02 | 9.73e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 65 | 3.83e-01 | -6.27e-02 | 8.97e-01 |
| GOBP REGULATION OF GLIOGENESIS | 53 | 4.30e-01 | -6.27e-02 | 9.14e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 7.74e-01 | -6.27e-02 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 62 | 3.94e-01 | 6.27e-02 | 8.97e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 7.32e-01 | 6.26e-02 | 9.70e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 33 | 5.34e-01 | -6.25e-02 | 9.40e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 33 | 5.34e-01 | -6.25e-02 | 9.40e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 4.19e-01 | -6.25e-02 | 9.08e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 20 | 6.29e-01 | 6.25e-02 | 9.58e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 7.46e-01 | 6.25e-02 | 9.70e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 107 | 2.65e-01 | 6.25e-02 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 27 | 5.75e-01 | 6.24e-02 | 9.44e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 626 | 8.37e-03 | 6.24e-02 | 4.17e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 6 | 7.91e-01 | 6.24e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 7.60e-01 | -6.23e-02 | 9.72e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 124 | 2.32e-01 | 6.23e-02 | 8.37e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 7.92e-01 | 6.23e-02 | 9.73e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 14 | 6.87e-01 | 6.23e-02 | 9.64e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 15 | 6.76e-01 | 6.23e-02 | 9.64e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 7 | 7.75e-01 | 6.23e-02 | 9.73e-01 |
| GOMF DEACETYLASE ACTIVITY | 31 | 5.49e-01 | 6.23e-02 | 9.40e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 43 | 4.80e-01 | 6.23e-02 | 9.26e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 73 | 3.58e-01 | -6.23e-02 | 8.90e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 135 | 2.12e-01 | -6.23e-02 | 8.32e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 8.09e-01 | 6.23e-02 | 9.75e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 147 | 1.94e-01 | 6.22e-02 | 8.18e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 22 | 6.14e-01 | 6.22e-02 | 9.55e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 5.62e-01 | 6.22e-02 | 9.44e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 8.10e-01 | -6.21e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 18 | 6.49e-01 | 6.20e-02 | 9.61e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 27 | 5.77e-01 | -6.20e-02 | 9.47e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 45 | 4.72e-01 | -6.20e-02 | 9.26e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 13 | 6.99e-01 | 6.19e-02 | 9.65e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 12 | 7.10e-01 | -6.19e-02 | 9.68e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 6.88e-01 | 6.19e-02 | 9.64e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 6.78e-01 | 6.19e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 16 | 6.69e-01 | -6.18e-02 | 9.64e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 423 | 3.03e-02 | 6.18e-02 | 5.71e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 51 | 4.45e-01 | 6.18e-02 | 9.17e-01 |
| GOBP CARDIAC CONDUCTION | 40 | 4.99e-01 | -6.18e-02 | 9.31e-01 |
| GOCC MICROTUBULE MINUS END | 5 | 8.11e-01 | 6.18e-02 | 9.75e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 81 | 3.37e-01 | 6.18e-02 | 8.83e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 22 | 6.17e-01 | -6.17e-02 | 9.55e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 7.63e-01 | -6.17e-02 | 9.72e-01 |
| GOBP NEURON FATE SPECIFICATION | 6 | 7.94e-01 | -6.16e-02 | 9.73e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 24 | 6.01e-01 | -6.16e-02 | 9.52e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 7.24e-01 | 6.16e-02 | 9.69e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 8 | 7.63e-01 | -6.16e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 7.94e-01 | 6.16e-02 | 9.73e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 267 | 8.47e-02 | 6.16e-02 | 7.03e-01 |
| GOBP MIRNA METABOLIC PROCESS | 70 | 3.74e-01 | -6.15e-02 | 8.96e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 43 | 4.85e-01 | 6.15e-02 | 9.29e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 94 | 3.04e-01 | -6.15e-02 | 8.75e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 8 | 7.63e-01 | -6.15e-02 | 9.72e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 24 | 6.02e-01 | -6.15e-02 | 9.52e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 19 | 6.43e-01 | -6.14e-02 | 9.59e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 6 | 7.95e-01 | -6.14e-02 | 9.73e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 8 | 7.64e-01 | -6.14e-02 | 9.72e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 88 | 3.21e-01 | -6.14e-02 | 8.76e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 32 | 5.49e-01 | 6.13e-02 | 9.40e-01 |
| GOBP RESPONSE TO PROGESTERONE | 25 | 5.96e-01 | -6.13e-02 | 9.51e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 7.79e-01 | -6.12e-02 | 9.73e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 37 | 5.20e-01 | -6.12e-02 | 9.35e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 6 | 7.95e-01 | -6.11e-02 | 9.73e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 7 | 7.79e-01 | 6.11e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 46 | 4.74e-01 | 6.11e-02 | 9.26e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 10 | 7.38e-01 | 6.11e-02 | 9.70e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 27 | 5.83e-01 | -6.10e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 11 | 7.26e-01 | -6.10e-02 | 9.69e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 7 | 7.80e-01 | -6.10e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 8.13e-01 | -6.09e-02 | 9.76e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 16 | 6.73e-01 | -6.09e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 619 | 1.04e-02 | -6.09e-02 | 4.43e-01 |
| GOCC CONTRACTILE FIBER | 122 | 2.46e-01 | -6.09e-02 | 8.49e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 11 | 7.27e-01 | -6.09e-02 | 9.69e-01 |
| GOMF CADHERIN BINDING | 250 | 9.87e-02 | -6.09e-02 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 9 | 7.52e-01 | -6.09e-02 | 9.71e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 47 | 4.71e-01 | 6.09e-02 | 9.26e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 389 | 4.06e-02 | 6.09e-02 | 6.16e-01 |
| GOBP MESODERM DEVELOPMENT | 53 | 4.44e-01 | 6.08e-02 | 9.17e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 9 | 7.52e-01 | -6.08e-02 | 9.71e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 13 | 7.04e-01 | -6.08e-02 | 9.66e-01 |
| GOCC AZUROPHIL GRANULE | 128 | 2.36e-01 | -6.08e-02 | 8.40e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 165 | 1.79e-01 | 6.08e-02 | 8.07e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 228 | 1.16e-01 | -6.07e-02 | 7.52e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 108 | 2.77e-01 | 6.07e-02 | 8.60e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 12 | 7.16e-01 | -6.06e-02 | 9.69e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 8.15e-01 | -6.06e-02 | 9.76e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 7 | 7.82e-01 | -6.05e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 8 | 7.67e-01 | -6.05e-02 | 9.72e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 148 | 2.06e-01 | 6.04e-02 | 8.28e-01 |
| GOCC NUCLEAR SPECK | 357 | 5.14e-02 | -6.04e-02 | 6.58e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 16 | 6.76e-01 | 6.04e-02 | 9.64e-01 |
| GOCC CENTROSOME | 496 | 2.25e-02 | 6.03e-02 | 5.34e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 72 | 3.77e-01 | 6.03e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 19 | 6.50e-01 | 6.02e-02 | 9.61e-01 |
| GOMF NF KAPPAB BINDING | 28 | 5.81e-01 | 6.02e-02 | 9.48e-01 |
| GOBP SYNAPSE ORGANIZATION | 214 | 1.30e-01 | 6.02e-02 | 7.57e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 187 | 1.57e-01 | 6.02e-02 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 91 | 3.22e-01 | -6.02e-02 | 8.76e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 767 | 5.18e-03 | -6.01e-02 | 3.66e-01 |
| GOBP MUSCLE ADAPTATION | 56 | 4.37e-01 | -6.01e-02 | 9.14e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 6.51e-01 | -6.00e-02 | 9.61e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 14 | 6.97e-01 | -6.00e-02 | 9.65e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 336 | 6.02e-02 | -6.00e-02 | 6.68e-01 |
| GOCC AGGRESOME | 25 | 6.04e-01 | 6.00e-02 | 9.52e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 465 | 2.81e-02 | -5.99e-02 | 5.64e-01 |
| GOBP MICROTUBULE NUCLEATION | 42 | 5.03e-01 | 5.98e-02 | 9.31e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 44 | 4.93e-01 | 5.98e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 18 | 6.61e-01 | 5.98e-02 | 9.62e-01 |
| GOBP ICOSANOID TRANSPORT | 20 | 6.43e-01 | 5.98e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 167 | 1.84e-01 | -5.98e-02 | 8.10e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 133 | 2.35e-01 | 5.98e-02 | 8.39e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 7.84e-01 | -5.97e-02 | 9.73e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 8.00e-01 | -5.97e-02 | 9.73e-01 |
| GOMF PROTEIN KINASE A BINDING | 34 | 5.47e-01 | 5.97e-02 | 9.40e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 50 | 4.66e-01 | -5.97e-02 | 9.25e-01 |
| GOBP CELL MATURATION | 86 | 3.39e-01 | 5.97e-02 | 8.83e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 86 | 3.40e-01 | -5.97e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 18 | 6.61e-01 | -5.97e-02 | 9.62e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 55 | 4.45e-01 | 5.96e-02 | 9.17e-01 |
| GOMF PDZ DOMAIN BINDING | 48 | 4.75e-01 | 5.96e-02 | 9.26e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 899 | 2.85e-03 | 5.96e-02 | 3.04e-01 |
| GOMF ANTIPORTER ACTIVITY | 83 | 3.49e-01 | -5.95e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 8 | 7.71e-01 | -5.95e-02 | 9.73e-01 |
| GOBP REGULATION OF DNA REPAIR | 186 | 1.63e-01 | 5.95e-02 | 8.00e-01 |
| GOBP HORMONE METABOLIC PROCESS | 91 | 3.28e-01 | 5.94e-02 | 8.76e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 10 | 7.45e-01 | -5.94e-02 | 9.70e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 101 | 3.04e-01 | 5.93e-02 | 8.75e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 137 | 2.32e-01 | 5.93e-02 | 8.37e-01 |
| GOBP RESPONSE TO CADMIUM ION | 37 | 5.33e-01 | 5.92e-02 | 9.40e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 5.18e-01 | 5.92e-02 | 9.35e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 5.07e-01 | 5.92e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 8 | 7.72e-01 | -5.91e-02 | 9.73e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 78 | 3.67e-01 | 5.91e-02 | 8.92e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 7.72e-01 | 5.91e-02 | 9.73e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 64 | 4.14e-01 | 5.91e-02 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 218 | 1.35e-01 | 5.90e-02 | 7.62e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 7.73e-01 | 5.89e-02 | 9.73e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 6 | 8.03e-01 | 5.89e-02 | 9.73e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 8 | 7.73e-01 | -5.89e-02 | 9.73e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 13 | 7.14e-01 | 5.88e-02 | 9.68e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 113 | 2.81e-01 | -5.88e-02 | 8.63e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 34 | 5.54e-01 | 5.87e-02 | 9.41e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 116 | 2.76e-01 | -5.87e-02 | 8.60e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 31 | 5.72e-01 | 5.87e-02 | 9.44e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 44 | 5.01e-01 | 5.87e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 123 | 2.62e-01 | -5.87e-02 | 8.51e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 8 | 7.74e-01 | 5.86e-02 | 9.73e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 8.04e-01 | -5.86e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 31 | 5.73e-01 | -5.86e-02 | 9.44e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 45 | 4.97e-01 | 5.86e-02 | 9.31e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 6 | 8.04e-01 | 5.86e-02 | 9.73e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1137 | 1.10e-03 | 5.85e-02 | 1.74e-01 |
| GOBP CYTOKINETIC PROCESS | 33 | 5.61e-01 | -5.85e-02 | 9.44e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 68 | 4.05e-01 | 5.85e-02 | 8.99e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 366 | 5.61e-02 | 5.85e-02 | 6.62e-01 |
| GOBP DIGESTION | 39 | 5.28e-01 | -5.85e-02 | 9.37e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 192 | 1.64e-01 | -5.84e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 7.89e-01 | 5.84e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 30 | 5.80e-01 | -5.84e-02 | 9.48e-01 |
| GOBP RESPONSE TO YEAST | 5 | 8.21e-01 | -5.84e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 70 | 4.00e-01 | 5.83e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 24 | 6.21e-01 | -5.83e-02 | 9.55e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 8.22e-01 | 5.82e-02 | 9.76e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 40 | 5.25e-01 | 5.82e-02 | 9.36e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 18 | 6.69e-01 | -5.82e-02 | 9.64e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 28 | 5.94e-01 | 5.82e-02 | 9.51e-01 |
| GOBP HEAD DEVELOPMENT | 407 | 4.57e-02 | 5.81e-02 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 86 | 3.52e-01 | -5.81e-02 | 8.88e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 21 | 6.45e-01 | -5.81e-02 | 9.60e-01 |
| GOBP RESPONSE TO CAMP | 46 | 4.96e-01 | -5.81e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 35 | 5.52e-01 | -5.81e-02 | 9.41e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 215 | 1.44e-01 | -5.80e-02 | 7.75e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 34 | 5.59e-01 | -5.80e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 42 | 5.16e-01 | 5.80e-02 | 9.34e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 44 | 5.06e-01 | -5.80e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 738 | 8.15e-03 | 5.79e-02 | 4.17e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 22 | 6.38e-01 | -5.79e-02 | 9.59e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 42 | 5.17e-01 | -5.79e-02 | 9.34e-01 |
| GOBP MATING BEHAVIOR | 13 | 7.18e-01 | -5.79e-02 | 9.69e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 7.64e-01 | -5.78e-02 | 9.72e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 5 | 8.23e-01 | 5.78e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 97 | 3.26e-01 | 5.78e-02 | 8.76e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 88 | 3.50e-01 | 5.77e-02 | 8.88e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 24 | 6.25e-01 | -5.77e-02 | 9.57e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 311 | 8.17e-02 | -5.77e-02 | 6.95e-01 |
| GOCC CENTRIOLE | 122 | 2.72e-01 | 5.77e-02 | 8.58e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 6 | 8.07e-01 | 5.77e-02 | 9.74e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 35 | 5.55e-01 | -5.77e-02 | 9.43e-01 |
| GOBP B CELL DIFFERENTIATION | 102 | 3.16e-01 | -5.76e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 255 | 1.15e-01 | 5.76e-02 | 7.52e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 3.49e-01 | -5.75e-02 | 8.87e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 69 | 4.09e-01 | -5.75e-02 | 9.02e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 8.24e-01 | -5.75e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 25 | 6.19e-01 | 5.75e-02 | 9.55e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 108 | 3.03e-01 | -5.75e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 50 | 4.82e-01 | 5.75e-02 | 9.27e-01 |
| GOBP RESPONSE TO STEROL | 18 | 6.73e-01 | 5.75e-02 | 9.64e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 84 | 3.64e-01 | -5.74e-02 | 8.92e-01 |
| GOCC COHESIN COMPLEX | 9 | 7.66e-01 | -5.73e-02 | 9.72e-01 |
| GOCC DISTAL AXON | 143 | 2.39e-01 | 5.72e-02 | 8.42e-01 |
| GOBP CENTROSOME DUPLICATION | 64 | 4.29e-01 | 5.72e-02 | 9.14e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 661 | 1.31e-02 | -5.72e-02 | 4.67e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 77 | 3.86e-01 | 5.72e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 14 | 7.11e-01 | -5.72e-02 | 9.68e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 12 | 7.32e-01 | 5.71e-02 | 9.70e-01 |
| GOBP HEMOSTASIS | 132 | 2.59e-01 | 5.71e-02 | 8.50e-01 |
| GOBP RESPONSE TO NEMATODE | 5 | 8.25e-01 | -5.70e-02 | 9.76e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 174 | 1.96e-01 | 5.70e-02 | 8.20e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 14 | 7.12e-01 | -5.70e-02 | 9.68e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 8 | 7.80e-01 | 5.69e-02 | 9.73e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 12 | 7.33e-01 | 5.69e-02 | 9.70e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 23 | 6.37e-01 | -5.69e-02 | 9.59e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 11 | 7.44e-01 | 5.69e-02 | 9.70e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 54 | 4.70e-01 | -5.69e-02 | 9.26e-01 |
| GOBP ERAD PATHWAY | 93 | 3.44e-01 | 5.69e-02 | 8.85e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 245 | 1.26e-01 | 5.69e-02 | 7.55e-01 |
| GOBP RESPONSE TO PAIN | 12 | 7.33e-01 | -5.69e-02 | 9.70e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 12 | 7.33e-01 | 5.69e-02 | 9.70e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 155 | 2.23e-01 | 5.69e-02 | 8.32e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 20 | 6.60e-01 | -5.68e-02 | 9.62e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 7.95e-01 | -5.68e-02 | 9.73e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 43 | 5.20e-01 | 5.68e-02 | 9.35e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 11 | 7.44e-01 | -5.68e-02 | 9.70e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 6 | 8.10e-01 | -5.68e-02 | 9.75e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 6.61e-01 | 5.67e-02 | 9.62e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 35 | 5.62e-01 | -5.67e-02 | 9.44e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 5 | 8.26e-01 | -5.67e-02 | 9.76e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 7.34e-01 | -5.67e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 89 | 3.56e-01 | -5.67e-02 | 8.88e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 7 | 7.95e-01 | 5.66e-02 | 9.73e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 81 | 3.79e-01 | -5.66e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 11 | 7.45e-01 | 5.65e-02 | 9.70e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 102 | 3.25e-01 | -5.65e-02 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 72 | 4.08e-01 | -5.65e-02 | 9.01e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 8 | 7.82e-01 | 5.65e-02 | 9.73e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 137 | 2.55e-01 | -5.65e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 38 | 5.47e-01 | 5.65e-02 | 9.40e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 8.27e-01 | 5.65e-02 | 9.76e-01 |
| GOBP IRON ION TRANSPORT | 34 | 5.69e-01 | -5.65e-02 | 9.44e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 10 | 7.57e-01 | -5.64e-02 | 9.72e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 53 | 4.78e-01 | -5.64e-02 | 9.26e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 12 | 7.35e-01 | 5.64e-02 | 9.70e-01 |
| GOBP REGULATION OF ANOIKIS | 17 | 6.88e-01 | -5.63e-02 | 9.64e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 363 | 6.69e-02 | -5.63e-02 | 6.72e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 9 | 7.70e-01 | 5.63e-02 | 9.73e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 8.11e-01 | -5.63e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 24 | 6.34e-01 | 5.62e-02 | 9.59e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 7.70e-01 | 5.62e-02 | 9.73e-01 |
| GOBP SISTER CHROMATID COHESION | 43 | 5.24e-01 | 5.62e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 35 | 5.65e-01 | 5.62e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 370 | 6.51e-02 | 5.62e-02 | 6.70e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 7.16e-01 | -5.62e-02 | 9.69e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 134 | 2.63e-01 | 5.61e-02 | 8.52e-01 |
| GOBP VACUOLE ORGANIZATION | 193 | 1.80e-01 | -5.61e-02 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 7.26e-01 | 5.61e-02 | 9.69e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 152 | 2.34e-01 | -5.61e-02 | 8.37e-01 |
| GOMF ACTIN MONOMER BINDING | 16 | 6.98e-01 | 5.61e-02 | 9.65e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 17 | 6.89e-01 | -5.61e-02 | 9.64e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 14 | 7.17e-01 | 5.61e-02 | 9.69e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 72 | 4.12e-01 | 5.60e-02 | 9.04e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 333 | 8.06e-02 | 5.60e-02 | 6.95e-01 |
| GOCC SAGA TYPE COMPLEX | 36 | 5.61e-01 | 5.60e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 47 | 5.07e-01 | 5.60e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 18 | 6.81e-01 | -5.59e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 8 | 7.84e-01 | -5.59e-02 | 9.73e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 7.60e-01 | 5.59e-02 | 9.72e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 12 | 7.38e-01 | 5.58e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 7 | 7.98e-01 | 5.58e-02 | 9.73e-01 |
| GOCC AXON CYTOPLASM | 47 | 5.08e-01 | 5.58e-02 | 9.31e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 10 | 7.60e-01 | 5.58e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 6 | 8.13e-01 | -5.58e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 16 | 7.00e-01 | 5.57e-02 | 9.65e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 12 | 7.38e-01 | -5.57e-02 | 9.70e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 123 | 2.87e-01 | 5.56e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 11 | 7.49e-01 | 5.56e-02 | 9.71e-01 |
| GOBP DTMP METABOLIC PROCESS | 5 | 8.29e-01 | -5.56e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 7.85e-01 | -5.56e-02 | 9.73e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 41 | 5.38e-01 | -5.56e-02 | 9.40e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 8.30e-01 | -5.55e-02 | 9.76e-01 |
| GOMF CORECEPTOR ACTIVITY | 26 | 6.24e-01 | -5.55e-02 | 9.57e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 7.99e-01 | 5.55e-02 | 9.73e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 5 | 8.30e-01 | -5.54e-02 | 9.76e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 8.14e-01 | 5.54e-02 | 9.76e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 83 | 3.84e-01 | 5.54e-02 | 8.97e-01 |
| GOMF DYSTROGLYCAN BINDING | 7 | 8.00e-01 | 5.54e-02 | 9.73e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 241 | 1.40e-01 | 5.54e-02 | 7.68e-01 |
| GOBP MEMBRANE DOCKING | 72 | 4.17e-01 | 5.54e-02 | 9.08e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 8.15e-01 | 5.53e-02 | 9.76e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 6.77e-01 | 5.53e-02 | 9.64e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 13 | 7.30e-01 | -5.53e-02 | 9.70e-01 |
| GOMF MISMATCHED DNA BINDING | 13 | 7.30e-01 | 5.53e-02 | 9.70e-01 |
| GOBP FEAR RESPONSE | 17 | 6.94e-01 | -5.52e-02 | 9.64e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 89 | 3.69e-01 | 5.52e-02 | 8.92e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 31 | 5.95e-01 | -5.52e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 86 | 3.77e-01 | 5.52e-02 | 8.97e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 6 | 8.15e-01 | 5.52e-02 | 9.76e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 25 | 6.33e-01 | -5.51e-02 | 9.59e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 11 | 7.52e-01 | -5.51e-02 | 9.71e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 7.12e-01 | 5.51e-02 | 9.68e-01 |
| GOMF ICOSANOID BINDING | 6 | 8.15e-01 | 5.51e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 116 | 3.06e-01 | -5.51e-02 | 8.75e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 18 | 6.86e-01 | 5.50e-02 | 9.64e-01 |
| GOBP MANNOSYLATION | 19 | 6.78e-01 | -5.50e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 19 | 6.78e-01 | 5.50e-02 | 9.64e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 6.79e-01 | 5.49e-02 | 9.64e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 7 | 8.02e-01 | 5.49e-02 | 9.73e-01 |
| GOCC DENDRITE CYTOPLASM | 19 | 6.79e-01 | 5.49e-02 | 9.64e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 8.02e-01 | 5.49e-02 | 9.73e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 200 | 1.83e-01 | 5.49e-02 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 8.32e-01 | -5.48e-02 | 9.76e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 81 | 3.94e-01 | 5.48e-02 | 8.97e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 310 | 9.90e-02 | 5.48e-02 | 7.33e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 33 | 5.86e-01 | 5.48e-02 | 9.49e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 7.76e-01 | 5.48e-02 | 9.73e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 20 | 6.72e-01 | -5.47e-02 | 9.64e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 21 | 6.64e-01 | 5.47e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 25 | 6.36e-01 | -5.47e-02 | 9.59e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 13 | 7.33e-01 | -5.47e-02 | 9.70e-01 |
| GOCC PCG PROTEIN COMPLEX | 32 | 5.92e-01 | -5.47e-02 | 9.51e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 10 | 7.64e-01 | 5.47e-02 | 9.72e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 64 | 4.50e-01 | 5.47e-02 | 9.21e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 8.02e-01 | -5.47e-02 | 9.73e-01 |
| GOMF INSULIN RECEPTOR BINDING | 15 | 7.14e-01 | -5.46e-02 | 9.69e-01 |
| GOCC OMEGASOME | 5 | 8.33e-01 | -5.46e-02 | 9.76e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 8.33e-01 | -5.46e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 19 | 6.81e-01 | -5.46e-02 | 9.64e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 8 | 7.90e-01 | -5.44e-02 | 9.73e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 7.90e-01 | 5.44e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 134 | 2.78e-01 | -5.44e-02 | 8.61e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 6 | 8.18e-01 | 5.44e-02 | 9.76e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 13 | 7.34e-01 | 5.44e-02 | 9.70e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 20 | 6.74e-01 | -5.44e-02 | 9.64e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 76 | 4.13e-01 | 5.44e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 6.98e-01 | 5.44e-02 | 9.65e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 6 | 8.18e-01 | -5.43e-02 | 9.76e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 26 | 6.32e-01 | -5.43e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 10 | 7.66e-01 | 5.43e-02 | 9.72e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 19 | 6.82e-01 | -5.43e-02 | 9.64e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 8.34e-01 | 5.43e-02 | 9.76e-01 |
| GOMF ISOMERASE ACTIVITY | 127 | 2.92e-01 | -5.42e-02 | 8.70e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 21 | 6.67e-01 | -5.42e-02 | 9.63e-01 |
| GOBP REGULATED EXOCYTOSIS | 138 | 2.73e-01 | 5.42e-02 | 8.58e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 23 | 6.53e-01 | 5.42e-02 | 9.62e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 11 | 7.56e-01 | -5.41e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 39 | 5.59e-01 | -5.41e-02 | 9.44e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 6 | 8.19e-01 | -5.41e-02 | 9.76e-01 |
| GOBP XENOBIOTIC TRANSPORT | 24 | 6.47e-01 | 5.41e-02 | 9.60e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 70 | 4.35e-01 | -5.41e-02 | 9.14e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 441 | 5.34e-02 | -5.40e-02 | 6.61e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 28 | 6.21e-01 | -5.40e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 14 | 7.27e-01 | -5.40e-02 | 9.69e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 367 | 7.75e-02 | 5.40e-02 | 6.92e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 70 | 4.35e-01 | -5.40e-02 | 9.14e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 7.57e-01 | 5.40e-02 | 9.72e-01 |
| GOCC NUCLEAR MEMBRANE | 241 | 1.51e-01 | 5.39e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 13 | 7.37e-01 | 5.39e-02 | 9.70e-01 |
| GOBP CENTROSOME SEPARATION | 11 | 7.57e-01 | 5.39e-02 | 9.72e-01 |
| GOBP RESPONSE TO LEPTIN | 11 | 7.57e-01 | 5.39e-02 | 9.72e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 12 | 7.47e-01 | 5.39e-02 | 9.71e-01 |
| GOMF METAL CLUSTER BINDING | 63 | 4.60e-01 | 5.39e-02 | 9.25e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 33 | 5.93e-01 | 5.38e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 257 | 1.39e-01 | -5.38e-02 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 8.20e-01 | 5.38e-02 | 9.76e-01 |
| GOBP RESPONSE TO COLD | 27 | 6.29e-01 | -5.38e-02 | 9.58e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 76 | 4.18e-01 | 5.38e-02 | 9.08e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 10 | 7.69e-01 | 5.38e-02 | 9.72e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 48 | 5.20e-01 | -5.38e-02 | 9.35e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 100 | 3.54e-01 | 5.37e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 24 | 6.49e-01 | -5.37e-02 | 9.61e-01 |
| GOBP HIPPO SIGNALING | 26 | 6.36e-01 | 5.37e-02 | 9.59e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 7.58e-01 | -5.37e-02 | 9.72e-01 |
| GOBP STEROL HOMEOSTASIS | 42 | 5.48e-01 | -5.36e-02 | 9.40e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 9 | 7.81e-01 | -5.36e-02 | 9.73e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 53 | 5.00e-01 | -5.36e-02 | 9.31e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 13 | 7.38e-01 | 5.36e-02 | 9.70e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 17 | 7.02e-01 | 5.36e-02 | 9.65e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 39 | 5.63e-01 | 5.36e-02 | 9.44e-01 |
| GOBP CATECHOLAMINE SECRETION | 17 | 7.02e-01 | 5.35e-02 | 9.65e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 32 | 6.00e-01 | -5.35e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 8 | 7.93e-01 | -5.35e-02 | 9.73e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 8.21e-01 | 5.35e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 22 | 6.64e-01 | 5.34e-02 | 9.63e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 32 | 6.01e-01 | -5.34e-02 | 9.52e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 7.94e-01 | -5.34e-02 | 9.73e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 32 | 6.02e-01 | 5.34e-02 | 9.52e-01 |
| GOBP RESPONSE TO HORMONE | 497 | 4.34e-02 | 5.33e-02 | 6.26e-01 |
| GOBP STEROID METABOLIC PROCESS | 157 | 2.50e-01 | -5.33e-02 | 8.50e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 6 | 8.21e-01 | 5.33e-02 | 9.76e-01 |
| GOCC INCLUSION BODY | 54 | 4.99e-01 | 5.33e-02 | 9.31e-01 |
| GOMF FIBRONECTIN BINDING | 17 | 7.04e-01 | -5.32e-02 | 9.66e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 80 | 4.12e-01 | -5.32e-02 | 9.04e-01 |
| GOCC SPINDLE MIDZONE | 25 | 6.46e-01 | 5.31e-02 | 9.60e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 188 | 2.10e-01 | -5.31e-02 | 8.32e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 34 | 5.92e-01 | 5.31e-02 | 9.51e-01 |
| GOBP MAINTENANCE OF LOCATION | 226 | 1.70e-01 | -5.31e-02 | 8.04e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 8.37e-01 | -5.31e-02 | 9.76e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 8.37e-01 | 5.31e-02 | 9.76e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 128 | 3.01e-01 | -5.31e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 38 | 5.72e-01 | -5.31e-02 | 9.44e-01 |
| GOMF CHEMOKINE ACTIVITY | 15 | 7.22e-01 | -5.30e-02 | 9.69e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 7.83e-01 | 5.30e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 13 | 7.41e-01 | -5.30e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 101 | 3.58e-01 | 5.30e-02 | 8.90e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 13 | 7.41e-01 | -5.30e-02 | 9.70e-01 |
| GOCC CELL CELL JUNCTION | 241 | 1.58e-01 | 5.30e-02 | 7.93e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 7.72e-01 | 5.30e-02 | 9.73e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 316 | 1.07e-01 | 5.30e-02 | 7.42e-01 |
| GOMF PROLINE RICH REGION BINDING | 14 | 7.32e-01 | -5.29e-02 | 9.70e-01 |
| GOBP TRANSPORT OF VIRUS | 16 | 7.14e-01 | 5.29e-02 | 9.68e-01 |
| GOBP RESPONSE TO ALCOHOL | 137 | 2.86e-01 | 5.29e-02 | 8.67e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 7.96e-01 | 5.29e-02 | 9.73e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 961 | 6.29e-03 | 5.29e-02 | 3.94e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 8.08e-01 | -5.29e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 34 | 5.94e-01 | 5.29e-02 | 9.51e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 175 | 2.29e-01 | 5.29e-02 | 8.34e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 30 | 6.17e-01 | -5.28e-02 | 9.55e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 7.96e-01 | -5.28e-02 | 9.73e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 21 | 6.75e-01 | -5.28e-02 | 9.64e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 345 | 9.38e-02 | 5.28e-02 | 7.27e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 23 | 6.61e-01 | 5.28e-02 | 9.62e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 21 | 6.76e-01 | 5.27e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 147 | 2.72e-01 | 5.27e-02 | 8.58e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 323 | 1.06e-01 | -5.26e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 106 | 3.50e-01 | 5.26e-02 | 8.88e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 7 | 8.10e-01 | -5.26e-02 | 9.75e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.23e-01 | 5.26e-02 | 9.76e-01 |
| GOBP TRANSPOSITION | 19 | 6.92e-01 | 5.26e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 10 | 7.74e-01 | 5.25e-02 | 9.73e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 7.63e-01 | 5.25e-02 | 9.72e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 8.39e-01 | -5.25e-02 | 9.77e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 195 | 2.08e-01 | 5.25e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 86 | 4.01e-01 | -5.25e-02 | 8.99e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 41 | 5.61e-01 | 5.25e-02 | 9.44e-01 |
| GOBP HEAT GENERATION | 10 | 7.74e-01 | 5.25e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 24 | 6.57e-01 | -5.24e-02 | 9.62e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 45 | 5.43e-01 | -5.24e-02 | 9.40e-01 |
| GOBP FEMALE GAMETE GENERATION | 75 | 4.33e-01 | 5.24e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 34 | 5.97e-01 | 5.24e-02 | 9.52e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 563 | 3.54e-02 | 5.24e-02 | 5.92e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 97 | 3.74e-01 | -5.23e-02 | 8.96e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 57 | 4.95e-01 | 5.23e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 16 | 7.17e-01 | -5.23e-02 | 9.69e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 10 | 7.75e-01 | 5.22e-02 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 11 | 7.64e-01 | 5.22e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 7 | 8.11e-01 | -5.22e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 27 | 6.39e-01 | -5.22e-02 | 9.59e-01 |
| GOCC SARCOLEMMA | 62 | 4.78e-01 | 5.22e-02 | 9.26e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 7.98e-01 | -5.21e-02 | 9.73e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 10 | 7.75e-01 | -5.21e-02 | 9.73e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 290 | 1.29e-01 | -5.21e-02 | 7.57e-01 |
| GOMF BETA CATENIN BINDING | 53 | 5.12e-01 | 5.21e-02 | 9.33e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 7.99e-01 | -5.21e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 24 | 6.59e-01 | -5.20e-02 | 9.62e-01 |
| GOBP TISSUE REMODELING | 87 | 4.02e-01 | 5.20e-02 | 8.99e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 293 | 1.27e-01 | -5.20e-02 | 7.55e-01 |
| GOBP RIBOSOME BIOGENESIS | 307 | 1.19e-01 | 5.20e-02 | 7.52e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 32 | 6.11e-01 | -5.20e-02 | 9.55e-01 |
| GOCC DENDRITIC TREE | 317 | 1.14e-01 | 5.20e-02 | 7.52e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 34 | 6.00e-01 | -5.19e-02 | 9.52e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 10 | 7.76e-01 | 5.19e-02 | 9.73e-01 |
| GOBP RESPONSE TO VIRUS | 317 | 1.14e-01 | 5.19e-02 | 7.52e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 165 | 2.52e-01 | 5.18e-02 | 8.50e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 9 | 7.88e-01 | 5.18e-02 | 9.73e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 97 | 3.79e-01 | -5.18e-02 | 8.97e-01 |
| GOBP FEVER GENERATION | 6 | 8.26e-01 | -5.17e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 14 | 7.38e-01 | 5.17e-02 | 9.70e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 5 | 8.41e-01 | 5.17e-02 | 9.78e-01 |
| GOCC NUCLEAR ENVELOPE | 384 | 8.44e-02 | 5.16e-02 | 7.03e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 50 | 5.28e-01 | 5.16e-02 | 9.37e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 6 | 8.27e-01 | 5.16e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 12 | 7.57e-01 | -5.15e-02 | 9.72e-01 |
| GOBP DNA METABOLIC PROCESS | 802 | 1.45e-02 | 5.15e-02 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 45 | 5.51e-01 | -5.15e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 26 | 6.50e-01 | -5.14e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 54 | 5.14e-01 | -5.14e-02 | 9.33e-01 |
| GOBP MIRNA PROCESSING | 41 | 5.69e-01 | 5.14e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 8 | 8.01e-01 | -5.14e-02 | 9.73e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 12 | 7.58e-01 | 5.14e-02 | 9.72e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 8 | 8.01e-01 | 5.14e-02 | 9.73e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 21 | 6.84e-01 | -5.14e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 21 | 6.84e-01 | 5.14e-02 | 9.64e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 8.28e-01 | -5.13e-02 | 9.76e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 61 | 4.89e-01 | 5.13e-02 | 9.30e-01 |
| GOBP RESPONSE TO VITAMIN | 42 | 5.66e-01 | 5.13e-02 | 9.44e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 8.28e-01 | -5.13e-02 | 9.76e-01 |
| GOBP CELLULAR SENESCENCE | 78 | 4.35e-01 | 5.12e-02 | 9.14e-01 |
| GOBP LUNG MORPHOGENESIS | 23 | 6.71e-01 | -5.12e-02 | 9.64e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 90 | 4.02e-01 | 5.12e-02 | 8.99e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 463 | 6.11e-02 | 5.12e-02 | 6.68e-01 |
| GOBP DNA REPAIR | 494 | 5.35e-02 | 5.11e-02 | 6.61e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 71 | 4.57e-01 | -5.11e-02 | 9.23e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 568 | 3.91e-02 | 5.11e-02 | 6.12e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 26 | 6.52e-01 | -5.11e-02 | 9.61e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 39 | 5.81e-01 | 5.11e-02 | 9.48e-01 |
| GOMF LYASE ACTIVITY | 126 | 3.23e-01 | 5.11e-02 | 8.76e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 8 | 8.03e-01 | 5.10e-02 | 9.73e-01 |
| GOBP FLUID TRANSPORT | 13 | 7.50e-01 | 5.10e-02 | 9.71e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 10 | 7.80e-01 | 5.10e-02 | 9.73e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 6.53e-01 | 5.10e-02 | 9.62e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 697 | 2.35e-02 | -5.10e-02 | 5.39e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 77 | 4.40e-01 | 5.10e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 120 | 3.36e-01 | 5.09e-02 | 8.83e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 26 | 6.53e-01 | 5.09e-02 | 9.62e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 5 | 8.44e-01 | -5.08e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 7.81e-01 | -5.08e-02 | 9.73e-01 |
| GOCC SPINDLE POLE | 138 | 3.04e-01 | 5.08e-02 | 8.75e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 43 | 5.65e-01 | -5.08e-02 | 9.44e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 402 | 8.27e-02 | 5.08e-02 | 6.99e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 66 | 4.76e-01 | 5.07e-02 | 9.26e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 8.16e-01 | 5.07e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 35 | 6.04e-01 | 5.07e-02 | 9.52e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 120 | 3.39e-01 | 5.07e-02 | 8.83e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 30 | 6.31e-01 | -5.07e-02 | 9.58e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 55 | 5.16e-01 | -5.07e-02 | 9.34e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 24 | 6.68e-01 | -5.06e-02 | 9.63e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 779 | 1.77e-02 | -5.06e-02 | 5.05e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 10 | 7.82e-01 | 5.05e-02 | 9.73e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 9 | 7.93e-01 | 5.05e-02 | 9.73e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 7 | 8.17e-01 | -5.05e-02 | 9.76e-01 |
| GOCC CELL DIVISION SITE | 53 | 5.25e-01 | 5.05e-02 | 9.36e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 7.82e-01 | 5.05e-02 | 9.73e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 20 | 6.96e-01 | 5.05e-02 | 9.65e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 68 | 4.73e-01 | -5.04e-02 | 9.26e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 59 | 5.04e-01 | -5.04e-02 | 9.31e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 178 | 2.48e-01 | 5.04e-02 | 8.49e-01 |
| GOBP FILOPODIUM ASSEMBLY | 43 | 5.68e-01 | -5.04e-02 | 9.44e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 6.76e-01 | 5.04e-02 | 9.64e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 13 | 7.53e-01 | 5.04e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 711 | 2.38e-02 | 5.03e-02 | 5.39e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 54 | 5.23e-01 | -5.03e-02 | 9.35e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 8.18e-01 | 5.03e-02 | 9.76e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 35 | 6.07e-01 | -5.03e-02 | 9.53e-01 |
| GOMF RAGE RECEPTOR BINDING | 9 | 7.94e-01 | -5.03e-02 | 9.73e-01 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 8.31e-01 | -5.03e-02 | 9.76e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 10 | 7.83e-01 | -5.02e-02 | 9.73e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 10 | 7.84e-01 | 5.02e-02 | 9.73e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 42 | 5.74e-01 | 5.01e-02 | 9.44e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 127 | 3.30e-01 | 5.01e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 20 | 6.98e-01 | -5.01e-02 | 9.65e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 17 | 7.21e-01 | -5.01e-02 | 9.69e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 199 | 2.25e-01 | -5.01e-02 | 8.32e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 53 | 5.29e-01 | 5.01e-02 | 9.37e-01 |
| GOBP ARTERY MORPHOGENESIS | 28 | 6.47e-01 | 5.00e-02 | 9.60e-01 |
| GOBP AMINO ACID TRANSPORT | 77 | 4.48e-01 | 5.00e-02 | 9.19e-01 |
| GOCC EXOCYTIC VESICLE | 129 | 3.28e-01 | 5.00e-02 | 8.76e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 12 | 7.64e-01 | 5.00e-02 | 9.72e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 13 | 7.55e-01 | 4.99e-02 | 9.72e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 5 | 8.47e-01 | 4.99e-02 | 9.79e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 60 | 5.04e-01 | -4.99e-02 | 9.31e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 160 | 2.77e-01 | 4.99e-02 | 8.61e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 12 | 7.65e-01 | -4.99e-02 | 9.72e-01 |
| GOCC FILOPODIUM TIP | 12 | 7.65e-01 | 4.99e-02 | 9.72e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 14 | 7.47e-01 | -4.98e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 8.33e-01 | -4.98e-02 | 9.76e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 268 | 1.62e-01 | -4.98e-02 | 7.98e-01 |
| GOCC MICROTUBULE PLUS END | 18 | 7.15e-01 | 4.98e-02 | 9.69e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 18 | 7.15e-01 | -4.98e-02 | 9.69e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 118 | 3.51e-01 | 4.98e-02 | 8.88e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 33 | 6.21e-01 | -4.98e-02 | 9.55e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 22 | 6.86e-01 | 4.97e-02 | 9.64e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 637 | 3.41e-02 | 4.97e-02 | 5.88e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 45 | 5.64e-01 | 4.97e-02 | 9.44e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 19 | 7.08e-01 | -4.97e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 7.66e-01 | 4.97e-02 | 9.72e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 42 | 5.78e-01 | -4.97e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 7.57e-01 | -4.96e-02 | 9.72e-01 |
| GOMF PORIN ACTIVITY | 6 | 8.33e-01 | 4.96e-02 | 9.76e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 78 | 4.49e-01 | -4.96e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 12 | 7.66e-01 | 4.96e-02 | 9.72e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 150 | 2.96e-01 | 4.96e-02 | 8.71e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 757 | 2.20e-02 | 4.96e-02 | 5.33e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 11 | 7.76e-01 | 4.96e-02 | 9.73e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 7.48e-01 | 4.95e-02 | 9.71e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 10 | 7.86e-01 | 4.95e-02 | 9.73e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 30 | 6.39e-01 | 4.95e-02 | 9.59e-01 |
| GOBP CELL MORPHOGENESIS | 509 | 5.81e-02 | 4.95e-02 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 13 | 7.58e-01 | -4.95e-02 | 9.72e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 17 | 7.24e-01 | -4.95e-02 | 9.69e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 7.40e-01 | -4.95e-02 | 9.70e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 12 | 7.67e-01 | -4.94e-02 | 9.72e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 7.77e-01 | -4.94e-02 | 9.73e-01 |
| GOCC MEMBRANE COAT | 84 | 4.34e-01 | -4.94e-02 | 9.14e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 258 | 1.74e-01 | 4.94e-02 | 8.07e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 6.34e-01 | 4.94e-02 | 9.59e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 126 | 3.39e-01 | 4.94e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 7.17e-01 | 4.94e-02 | 9.69e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 72 | 4.70e-01 | 4.94e-02 | 9.26e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 15 | 7.41e-01 | -4.93e-02 | 9.70e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 10 | 7.87e-01 | 4.93e-02 | 9.73e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 662 | 3.23e-02 | 4.93e-02 | 5.87e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 7.03e-01 | -4.93e-02 | 9.65e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 111 | 3.70e-01 | 4.93e-02 | 8.92e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 171 | 2.68e-01 | 4.93e-02 | 8.56e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 37 | 6.05e-01 | -4.91e-02 | 9.52e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 7.99e-01 | 4.91e-02 | 9.73e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 6.84e-01 | 4.91e-02 | 9.64e-01 |
| GOMF CHOLESTEROL BINDING | 33 | 6.26e-01 | -4.90e-02 | 9.58e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 13 | 7.60e-01 | -4.90e-02 | 9.72e-01 |
| GOCC MICROTUBULE END | 24 | 6.78e-01 | 4.90e-02 | 9.64e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 6 | 8.35e-01 | 4.90e-02 | 9.76e-01 |
| GOMF PHOSPHATASE ACTIVITY | 182 | 2.56e-01 | 4.90e-02 | 8.50e-01 |
| GOMF GROWTH FACTOR BINDING | 57 | 5.23e-01 | 4.90e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 11 | 7.79e-01 | -4.90e-02 | 9.73e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 27 | 6.60e-01 | 4.90e-02 | 9.62e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 253 | 1.82e-01 | -4.89e-02 | 8.07e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 9 | 7.99e-01 | -4.89e-02 | 9.73e-01 |
| GOBP NCRNA METABOLIC PROCESS | 521 | 5.83e-02 | 4.89e-02 | 6.64e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 529 | 5.66e-02 | -4.89e-02 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 43 | 5.79e-01 | 4.89e-02 | 9.48e-01 |
| GOBP LEUKOCYTE MIGRATION | 226 | 2.07e-01 | -4.89e-02 | 8.29e-01 |
| GOBP N GLYCAN PROCESSING | 13 | 7.61e-01 | 4.88e-02 | 9.72e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 14 | 7.52e-01 | -4.88e-02 | 9.71e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 7.28e-01 | 4.88e-02 | 9.69e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 47 | 5.64e-01 | 4.87e-02 | 9.44e-01 |
| GOBP MICROTUBULE BASED PROCESS | 581 | 4.72e-02 | 4.87e-02 | 6.41e-01 |
| GOBP T CELL CHEMOTAXIS | 16 | 7.36e-01 | -4.87e-02 | 9.70e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 8.24e-01 | -4.86e-02 | 9.76e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 8 | 8.12e-01 | -4.86e-02 | 9.75e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 8 | 8.12e-01 | -4.86e-02 | 9.75e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 272 | 1.70e-01 | -4.86e-02 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 16 | 7.37e-01 | -4.86e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 7.81e-01 | -4.85e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 13 | 7.63e-01 | 4.84e-02 | 9.72e-01 |
| GOBP REGULATION OF CELL KILLING | 77 | 4.64e-01 | 4.83e-02 | 9.25e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 75 | 4.70e-01 | 4.83e-02 | 9.26e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 63 | 5.08e-01 | -4.83e-02 | 9.31e-01 |
| GOBP RESPONSE TO KETONE | 112 | 3.79e-01 | 4.82e-02 | 8.97e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 58 | 5.26e-01 | 4.82e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 63 | 5.08e-01 | 4.82e-02 | 9.31e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 6.71e-01 | -4.82e-02 | 9.64e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 35 | 6.22e-01 | -4.82e-02 | 9.55e-01 |
| GOMF CHEMOKINE BINDING | 14 | 7.55e-01 | -4.82e-02 | 9.72e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 35 | 6.22e-01 | 4.81e-02 | 9.56e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 52 | 5.49e-01 | -4.81e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 90 | 4.32e-01 | -4.80e-02 | 9.14e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 69 | 4.91e-01 | -4.80e-02 | 9.31e-01 |
| GOBP NUCLEOTIDE SALVAGE | 16 | 7.40e-01 | -4.80e-02 | 9.70e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 15 | 7.48e-01 | 4.79e-02 | 9.71e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 105 | 3.97e-01 | -4.79e-02 | 8.98e-01 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 7.25e-01 | -4.79e-02 | 9.69e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 5.47e-01 | 4.79e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 55 | 5.40e-01 | -4.78e-02 | 9.40e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 8.53e-01 | 4.78e-02 | 9.81e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 160 | 2.98e-01 | 4.78e-02 | 8.71e-01 |
| GOBP TRACHEA DEVELOPMENT | 11 | 7.84e-01 | -4.78e-02 | 9.73e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 127 | 3.53e-01 | 4.78e-02 | 8.88e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 95 | 4.22e-01 | -4.78e-02 | 9.11e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 8.53e-01 | -4.78e-02 | 9.81e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 221 | 2.23e-01 | 4.77e-02 | 8.32e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 515 | 6.63e-02 | 4.77e-02 | 6.72e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 5 | 8.54e-01 | 4.76e-02 | 9.81e-01 |
| GOBP REGULATION OF DNA LIGATION | 5 | 8.54e-01 | -4.76e-02 | 9.81e-01 |
| GOMF PHOSPHOLIPID BINDING | 305 | 1.55e-01 | 4.76e-02 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 31 | 6.46e-01 | -4.76e-02 | 9.60e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 655 | 3.97e-02 | -4.76e-02 | 6.15e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 5 | 8.54e-01 | -4.76e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 64 | 5.11e-01 | 4.75e-02 | 9.32e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 260 | 1.89e-01 | -4.75e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 252 | 1.96e-01 | -4.75e-02 | 8.20e-01 |
| GOMF KINASE ACTIVITY | 518 | 6.67e-02 | 4.75e-02 | 6.72e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 54 | 5.47e-01 | -4.75e-02 | 9.40e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 84 | 4.53e-01 | -4.75e-02 | 9.21e-01 |
| GOBP MYOBLAST FUSION | 22 | 7.00e-01 | -4.75e-02 | 9.65e-01 |
| GOBP TOLERANCE INDUCTION | 17 | 7.35e-01 | 4.74e-02 | 9.70e-01 |
| GOCC ASTROCYTE PROJECTION | 5 | 8.54e-01 | -4.74e-02 | 9.81e-01 |
| GOBP CELL PART MORPHOGENESIS | 340 | 1.35e-01 | 4.74e-02 | 7.62e-01 |
| GOBP BONE CELL DEVELOPMENT | 12 | 7.76e-01 | 4.74e-02 | 9.73e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 7 | 8.28e-01 | -4.73e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 10 | 7.96e-01 | -4.73e-02 | 9.73e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 6.60e-01 | -4.72e-02 | 9.62e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 414 | 1.01e-01 | 4.72e-02 | 7.39e-01 |
| GOCC HETEROCHROMATIN | 62 | 5.21e-01 | 4.72e-02 | 9.35e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 8.41e-01 | -4.72e-02 | 9.78e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 7.08e-01 | 4.72e-02 | 9.67e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 105 | 4.04e-01 | -4.72e-02 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 23 | 6.95e-01 | 4.72e-02 | 9.65e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 33 | 6.39e-01 | -4.71e-02 | 9.59e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 8 | 8.17e-01 | 4.71e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 7.97e-01 | -4.71e-02 | 9.73e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 14 | 7.61e-01 | 4.70e-02 | 9.72e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 23 | 6.97e-01 | -4.70e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 51 | 5.62e-01 | 4.70e-02 | 9.44e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 19 | 7.23e-01 | 4.69e-02 | 9.69e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 7.24e-01 | -4.69e-02 | 9.69e-01 |
| GOBP NUCLEAR EXPORT | 150 | 3.23e-01 | 4.69e-02 | 8.76e-01 |
| GOCC MICROBODY MEMBRANE | 55 | 5.48e-01 | -4.68e-02 | 9.40e-01 |
| GOMF CALMODULIN BINDING | 107 | 4.03e-01 | -4.68e-02 | 8.99e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 54 | 5.52e-01 | -4.68e-02 | 9.41e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 198 | 2.58e-01 | 4.68e-02 | 8.50e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 10 | 7.98e-01 | 4.68e-02 | 9.73e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1380 | 4.49e-03 | 4.68e-02 | 3.48e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 256 | 2.00e-01 | 4.67e-02 | 8.25e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 7 | 8.31e-01 | 4.67e-02 | 9.76e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 13 | 7.71e-01 | -4.67e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 14 | 7.62e-01 | -4.67e-02 | 9.72e-01 |
| GOBP REGULATION OF BONE REMODELING | 26 | 6.80e-01 | -4.67e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 7.89e-01 | 4.67e-02 | 9.73e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 965 | 1.58e-02 | -4.67e-02 | 4.85e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 831 | 2.44e-02 | 4.66e-02 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 25 | 6.87e-01 | -4.66e-02 | 9.64e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 101 | 4.20e-01 | -4.66e-02 | 9.09e-01 |
| GOBP SYNAPTIC SIGNALING | 340 | 1.42e-01 | 4.66e-02 | 7.75e-01 |
| GOBP STEROL TRANSPORT | 76 | 4.84e-01 | -4.65e-02 | 9.28e-01 |
| GOBP DNA MODIFICATION | 79 | 4.76e-01 | 4.65e-02 | 9.26e-01 |
| GOCC PROTEIN KINASE COMPLEX | 108 | 4.05e-01 | 4.64e-02 | 8.99e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 24 | 6.94e-01 | 4.64e-02 | 9.65e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 43 | 5.99e-01 | 4.64e-02 | 9.52e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 25 | 6.89e-01 | -4.63e-02 | 9.64e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 659 | 4.51e-02 | 4.63e-02 | 6.33e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 8.58e-01 | 4.63e-02 | 9.81e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 29 | 6.67e-01 | 4.62e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 19 | 7.27e-01 | 4.62e-02 | 9.69e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 22 | 7.08e-01 | -4.62e-02 | 9.66e-01 |
| GOBP REGULATION OF PH | 70 | 5.04e-01 | -4.62e-02 | 9.31e-01 |
| GOBP T CELL HOMEOSTASIS | 35 | 6.37e-01 | 4.62e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 5 | 8.58e-01 | 4.61e-02 | 9.81e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 33 | 6.47e-01 | 4.61e-02 | 9.60e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 17 | 7.42e-01 | 4.61e-02 | 9.70e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 5 | 8.58e-01 | 4.60e-02 | 9.81e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 33 | 6.48e-01 | 4.60e-02 | 9.60e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 35 | 6.38e-01 | -4.60e-02 | 9.59e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 13 | 7.74e-01 | -4.60e-02 | 9.73e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 8.11e-01 | -4.60e-02 | 9.75e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 55 | 5.56e-01 | -4.60e-02 | 9.43e-01 |
| GOBP REGULATION OF CELL SHAPE | 97 | 4.35e-01 | 4.60e-02 | 9.14e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 50 | 5.74e-01 | 4.59e-02 | 9.44e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 65 | 5.23e-01 | 4.59e-02 | 9.35e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 6.91e-01 | 4.59e-02 | 9.64e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 26 | 6.86e-01 | 4.59e-02 | 9.64e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 274 | 1.93e-01 | 4.59e-02 | 8.17e-01 |
| GOCC ACTIN CYTOSKELETON | 293 | 1.79e-01 | 4.58e-02 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 95 | 4.41e-01 | 4.58e-02 | 9.16e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 453 | 9.74e-02 | 4.58e-02 | 7.33e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 9 | 8.12e-01 | 4.58e-02 | 9.75e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 116 | 3.96e-01 | 4.57e-02 | 8.98e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 581 | 6.21e-02 | 4.57e-02 | 6.68e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 41 | 6.13e-01 | -4.57e-02 | 9.55e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 63 | 5.31e-01 | 4.57e-02 | 9.38e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 58 | 5.48e-01 | -4.57e-02 | 9.40e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 36 | 6.35e-01 | -4.57e-02 | 9.59e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 15 | 7.60e-01 | 4.56e-02 | 9.72e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 14 | 7.68e-01 | -4.56e-02 | 9.72e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 77 | 4.90e-01 | -4.56e-02 | 9.30e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 5 | 8.60e-01 | 4.56e-02 | 9.82e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 13 | 7.76e-01 | 4.55e-02 | 9.73e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 10 | 8.03e-01 | 4.55e-02 | 9.73e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 7.85e-01 | 4.55e-02 | 9.73e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 7.77e-01 | 4.55e-02 | 9.73e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 9 | 8.13e-01 | -4.55e-02 | 9.76e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 59 | 5.46e-01 | 4.55e-02 | 9.40e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 121 | 3.89e-01 | 4.55e-02 | 8.97e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 24 | 7.00e-01 | 4.54e-02 | 9.65e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 8.04e-01 | 4.54e-02 | 9.73e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 8.04e-01 | 4.54e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 94 | 4.48e-01 | -4.54e-02 | 9.19e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 138 | 3.59e-01 | 4.54e-02 | 8.90e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 64 | 5.31e-01 | -4.53e-02 | 9.39e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 6.29e-01 | -4.53e-02 | 9.58e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 42 | 6.12e-01 | -4.52e-02 | 9.55e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 7 | 8.36e-01 | -4.52e-02 | 9.76e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 18 | 7.40e-01 | 4.52e-02 | 9.70e-01 |
| GOBP B CELL ACTIVATION | 202 | 2.70e-01 | -4.52e-02 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 18 | 7.40e-01 | 4.52e-02 | 9.70e-01 |
| GOBP TUBE MORPHOGENESIS | 439 | 1.07e-01 | 4.52e-02 | 7.42e-01 |
| GOBP MRNA TRANSPORT | 112 | 4.10e-01 | 4.52e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 80 | 4.86e-01 | -4.52e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 531 | 7.77e-02 | 4.52e-02 | 6.92e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 15 | 7.62e-01 | -4.51e-02 | 9.72e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 159 | 3.28e-01 | -4.51e-02 | 8.76e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 156 | 3.32e-01 | 4.51e-02 | 8.80e-01 |
| GOBP B CELL PROLIFERATION | 62 | 5.40e-01 | -4.51e-02 | 9.40e-01 |
| GOBP SPERM MOTILITY | 44 | 6.06e-01 | 4.50e-02 | 9.52e-01 |
| GOMF CYTOKINE BINDING | 70 | 5.16e-01 | 4.50e-02 | 9.34e-01 |
| GOBP CENTRIOLE ASSEMBLY | 41 | 6.18e-01 | 4.50e-02 | 9.55e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 6 | 8.49e-01 | 4.50e-02 | 9.80e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 8 | 8.26e-01 | 4.49e-02 | 9.76e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 25 | 6.98e-01 | -4.49e-02 | 9.65e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 30 | 6.71e-01 | 4.49e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 8.06e-01 | 4.48e-02 | 9.74e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 53 | 5.73e-01 | 4.48e-02 | 9.44e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 8.62e-01 | 4.48e-02 | 9.82e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 29 | 6.77e-01 | 4.48e-02 | 9.64e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 25 | 6.99e-01 | 4.48e-02 | 9.65e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 5 | 8.62e-01 | 4.48e-02 | 9.82e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 77 | 4.98e-01 | 4.47e-02 | 9.31e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 19 | 7.36e-01 | -4.47e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 8 | 8.27e-01 | -4.47e-02 | 9.76e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 7.05e-01 | 4.47e-02 | 9.66e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 33 | 6.57e-01 | -4.47e-02 | 9.62e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 23 | 7.11e-01 | 4.47e-02 | 9.68e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 7 | 8.38e-01 | -4.47e-02 | 9.77e-01 |
| GOBP VACUOLAR LOCALIZATION | 71 | 5.16e-01 | 4.47e-02 | 9.34e-01 |
| GOCC VESICLE TETHERING COMPLEX | 53 | 5.74e-01 | -4.47e-02 | 9.44e-01 |
| GOBP DETOXIFICATION | 75 | 5.04e-01 | -4.47e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 8.27e-01 | 4.46e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 7 | 8.38e-01 | 4.46e-02 | 9.77e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 5 | 8.63e-01 | -4.46e-02 | 9.82e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 20 | 7.30e-01 | -4.46e-02 | 9.70e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 62 | 5.44e-01 | -4.46e-02 | 9.40e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 51 | 5.83e-01 | -4.45e-02 | 9.48e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 623 | 6.06e-02 | -4.45e-02 | 6.68e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 8.50e-01 | -4.45e-02 | 9.81e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 11 | 7.99e-01 | -4.45e-02 | 9.73e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 13 | 7.81e-01 | -4.45e-02 | 9.73e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 36 | 6.45e-01 | -4.44e-02 | 9.60e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 134 | 3.76e-01 | 4.44e-02 | 8.97e-01 |
| GOMF ANTIGEN BINDING | 54 | 5.73e-01 | 4.44e-02 | 9.44e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 85 | 4.80e-01 | -4.44e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 20 | 7.31e-01 | -4.44e-02 | 9.70e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 14 | 7.74e-01 | -4.44e-02 | 9.73e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 23 | 7.13e-01 | -4.43e-02 | 9.68e-01 |
| GOBP CYTOKINESIS | 134 | 3.77e-01 | 4.43e-02 | 8.97e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 6.85e-01 | 4.43e-02 | 9.64e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 12 | 7.90e-01 | -4.43e-02 | 9.73e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 55 | 5.71e-01 | 4.43e-02 | 9.44e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 32 | 6.65e-01 | -4.42e-02 | 9.63e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 9 | 8.18e-01 | -4.42e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 5 | 8.64e-01 | -4.42e-02 | 9.83e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 20 | 7.33e-01 | 4.42e-02 | 9.70e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 91 | 4.67e-01 | 4.41e-02 | 9.25e-01 |
| GOMF HEPARIN BINDING | 46 | 6.05e-01 | 4.41e-02 | 9.52e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 8.64e-01 | 4.41e-02 | 9.83e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 103 | 4.40e-01 | 4.41e-02 | 9.15e-01 |
| GOBP TUBE DEVELOPMENT | 550 | 7.99e-02 | 4.41e-02 | 6.95e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 102 | 4.43e-01 | -4.41e-02 | 9.16e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 51 | 5.87e-01 | 4.40e-02 | 9.50e-01 |
| GOCC GOLGI CIS CISTERNA | 11 | 8.00e-01 | 4.40e-02 | 9.73e-01 |
| GOBP GOLGI RIBBON FORMATION | 9 | 8.19e-01 | 4.40e-02 | 9.76e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 22 | 7.21e-01 | 4.40e-02 | 9.69e-01 |
| GOBP VESICLE LOCALIZATION | 168 | 3.26e-01 | -4.40e-02 | 8.76e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 22 | 7.21e-01 | 4.40e-02 | 9.69e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 14 | 7.76e-01 | -4.39e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 27 | 6.93e-01 | -4.39e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 13 | 7.84e-01 | -4.39e-02 | 9.73e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 16 | 7.61e-01 | 4.39e-02 | 9.72e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 28 | 6.88e-01 | -4.39e-02 | 9.64e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 61 | 5.54e-01 | 4.39e-02 | 9.41e-01 |
| GOBP ER OVERLOAD RESPONSE | 10 | 8.10e-01 | -4.38e-02 | 9.75e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 23 | 7.16e-01 | -4.38e-02 | 9.69e-01 |
| GOMF HORMONE BINDING | 29 | 6.83e-01 | 4.38e-02 | 9.64e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 11 | 8.01e-01 | -4.38e-02 | 9.73e-01 |
| GOCC BRUSH BORDER | 52 | 5.85e-01 | -4.38e-02 | 9.49e-01 |
| GOBP TISSUE MIGRATION | 181 | 3.11e-01 | 4.38e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 372 | 1.50e-01 | -4.38e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 79 | 5.02e-01 | -4.37e-02 | 9.31e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 8.41e-01 | 4.37e-02 | 9.78e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 10 | 8.11e-01 | 4.37e-02 | 9.75e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 5 | 8.66e-01 | -4.37e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 52 | 5.86e-01 | -4.37e-02 | 9.49e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 8 | 8.31e-01 | 4.37e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 7.85e-01 | -4.37e-02 | 9.73e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 49 | 5.97e-01 | -4.37e-02 | 9.52e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 26 | 7.00e-01 | -4.37e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 10 | 8.11e-01 | 4.37e-02 | 9.75e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 12 | 7.94e-01 | 4.36e-02 | 9.73e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 96 | 4.61e-01 | 4.36e-02 | 9.25e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 58 | 5.66e-01 | 4.36e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 12 | 7.94e-01 | 4.35e-02 | 9.73e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 28 | 6.91e-01 | 4.35e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 45 | 6.15e-01 | -4.34e-02 | 9.55e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 22 | 7.25e-01 | -4.34e-02 | 9.69e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 11 | 8.03e-01 | 4.34e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 34 | 6.62e-01 | 4.34e-02 | 9.62e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 286 | 2.09e-01 | 4.34e-02 | 8.30e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 102 | 4.51e-01 | -4.33e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 68 | 5.37e-01 | 4.33e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 8.32e-01 | 4.33e-02 | 9.76e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 18 | 7.51e-01 | 4.33e-02 | 9.71e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 7.95e-01 | -4.33e-02 | 9.73e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 7 | 8.43e-01 | 4.32e-02 | 9.78e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 32 | 6.73e-01 | -4.32e-02 | 9.64e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 192 | 3.04e-01 | 4.32e-02 | 8.75e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 22 | 7.26e-01 | 4.31e-02 | 9.69e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 7.04e-01 | 4.31e-02 | 9.66e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 124 | 4.09e-01 | 4.31e-02 | 9.02e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 56 | 5.78e-01 | 4.30e-02 | 9.47e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 54 | 5.85e-01 | -4.30e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 9 | 8.23e-01 | 4.30e-02 | 9.76e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 53 | 5.89e-01 | 4.30e-02 | 9.50e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 8 | 8.33e-01 | -4.30e-02 | 9.76e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 29 | 6.89e-01 | 4.29e-02 | 9.64e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 9 | 8.24e-01 | -4.29e-02 | 9.76e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 22 | 7.28e-01 | 4.29e-02 | 9.69e-01 |
| GOBP PROTEOLYSIS | 1079 | 1.95e-02 | -4.29e-02 | 5.18e-01 |
| GOMF MANGANESE ION BINDING | 55 | 5.82e-01 | -4.29e-02 | 9.48e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 132 | 3.96e-01 | -4.29e-02 | 8.98e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 66 | 5.47e-01 | 4.29e-02 | 9.40e-01 |
| GOBP LACTATION | 25 | 7.11e-01 | -4.29e-02 | 9.68e-01 |
| GOBP PROTEIN METHYLATION | 67 | 5.45e-01 | 4.29e-02 | 9.40e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 8.68e-01 | -4.28e-02 | 9.83e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 74 | 5.25e-01 | -4.28e-02 | 9.36e-01 |
| GOMF CHROMATIN BINDING | 428 | 1.32e-01 | 4.28e-02 | 7.57e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 11 | 8.06e-01 | 4.28e-02 | 9.74e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 267 | 2.31e-01 | -4.28e-02 | 8.37e-01 |
| GOCC CLATHRIN VESICLE COAT | 27 | 7.01e-01 | -4.28e-02 | 9.65e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 8.06e-01 | 4.27e-02 | 9.74e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 35 | 6.62e-01 | -4.27e-02 | 9.62e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 237 | 2.59e-01 | 4.27e-02 | 8.50e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 16 | 7.67e-01 | 4.27e-02 | 9.72e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 26 | 7.06e-01 | 4.27e-02 | 9.66e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 8.69e-01 | -4.27e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 21 | 7.35e-01 | -4.26e-02 | 9.70e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 652 | 6.63e-02 | 4.26e-02 | 6.72e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 517 | 1.01e-01 | 4.26e-02 | 7.38e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 20 | 7.42e-01 | 4.26e-02 | 9.70e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 22 | 7.30e-01 | 4.26e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 273 | 2.28e-01 | 4.25e-02 | 8.34e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 6.59e-01 | 4.25e-02 | 9.62e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 43 | 6.30e-01 | -4.25e-02 | 9.58e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 70 | 5.40e-01 | -4.25e-02 | 9.40e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 18 | 7.55e-01 | -4.24e-02 | 9.72e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 40 | 6.43e-01 | 4.24e-02 | 9.59e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 8.57e-01 | 4.24e-02 | 9.81e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 67 | 5.49e-01 | 4.24e-02 | 9.40e-01 |
| GOBP EMBRYONIC CLEAVAGE | 6 | 8.58e-01 | 4.23e-02 | 9.81e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 39 | 6.48e-01 | 4.23e-02 | 9.60e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 8.58e-01 | 4.23e-02 | 9.81e-01 |
| GOBP MIDBODY ABSCISSION | 14 | 7.84e-01 | -4.22e-02 | 9.73e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 12 | 8.00e-01 | -4.22e-02 | 9.73e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 265 | 2.39e-01 | -4.22e-02 | 8.42e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 8.70e-01 | -4.22e-02 | 9.83e-01 |
| GOCC CELL BODY | 272 | 2.33e-01 | 4.22e-02 | 8.37e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 6.80e-01 | 4.22e-02 | 9.64e-01 |
| GOBP PROTEIN POLYMERIZATION | 198 | 3.08e-01 | 4.22e-02 | 8.75e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1301 | 1.25e-02 | -4.22e-02 | 4.67e-01 |
| GOBP CELL RECOGNITION | 68 | 5.49e-01 | 4.21e-02 | 9.40e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 8.71e-01 | 4.21e-02 | 9.83e-01 |
| GOBP MICROVILLUS ORGANIZATION | 18 | 7.57e-01 | 4.21e-02 | 9.72e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 18 | 7.57e-01 | -4.21e-02 | 9.72e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 242 | 2.62e-01 | 4.20e-02 | 8.51e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 23 | 7.27e-01 | 4.20e-02 | 9.69e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 16 | 7.71e-01 | 4.20e-02 | 9.73e-01 |
| GOMF APOLIPOPROTEIN BINDING | 9 | 8.27e-01 | 4.20e-02 | 9.76e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 8.59e-01 | 4.20e-02 | 9.81e-01 |
| GOCC SIDE OF MEMBRANE | 382 | 1.63e-01 | 4.19e-02 | 7.99e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 62 | 5.69e-01 | 4.19e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 28 | 7.02e-01 | 4.18e-02 | 9.65e-01 |
| GOMF CLATHRIN BINDING | 44 | 6.32e-01 | -4.18e-02 | 9.58e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 10 | 8.19e-01 | -4.18e-02 | 9.76e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 51 | 6.06e-01 | 4.18e-02 | 9.53e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 382 | 1.64e-01 | 4.18e-02 | 8.01e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1181 | 1.79e-02 | -4.18e-02 | 5.05e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 5 | 8.72e-01 | -4.17e-02 | 9.83e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 5 | 8.72e-01 | -4.17e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 13 | 7.95e-01 | 4.17e-02 | 9.73e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 17 | 7.66e-01 | 4.17e-02 | 9.72e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 8.49e-01 | -4.17e-02 | 9.80e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 70 | 5.47e-01 | -4.17e-02 | 9.40e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 6 | 8.60e-01 | -4.16e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 379 | 1.67e-01 | 4.16e-02 | 8.04e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 45 | 6.30e-01 | -4.16e-02 | 9.58e-01 |
| GOCC PHAGOCYTIC VESICLE | 123 | 4.27e-01 | 4.16e-02 | 9.13e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 88 | 5.01e-01 | 4.15e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 120 | 4.33e-01 | -4.15e-02 | 9.14e-01 |
| GOBP PLATELET AGGREGATION | 47 | 6.23e-01 | -4.14e-02 | 9.57e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 13 | 7.96e-01 | 4.14e-02 | 9.73e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 100 | 4.75e-01 | 4.14e-02 | 9.26e-01 |
| GOMF SMAD BINDING | 55 | 5.95e-01 | 4.14e-02 | 9.51e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 10 | 8.21e-01 | 4.14e-02 | 9.76e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 8 | 8.39e-01 | 4.14e-02 | 9.77e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 10 | 8.21e-01 | -4.14e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 257 | 2.56e-01 | 4.14e-02 | 8.50e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 26 | 7.15e-01 | -4.14e-02 | 9.69e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 8 | 8.40e-01 | -4.14e-02 | 9.77e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 16 | 7.75e-01 | -4.13e-02 | 9.73e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 15 | 7.82e-01 | -4.13e-02 | 9.73e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 36 | 6.68e-01 | 4.13e-02 | 9.63e-01 |
| GOCC SITE OF POLARIZED GROWTH | 111 | 4.53e-01 | 4.13e-02 | 9.21e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 41 | 6.47e-01 | -4.13e-02 | 9.60e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 15 | 7.82e-01 | -4.13e-02 | 9.73e-01 |
| GOCC PODOSOME | 23 | 7.32e-01 | 4.13e-02 | 9.70e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 11 | 8.13e-01 | -4.13e-02 | 9.75e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 33 | 6.82e-01 | 4.13e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 32 | 6.86e-01 | -4.13e-02 | 9.64e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 262 | 2.52e-01 | -4.13e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 7.27e-01 | -4.12e-02 | 9.69e-01 |
| GOBP ORGANIC ANION TRANSPORT | 213 | 3.02e-01 | 4.12e-02 | 8.74e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 256 | 2.59e-01 | 4.12e-02 | 8.50e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 120 | 4.37e-01 | -4.12e-02 | 9.14e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 57 | 5.91e-01 | 4.12e-02 | 9.51e-01 |
| GOCC CILIARY ROOTLET | 10 | 8.22e-01 | -4.11e-02 | 9.76e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 8.73e-01 | 4.11e-02 | 9.83e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 5.13e-01 | -4.11e-02 | 9.33e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 161 | 3.69e-01 | -4.11e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 77 | 5.33e-01 | -4.11e-02 | 9.40e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 7.33e-01 | -4.11e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 10 | 8.22e-01 | -4.10e-02 | 9.76e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 8.51e-01 | 4.10e-02 | 9.81e-01 |
| GOBP ANOIKIS | 26 | 7.18e-01 | -4.10e-02 | 9.69e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 5 | 8.74e-01 | 4.10e-02 | 9.83e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 8.51e-01 | -4.10e-02 | 9.81e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 8.74e-01 | 4.09e-02 | 9.83e-01 |
| GOBP REGULATION OF VESICLE FUSION | 12 | 8.06e-01 | 4.09e-02 | 9.74e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 20 | 7.51e-01 | 4.09e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 22 | 7.40e-01 | 4.09e-02 | 9.70e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 54 | 6.04e-01 | 4.09e-02 | 9.52e-01 |
| GOMF OXYGEN BINDING | 9 | 8.32e-01 | -4.08e-02 | 9.76e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 416 | 1.56e-01 | 4.08e-02 | 7.89e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 8.07e-01 | 4.08e-02 | 9.74e-01 |
| GOBP SPERM EGG RECOGNITION | 20 | 7.52e-01 | 4.08e-02 | 9.71e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 8.42e-01 | 4.07e-02 | 9.78e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 961 | 3.55e-02 | -4.07e-02 | 5.92e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 248 | 2.71e-01 | 4.07e-02 | 8.58e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 137 | 4.13e-01 | 4.06e-02 | 9.05e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 32 | 6.91e-01 | -4.06e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 159 | 3.78e-01 | -4.06e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 8.75e-01 | -4.06e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 94 | 4.97e-01 | -4.06e-02 | 9.31e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 52 | 6.13e-01 | 4.05e-02 | 9.55e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 267 | 2.57e-01 | -4.05e-02 | 8.50e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 51 | 6.17e-01 | 4.05e-02 | 9.55e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 459 | 1.40e-01 | -4.05e-02 | 7.68e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 8.53e-01 | 4.05e-02 | 9.81e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 9 | 8.34e-01 | -4.04e-02 | 9.76e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 31 | 6.98e-01 | -4.04e-02 | 9.65e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 38 | 6.67e-01 | -4.03e-02 | 9.63e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 13 | 8.01e-01 | 4.03e-02 | 9.73e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 8.76e-01 | 4.03e-02 | 9.84e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 407 | 1.66e-01 | 4.03e-02 | 8.04e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 154 | 3.90e-01 | 4.03e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 116 | 4.55e-01 | 4.03e-02 | 9.22e-01 |
| GOBP BLOOD VESSEL REMODELING | 20 | 7.55e-01 | 4.03e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 40 | 6.60e-01 | -4.03e-02 | 9.62e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 8 | 8.44e-01 | -4.02e-02 | 9.78e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 48 | 6.30e-01 | 4.02e-02 | 9.58e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 126 | 4.37e-01 | -4.02e-02 | 9.14e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 38 | 6.69e-01 | 4.02e-02 | 9.64e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 148 | 4.00e-01 | -4.01e-02 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 56 | 6.04e-01 | -4.01e-02 | 9.52e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 116 | 4.56e-01 | 4.01e-02 | 9.23e-01 |
| GOBP ECTODERM DEVELOPMENT | 13 | 8.02e-01 | 4.01e-02 | 9.73e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 21 | 7.51e-01 | 4.01e-02 | 9.71e-01 |
| GOBP GRANULOCYTE MIGRATION | 81 | 5.33e-01 | 4.01e-02 | 9.40e-01 |
| GOBP PHOSPHORYLATION | 1014 | 3.39e-02 | 4.01e-02 | 5.88e-01 |
| GOBP RECEPTOR RECYCLING | 37 | 6.73e-01 | -4.01e-02 | 9.64e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 17 | 7.75e-01 | 4.01e-02 | 9.73e-01 |
| GOBP MUSCLE ATROPHY | 5 | 8.77e-01 | 4.00e-02 | 9.84e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 13 | 8.03e-01 | -4.00e-02 | 9.73e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 39 | 6.66e-01 | -4.00e-02 | 9.63e-01 |
| GOMF AMIDE BINDING | 231 | 2.97e-01 | 4.00e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 94 | 5.04e-01 | 4.00e-02 | 9.31e-01 |
| GOBP MELANOSOME ASSEMBLY | 18 | 7.69e-01 | 3.99e-02 | 9.72e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 333 | 2.13e-01 | 3.99e-02 | 8.32e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 35 | 6.83e-01 | 3.99e-02 | 9.64e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 13 | 8.03e-01 | 3.99e-02 | 9.73e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 8.55e-01 | 3.99e-02 | 9.81e-01 |
| GOBP TORC2 SIGNALING | 14 | 7.96e-01 | -3.99e-02 | 9.73e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 8.77e-01 | -3.99e-02 | 9.84e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 24 | 7.35e-01 | -3.99e-02 | 9.70e-01 |
| GOBP CARTILAGE DEVELOPMENT | 83 | 5.31e-01 | 3.99e-02 | 9.38e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 50 | 6.26e-01 | 3.98e-02 | 9.58e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 95 | 5.03e-01 | 3.98e-02 | 9.31e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 71 | 5.62e-01 | 3.98e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 10 | 8.28e-01 | -3.98e-02 | 9.76e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 89 | 5.17e-01 | 3.98e-02 | 9.35e-01 |
| GOBP CELLULAR RESPONSE TO PH | 10 | 8.28e-01 | -3.98e-02 | 9.76e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 18 | 7.70e-01 | -3.97e-02 | 9.73e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 6 | 8.66e-01 | 3.97e-02 | 9.83e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 7.47e-01 | 3.97e-02 | 9.71e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 36 | 6.80e-01 | 3.97e-02 | 9.64e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 8.20e-01 | -3.97e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 9 | 8.37e-01 | -3.97e-02 | 9.76e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 7 | 8.56e-01 | -3.96e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 111 | 4.72e-01 | -3.96e-02 | 9.26e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 122 | 4.51e-01 | -3.96e-02 | 9.21e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 370 | 1.93e-01 | 3.96e-02 | 8.17e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 49 | 6.32e-01 | -3.96e-02 | 9.58e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 42 | 6.58e-01 | -3.96e-02 | 9.62e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 8.56e-01 | -3.95e-02 | 9.81e-01 |
| GOBP GLIAL CELL PROLIFERATION | 34 | 6.90e-01 | 3.95e-02 | 9.64e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 6 | 8.67e-01 | 3.95e-02 | 9.83e-01 |
| GOBP AMIDE METABOLIC PROCESS | 893 | 4.87e-02 | -3.95e-02 | 6.48e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 7.91e-01 | -3.95e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 72 | 5.63e-01 | 3.95e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 38 | 6.74e-01 | -3.95e-02 | 9.64e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 8.13e-01 | 3.94e-02 | 9.76e-01 |
| GOBP INFLAMMATORY RESPONSE | 498 | 1.36e-01 | 3.94e-02 | 7.62e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 67 | 5.78e-01 | -3.93e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 21 | 7.55e-01 | -3.93e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 141 | 4.22e-01 | 3.93e-02 | 9.11e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 38 | 6.75e-01 | -3.93e-02 | 9.64e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 78 | 5.49e-01 | 3.93e-02 | 9.40e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 8.14e-01 | 3.93e-02 | 9.76e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 131 | 4.39e-01 | 3.92e-02 | 9.15e-01 |
| GOBP RECEPTOR INTERNALIZATION | 81 | 5.43e-01 | -3.92e-02 | 9.40e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 23 | 7.45e-01 | -3.92e-02 | 9.70e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 22 | 7.51e-01 | 3.91e-02 | 9.71e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 14 | 8.00e-01 | 3.91e-02 | 9.73e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 19 | 7.68e-01 | -3.91e-02 | 9.72e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 81 | 5.44e-01 | -3.90e-02 | 9.40e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 45 | 6.51e-01 | 3.90e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 9 | 8.39e-01 | -3.90e-02 | 9.77e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 79 | 5.50e-01 | 3.90e-02 | 9.40e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 8.31e-01 | 3.90e-02 | 9.76e-01 |
| GOBP GLIAL CELL MIGRATION | 36 | 6.86e-01 | 3.90e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 44 | 6.55e-01 | -3.89e-02 | 9.62e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 15 | 7.94e-01 | 3.89e-02 | 9.73e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 62 | 5.96e-01 | -3.89e-02 | 9.51e-01 |
| GOBP OOCYTE MATURATION | 15 | 7.94e-01 | 3.89e-02 | 9.73e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 119 | 4.65e-01 | -3.89e-02 | 9.25e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 8.49e-01 | -3.89e-02 | 9.80e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 351 | 2.14e-01 | -3.88e-02 | 8.32e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 118 | 4.67e-01 | -3.88e-02 | 9.25e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 8.02e-01 | -3.88e-02 | 9.73e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 192 | 3.56e-01 | 3.88e-02 | 8.88e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 173 | 3.80e-01 | 3.88e-02 | 8.97e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 18 | 7.76e-01 | -3.88e-02 | 9.73e-01 |
| GOBP EOSINOPHIL MIGRATION | 8 | 8.50e-01 | -3.87e-02 | 9.80e-01 |
| GOBP LEARNING | 68 | 5.81e-01 | 3.87e-02 | 9.48e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 6 | 8.70e-01 | -3.87e-02 | 9.83e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 115 | 4.74e-01 | -3.87e-02 | 9.26e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 5 | 8.81e-01 | -3.87e-02 | 9.85e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 67 | 5.84e-01 | 3.87e-02 | 9.49e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 71 | 5.74e-01 | -3.87e-02 | 9.44e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 14 | 8.02e-01 | 3.86e-02 | 9.73e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 34 | 6.97e-01 | -3.86e-02 | 9.65e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 204 | 3.44e-01 | -3.86e-02 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 709 | 8.38e-02 | 3.86e-02 | 7.03e-01 |
| GOBP MACROAUTOPHAGY | 296 | 2.56e-01 | -3.86e-02 | 8.50e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 100 | 5.06e-01 | -3.86e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 138 | 4.35e-01 | 3.86e-02 | 9.14e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 30 | 7.15e-01 | -3.85e-02 | 9.69e-01 |
| GOBP MESENCHYME DEVELOPMENT | 142 | 4.29e-01 | 3.85e-02 | 9.14e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 64 | 5.95e-01 | -3.84e-02 | 9.51e-01 |
| GOBP APOPTOTIC PROCESS | 1237 | 2.61e-02 | -3.84e-02 | 5.51e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 8.11e-01 | 3.84e-02 | 9.75e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 31 | 7.12e-01 | 3.84e-02 | 9.68e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 176 | 3.82e-01 | 3.84e-02 | 8.97e-01 |
| GOBP NEURON MIGRATION | 87 | 5.37e-01 | 3.83e-02 | 9.40e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 121 | 4.67e-01 | -3.83e-02 | 9.25e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 15 | 7.97e-01 | -3.83e-02 | 9.73e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 87 | 5.37e-01 | 3.83e-02 | 9.40e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 10 | 8.34e-01 | 3.83e-02 | 9.76e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 7.22e-01 | 3.83e-02 | 9.69e-01 |
| GOBP PLATELET ACTIVATION | 84 | 5.45e-01 | 3.83e-02 | 9.40e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 6 | 8.71e-01 | -3.82e-02 | 9.83e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 37 | 6.87e-01 | -3.82e-02 | 9.64e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 295 | 2.61e-01 | -3.82e-02 | 8.51e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 8 | 8.52e-01 | -3.82e-02 | 9.81e-01 |
| GOBP GRANULOCYTE ACTIVATION | 36 | 6.92e-01 | -3.82e-02 | 9.64e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 9 | 8.43e-01 | -3.82e-02 | 9.78e-01 |
| GOMF SYMPORTER ACTIVITY | 65 | 5.95e-01 | 3.82e-02 | 9.51e-01 |
| GOBP ORGAN GROWTH | 82 | 5.51e-01 | 3.81e-02 | 9.40e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 17 | 7.85e-01 | -3.81e-02 | 9.73e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 36 | 6.92e-01 | 3.81e-02 | 9.64e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 113 | 4.85e-01 | -3.81e-02 | 9.29e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 84 | 5.47e-01 | 3.81e-02 | 9.40e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 59 | 6.13e-01 | 3.81e-02 | 9.55e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 259 | 2.94e-01 | -3.80e-02 | 8.71e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 30 | 7.19e-01 | 3.80e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 83 | 5.50e-01 | 3.80e-02 | 9.40e-01 |
| GOMF DAMAGED DNA BINDING | 63 | 6.02e-01 | -3.80e-02 | 9.52e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 7.10e-01 | 3.80e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 125 | 4.65e-01 | 3.80e-02 | 9.25e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 11 | 8.28e-01 | 3.79e-02 | 9.76e-01 |
| GOBP DEFENSE RESPONSE | 1067 | 3.99e-02 | 3.79e-02 | 6.15e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 861 | 6.28e-02 | -3.79e-02 | 6.68e-01 |
| GOCC SMAD PROTEIN COMPLEX | 6 | 8.72e-01 | 3.79e-02 | 9.83e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 58 | 6.18e-01 | -3.78e-02 | 9.55e-01 |
| GOBP MUSCLE CELL MIGRATION | 47 | 6.54e-01 | -3.78e-02 | 9.62e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 7 | 8.62e-01 | -3.78e-02 | 9.82e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 236 | 3.19e-01 | 3.78e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 24 | 7.49e-01 | 3.78e-02 | 9.71e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 50 | 6.44e-01 | -3.78e-02 | 9.60e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 74 | 5.75e-01 | -3.78e-02 | 9.44e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 13 | 8.14e-01 | 3.78e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 7 | 8.63e-01 | 3.77e-02 | 9.82e-01 |
| GOBP RNA CATABOLIC PROCESS | 256 | 3.01e-01 | 3.77e-02 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 8 | 8.53e-01 | -3.77e-02 | 9.81e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 8.73e-01 | -3.77e-02 | 9.83e-01 |
| GOCC SECONDARY LYSOSOME | 17 | 7.88e-01 | -3.76e-02 | 9.73e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 17 | 7.88e-01 | 3.76e-02 | 9.73e-01 |
| GOBP RRNA BASE METHYLATION | 8 | 8.54e-01 | -3.76e-02 | 9.81e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 631 | 1.11e-01 | 3.76e-02 | 7.49e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 455 | 1.73e-01 | 3.76e-02 | 8.07e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 5 | 8.84e-01 | -3.76e-02 | 9.86e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.84e-01 | -3.76e-02 | 9.86e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 11 | 8.29e-01 | 3.76e-02 | 9.76e-01 |
| GOCC SPERM MIDPIECE | 24 | 7.50e-01 | -3.76e-02 | 9.71e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 9 | 8.45e-01 | -3.75e-02 | 9.79e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 9 | 8.45e-01 | -3.75e-02 | 9.79e-01 |
| GOCC PRC1 COMPLEX | 14 | 8.08e-01 | -3.75e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 96 | 5.26e-01 | -3.75e-02 | 9.36e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 13 | 8.15e-01 | -3.75e-02 | 9.76e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 47 | 6.57e-01 | 3.75e-02 | 9.62e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 46 | 6.61e-01 | -3.74e-02 | 9.62e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 197 | 3.67e-01 | 3.74e-02 | 8.92e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 8.02e-01 | -3.74e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 5 | 8.85e-01 | 3.73e-02 | 9.86e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 101 | 5.18e-01 | -3.73e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 5 | 8.85e-01 | 3.73e-02 | 9.86e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 126 | 4.71e-01 | 3.73e-02 | 9.26e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 160 | 4.17e-01 | -3.73e-02 | 9.08e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 33 | 7.11e-01 | 3.73e-02 | 9.68e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 14 | 8.09e-01 | 3.73e-02 | 9.75e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 8.31e-01 | 3.73e-02 | 9.76e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 8.64e-01 | 3.73e-02 | 9.83e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 5 | 8.85e-01 | -3.73e-02 | 9.86e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 423 | 1.92e-01 | 3.72e-02 | 8.17e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 4.68e-01 | 3.72e-02 | 9.26e-01 |
| GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION | 5 | 8.85e-01 | 3.72e-02 | 9.86e-01 |
| GOBP DOSAGE COMPENSATION | 28 | 7.33e-01 | -3.72e-02 | 9.70e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 9 | 8.47e-01 | 3.72e-02 | 9.79e-01 |
| GOBP REGULATION OF XENOPHAGY | 8 | 8.55e-01 | -3.72e-02 | 9.81e-01 |
| GOBP CHOLESTEROL EFFLUX | 30 | 7.25e-01 | -3.71e-02 | 9.69e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 8.75e-01 | -3.71e-02 | 9.84e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 8.56e-01 | 3.71e-02 | 9.81e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 7.53e-01 | -3.71e-02 | 9.71e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 38 | 6.93e-01 | -3.71e-02 | 9.64e-01 |
| GOBP RESPONSE TO UV C | 12 | 8.24e-01 | -3.71e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 99 | 5.25e-01 | 3.71e-02 | 9.36e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 205 | 3.62e-01 | 3.70e-02 | 8.92e-01 |
| GOBP BODY MORPHOGENESIS | 27 | 7.39e-01 | -3.70e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 68 | 5.98e-01 | 3.70e-02 | 9.52e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 8.86e-01 | 3.70e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 95 | 5.34e-01 | -3.70e-02 | 9.40e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 10 | 8.40e-01 | -3.69e-02 | 9.77e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 20 | 7.75e-01 | 3.69e-02 | 9.73e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 52 | 6.46e-01 | -3.69e-02 | 9.60e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 34 | 7.10e-01 | -3.69e-02 | 9.68e-01 |
| GOCC NUCLEOID | 42 | 6.79e-01 | 3.69e-02 | 9.64e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 45 | 6.69e-01 | 3.68e-02 | 9.64e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 59 | 6.25e-01 | -3.68e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 263 | 3.07e-01 | 3.68e-02 | 8.75e-01 |
| GOCC AUTOPHAGOSOME | 100 | 5.26e-01 | -3.68e-02 | 9.36e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 8.40e-01 | -3.68e-02 | 9.77e-01 |
| GOBP ANIMAL ORGAN MATURATION | 16 | 7.99e-01 | 3.67e-02 | 9.73e-01 |
| GOBP LIPID HOMEOSTASIS | 84 | 5.61e-01 | -3.67e-02 | 9.44e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 41 | 6.85e-01 | -3.67e-02 | 9.64e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 48 | 6.61e-01 | -3.67e-02 | 9.62e-01 |
| GOCC CORVET COMPLEX | 7 | 8.67e-01 | 3.66e-02 | 9.83e-01 |
| GOCC CMG COMPLEX | 6 | 8.77e-01 | -3.66e-02 | 9.84e-01 |
| GOBP NEUROGENESIS | 868 | 7.15e-02 | 3.66e-02 | 6.78e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 127 | 4.77e-01 | -3.66e-02 | 9.26e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 470 | 1.78e-01 | -3.65e-02 | 8.07e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 39 | 6.93e-01 | 3.65e-02 | 9.64e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 37 | 7.01e-01 | -3.65e-02 | 9.65e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 9 | 8.50e-01 | 3.65e-02 | 9.81e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 38 | 6.97e-01 | 3.65e-02 | 9.65e-01 |
| GOCC KINOCILIUM | 5 | 8.88e-01 | 3.65e-02 | 9.86e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 8 | 8.58e-01 | -3.65e-02 | 9.81e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 100 | 5.29e-01 | 3.65e-02 | 9.38e-01 |
| GOCC CONDENSED CHROMOSOME | 211 | 3.63e-01 | 3.65e-02 | 8.92e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 335 | 2.54e-01 | 3.64e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 7 | 8.68e-01 | 3.64e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 6.18e-01 | 3.64e-02 | 9.55e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 40 | 6.91e-01 | -3.64e-02 | 9.64e-01 |
| GOCC GABA ERGIC SYNAPSE | 22 | 7.68e-01 | 3.64e-02 | 9.72e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 8.42e-01 | -3.64e-02 | 9.78e-01 |
| GOCC MSL COMPLEX | 5 | 8.88e-01 | 3.63e-02 | 9.86e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 199 | 3.79e-01 | 3.63e-02 | 8.97e-01 |
| GOCC VESICLE COAT | 55 | 6.42e-01 | -3.63e-02 | 9.59e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 120 | 4.93e-01 | -3.63e-02 | 9.31e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 29 | 7.35e-01 | -3.63e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 14 | 8.14e-01 | -3.62e-02 | 9.76e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 96 | 5.40e-01 | 3.62e-02 | 9.40e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 45 | 6.74e-01 | -3.62e-02 | 9.64e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 137 | 4.65e-01 | -3.62e-02 | 9.25e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 10 | 8.43e-01 | 3.62e-02 | 9.78e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 8.28e-01 | -3.62e-02 | 9.76e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 118 | 4.98e-01 | -3.62e-02 | 9.31e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 8.89e-01 | -3.62e-02 | 9.86e-01 |
| GOMF SNRNA BINDING | 45 | 6.75e-01 | 3.62e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 32 | 7.23e-01 | -3.62e-02 | 9.69e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 8.89e-01 | -3.61e-02 | 9.86e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 134 | 4.72e-01 | 3.61e-02 | 9.26e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 15 | 8.09e-01 | -3.61e-02 | 9.75e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 103 | 5.28e-01 | -3.61e-02 | 9.37e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 258 | 3.22e-01 | -3.60e-02 | 8.76e-01 |
| GOCC CCR4 NOT COMPLEX | 13 | 8.22e-01 | -3.60e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 38 | 7.01e-01 | 3.60e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 8 | 8.60e-01 | 3.60e-02 | 9.82e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 16 | 8.03e-01 | -3.60e-02 | 9.73e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 7 | 8.69e-01 | 3.60e-02 | 9.83e-01 |
| GOBP PEPTIDE TRANSPORT | 131 | 4.78e-01 | -3.60e-02 | 9.26e-01 |
| GOCC RUFFLE | 135 | 4.72e-01 | -3.59e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 367 | 2.41e-01 | -3.58e-02 | 8.43e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 24 | 7.61e-01 | 3.58e-02 | 9.72e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 89 | 5.60e-01 | 3.58e-02 | 9.44e-01 |
| GOMF HSP70 PROTEIN BINDING | 40 | 6.96e-01 | 3.58e-02 | 9.65e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 7.87e-01 | 3.58e-02 | 9.73e-01 |
| GOCC ENDOSOME MEMBRANE | 419 | 2.13e-01 | -3.57e-02 | 8.32e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.80e-01 | -3.57e-02 | 9.84e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 35 | 7.15e-01 | -3.56e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 113 | 5.14e-01 | 3.56e-02 | 9.33e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1020 | 5.88e-02 | 3.56e-02 | 6.64e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 59 | 6.36e-01 | 3.56e-02 | 9.59e-01 |
| GOCC SEX CHROMOSOME | 23 | 7.68e-01 | -3.56e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 55 | 6.48e-01 | 3.56e-02 | 9.60e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 463 | 1.93e-01 | -3.56e-02 | 8.17e-01 |
| GOCC MICROTUBULE | 293 | 2.97e-01 | 3.56e-02 | 8.71e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 6 | 8.80e-01 | -3.55e-02 | 9.85e-01 |
| GOBP SPROUTING ANGIOGENESIS | 69 | 6.10e-01 | 3.55e-02 | 9.55e-01 |
| GOCC MYOSIN COMPLEX | 24 | 7.64e-01 | -3.55e-02 | 9.72e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 27 | 7.50e-01 | 3.54e-02 | 9.71e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 34 | 7.21e-01 | 3.54e-02 | 9.69e-01 |
| GOBP GENOMIC IMPRINTING | 10 | 8.46e-01 | 3.54e-02 | 9.79e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 139 | 4.73e-01 | 3.54e-02 | 9.26e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 443 | 2.06e-01 | 3.53e-02 | 8.28e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 857 | 8.36e-02 | -3.53e-02 | 7.03e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 16 | 8.07e-01 | 3.53e-02 | 9.74e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 19 | 7.90e-01 | -3.53e-02 | 9.73e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 28 | 7.47e-01 | 3.52e-02 | 9.71e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 8.72e-01 | -3.52e-02 | 9.83e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 12 | 8.33e-01 | -3.52e-02 | 9.76e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 250 | 3.40e-01 | -3.52e-02 | 8.84e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 17 | 8.02e-01 | -3.52e-02 | 9.73e-01 |
| GOBP RECEPTOR CLUSTERING | 30 | 7.39e-01 | 3.51e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 119 | 5.09e-01 | -3.51e-02 | 9.31e-01 |
| GOBP SEX DIFFERENTIATION | 129 | 4.92e-01 | 3.51e-02 | 9.31e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 56 | 6.50e-01 | 3.51e-02 | 9.61e-01 |
| GOBP RESPONSE TO CHEMOKINE | 40 | 7.02e-01 | -3.50e-02 | 9.65e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 8 | 8.64e-01 | -3.50e-02 | 9.83e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 40 | 7.02e-01 | -3.50e-02 | 9.65e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 8.73e-01 | 3.50e-02 | 9.83e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 186 | 4.12e-01 | 3.50e-02 | 9.04e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 393 | 2.37e-01 | -3.50e-02 | 8.40e-01 |
| GOMF TRANSPORTER ACTIVITY | 606 | 1.46e-01 | -3.50e-02 | 7.77e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 113 | 5.22e-01 | -3.49e-02 | 9.35e-01 |
| GOBP STEM CELL DIFFERENTIATION | 129 | 4.95e-01 | 3.49e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 130 | 4.94e-01 | 3.48e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 8.93e-01 | 3.48e-02 | 9.87e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 87 | 5.75e-01 | -3.48e-02 | 9.45e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 196 | 4.03e-01 | -3.48e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 12 | 8.35e-01 | 3.47e-02 | 9.76e-01 |
| GOCC CELL CORTEX | 185 | 4.17e-01 | 3.47e-02 | 9.08e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 11 | 8.42e-01 | 3.46e-02 | 9.78e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 5 | 8.93e-01 | 3.46e-02 | 9.87e-01 |
| GOMF IRON ION BINDING | 67 | 6.25e-01 | 3.46e-02 | 9.57e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 123 | 5.09e-01 | -3.46e-02 | 9.31e-01 |
| GOMF KINESIN BINDING | 31 | 7.39e-01 | 3.45e-02 | 9.70e-01 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 8.29e-01 | -3.45e-02 | 9.76e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 50 | 6.73e-01 | -3.45e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 8.58e-01 | 3.45e-02 | 9.81e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 12 | 8.36e-01 | -3.45e-02 | 9.76e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 21 | 7.84e-01 | 3.45e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 14 | 8.23e-01 | -3.45e-02 | 9.76e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 13 | 8.29e-01 | -3.45e-02 | 9.76e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 28 | 7.52e-01 | -3.45e-02 | 9.71e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 9 | 8.58e-01 | -3.45e-02 | 9.81e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 157 | 4.57e-01 | 3.45e-02 | 9.23e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 6.47e-01 | 3.45e-02 | 9.60e-01 |
| GOBP AMP METABOLIC PROCESS | 16 | 8.11e-01 | 3.45e-02 | 9.75e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 17 | 8.06e-01 | 3.44e-02 | 9.74e-01 |
| GOMF STEROID BINDING | 54 | 6.62e-01 | 3.44e-02 | 9.62e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 17 | 8.06e-01 | -3.44e-02 | 9.74e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 5 | 8.94e-01 | 3.44e-02 | 9.87e-01 |
| GOBP COPPER ION TRANSPORT | 13 | 8.30e-01 | 3.43e-02 | 9.76e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 8.07e-01 | -3.43e-02 | 9.74e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 126 | 5.07e-01 | 3.43e-02 | 9.31e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 9 | 8.59e-01 | 3.43e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 29 | 7.50e-01 | 3.43e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 28 | 7.54e-01 | 3.42e-02 | 9.72e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 27 | 7.58e-01 | -3.42e-02 | 9.72e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 43 | 6.98e-01 | -3.42e-02 | 9.65e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 85 | 5.86e-01 | -3.42e-02 | 9.49e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 55 | 6.61e-01 | 3.42e-02 | 9.62e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 83 | 5.92e-01 | 3.41e-02 | 9.51e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 78 | 6.03e-01 | 3.41e-02 | 9.52e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 31 | 7.43e-01 | -3.41e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 145 | 4.80e-01 | 3.40e-02 | 9.26e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 33 | 7.35e-01 | -3.40e-02 | 9.70e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 8 | 8.68e-01 | 3.40e-02 | 9.83e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 66 | 6.33e-01 | -3.40e-02 | 9.59e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 33 | 7.36e-01 | 3.40e-02 | 9.70e-01 |
| GOCC PORE COMPLEX | 17 | 8.09e-01 | 3.40e-02 | 9.75e-01 |
| GOMF AMYLOID BETA BINDING | 53 | 6.70e-01 | -3.39e-02 | 9.64e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 15 | 8.20e-01 | -3.39e-02 | 9.76e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 49 | 6.82e-01 | 3.39e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 9 | 8.61e-01 | 3.38e-02 | 9.82e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 86 | 5.88e-01 | 3.38e-02 | 9.50e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 7.94e-01 | 3.38e-02 | 9.73e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 75 | 6.14e-01 | -3.37e-02 | 9.55e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 14 | 8.27e-01 | 3.37e-02 | 9.76e-01 |
| GOMF PRE MRNA BINDING | 30 | 7.50e-01 | -3.37e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 20 | 7.94e-01 | 3.37e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 39 | 7.17e-01 | -3.36e-02 | 9.69e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 856 | 9.98e-02 | 3.36e-02 | 7.36e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 332 | 2.95e-01 | 3.36e-02 | 8.71e-01 |
| GOBP GLIAL CELL ACTIVATION | 36 | 7.27e-01 | -3.36e-02 | 9.69e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 7.72e-01 | 3.36e-02 | 9.73e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 8.28e-01 | -3.36e-02 | 9.76e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 8 | 8.69e-01 | -3.36e-02 | 9.83e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 229 | 3.83e-01 | -3.36e-02 | 8.97e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 7.85e-01 | 3.35e-02 | 9.73e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 7 | 8.78e-01 | 3.35e-02 | 9.84e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 8.34e-01 | -3.35e-02 | 9.76e-01 |
| GOMF INTEGRIN BINDING | 66 | 6.38e-01 | -3.35e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 8.87e-01 | -3.35e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 9 | 8.62e-01 | -3.35e-02 | 9.82e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 5 | 8.97e-01 | 3.35e-02 | 9.88e-01 |
| GOMF GTPASE ACTIVITY | 229 | 3.85e-01 | -3.35e-02 | 8.97e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 34 | 7.36e-01 | 3.34e-02 | 9.70e-01 |
| GOBP REPRODUCTION | 700 | 1.36e-01 | 3.34e-02 | 7.62e-01 |
| GOBP PROTEIN MATURATION | 371 | 2.72e-01 | 3.34e-02 | 8.58e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 8 | 8.70e-01 | -3.34e-02 | 9.83e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 15 | 8.23e-01 | -3.34e-02 | 9.76e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 502 | 2.05e-01 | 3.34e-02 | 8.28e-01 |
| GOBP IMPORT INTO CELL | 557 | 1.83e-01 | 3.33e-02 | 8.07e-01 |
| GOBP MRNA PROCESSING | 424 | 2.42e-01 | -3.33e-02 | 8.44e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 23 | 7.82e-01 | -3.33e-02 | 9.73e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 101 | 5.64e-01 | -3.33e-02 | 9.44e-01 |
| GOBP RESPONSE TO LEUCINE | 13 | 8.35e-01 | 3.33e-02 | 9.76e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 36 | 7.30e-01 | -3.32e-02 | 9.70e-01 |
| GOCC A BAND | 15 | 8.24e-01 | 3.32e-02 | 9.76e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 79 | 6.11e-01 | -3.31e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 13 | 8.36e-01 | 3.31e-02 | 9.76e-01 |
| GOBP REGULATION OF PIGMENTATION | 10 | 8.56e-01 | 3.31e-02 | 9.81e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 8.56e-01 | -3.31e-02 | 9.81e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 66 | 6.42e-01 | -3.31e-02 | 9.59e-01 |
| GOMF OXYSTEROL BINDING | 6 | 8.88e-01 | 3.31e-02 | 9.86e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 17 | 8.13e-01 | -3.31e-02 | 9.76e-01 |
| GOCC PML BODY | 97 | 5.74e-01 | 3.31e-02 | 9.44e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 118 | 5.36e-01 | -3.31e-02 | 9.40e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 37 | 7.28e-01 | 3.30e-02 | 9.70e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 8.43e-01 | -3.30e-02 | 9.78e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 693 | 1.43e-01 | 3.30e-02 | 7.75e-01 |
| GOBP AMINE TRANSPORT | 36 | 7.32e-01 | 3.30e-02 | 9.70e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 61 | 6.56e-01 | 3.30e-02 | 9.62e-01 |
| GOBP RESPONSE TO STARVATION | 159 | 4.75e-01 | 3.29e-02 | 9.26e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 38 | 7.26e-01 | 3.29e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 84 | 6.03e-01 | -3.28e-02 | 9.52e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 21 | 7.95e-01 | 3.28e-02 | 9.73e-01 |
| GOBP EXOCYTIC PROCESS | 58 | 6.66e-01 | 3.28e-02 | 9.63e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 5 | 8.99e-01 | -3.27e-02 | 9.88e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 8.51e-01 | -3.27e-02 | 9.81e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 207 | 4.20e-01 | -3.26e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 415 | 2.58e-01 | 3.26e-02 | 8.50e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 70 | 6.38e-01 | 3.26e-02 | 9.59e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 995 | 8.76e-02 | -3.26e-02 | 7.11e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 45 | 7.06e-01 | 3.25e-02 | 9.66e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 20 | 8.01e-01 | -3.25e-02 | 9.73e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 7.58e-01 | -3.25e-02 | 9.72e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 120 | 5.41e-01 | -3.24e-02 | 9.40e-01 |
| GOBP GROOMING BEHAVIOR | 5 | 9.00e-01 | 3.24e-02 | 9.88e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 114 | 5.51e-01 | 3.24e-02 | 9.40e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 46 | 7.04e-01 | 3.24e-02 | 9.66e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 6 | 8.91e-01 | -3.23e-02 | 9.87e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 37 | 7.34e-01 | -3.23e-02 | 9.70e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 7 | 8.82e-01 | -3.23e-02 | 9.86e-01 |
| GOMF CYCLIN BINDING | 22 | 7.93e-01 | 3.23e-02 | 9.73e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 33 | 7.48e-01 | -3.23e-02 | 9.71e-01 |
| GOCC PLASMA MEMBRANE REGION | 599 | 1.82e-01 | 3.23e-02 | 8.07e-01 |
| GOCC ENVELOPE | 1025 | 8.64e-02 | -3.22e-02 | 7.11e-01 |
| GOMF GAMMA TUBULIN BINDING | 27 | 7.72e-01 | 3.22e-02 | 9.73e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 116 | 5.50e-01 | -3.22e-02 | 9.40e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 55 | 6.80e-01 | 3.22e-02 | 9.64e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 115 | 5.52e-01 | 3.22e-02 | 9.40e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 70 | 6.42e-01 | -3.22e-02 | 9.59e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 9.01e-01 | -3.22e-02 | 9.88e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 414 | 2.65e-01 | -3.22e-02 | 8.52e-01 |
| GOCC TRANS GOLGI NETWORK | 202 | 4.32e-01 | -3.22e-02 | 9.14e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 119 | 5.46e-01 | -3.21e-02 | 9.40e-01 |
| GOMF CYTOKINE ACTIVITY | 59 | 6.70e-01 | -3.21e-02 | 9.64e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 29 | 7.65e-01 | -3.21e-02 | 9.72e-01 |
| GOMF MIRNA BINDING | 32 | 7.54e-01 | -3.21e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 50 | 6.96e-01 | 3.20e-02 | 9.65e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 17 | 8.19e-01 | -3.20e-02 | 9.76e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 10 | 8.61e-01 | 3.20e-02 | 9.82e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 11 | 8.54e-01 | 3.20e-02 | 9.81e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 31 | 7.58e-01 | -3.19e-02 | 9.72e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 50 | 6.96e-01 | -3.19e-02 | 9.65e-01 |
| GOBP CHROMATIN REMODELING | 467 | 2.42e-01 | 3.18e-02 | 8.43e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 29 | 7.67e-01 | 3.18e-02 | 9.72e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 52 | 6.92e-01 | 3.18e-02 | 9.64e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 30 | 7.63e-01 | 3.18e-02 | 9.72e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.93e-01 | -3.18e-02 | 9.87e-01 |
| GOBP VIRAL TRANSCRIPTION | 45 | 7.12e-01 | 3.18e-02 | 9.68e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 8.76e-01 | 3.18e-02 | 9.84e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 450 | 2.51e-01 | -3.18e-02 | 8.50e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 11 | 8.55e-01 | -3.18e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 53 | 6.89e-01 | -3.18e-02 | 9.64e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 227 | 4.12e-01 | 3.17e-02 | 9.04e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 208 | 4.32e-01 | 3.17e-02 | 9.14e-01 |
| GOBP GOLGI ORGANIZATION | 122 | 5.46e-01 | -3.17e-02 | 9.40e-01 |
| GOMF MANNOSE BINDING | 15 | 8.32e-01 | 3.17e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 362 | 3.04e-01 | 3.17e-02 | 8.75e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 8.69e-01 | -3.16e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 44 | 7.17e-01 | 3.16e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 84 | 6.17e-01 | -3.16e-02 | 9.55e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 64 | 6.63e-01 | 3.16e-02 | 9.62e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 890 | 1.16e-01 | 3.16e-02 | 7.52e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 76 | 6.35e-01 | -3.16e-02 | 9.59e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 8 | 8.77e-01 | -3.15e-02 | 9.84e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 214 | 4.29e-01 | -3.15e-02 | 9.14e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 8 | 8.77e-01 | 3.15e-02 | 9.84e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 723 | 1.55e-01 | 3.15e-02 | 7.89e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 7 | 8.85e-01 | -3.14e-02 | 9.86e-01 |
| GOMF MAGNESIUM ION BINDING | 163 | 4.90e-01 | 3.14e-02 | 9.30e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 8.86e-01 | 3.14e-02 | 9.86e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 32 | 7.59e-01 | -3.14e-02 | 9.72e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 8.78e-01 | -3.14e-02 | 9.84e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 116 | 5.61e-01 | -3.13e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 10 | 8.64e-01 | -3.13e-02 | 9.83e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 16 | 8.28e-01 | 3.13e-02 | 9.76e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 8 | 8.78e-01 | -3.13e-02 | 9.84e-01 |
| GOCC OUTER MEMBRANE | 197 | 4.51e-01 | -3.13e-02 | 9.21e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 23 | 7.95e-01 | -3.12e-02 | 9.73e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 30 | 7.68e-01 | -3.11e-02 | 9.72e-01 |
| GOBP VACUOLAR TRANSPORT | 142 | 5.23e-01 | -3.11e-02 | 9.35e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 7 | 8.87e-01 | -3.11e-02 | 9.86e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 49 | 7.07e-01 | 3.11e-02 | 9.66e-01 |
| GOCC WASH COMPLEX | 9 | 8.72e-01 | -3.10e-02 | 9.83e-01 |
| GOCC INO80 COMPLEX | 15 | 8.36e-01 | 3.10e-02 | 9.76e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 15 | 8.36e-01 | 3.09e-02 | 9.76e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 384 | 3.02e-01 | 3.09e-02 | 8.74e-01 |
| GOBP SPINDLE ORGANIZATION | 159 | 5.03e-01 | -3.09e-02 | 9.31e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 8 | 8.80e-01 | 3.08e-02 | 9.84e-01 |
| GOBP CHROMOSOME LOCALIZATION | 86 | 6.22e-01 | 3.08e-02 | 9.55e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 8.60e-01 | 3.08e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 33 | 7.60e-01 | -3.08e-02 | 9.72e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 20 | 8.12e-01 | -3.08e-02 | 9.75e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 8.88e-01 | -3.07e-02 | 9.86e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 466 | 2.59e-01 | 3.07e-02 | 8.50e-01 |
| GOCC ATAC COMPLEX | 13 | 8.48e-01 | -3.07e-02 | 9.80e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 228 | 4.26e-01 | 3.07e-02 | 9.13e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 22 | 8.04e-01 | -3.07e-02 | 9.73e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 24 | 7.95e-01 | 3.06e-02 | 9.73e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 57 | 6.90e-01 | -3.06e-02 | 9.64e-01 |
| GOBP NEUTROPHIL MIGRATION | 67 | 6.66e-01 | 3.06e-02 | 9.63e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 8 | 8.81e-01 | 3.05e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 78 | 6.42e-01 | -3.05e-02 | 9.59e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 8.97e-01 | -3.04e-02 | 9.88e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 225 | 4.33e-01 | 3.04e-02 | 9.14e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 81 | 6.37e-01 | -3.04e-02 | 9.59e-01 |
| GOBP INNATE IMMUNE RESPONSE | 628 | 1.99e-01 | 3.04e-02 | 8.23e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 8.98e-01 | -3.04e-02 | 9.88e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 155 | 5.16e-01 | 3.03e-02 | 9.34e-01 |
| GOBP GAMETE GENERATION | 373 | 3.18e-01 | 3.03e-02 | 8.76e-01 |
| GOBP DEPHOSPHORYLATION | 220 | 4.40e-01 | 3.03e-02 | 9.15e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 196 | 4.66e-01 | 3.03e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 84 | 6.32e-01 | 3.03e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 6 | 8.98e-01 | 3.03e-02 | 9.88e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 6 | 8.98e-01 | 3.02e-02 | 9.88e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 55 | 6.98e-01 | -3.02e-02 | 9.65e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 16 | 8.34e-01 | 3.02e-02 | 9.76e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 8.50e-01 | 3.02e-02 | 9.81e-01 |
| GOBP OOCYTE DIFFERENTIATION | 29 | 7.78e-01 | 3.02e-02 | 9.73e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 68 | 6.68e-01 | -3.01e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 58 | 6.92e-01 | 3.01e-02 | 9.64e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 8.63e-01 | -3.01e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 60 | 6.87e-01 | 3.01e-02 | 9.64e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 109 | 5.88e-01 | 3.01e-02 | 9.50e-01 |
| GOBP NADP METABOLIC PROCESS | 33 | 7.65e-01 | -3.01e-02 | 9.72e-01 |
| GOBP RESPONSE TO ETHER | 9 | 8.76e-01 | 3.01e-02 | 9.84e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 23 | 8.03e-01 | 3.01e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 70 | 6.64e-01 | -3.00e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 8.91e-01 | -3.00e-02 | 9.87e-01 |
| GOBP MEMBRANE ORGANIZATION | 584 | 2.20e-01 | -3.00e-02 | 8.32e-01 |
| GOMF PEPTIDE BINDING | 178 | 4.93e-01 | 2.99e-02 | 9.31e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 691 | 1.86e-01 | -2.99e-02 | 8.11e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 47 | 7.23e-01 | 2.99e-02 | 9.69e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 332 | 3.52e-01 | 2.99e-02 | 8.88e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 10 | 8.70e-01 | -2.98e-02 | 9.83e-01 |
| GOBP PHAGOCYTOSIS | 166 | 5.09e-01 | 2.98e-02 | 9.31e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 139 | 5.45e-01 | 2.98e-02 | 9.40e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 61 | 6.88e-01 | 2.98e-02 | 9.64e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 231 | 4.38e-01 | -2.97e-02 | 9.15e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 12 | 8.59e-01 | 2.97e-02 | 9.81e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 7 | 8.92e-01 | 2.97e-02 | 9.87e-01 |
| GOCC P BODY | 85 | 6.36e-01 | 2.97e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1032 | 1.13e-01 | -2.97e-02 | 7.51e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 137 | 5.49e-01 | -2.97e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 24 | 8.01e-01 | -2.97e-02 | 9.73e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 62 | 6.86e-01 | 2.97e-02 | 9.64e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 312 | 3.70e-01 | 2.97e-02 | 8.92e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 8.92e-01 | -2.97e-02 | 9.87e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 68 | 6.73e-01 | 2.96e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 32 | 7.72e-01 | -2.96e-02 | 9.73e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 14 | 8.48e-01 | -2.96e-02 | 9.80e-01 |
| GOBP FERTILIZATION | 74 | 6.60e-01 | 2.96e-02 | 9.62e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 436 | 2.93e-01 | 2.96e-02 | 8.70e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 30 | 7.79e-01 | -2.96e-02 | 9.73e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 8 | 8.85e-01 | 2.96e-02 | 9.86e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 125 | 5.69e-01 | 2.95e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 62 | 6.88e-01 | -2.95e-02 | 9.64e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 44 | 7.35e-01 | 2.95e-02 | 9.70e-01 |
| GOBP RESPONSE TO ISCHEMIA | 40 | 7.47e-01 | -2.95e-02 | 9.71e-01 |
| GOBP VASODILATION | 20 | 8.19e-01 | 2.95e-02 | 9.76e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 24 | 8.03e-01 | 2.95e-02 | 9.73e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 9.09e-01 | 2.95e-02 | 9.91e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 60 | 6.94e-01 | 2.94e-02 | 9.64e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 189 | 4.87e-01 | 2.94e-02 | 9.30e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 192 | 4.83e-01 | -2.94e-02 | 9.28e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 19 | 8.24e-01 | -2.94e-02 | 9.76e-01 |
| GOBP REACTIVE GLIOSIS | 5 | 9.09e-01 | -2.94e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 16 | 8.39e-01 | 2.94e-02 | 9.77e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 42 | 7.42e-01 | 2.94e-02 | 9.70e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 22 | 8.12e-01 | 2.93e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 72 | 6.67e-01 | -2.93e-02 | 9.63e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 18 | 8.30e-01 | -2.93e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 250 | 4.27e-01 | 2.93e-02 | 9.13e-01 |
| GOCC ENDOSOME | 745 | 1.79e-01 | -2.93e-02 | 8.07e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 26 | 7.96e-01 | -2.93e-02 | 9.73e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 24 | 8.04e-01 | -2.93e-02 | 9.73e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 389 | 3.25e-01 | 2.92e-02 | 8.76e-01 |
| GOCC CYTOPLASMIC REGION | 147 | 5.42e-01 | 2.92e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 190 | 4.89e-01 | 2.92e-02 | 9.30e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 312 | 3.77e-01 | 2.92e-02 | 8.97e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 241 | 4.37e-01 | -2.92e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 10 | 8.73e-01 | 2.92e-02 | 9.83e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 98 | 6.19e-01 | -2.92e-02 | 9.55e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 759 | 1.77e-01 | 2.91e-02 | 8.07e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 222 | 4.56e-01 | 2.91e-02 | 9.23e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 9 | 8.80e-01 | 2.91e-02 | 9.84e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 35 | 7.66e-01 | -2.91e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 15 | 8.46e-01 | -2.91e-02 | 9.79e-01 |
| GOMF ZINC ION BINDING | 535 | 2.55e-01 | 2.91e-02 | 8.50e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 8.68e-01 | -2.89e-02 | 9.83e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 9.02e-01 | -2.89e-02 | 9.89e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 9 | 8.81e-01 | 2.89e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 308 | 3.86e-01 | 2.89e-02 | 8.97e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 17 | 8.37e-01 | 2.88e-02 | 9.76e-01 |
| GOBP PHOTOPERIODISM | 21 | 8.19e-01 | -2.88e-02 | 9.76e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 72 | 6.73e-01 | 2.88e-02 | 9.64e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 52 | 7.20e-01 | -2.88e-02 | 9.69e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 11 | 8.69e-01 | 2.88e-02 | 9.83e-01 |
| GOCC CELL SURFACE | 411 | 3.21e-01 | 2.88e-02 | 8.76e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 295 | 3.98e-01 | 2.87e-02 | 8.98e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 32 | 7.79e-01 | 2.87e-02 | 9.73e-01 |
| GOCC NUCLEAR CHROMOSOME | 174 | 5.15e-01 | 2.87e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 103 | 6.15e-01 | -2.87e-02 | 9.55e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 430 | 3.11e-01 | -2.87e-02 | 8.76e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 46 | 7.37e-01 | 2.87e-02 | 9.70e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 13 | 8.58e-01 | 2.87e-02 | 9.81e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 55 | 7.13e-01 | -2.87e-02 | 9.68e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 7.66e-01 | -2.86e-02 | 9.72e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 133 | 5.70e-01 | 2.86e-02 | 9.44e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 8.05e-01 | -2.86e-02 | 9.74e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 8.17e-01 | -2.86e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 283 | 4.11e-01 | 2.85e-02 | 9.04e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 5 | 9.12e-01 | 2.85e-02 | 9.91e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 11 | 8.70e-01 | -2.85e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 69 | 6.83e-01 | 2.85e-02 | 9.64e-01 |
| GOBP FAT CELL DIFFERENTIATION | 142 | 5.59e-01 | -2.84e-02 | 9.44e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 17 | 8.39e-01 | 2.84e-02 | 9.77e-01 |
| GOCC VARICOSITY | 5 | 9.12e-01 | 2.84e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 53 | 7.21e-01 | 2.84e-02 | 9.69e-01 |
| GOBP ACROSOME REACTION | 12 | 8.65e-01 | 2.84e-02 | 9.83e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 144 | 5.58e-01 | -2.83e-02 | 9.44e-01 |
| GOBP VESICLE TETHERING | 32 | 7.82e-01 | -2.83e-02 | 9.73e-01 |
| GOBP GOLGI DISASSEMBLY | 5 | 9.13e-01 | -2.83e-02 | 9.91e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 63 | 6.98e-01 | 2.83e-02 | 9.65e-01 |
| GOCC MALE GERM CELL NUCLEUS | 33 | 7.79e-01 | 2.83e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 145 | 5.58e-01 | 2.83e-02 | 9.44e-01 |
| GOBP PROTEIN HYDROXYLATION | 18 | 8.36e-01 | -2.83e-02 | 9.76e-01 |
| GOCC MULTIVESICULAR BODY | 39 | 7.61e-01 | -2.82e-02 | 9.72e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 160 | 5.39e-01 | 2.82e-02 | 9.40e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 9.13e-01 | 2.82e-02 | 9.91e-01 |
| GOMF LAMININ BINDING | 12 | 8.66e-01 | -2.82e-02 | 9.83e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 9.13e-01 | 2.81e-02 | 9.91e-01 |
| GOBP DNA STRAND ELONGATION | 35 | 7.74e-01 | -2.81e-02 | 9.73e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 131 | 5.79e-01 | -2.81e-02 | 9.48e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 11 | 8.72e-01 | -2.81e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 27 | 8.01e-01 | -2.81e-02 | 9.73e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 418 | 3.28e-01 | 2.81e-02 | 8.76e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 147 | 5.58e-01 | -2.81e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 35 | 7.74e-01 | 2.81e-02 | 9.73e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 79 | 6.67e-01 | -2.81e-02 | 9.63e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 12 | 8.66e-01 | -2.80e-02 | 9.83e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 22 | 8.20e-01 | 2.80e-02 | 9.76e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 28 | 7.97e-01 | -2.80e-02 | 9.73e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 683 | 2.17e-01 | -2.80e-02 | 8.32e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 15 | 8.51e-01 | -2.80e-02 | 9.81e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 572 | 2.57e-01 | 2.80e-02 | 8.50e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 21 | 8.24e-01 | -2.80e-02 | 9.76e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 83 | 6.60e-01 | 2.80e-02 | 9.62e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 6 | 9.06e-01 | -2.79e-02 | 9.90e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 81 | 6.65e-01 | -2.79e-02 | 9.63e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 126 | 5.90e-01 | -2.78e-02 | 9.51e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 29 | 7.95e-01 | 2.78e-02 | 9.73e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 943 | 1.54e-01 | 2.78e-02 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 30 | 7.92e-01 | 2.78e-02 | 9.73e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 133 | 5.81e-01 | 2.78e-02 | 9.48e-01 |
| GOCC DESMOSOME | 10 | 8.79e-01 | 2.78e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 68 | 6.93e-01 | -2.78e-02 | 9.64e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 112 | 6.13e-01 | -2.78e-02 | 9.55e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 35 | 7.77e-01 | 2.77e-02 | 9.73e-01 |
| GOBP ODONTOGENESIS | 45 | 7.48e-01 | -2.77e-02 | 9.71e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 195 | 5.06e-01 | -2.77e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 9 | 8.86e-01 | -2.77e-02 | 9.86e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 64 | 7.02e-01 | -2.76e-02 | 9.65e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 7 | 8.99e-01 | -2.76e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 8 | 8.92e-01 | 2.76e-02 | 9.87e-01 |
| GOMF P53 BINDING | 54 | 7.26e-01 | 2.76e-02 | 9.69e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 181 | 5.24e-01 | 2.76e-02 | 9.35e-01 |
| GOBP CELL ACTIVATION | 765 | 2.01e-01 | 2.76e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 468 | 3.11e-01 | 2.76e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 70 | 6.91e-01 | -2.75e-02 | 9.64e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 8.59e-01 | 2.75e-02 | 9.81e-01 |
| GOMF STEROL BINDING | 41 | 7.61e-01 | -2.75e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 811 | 1.90e-01 | 2.74e-02 | 8.15e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 47 | 7.45e-01 | 2.74e-02 | 9.70e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 28 | 8.02e-01 | -2.74e-02 | 9.73e-01 |
| GOBP CELL ADHESION | 746 | 2.08e-01 | 2.74e-02 | 8.30e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 9.00e-01 | 2.74e-02 | 9.88e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 122 | 6.02e-01 | -2.74e-02 | 9.52e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 165 | 5.45e-01 | 2.74e-02 | 9.40e-01 |
| GOBP ENDOSOMAL TRANSPORT | 206 | 5.00e-01 | -2.74e-02 | 9.31e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 69 | 6.95e-01 | 2.73e-02 | 9.65e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 683 | 2.29e-01 | 2.73e-02 | 8.34e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 47 | 7.46e-01 | 2.73e-02 | 9.71e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 68 | 6.98e-01 | -2.73e-02 | 9.65e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 49 | 7.42e-01 | -2.73e-02 | 9.70e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 142 | 5.76e-01 | 2.72e-02 | 9.46e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 453 | 3.25e-01 | 2.72e-02 | 8.76e-01 |
| GOBP REGULATION OF AXON EXTENSION | 49 | 7.42e-01 | 2.72e-02 | 9.70e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 59 | 7.19e-01 | -2.71e-02 | 9.69e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 5 | 9.16e-01 | -2.71e-02 | 9.92e-01 |
| GOBP RESPONSE TO TUMOR CELL | 33 | 7.88e-01 | 2.71e-02 | 9.73e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 30 | 7.97e-01 | 2.71e-02 | 9.73e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 7.67e-01 | -2.71e-02 | 9.72e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 11 | 8.77e-01 | 2.70e-02 | 9.84e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 9.17e-01 | 2.70e-02 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 32 | 7.92e-01 | -2.70e-02 | 9.73e-01 |
| GOCC CHROMOSOME | 1216 | 1.21e-01 | 2.70e-02 | 7.52e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 8.61e-01 | -2.70e-02 | 9.82e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 8.72e-01 | 2.70e-02 | 9.83e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 15 | 8.57e-01 | 2.70e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 9.17e-01 | -2.70e-02 | 9.92e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 8.72e-01 | 2.69e-02 | 9.83e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 239 | 4.75e-01 | -2.69e-02 | 9.26e-01 |
| GOBP CAMP MEDIATED SIGNALING | 21 | 8.31e-01 | -2.69e-02 | 9.76e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 121 | 6.10e-01 | -2.69e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 15 | 8.57e-01 | 2.69e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 110 | 6.28e-01 | 2.68e-02 | 9.58e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 24 | 8.20e-01 | -2.68e-02 | 9.76e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 22 | 8.28e-01 | 2.68e-02 | 9.76e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 19 | 8.40e-01 | 2.68e-02 | 9.77e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 657 | 2.48e-01 | 2.67e-02 | 8.49e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 38 | 7.76e-01 | 2.67e-02 | 9.73e-01 |
| GOCC CORTICAL CYTOSKELETON | 58 | 7.25e-01 | 2.67e-02 | 9.69e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 236 | 4.82e-01 | 2.67e-02 | 9.27e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 92 | 6.59e-01 | 2.66e-02 | 9.62e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 26 | 8.14e-01 | -2.66e-02 | 9.76e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 150 | 5.77e-01 | 2.65e-02 | 9.47e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 38 | 7.78e-01 | 2.64e-02 | 9.73e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 14 | 8.64e-01 | -2.64e-02 | 9.83e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 47 | 7.54e-01 | 2.64e-02 | 9.72e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 855 | 1.97e-01 | 2.64e-02 | 8.22e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 440 | 3.47e-01 | 2.64e-02 | 8.87e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 8.03e-01 | 2.63e-02 | 9.73e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 16 | 8.55e-01 | 2.63e-02 | 9.81e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 346 | 4.03e-01 | 2.63e-02 | 8.99e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 231 | 4.93e-01 | 2.63e-02 | 9.31e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 73 | 6.98e-01 | 2.63e-02 | 9.65e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 442 | 3.47e-01 | 2.63e-02 | 8.87e-01 |
| GOCC PHOSPHATASE COMPLEX | 46 | 7.58e-01 | -2.63e-02 | 9.72e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 8.24e-01 | -2.62e-02 | 9.76e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 33 | 7.94e-01 | -2.62e-02 | 9.73e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 9 | 8.92e-01 | -2.62e-02 | 9.87e-01 |
| GOCC VACUOLAR MEMBRANE | 393 | 3.76e-01 | -2.62e-02 | 8.97e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 401 | 3.72e-01 | 2.61e-02 | 8.95e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 22 | 8.32e-01 | -2.61e-02 | 9.76e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 11 | 8.81e-01 | 2.61e-02 | 9.85e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 16 | 8.57e-01 | -2.61e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 8.52e-01 | 2.61e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 30 | 8.05e-01 | -2.61e-02 | 9.74e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 782 | 2.22e-01 | 2.60e-02 | 8.32e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 21 | 8.37e-01 | -2.60e-02 | 9.76e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 20 | 8.41e-01 | -2.60e-02 | 9.78e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 7 | 9.05e-01 | -2.59e-02 | 9.90e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 83 | 6.84e-01 | -2.59e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 755 | 2.32e-01 | 2.59e-02 | 8.37e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 10 | 8.87e-01 | -2.59e-02 | 9.86e-01 |
| GOBP REGULATION OF BINDING | 184 | 5.46e-01 | -2.59e-02 | 9.40e-01 |
| GOCC ATPASE COMPLEX | 131 | 6.09e-01 | 2.59e-02 | 9.55e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 62 | 7.25e-01 | 2.59e-02 | 9.69e-01 |
| GOCC LYSOSOMAL LUMEN | 63 | 7.23e-01 | 2.59e-02 | 9.69e-01 |
| GOBP VASCULATURE DEVELOPMENT | 381 | 3.89e-01 | 2.58e-02 | 8.97e-01 |
| GOMF HSP90 PROTEIN BINDING | 31 | 8.04e-01 | 2.58e-02 | 9.73e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 50 | 7.53e-01 | -2.58e-02 | 9.71e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 75 | 7.00e-01 | 2.58e-02 | 9.65e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 8.42e-01 | 2.58e-02 | 9.78e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 38 | 7.84e-01 | -2.57e-02 | 9.73e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 826 | 2.15e-01 | -2.57e-02 | 8.32e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 9.21e-01 | -2.57e-02 | 9.92e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 15 | 8.63e-01 | 2.57e-02 | 9.82e-01 |
| GOMF NUCLEOSIDE BINDING | 7 | 9.06e-01 | -2.57e-02 | 9.90e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 14 | 8.68e-01 | 2.57e-02 | 9.83e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 46 | 7.63e-01 | 2.57e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 12 | 8.78e-01 | 2.57e-02 | 9.84e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 7 | 9.07e-01 | 2.56e-02 | 9.90e-01 |
| GOMF POTASSIUM ION BINDING | 7 | 9.07e-01 | 2.56e-02 | 9.90e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 387 | 3.90e-01 | 2.56e-02 | 8.97e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 25 | 8.25e-01 | 2.56e-02 | 9.76e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 29 | 8.12e-01 | -2.56e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 13 | 8.73e-01 | 2.56e-02 | 9.83e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 25 | 8.25e-01 | 2.56e-02 | 9.76e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 6 | 9.14e-01 | -2.56e-02 | 9.91e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 166 | 5.71e-01 | 2.56e-02 | 9.44e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 27 | 8.19e-01 | -2.55e-02 | 9.76e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 7.05e-01 | 2.55e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 411 | 3.79e-01 | 2.55e-02 | 8.97e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 28 | 8.16e-01 | -2.55e-02 | 9.76e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 505 | 3.31e-01 | 2.55e-02 | 8.79e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 8.69e-01 | 2.54e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 31 | 8.07e-01 | -2.54e-02 | 9.74e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 22 | 8.37e-01 | -2.54e-02 | 9.76e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 19 | 8.48e-01 | 2.53e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 9.22e-01 | 2.53e-02 | 9.92e-01 |
| GOBP REGULATION OF TRANSPORT | 970 | 1.89e-01 | 2.53e-02 | 8.14e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 8.45e-01 | 2.53e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 11 | 8.85e-01 | -2.53e-02 | 9.86e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 75 | 7.05e-01 | 2.53e-02 | 9.66e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 9.15e-01 | -2.53e-02 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 24 | 8.31e-01 | 2.52e-02 | 9.76e-01 |
| GOBP MEMBRANE FUSION | 123 | 6.30e-01 | 2.52e-02 | 9.58e-01 |
| GOBP TOR SIGNALING | 135 | 6.14e-01 | -2.52e-02 | 9.55e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 8.96e-01 | -2.52e-02 | 9.88e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 33 | 8.02e-01 | -2.52e-02 | 9.73e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 27 | 8.21e-01 | 2.52e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 12 | 8.80e-01 | 2.52e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 8.62e-01 | -2.52e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 26 | 8.24e-01 | -2.52e-02 | 9.76e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 7 | 9.08e-01 | 2.52e-02 | 9.90e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 35 | 7.97e-01 | 2.51e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 590 | 3.02e-01 | 2.51e-02 | 8.74e-01 |
| GOBP VIRAL BUDDING | 23 | 8.35e-01 | 2.51e-02 | 9.76e-01 |
| GOMF ANNEALING ACTIVITY | 8 | 9.02e-01 | 2.51e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 455 | 3.63e-01 | 2.51e-02 | 8.92e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 22 | 8.39e-01 | -2.50e-02 | 9.77e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 116 | 6.42e-01 | 2.50e-02 | 9.59e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 338 | 4.32e-01 | 2.50e-02 | 9.14e-01 |
| GOBP T CELL PROLIFERATION | 147 | 6.02e-01 | 2.50e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 9 | 8.97e-01 | 2.50e-02 | 9.88e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 390 | 4.00e-01 | 2.50e-02 | 8.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 47 | 7.68e-01 | -2.49e-02 | 9.72e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 24 | 8.33e-01 | -2.49e-02 | 9.76e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 43 | 7.78e-01 | -2.49e-02 | 9.73e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 8.72e-01 | -2.49e-02 | 9.83e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 300 | 4.61e-01 | 2.49e-02 | 9.25e-01 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 8.51e-01 | -2.48e-02 | 9.81e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 126 | 6.31e-01 | 2.48e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 159 | 5.90e-01 | 2.48e-02 | 9.51e-01 |
| GOBP RENAL ABSORPTION | 14 | 8.73e-01 | 2.48e-02 | 9.83e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 15 | 8.68e-01 | 2.48e-02 | 9.83e-01 |
| GOBP RESPONSE TO FATTY ACID | 33 | 8.06e-01 | 2.47e-02 | 9.74e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 78 | 7.07e-01 | 2.47e-02 | 9.66e-01 |
| GOBP SENSORY PERCEPTION | 177 | 5.73e-01 | 2.46e-02 | 9.44e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 97 | 6.76e-01 | 2.46e-02 | 9.64e-01 |
| GOBP RESPONSE TO AXON INJURY | 38 | 7.93e-01 | -2.46e-02 | 9.73e-01 |
| GOBP ERBB SIGNALING PATHWAY | 78 | 7.07e-01 | -2.46e-02 | 9.66e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 5 | 9.24e-01 | 2.46e-02 | 9.93e-01 |
| GOBP AMINE METABOLIC PROCESS | 54 | 7.55e-01 | 2.46e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 108 | 6.59e-01 | -2.46e-02 | 9.62e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 304 | 4.63e-01 | -2.46e-02 | 9.25e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 27 | 8.25e-01 | 2.46e-02 | 9.76e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 40 | 7.88e-01 | 2.46e-02 | 9.73e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 12 | 8.83e-01 | -2.46e-02 | 9.86e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 48 | 7.69e-01 | 2.45e-02 | 9.72e-01 |
| GOBP OVULATION CYCLE PROCESS | 21 | 8.46e-01 | 2.45e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 288 | 4.76e-01 | 2.45e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 21 | 8.46e-01 | -2.45e-02 | 9.79e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 14 | 8.74e-01 | 2.44e-02 | 9.83e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 53 | 7.59e-01 | -2.44e-02 | 9.72e-01 |
| GOMF LIPID KINASE ACTIVITY | 33 | 8.09e-01 | 2.44e-02 | 9.75e-01 |
| GOBP VASCULAR WOUND HEALING | 9 | 8.99e-01 | 2.44e-02 | 9.88e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 147 | 6.11e-01 | -2.44e-02 | 9.55e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 222 | 5.34e-01 | -2.43e-02 | 9.40e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 7.26e-01 | -2.43e-02 | 9.69e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 14 | 8.75e-01 | -2.43e-02 | 9.84e-01 |
| GOMF ACTIN BINDING | 260 | 5.04e-01 | 2.42e-02 | 9.31e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 55 | 7.56e-01 | 2.42e-02 | 9.72e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 30 | 8.19e-01 | 2.42e-02 | 9.76e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 487 | 3.65e-01 | -2.42e-02 | 8.92e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 9.12e-01 | 2.42e-02 | 9.91e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 5 | 9.26e-01 | 2.41e-02 | 9.94e-01 |
| GOMF COLLAGEN BINDING | 25 | 8.35e-01 | -2.41e-02 | 9.76e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 313 | 4.68e-01 | 2.40e-02 | 9.26e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 9 | 9.01e-01 | -2.40e-02 | 9.88e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 59 | 7.51e-01 | -2.39e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 29 | 8.24e-01 | -2.39e-02 | 9.76e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 40 | 7.94e-01 | -2.38e-02 | 9.73e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 76 | 7.20e-01 | -2.38e-02 | 9.69e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 16 | 8.69e-01 | 2.38e-02 | 9.83e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 48 | 7.75e-01 | 2.38e-02 | 9.73e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 76 | 7.20e-01 | 2.38e-02 | 9.69e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 8.47e-01 | 2.38e-02 | 9.79e-01 |
| GOBP STEM CELL DEVELOPMENT | 41 | 7.92e-01 | -2.38e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 30 | 8.22e-01 | 2.38e-02 | 9.76e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 8.62e-01 | -2.38e-02 | 9.82e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 9 | 9.02e-01 | 2.37e-02 | 9.89e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 26 | 8.35e-01 | -2.36e-02 | 9.76e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 68 | 7.36e-01 | 2.36e-02 | 9.70e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 16 | 8.70e-01 | 2.36e-02 | 9.83e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 23 | 8.45e-01 | -2.36e-02 | 9.79e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 31 | 8.20e-01 | 2.36e-02 | 9.76e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 6 | 9.20e-01 | 2.36e-02 | 9.92e-01 |
| GOBP BONE RESORPTION | 41 | 7.94e-01 | 2.36e-02 | 9.73e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 169 | 5.98e-01 | -2.36e-02 | 9.52e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 7.80e-01 | -2.36e-02 | 9.73e-01 |
| GOCC CIA COMPLEX | 5 | 9.27e-01 | 2.35e-02 | 9.94e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 193 | 5.74e-01 | 2.35e-02 | 9.44e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 20 | 8.56e-01 | 2.35e-02 | 9.81e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 8.93e-01 | 2.35e-02 | 9.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 75 | 7.25e-01 | -2.35e-02 | 9.69e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 6 | 9.21e-01 | 2.35e-02 | 9.92e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 11 | 8.93e-01 | -2.35e-02 | 9.87e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 28 | 8.30e-01 | 2.34e-02 | 9.76e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 19 | 8.60e-01 | -2.34e-02 | 9.82e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 13 | 8.84e-01 | 2.34e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 934 | 2.34e-01 | 2.34e-02 | 8.37e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 65 | 7.45e-01 | 2.33e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 9.28e-01 | -2.33e-02 | 9.94e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 156 | 6.16e-01 | 2.33e-02 | 9.55e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 87 | 7.08e-01 | -2.33e-02 | 9.66e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 99 | 6.89e-01 | 2.33e-02 | 9.64e-01 |
| GOCC COATED VESICLE | 236 | 5.39e-01 | -2.33e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 269 | 5.13e-01 | 2.33e-02 | 9.33e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 23 | 8.47e-01 | -2.33e-02 | 9.79e-01 |
| GOBP VIRAL GENE EXPRESSION | 93 | 6.99e-01 | 2.32e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 44 | 7.90e-01 | -2.32e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 7 | 9.15e-01 | 2.32e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 62 | 7.52e-01 | 2.32e-02 | 9.71e-01 |
| GOCC CLATHRIN COATED VESICLE | 149 | 6.26e-01 | -2.32e-02 | 9.58e-01 |
| GOBP HEART DEVELOPMENT | 306 | 4.88e-01 | 2.32e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 40 | 8.00e-01 | -2.32e-02 | 9.73e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 26 | 8.38e-01 | 2.32e-02 | 9.77e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 9.22e-01 | 2.31e-02 | 9.92e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 20 | 8.58e-01 | 2.31e-02 | 9.81e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 25 | 8.42e-01 | 2.30e-02 | 9.78e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 227 | 5.51e-01 | 2.30e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 81 | 7.20e-01 | 2.30e-02 | 9.69e-01 |
| GOBP PROTEIN PROCESSING | 137 | 6.42e-01 | -2.30e-02 | 9.59e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 167 | 6.09e-01 | -2.30e-02 | 9.54e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 357 | 4.58e-01 | -2.30e-02 | 9.23e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 147 | 6.31e-01 | -2.30e-02 | 9.58e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 284 | 5.07e-01 | -2.30e-02 | 9.31e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 9.05e-01 | 2.29e-02 | 9.90e-01 |
| GOBP IRON IMPORT INTO CELL | 5 | 9.29e-01 | 2.29e-02 | 9.94e-01 |
| GOMF MYOSIN BINDING | 37 | 8.10e-01 | 2.29e-02 | 9.75e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 29 | 8.31e-01 | 2.29e-02 | 9.76e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 668 | 3.19e-01 | 2.29e-02 | 8.76e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 21 | 8.56e-01 | 2.28e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 63 | 7.54e-01 | 2.28e-02 | 9.72e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 26 | 8.41e-01 | -2.28e-02 | 9.77e-01 |
| GOMF DELTA CATENIN BINDING | 5 | 9.30e-01 | -2.28e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 47 | 7.87e-01 | 2.28e-02 | 9.73e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 35 | 8.16e-01 | -2.27e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 17 | 8.71e-01 | -2.27e-02 | 9.83e-01 |
| GOBP BASE EXCISION REPAIR | 40 | 8.04e-01 | 2.27e-02 | 9.73e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 83 | 7.22e-01 | 2.27e-02 | 9.69e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 52 | 7.78e-01 | -2.26e-02 | 9.73e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 11 | 8.97e-01 | -2.26e-02 | 9.88e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 9.12e-01 | 2.26e-02 | 9.91e-01 |
| GOBP BRAIN MORPHOGENESIS | 18 | 8.68e-01 | 2.26e-02 | 9.83e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 74 | 7.37e-01 | 2.26e-02 | 9.70e-01 |
| GOBP REGULATION OF CELL CYCLE | 768 | 2.94e-01 | 2.25e-02 | 8.71e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 11 | 8.97e-01 | -2.25e-02 | 9.88e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 29 | 8.34e-01 | -2.25e-02 | 9.76e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 66 | 7.52e-01 | -2.25e-02 | 9.71e-01 |
| GOCC CATALYTIC COMPLEX | 1431 | 1.65e-01 | -2.25e-02 | 8.03e-01 |
| GOMF U4 SNRNA BINDING | 6 | 9.24e-01 | 2.25e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 125 | 6.65e-01 | 2.25e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 32 | 8.26e-01 | 2.25e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 33 | 8.24e-01 | -2.24e-02 | 9.76e-01 |
| GOBP SEXUAL REPRODUCTION | 512 | 3.89e-01 | 2.24e-02 | 8.97e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 8 | 9.13e-01 | -2.24e-02 | 9.91e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 54 | 7.76e-01 | -2.24e-02 | 9.73e-01 |
| GOCC NUCLEAR PERIPHERY | 128 | 6.63e-01 | 2.24e-02 | 9.62e-01 |
| GOBP BEHAVIOR | 288 | 5.16e-01 | -2.24e-02 | 9.34e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 131 | 6.59e-01 | 2.24e-02 | 9.62e-01 |
| GOBP DEVELOPMENTAL GROWTH | 347 | 4.78e-01 | 2.23e-02 | 9.26e-01 |
| GOBP RESPONSE TO RADIATION | 281 | 5.22e-01 | 2.23e-02 | 9.35e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 8.33e-01 | -2.22e-02 | 9.76e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 9 | 9.08e-01 | 2.22e-02 | 9.90e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 33 | 8.25e-01 | -2.22e-02 | 9.76e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 376 | 4.63e-01 | 2.22e-02 | 9.25e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 55 | 7.76e-01 | -2.22e-02 | 9.73e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 25 | 8.48e-01 | 2.22e-02 | 9.80e-01 |
| GOCC NUCLEAR LAMINA | 11 | 8.99e-01 | 2.22e-02 | 9.88e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 54 | 7.79e-01 | 2.21e-02 | 9.73e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 375 | 4.65e-01 | 2.21e-02 | 9.25e-01 |
| GOBP REGULATION OF CELL GROWTH | 249 | 5.50e-01 | -2.21e-02 | 9.40e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 45 | 7.98e-01 | 2.20e-02 | 9.73e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 9.14e-01 | -2.20e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 82 | 7.31e-01 | 2.20e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 34 | 8.25e-01 | -2.20e-02 | 9.76e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 37 | 8.17e-01 | 2.20e-02 | 9.76e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 16 | 8.79e-01 | 2.20e-02 | 9.84e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 92 | 7.17e-01 | 2.19e-02 | 9.69e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 231 | 5.67e-01 | 2.19e-02 | 9.44e-01 |
| GOCC SNARE COMPLEX | 38 | 8.16e-01 | -2.19e-02 | 9.76e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 66 | 7.59e-01 | -2.19e-02 | 9.72e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 55 | 7.79e-01 | 2.19e-02 | 9.73e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 8.04e-01 | 2.18e-02 | 9.73e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 151 | 6.44e-01 | 2.18e-02 | 9.60e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 11 | 9.00e-01 | 2.18e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 135 | 6.62e-01 | 2.18e-02 | 9.62e-01 |
| GOBP CHLORIDE TRANSPORT | 43 | 8.05e-01 | 2.18e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 28 | 8.42e-01 | 2.18e-02 | 9.78e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 15 | 8.84e-01 | 2.18e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 137 | 6.61e-01 | 2.18e-02 | 9.62e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 60 | 7.71e-01 | -2.18e-02 | 9.73e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 8.88e-01 | 2.17e-02 | 9.86e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 9.27e-01 | -2.17e-02 | 9.94e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 8.97e-01 | -2.17e-02 | 9.88e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 89 | 7.24e-01 | 2.17e-02 | 9.69e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 138 | 6.61e-01 | -2.17e-02 | 9.62e-01 |
| GOCC SYNAPSE | 758 | 3.16e-01 | -2.17e-02 | 8.76e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 22 | 8.61e-01 | 2.16e-02 | 9.82e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 298 | 5.23e-01 | -2.16e-02 | 9.35e-01 |
| GOBP CELL SUBSTRATE ADHESION | 187 | 6.11e-01 | 2.16e-02 | 9.55e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 7.50e-01 | 2.16e-02 | 9.71e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 77 | 7.44e-01 | -2.16e-02 | 9.70e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 9.06e-01 | -2.16e-02 | 9.90e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 52 | 7.88e-01 | -2.15e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 242 | 5.66e-01 | 2.15e-02 | 9.44e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 142 | 6.59e-01 | 2.15e-02 | 9.62e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 6 | 9.27e-01 | 2.15e-02 | 9.94e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 17 | 8.78e-01 | 2.15e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 9.27e-01 | -2.15e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 67 | 7.62e-01 | 2.15e-02 | 9.72e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 185 | 6.16e-01 | 2.14e-02 | 9.55e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1062 | 2.47e-01 | 2.14e-02 | 8.49e-01 |
| GOBP NUCLEUS ORGANIZATION | 117 | 6.90e-01 | 2.14e-02 | 9.64e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 194 | 6.09e-01 | -2.14e-02 | 9.54e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 51 | 7.92e-01 | 2.14e-02 | 9.73e-01 |
| GOBP PIGMENTATION | 71 | 7.56e-01 | 2.14e-02 | 9.72e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 9.34e-01 | -2.13e-02 | 9.94e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 76 | 7.48e-01 | 2.13e-02 | 9.71e-01 |
| GOBP VIRAL TRANSLATION | 20 | 8.69e-01 | 2.13e-02 | 9.83e-01 |
| GOBP GTP METABOLIC PROCESS | 21 | 8.66e-01 | -2.13e-02 | 9.83e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 35 | 8.28e-01 | 2.13e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 27 | 8.48e-01 | -2.13e-02 | 9.80e-01 |
| GOCC MIB COMPLEX | 13 | 8.95e-01 | 2.12e-02 | 9.87e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 7.90e-01 | 2.12e-02 | 9.73e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 74 | 7.53e-01 | -2.11e-02 | 9.71e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 77 | 7.49e-01 | 2.11e-02 | 9.71e-01 |
| GOBP CELL KILLING | 131 | 6.78e-01 | -2.11e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 134 | 6.75e-01 | -2.10e-02 | 9.64e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 29 | 8.45e-01 | 2.10e-02 | 9.79e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 14 | 8.92e-01 | 2.10e-02 | 9.87e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 9.35e-01 | -2.10e-02 | 9.94e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 8 | 9.18e-01 | -2.10e-02 | 9.92e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 499 | 4.27e-01 | 2.10e-02 | 9.13e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 365 | 4.94e-01 | -2.10e-02 | 9.31e-01 |
| GOBP FIBROBLAST MIGRATION | 40 | 8.19e-01 | -2.09e-02 | 9.76e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 443 | 4.54e-01 | -2.09e-02 | 9.22e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 14 | 8.92e-01 | 2.09e-02 | 9.87e-01 |
| GOBP RESPONSE TO X RAY | 24 | 8.60e-01 | -2.09e-02 | 9.82e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 6 | 9.30e-01 | 2.08e-02 | 9.94e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 383 | 4.88e-01 | 2.08e-02 | 9.30e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 9.30e-01 | -2.08e-02 | 9.94e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 448 | 4.54e-01 | 2.08e-02 | 9.22e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 10 | 9.10e-01 | 2.08e-02 | 9.91e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 255 | 5.70e-01 | 2.07e-02 | 9.44e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 8.32e-01 | -2.07e-02 | 9.76e-01 |
| GOBP MEMBRANE INVAGINATION | 45 | 8.10e-01 | -2.07e-02 | 9.75e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 22 | 8.67e-01 | 2.07e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 9.25e-01 | -2.06e-02 | 9.93e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 15 | 8.90e-01 | 2.06e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 10 | 9.10e-01 | 2.06e-02 | 9.91e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 5 | 9.36e-01 | -2.06e-02 | 9.95e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 19 | 8.77e-01 | 2.06e-02 | 9.84e-01 |
| GOBP CELL CYCLE PROCESS | 907 | 3.01e-01 | 2.06e-02 | 8.74e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 97 | 7.27e-01 | -2.06e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 68 | 7.70e-01 | -2.05e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 9.37e-01 | 2.05e-02 | 9.95e-01 |
| GOBP MACROPHAGE ACTIVATION | 71 | 7.65e-01 | 2.05e-02 | 9.72e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 38 | 8.27e-01 | -2.05e-02 | 9.76e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 9.02e-01 | -2.05e-02 | 9.89e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 9.06e-01 | -2.05e-02 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 332 | 5.24e-01 | -2.05e-02 | 9.35e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 9.11e-01 | -2.04e-02 | 9.91e-01 |
| GOBP RESPONSE TO HEAT | 73 | 7.64e-01 | 2.04e-02 | 9.72e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 12 | 9.03e-01 | 2.04e-02 | 9.89e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 102 | 7.23e-01 | -2.04e-02 | 9.69e-01 |
| GOBP REGULATION OF CELL DIVISION | 103 | 7.22e-01 | 2.04e-02 | 9.69e-01 |
| GOCC MCM COMPLEX | 7 | 9.26e-01 | 2.04e-02 | 9.94e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 39 | 8.26e-01 | -2.03e-02 | 9.76e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 9.37e-01 | 2.03e-02 | 9.95e-01 |
| GOBP T CELL DIFFERENTIATION | 237 | 5.93e-01 | 2.03e-02 | 9.51e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 7 | 9.26e-01 | -2.02e-02 | 9.94e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 164 | 6.56e-01 | 2.02e-02 | 9.62e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 12 | 9.04e-01 | -2.02e-02 | 9.89e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 12 | 9.04e-01 | 2.02e-02 | 9.89e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 29 | 8.51e-01 | 2.02e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 22 | 8.70e-01 | -2.01e-02 | 9.83e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 6 | 9.32e-01 | 2.01e-02 | 9.94e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 43 | 8.19e-01 | -2.01e-02 | 9.76e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 9 | 9.17e-01 | 2.01e-02 | 9.92e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 9 | 9.17e-01 | 2.01e-02 | 9.92e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 9.32e-01 | 2.01e-02 | 9.94e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 623 | 3.97e-01 | 2.01e-02 | 8.98e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 8.93e-01 | 2.01e-02 | 9.87e-01 |
| GOBP CELL GROWTH | 297 | 5.54e-01 | -2.01e-02 | 9.41e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 9 | 9.17e-01 | 2.01e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 94 | 7.37e-01 | 2.01e-02 | 9.70e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 118 | 7.07e-01 | -2.01e-02 | 9.66e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 163 | 6.60e-01 | -2.00e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 325 | 5.38e-01 | 2.00e-02 | 9.40e-01 |
| GOBP TISSUE HOMEOSTASIS | 141 | 6.83e-01 | 2.00e-02 | 9.64e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 582 | 4.15e-01 | 2.00e-02 | 9.08e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 36 | 8.36e-01 | -2.00e-02 | 9.76e-01 |
| GOMF DEATH DOMAIN BINDING | 10 | 9.13e-01 | 1.99e-02 | 9.91e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 8.58e-01 | 1.99e-02 | 9.81e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 11 | 9.09e-01 | 1.99e-02 | 9.91e-01 |
| GOBP OSSIFICATION | 214 | 6.18e-01 | 1.99e-02 | 9.55e-01 |
| GOBP REGULATION OF SECRETION | 328 | 5.39e-01 | -1.98e-02 | 9.40e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 62 | 7.87e-01 | -1.98e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 138 | 6.89e-01 | -1.98e-02 | 9.64e-01 |
| GOCC MITOTIC SPINDLE | 135 | 6.92e-01 | -1.98e-02 | 9.64e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 9.39e-01 | 1.98e-02 | 9.95e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 9.39e-01 | 1.98e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 17 | 8.88e-01 | -1.97e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 15 | 8.95e-01 | 1.97e-02 | 9.87e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 33 | 8.45e-01 | -1.97e-02 | 9.79e-01 |
| GOBP MALE GAMETE GENERATION | 281 | 5.72e-01 | 1.97e-02 | 9.44e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 89 | 7.49e-01 | -1.97e-02 | 9.71e-01 |
| GOBP MACROMOLECULE DEACYLATION | 58 | 7.96e-01 | -1.97e-02 | 9.73e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 113 | 7.19e-01 | 1.96e-02 | 9.69e-01 |
| GOCC CLATHRIN COATED PIT | 57 | 7.98e-01 | 1.96e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 21 | 8.77e-01 | 1.96e-02 | 9.84e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 9.19e-01 | 1.96e-02 | 9.92e-01 |
| GOCC PROTEIN LIPID COMPLEX | 18 | 8.86e-01 | -1.95e-02 | 9.86e-01 |
| GOMF PEPTIDASE ACTIVITY | 301 | 5.62e-01 | -1.95e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 108 | 7.26e-01 | 1.95e-02 | 9.69e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1078 | 2.89e-01 | -1.95e-02 | 8.69e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 97 | 7.41e-01 | 1.95e-02 | 9.70e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 65 | 7.87e-01 | 1.94e-02 | 9.73e-01 |
| GOBP CELL CELL SIGNALING | 770 | 3.65e-01 | 1.94e-02 | 8.92e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 29 | 8.57e-01 | -1.94e-02 | 9.81e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 9.04e-01 | -1.94e-02 | 9.89e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 9.24e-01 | -1.94e-02 | 9.93e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 9 | 9.20e-01 | -1.94e-02 | 9.92e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 265 | 5.90e-01 | -1.93e-02 | 9.51e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 18 | 8.87e-01 | 1.93e-02 | 9.86e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 30 | 8.55e-01 | 1.93e-02 | 9.81e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 28 | 8.60e-01 | -1.93e-02 | 9.82e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 349 | 5.40e-01 | -1.92e-02 | 9.40e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 67 | 7.87e-01 | 1.91e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 615 | 4.23e-01 | -1.91e-02 | 9.12e-01 |
| GOBP CELL CHEMOTAXIS | 163 | 6.74e-01 | -1.91e-02 | 9.64e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 19 | 8.85e-01 | 1.91e-02 | 9.86e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 50 | 8.15e-01 | -1.91e-02 | 9.76e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 7 | 9.30e-01 | -1.91e-02 | 9.94e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 11 | 9.13e-01 | -1.91e-02 | 9.91e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 83 | 7.65e-01 | 1.90e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.41e-01 | 1.90e-02 | 9.95e-01 |
| GOBP THYMUS DEVELOPMENT | 33 | 8.50e-01 | 1.90e-02 | 9.81e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 19 | 8.86e-01 | 1.90e-02 | 9.86e-01 |
| GOMF LIPID BINDING | 493 | 4.75e-01 | 1.89e-02 | 9.26e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 9 | 9.22e-01 | 1.89e-02 | 9.92e-01 |
| GOBP RNA SURVEILLANCE | 17 | 8.93e-01 | 1.89e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 38 | 8.41e-01 | 1.89e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 84 | 7.66e-01 | -1.88e-02 | 9.72e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 9.07e-01 | 1.88e-02 | 9.90e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 16 | 8.97e-01 | 1.88e-02 | 9.88e-01 |
| GOCC COATED VESICLE MEMBRANE | 152 | 6.90e-01 | -1.88e-02 | 9.64e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 120 | 7.23e-01 | -1.88e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 25 | 8.71e-01 | -1.88e-02 | 9.83e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 9.03e-01 | -1.87e-02 | 9.89e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 159 | 6.85e-01 | 1.87e-02 | 9.64e-01 |
| GOCC SIN3 TYPE COMPLEX | 21 | 8.82e-01 | 1.87e-02 | 9.86e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 23 | 8.77e-01 | -1.87e-02 | 9.84e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 7 | 9.32e-01 | 1.87e-02 | 9.94e-01 |
| GOCC NUCLEOLUS | 849 | 3.64e-01 | 1.86e-02 | 8.92e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 43 | 8.33e-01 | -1.86e-02 | 9.76e-01 |
| GOBP REGULATION OF AUTOPHAGY | 290 | 5.88e-01 | -1.86e-02 | 9.50e-01 |
| GOBP REGULATION OF JNK CASCADE | 93 | 7.57e-01 | 1.86e-02 | 9.72e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 7 | 9.32e-01 | -1.85e-02 | 9.94e-01 |
| GOBP BONE GROWTH | 13 | 9.08e-01 | -1.85e-02 | 9.90e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 142 | 7.04e-01 | 1.85e-02 | 9.66e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 112 | 7.35e-01 | -1.85e-02 | 9.70e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 5 | 9.43e-01 | 1.85e-02 | 9.95e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 28 | 8.66e-01 | -1.85e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 9 | 9.24e-01 | -1.85e-02 | 9.93e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 20 | 8.86e-01 | -1.84e-02 | 9.86e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 99 | 7.52e-01 | -1.84e-02 | 9.71e-01 |
| GOBP GLAND DEVELOPMENT | 217 | 6.41e-01 | 1.84e-02 | 9.59e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 8.87e-01 | 1.84e-02 | 9.86e-01 |
| GOBP BONE REMODELING | 48 | 8.25e-01 | 1.84e-02 | 9.76e-01 |
| GOCC CLATHRIN COAT | 39 | 8.43e-01 | 1.84e-02 | 9.78e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 433 | 5.15e-01 | 1.84e-02 | 9.34e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 9.09e-01 | -1.83e-02 | 9.91e-01 |
| GOCC ACROSOMAL VESICLE | 59 | 8.08e-01 | 1.83e-02 | 9.74e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 106 | 7.45e-01 | -1.83e-02 | 9.70e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 8 | 9.29e-01 | -1.83e-02 | 9.94e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 166 | 6.85e-01 | 1.83e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 27 | 8.69e-01 | 1.83e-02 | 9.83e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 958 | 3.46e-01 | 1.83e-02 | 8.87e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 158 | 6.93e-01 | 1.82e-02 | 9.64e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 50 | 8.24e-01 | 1.82e-02 | 9.76e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 374 | 5.49e-01 | 1.81e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 338 | 5.69e-01 | 1.81e-02 | 9.44e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 107 | 7.47e-01 | 1.80e-02 | 9.71e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 5 | 9.44e-01 | -1.80e-02 | 9.95e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 72 | 7.92e-01 | -1.80e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 9 | 9.25e-01 | 1.80e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 5 | 9.45e-01 | -1.79e-02 | 9.95e-01 |
| GOBP SPINDLE ASSEMBLY | 105 | 7.52e-01 | -1.79e-02 | 9.71e-01 |
| GOCC CENTRIOLAR SATELLITE | 86 | 7.74e-01 | 1.79e-02 | 9.73e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 229 | 6.43e-01 | 1.78e-02 | 9.59e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 125 | 7.32e-01 | -1.78e-02 | 9.70e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1043 | 3.40e-01 | -1.78e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 5 | 9.45e-01 | 1.78e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 21 | 8.88e-01 | -1.78e-02 | 9.86e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 17 | 8.99e-01 | 1.78e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 9.40e-01 | -1.77e-02 | 9.95e-01 |
| GOBP NCRNA TRANSCRIPTION | 96 | 7.64e-01 | 1.77e-02 | 9.72e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 37 | 8.52e-01 | -1.77e-02 | 9.81e-01 |
| GOBP LIPID LOCALIZATION | 262 | 6.23e-01 | 1.77e-02 | 9.56e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 9.35e-01 | -1.77e-02 | 9.94e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 20 | 8.91e-01 | 1.76e-02 | 9.87e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 133 | 7.26e-01 | -1.76e-02 | 9.69e-01 |
| GOCC MMXD COMPLEX | 5 | 9.46e-01 | -1.76e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 92 | 7.71e-01 | 1.76e-02 | 9.73e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 116 | 7.44e-01 | 1.76e-02 | 9.70e-01 |
| GOBP NEPHRON MORPHOGENESIS | 24 | 8.82e-01 | 1.76e-02 | 9.85e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 357 | 5.71e-01 | 1.76e-02 | 9.44e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 9.41e-01 | 1.75e-02 | 9.95e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 9.46e-01 | -1.75e-02 | 9.95e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 9.46e-01 | 1.75e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 25 | 8.80e-01 | 1.75e-02 | 9.84e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 9.41e-01 | 1.75e-02 | 9.95e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 169 | 6.96e-01 | 1.75e-02 | 9.65e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 464 | 5.22e-01 | -1.75e-02 | 9.35e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 27 | 8.75e-01 | -1.75e-02 | 9.84e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 9.20e-01 | 1.74e-02 | 9.92e-01 |
| GOBP POLYOL METABOLIC PROCESS | 66 | 8.07e-01 | -1.74e-02 | 9.74e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 81 | 7.87e-01 | -1.74e-02 | 9.73e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 21 | 8.90e-01 | 1.74e-02 | 9.87e-01 |
| GOBP PROTEIN TARGETING | 274 | 6.22e-01 | -1.74e-02 | 9.56e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 123 | 7.40e-01 | 1.74e-02 | 9.70e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 147 | 7.17e-01 | -1.74e-02 | 9.69e-01 |
| GOCC RECYCLING ENDOSOME | 145 | 7.19e-01 | 1.73e-02 | 9.69e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1008 | 3.61e-01 | 1.73e-02 | 8.91e-01 |
| GOBP GROWTH | 517 | 5.05e-01 | -1.73e-02 | 9.31e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 9.17e-01 | 1.73e-02 | 9.92e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 167 | 7.01e-01 | 1.73e-02 | 9.65e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 9.29e-01 | -1.73e-02 | 9.94e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 41 | 8.49e-01 | -1.72e-02 | 9.80e-01 |
| GOBP EYE MORPHOGENESIS | 62 | 8.15e-01 | 1.72e-02 | 9.76e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 16 | 9.05e-01 | 1.72e-02 | 9.90e-01 |
| GOBP TAXIS | 234 | 6.51e-01 | 1.72e-02 | 9.61e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 9.21e-01 | 1.72e-02 | 9.92e-01 |
| GOBP ENDOCYTOSIS | 475 | 5.25e-01 | 1.72e-02 | 9.36e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 39 | 8.53e-01 | 1.71e-02 | 9.81e-01 |
| GOBP L GLUTAMATE IMPORT | 24 | 8.84e-01 | -1.71e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 54 | 8.28e-01 | 1.71e-02 | 9.76e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 78 | 7.94e-01 | -1.71e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 37 | 8.57e-01 | -1.71e-02 | 9.81e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 144 | 7.25e-01 | -1.70e-02 | 9.69e-01 |
| GOCC ACTIN FILAMENT | 65 | 8.14e-01 | 1.69e-02 | 9.76e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 29 | 8.75e-01 | -1.69e-02 | 9.84e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 260 | 6.41e-01 | 1.69e-02 | 9.59e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 8.96e-01 | -1.69e-02 | 9.88e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 6 | 9.43e-01 | 1.69e-02 | 9.95e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 15 | 9.10e-01 | -1.68e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 89 | 7.85e-01 | -1.68e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 676 | 4.63e-01 | 1.68e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 514 | 5.21e-01 | 1.67e-02 | 9.35e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 60 | 8.23e-01 | 1.67e-02 | 9.76e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 54 | 8.32e-01 | -1.67e-02 | 9.76e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 753 | 4.42e-01 | 1.67e-02 | 9.16e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 92 | 7.83e-01 | -1.67e-02 | 9.73e-01 |
| GOMF CHITIN BINDING | 5 | 9.49e-01 | 1.66e-02 | 9.95e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 287 | 6.31e-01 | 1.66e-02 | 9.58e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 33 | 8.69e-01 | -1.66e-02 | 9.83e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 11 | 9.24e-01 | -1.65e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 218 | 6.76e-01 | 1.65e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 118 | 7.58e-01 | -1.65e-02 | 9.72e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 183 | 7.02e-01 | 1.65e-02 | 9.65e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 77 | 8.03e-01 | -1.64e-02 | 9.73e-01 |
| GOBP CELL MATRIX ADHESION | 125 | 7.52e-01 | -1.64e-02 | 9.71e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 143 | 7.35e-01 | -1.64e-02 | 9.70e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 52 | 8.38e-01 | 1.64e-02 | 9.77e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 33 | 8.71e-01 | -1.64e-02 | 9.83e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 21 | 8.97e-01 | -1.64e-02 | 9.88e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 92 | 7.87e-01 | -1.64e-02 | 9.73e-01 |
| GOBP GASTRULATION | 93 | 7.86e-01 | -1.63e-02 | 9.73e-01 |
| GOBP CELL MOTILITY | 881 | 4.19e-01 | 1.63e-02 | 9.08e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 61 | 8.26e-01 | 1.63e-02 | 9.76e-01 |
| GOBP PROTEIN ACETYLATION | 85 | 7.95e-01 | 1.63e-02 | 9.73e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 13 | 9.19e-01 | -1.63e-02 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 53 | 8.38e-01 | 1.62e-02 | 9.77e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 38 | 8.63e-01 | 1.62e-02 | 9.82e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 786 | 4.45e-01 | -1.62e-02 | 9.17e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 15 | 9.13e-01 | 1.62e-02 | 9.91e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1038 | 3.87e-01 | 1.62e-02 | 8.97e-01 |
| GOCC PRERIBOSOME | 102 | 7.79e-01 | 1.61e-02 | 9.73e-01 |
| GOBP INTEGRIN ACTIVATION | 13 | 9.20e-01 | 1.60e-02 | 9.92e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 122 | 7.60e-01 | -1.60e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 133 | 7.50e-01 | 1.60e-02 | 9.71e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 15 | 9.14e-01 | -1.60e-02 | 9.92e-01 |
| GOBP JNK CASCADE | 119 | 7.64e-01 | 1.60e-02 | 9.72e-01 |
| GOCC SECRETORY GRANULE | 574 | 5.17e-01 | 1.60e-02 | 9.35e-01 |
| GOCC GOLGI APPARATUS | 1091 | 3.82e-01 | 1.60e-02 | 8.97e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 28 | 8.84e-01 | -1.59e-02 | 9.86e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 101 | 7.82e-01 | -1.59e-02 | 9.73e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 146 | 7.41e-01 | -1.59e-02 | 9.70e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 267 | 6.57e-01 | -1.59e-02 | 9.62e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 13 | 9.21e-01 | 1.59e-02 | 9.92e-01 |
| GOBP DNA DAMAGE RESPONSE | 724 | 4.74e-01 | 1.58e-02 | 9.26e-01 |
| GOCC VACUOLE | 648 | 4.97e-01 | -1.58e-02 | 9.31e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 159 | 7.32e-01 | -1.58e-02 | 9.70e-01 |
| GOBP FORELIMB MORPHOGENESIS | 15 | 9.16e-01 | 1.58e-02 | 9.92e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 66 | 8.25e-01 | 1.57e-02 | 9.76e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 8.98e-01 | 1.57e-02 | 9.88e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 9.43e-01 | 1.57e-02 | 9.95e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 15 | 9.16e-01 | 1.57e-02 | 9.92e-01 |
| GOCC POSTSYNAPSE | 335 | 6.25e-01 | 1.56e-02 | 9.57e-01 |
| GOCC MICROBODY | 109 | 7.79e-01 | -1.56e-02 | 9.73e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 9.47e-01 | 1.56e-02 | 9.95e-01 |
| GOCC SECRETORY VESICLE | 664 | 4.99e-01 | 1.56e-02 | 9.31e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 120 | 7.69e-01 | -1.56e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 29 | 8.85e-01 | -1.56e-02 | 9.86e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 23 | 8.97e-01 | -1.55e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 600 | 5.20e-01 | 1.55e-02 | 9.35e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 9.33e-01 | -1.55e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 55 | 8.43e-01 | 1.55e-02 | 9.78e-01 |
| GOBP REGULATION OF GROWTH | 341 | 6.26e-01 | -1.55e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 92 | 7.98e-01 | 1.54e-02 | 9.73e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 8 | 9.40e-01 | 1.54e-02 | 9.95e-01 |
| GOMF CASPASE BINDING | 7 | 9.44e-01 | -1.54e-02 | 9.95e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 72 | 8.21e-01 | 1.54e-02 | 9.76e-01 |
| GOCC ACROSOMAL MEMBRANE | 11 | 9.29e-01 | -1.54e-02 | 9.94e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 9 | 9.36e-01 | 1.54e-02 | 9.95e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 9.44e-01 | -1.54e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 8.99e-01 | 1.53e-02 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 31 | 8.83e-01 | -1.53e-02 | 9.86e-01 |
| GOCC BRUSH BORDER MEMBRANE | 24 | 8.97e-01 | -1.53e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 148 | 7.49e-01 | -1.53e-02 | 9.71e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 9.53e-01 | -1.52e-02 | 9.96e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 39 | 8.70e-01 | -1.52e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 26 | 8.94e-01 | 1.51e-02 | 9.87e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 66 | 8.32e-01 | -1.51e-02 | 9.76e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 164 | 7.39e-01 | 1.51e-02 | 9.70e-01 |
| GOBP NADPH REGENERATION | 19 | 9.10e-01 | 1.51e-02 | 9.91e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 96 | 8.00e-01 | 1.50e-02 | 9.73e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 242 | 6.89e-01 | 1.50e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 9.41e-01 | -1.50e-02 | 9.95e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 15 | 9.20e-01 | -1.50e-02 | 9.92e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 17 | 9.15e-01 | -1.49e-02 | 9.92e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 39 | 8.72e-01 | -1.49e-02 | 9.83e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 766 | 4.89e-01 | 1.49e-02 | 9.30e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 253 | 6.87e-01 | -1.48e-02 | 9.64e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 81 | 8.18e-01 | -1.48e-02 | 9.76e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 27 | 8.94e-01 | 1.48e-02 | 9.87e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 9.36e-01 | 1.47e-02 | 9.94e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 129 | 7.73e-01 | 1.47e-02 | 9.73e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 9.36e-01 | 1.47e-02 | 9.94e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 9.50e-01 | -1.47e-02 | 9.96e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 71 | 8.31e-01 | 1.47e-02 | 9.76e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 9.01e-01 | -1.47e-02 | 9.88e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 213 | 7.13e-01 | -1.47e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 327 | 6.51e-01 | 1.46e-02 | 9.61e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 59 | 8.46e-01 | 1.46e-02 | 9.79e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 46 | 8.64e-01 | -1.46e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 736 | 5.05e-01 | 1.46e-02 | 9.31e-01 |
| GOBP RNA PROCESSING | 846 | 4.78e-01 | 1.46e-02 | 9.26e-01 |
| GOMF POLYSACCHARIDE BINDING | 11 | 9.33e-01 | 1.46e-02 | 9.94e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 29 | 8.92e-01 | -1.46e-02 | 9.87e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 54 | 8.53e-01 | -1.46e-02 | 9.81e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 14 | 9.25e-01 | 1.46e-02 | 9.94e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 188 | 7.32e-01 | 1.46e-02 | 9.70e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 9.25e-01 | 1.45e-02 | 9.94e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 28 | 8.94e-01 | -1.45e-02 | 9.87e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 8.73e-01 | 1.44e-02 | 9.83e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 6 | 9.51e-01 | 1.44e-02 | 9.96e-01 |
| GOBP BLASTOCYST GROWTH | 17 | 9.18e-01 | -1.44e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 9.44e-01 | -1.44e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 280 | 6.81e-01 | 1.44e-02 | 9.64e-01 |
| GOMF ATPASE BINDING | 57 | 8.52e-01 | 1.43e-02 | 9.81e-01 |
| GOBP ACID SECRETION | 18 | 9.16e-01 | 1.43e-02 | 9.92e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 7 | 9.48e-01 | 1.43e-02 | 9.95e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 35 | 8.84e-01 | 1.43e-02 | 9.86e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 59 | 8.50e-01 | 1.43e-02 | 9.81e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 9.38e-01 | 1.42e-02 | 9.95e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 25 | 9.02e-01 | 1.42e-02 | 9.89e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 74 | 8.33e-01 | 1.42e-02 | 9.76e-01 |
| GOCC PRESPLICEOSOME | 16 | 9.22e-01 | -1.41e-02 | 9.92e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 9.52e-01 | -1.41e-02 | 9.96e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 8 | 9.45e-01 | -1.41e-02 | 9.95e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 17 | 9.20e-01 | 1.40e-02 | 9.92e-01 |
| GOMF WW DOMAIN BINDING | 12 | 9.33e-01 | -1.40e-02 | 9.94e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 10 | 9.39e-01 | -1.40e-02 | 9.95e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 111 | 8.00e-01 | -1.40e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 33 | 8.90e-01 | 1.40e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 111 | 8.00e-01 | 1.40e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 23 | 9.08e-01 | -1.39e-02 | 9.90e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 6 | 9.53e-01 | 1.39e-02 | 9.96e-01 |
| GOBP RESPONSE TO LIPID | 517 | 5.91e-01 | -1.39e-02 | 9.51e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 5 | 9.57e-01 | -1.39e-02 | 9.96e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 585 | 5.71e-01 | 1.39e-02 | 9.44e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 9.21e-01 | -1.39e-02 | 9.92e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 5 | 9.57e-01 | 1.38e-02 | 9.96e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 5 | 9.57e-01 | 1.38e-02 | 9.96e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 34 | 8.89e-01 | -1.38e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 158 | 7.65e-01 | -1.38e-02 | 9.72e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 139 | 7.80e-01 | -1.38e-02 | 9.73e-01 |
| GOCC MIDBODY | 165 | 7.61e-01 | 1.38e-02 | 9.72e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 67 | 8.46e-01 | 1.37e-02 | 9.79e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 13 | 9.32e-01 | 1.37e-02 | 9.94e-01 |
| GOCC M BAND | 10 | 9.40e-01 | 1.37e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 9.54e-01 | 1.37e-02 | 9.96e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 9.58e-01 | 1.37e-02 | 9.96e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 9.58e-01 | 1.37e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 26 | 9.04e-01 | -1.37e-02 | 9.89e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 77 | 8.36e-01 | -1.36e-02 | 9.76e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 76 | 8.38e-01 | -1.36e-02 | 9.77e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 334 | 6.72e-01 | 1.36e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 12 | 9.35e-01 | -1.36e-02 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 39 | 8.84e-01 | 1.35e-02 | 9.86e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 92 | 8.23e-01 | 1.35e-02 | 9.76e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 48 | 8.72e-01 | 1.35e-02 | 9.83e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 15 | 9.28e-01 | -1.35e-02 | 9.94e-01 |
| GOBP MANGANESE ION TRANSPORT | 8 | 9.47e-01 | -1.35e-02 | 9.95e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 9.51e-01 | 1.34e-02 | 9.96e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1152 | 4.51e-01 | -1.34e-02 | 9.21e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1467 | 4.04e-01 | 1.34e-02 | 8.99e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 351 | 6.69e-01 | -1.34e-02 | 9.64e-01 |
| GOBP KINETOCHORE ORGANIZATION | 18 | 9.22e-01 | 1.34e-02 | 9.92e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 34 | 8.93e-01 | 1.33e-02 | 9.87e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 275 | 7.05e-01 | 1.33e-02 | 9.66e-01 |
| GOBP RESPONSE TO UV | 117 | 8.04e-01 | 1.33e-02 | 9.73e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 14 | 9.32e-01 | -1.32e-02 | 9.94e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 55 | 8.65e-01 | -1.32e-02 | 9.83e-01 |
| GOBP MONOAMINE TRANSPORT | 28 | 9.04e-01 | 1.32e-02 | 9.89e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 6 | 9.55e-01 | 1.32e-02 | 9.96e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 18 | 9.23e-01 | 1.32e-02 | 9.93e-01 |
| GOBP RESPONSE TO ACTIVITY | 38 | 8.88e-01 | -1.32e-02 | 9.86e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 8 | 9.49e-01 | -1.32e-02 | 9.95e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 8 | 9.49e-01 | -1.32e-02 | 9.95e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 73 | 8.46e-01 | 1.32e-02 | 9.79e-01 |
| GOBP KERATINOCYTE MIGRATION | 10 | 9.43e-01 | -1.31e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 462 | 6.32e-01 | -1.31e-02 | 9.58e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 37 | 8.91e-01 | -1.30e-02 | 9.87e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 66 | 8.55e-01 | -1.30e-02 | 9.81e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 10 | 9.43e-01 | 1.30e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 15 | 9.31e-01 | 1.30e-02 | 9.94e-01 |
| GOBP INORGANIC ANION TRANSPORT | 68 | 8.54e-01 | 1.29e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 21 | 9.19e-01 | 1.29e-02 | 9.92e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 860 | 5.28e-01 | 1.29e-02 | 9.37e-01 |
| GOMF U6 SNRNA BINDING | 14 | 9.34e-01 | 1.29e-02 | 9.94e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 68 | 8.55e-01 | -1.28e-02 | 9.81e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 106 | 8.20e-01 | 1.28e-02 | 9.76e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 9.57e-01 | 1.28e-02 | 9.96e-01 |
| GOBP ACTION POTENTIAL | 55 | 8.70e-01 | 1.27e-02 | 9.83e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 13 | 9.37e-01 | -1.27e-02 | 9.95e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 9.37e-01 | 1.27e-02 | 9.95e-01 |
| GOCC SYNAPTIC MEMBRANE | 147 | 7.92e-01 | -1.26e-02 | 9.73e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 630 | 5.93e-01 | 1.26e-02 | 9.51e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 488 | 6.37e-01 | -1.26e-02 | 9.59e-01 |
| GOCC VESICLE LUMEN | 240 | 7.38e-01 | -1.26e-02 | 9.70e-01 |
| GOBP REGENERATION | 95 | 8.33e-01 | 1.26e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 10 | 9.45e-01 | 1.25e-02 | 9.95e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 33 | 9.01e-01 | 1.25e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 15 | 9.33e-01 | 1.25e-02 | 9.94e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 9.48e-01 | 1.25e-02 | 9.95e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 8.79e-01 | 1.25e-02 | 9.84e-01 |
| GOMF ADP BINDING | 32 | 9.03e-01 | 1.25e-02 | 9.89e-01 |
| GOBP RHYTHMIC PROCESS | 176 | 7.76e-01 | -1.25e-02 | 9.73e-01 |
| GOBP CELL CYCLE | 1272 | 4.65e-01 | 1.25e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 466 | 6.48e-01 | -1.24e-02 | 9.60e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 46 | 8.84e-01 | -1.24e-02 | 9.86e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 129 | 8.08e-01 | 1.24e-02 | 9.74e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 5 | 9.62e-01 | 1.24e-02 | 9.96e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 65 | 8.63e-01 | 1.24e-02 | 9.82e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 11 | 9.43e-01 | -1.24e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 35 | 8.99e-01 | -1.24e-02 | 9.88e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 68 | 8.60e-01 | -1.24e-02 | 9.82e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 155 | 7.91e-01 | 1.23e-02 | 9.73e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 9.55e-01 | 1.23e-02 | 9.96e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 11 | 9.44e-01 | -1.23e-02 | 9.95e-01 |
| GOBP PALLIUM DEVELOPMENT | 110 | 8.24e-01 | 1.23e-02 | 9.76e-01 |
| GOBP SYNAPSE ASSEMBLY | 74 | 8.55e-01 | -1.23e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 48 | 8.83e-01 | 1.22e-02 | 9.86e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 26 | 9.14e-01 | -1.22e-02 | 9.91e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 230 | 7.50e-01 | 1.22e-02 | 9.71e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 32 | 9.05e-01 | -1.22e-02 | 9.89e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 17 | 9.30e-01 | 1.22e-02 | 9.94e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 28 | 9.11e-01 | -1.22e-02 | 9.91e-01 |
| GOBP RESPONSE TO PROTOZOAN | 22 | 9.21e-01 | -1.22e-02 | 9.92e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 9.62e-01 | 1.21e-02 | 9.96e-01 |
| GOBP HISTONE MODIFICATION | 105 | 8.30e-01 | 1.21e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 162 | 7.91e-01 | -1.21e-02 | 9.73e-01 |
| GOBP RESPONSE TO WOUNDING | 297 | 7.21e-01 | 1.21e-02 | 9.69e-01 |
| GOBP CATECHOLAMINE UPTAKE | 5 | 9.63e-01 | -1.21e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 29 | 9.10e-01 | -1.21e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 9.45e-01 | 1.21e-02 | 9.95e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 114 | 8.25e-01 | -1.20e-02 | 9.76e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 52 | 8.81e-01 | 1.20e-02 | 9.85e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 5 | 9.63e-01 | -1.20e-02 | 9.96e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 9.51e-01 | 1.20e-02 | 9.96e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 9.63e-01 | -1.19e-02 | 9.96e-01 |
| GOBP MUSCLE CONTRACTION | 153 | 8.00e-01 | -1.19e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 57 | 8.76e-01 | -1.19e-02 | 9.84e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 87 | 8.48e-01 | -1.19e-02 | 9.80e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 626 | 6.17e-01 | -1.18e-02 | 9.55e-01 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 9.29e-01 | -1.18e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 79 | 8.56e-01 | 1.18e-02 | 9.81e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 9.37e-01 | -1.18e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 10 | 9.49e-01 | 1.18e-02 | 9.95e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 16 | 9.35e-01 | -1.18e-02 | 9.94e-01 |
| GOBP RESPONSE TO CAFFEINE | 10 | 9.49e-01 | 1.17e-02 | 9.95e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 17 | 9.33e-01 | 1.17e-02 | 9.94e-01 |
| GOCC METHYLOSOME | 12 | 9.44e-01 | 1.17e-02 | 9.95e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 7 | 9.57e-01 | -1.17e-02 | 9.96e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 62 | 8.73e-01 | -1.17e-02 | 9.83e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 181 | 7.86e-01 | 1.17e-02 | 9.73e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 20 | 9.28e-01 | -1.17e-02 | 9.94e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 13 | 9.42e-01 | -1.17e-02 | 9.95e-01 |
| GOMF TRANSITION METAL ION BINDING | 676 | 6.09e-01 | 1.17e-02 | 9.54e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 9.57e-01 | 1.17e-02 | 9.96e-01 |
| GOCC MAIN AXON | 28 | 9.16e-01 | -1.16e-02 | 9.92e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 25 | 9.20e-01 | -1.16e-02 | 9.92e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 9.61e-01 | 1.16e-02 | 9.96e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 7 | 9.58e-01 | 1.15e-02 | 9.96e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 7 | 9.58e-01 | 1.15e-02 | 9.96e-01 |
| GOBP REGULATION OF CELL ADHESION | 480 | 6.70e-01 | 1.14e-02 | 9.64e-01 |
| GOBP CELLULAR PIGMENTATION | 48 | 8.91e-01 | 1.14e-02 | 9.87e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 9.65e-01 | 1.14e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 17 | 9.35e-01 | -1.14e-02 | 9.94e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 25 | 9.22e-01 | -1.14e-02 | 9.92e-01 |
| GOCC TERTIARY GRANULE | 130 | 8.24e-01 | 1.13e-02 | 9.76e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 50 | 8.90e-01 | -1.13e-02 | 9.87e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 494 | 6.69e-01 | 1.13e-02 | 9.64e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 23 | 9.26e-01 | 1.13e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 531 | 6.61e-01 | 1.12e-02 | 9.62e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 53 | 8.88e-01 | -1.12e-02 | 9.86e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 134 | 8.23e-01 | -1.12e-02 | 9.76e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 189 | 7.91e-01 | 1.12e-02 | 9.73e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 12 | 9.47e-01 | 1.12e-02 | 9.95e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 10 | 9.51e-01 | -1.11e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 623 | 6.40e-01 | 1.11e-02 | 9.59e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 8 | 9.57e-01 | 1.11e-02 | 9.96e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 13 | 9.45e-01 | -1.11e-02 | 9.95e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 779 | 6.05e-01 | 1.10e-02 | 9.52e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 151 | 8.15e-01 | 1.10e-02 | 9.76e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 8 | 9.57e-01 | -1.10e-02 | 9.96e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 6 | 9.63e-01 | -1.10e-02 | 9.96e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 9.63e-01 | 1.10e-02 | 9.96e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 77 | 8.69e-01 | 1.09e-02 | 9.83e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 62 | 8.82e-01 | -1.09e-02 | 9.86e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 39 | 9.06e-01 | 1.09e-02 | 9.90e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 197 | 7.93e-01 | 1.09e-02 | 9.73e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 162 | 8.12e-01 | -1.09e-02 | 9.75e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 9.63e-01 | -1.09e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 12 | 9.48e-01 | -1.08e-02 | 9.95e-01 |
| GOMF KINASE BINDING | 547 | 6.68e-01 | -1.08e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 13 | 9.46e-01 | -1.08e-02 | 9.95e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 74 | 8.72e-01 | -1.08e-02 | 9.83e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 219 | 7.85e-01 | 1.08e-02 | 9.73e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 367 | 7.25e-01 | 1.07e-02 | 9.69e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 33 | 9.15e-01 | 1.07e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 52 | 8.94e-01 | 1.07e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 20 | 9.34e-01 | -1.07e-02 | 9.94e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 7 | 9.61e-01 | 1.07e-02 | 9.96e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 33 | 9.16e-01 | 1.07e-02 | 9.92e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 330 | 7.41e-01 | 1.06e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 55 | 8.92e-01 | -1.06e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 29 | 9.22e-01 | -1.06e-02 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 10 | 9.54e-01 | 1.06e-02 | 9.96e-01 |
| GOBP DIOL METABOLIC PROCESS | 18 | 9.38e-01 | 1.05e-02 | 9.95e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 11 | 9.52e-01 | 1.05e-02 | 9.96e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 9.54e-01 | -1.05e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 9.68e-01 | -1.05e-02 | 9.96e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 57 | 8.91e-01 | -1.05e-02 | 9.87e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 33 | 9.17e-01 | -1.05e-02 | 9.92e-01 |
| GOBP VOCALIZATION BEHAVIOR | 5 | 9.68e-01 | -1.05e-02 | 9.96e-01 |
| GOBP MAST CELL ACTIVATION | 52 | 8.96e-01 | 1.05e-02 | 9.88e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 90 | 8.64e-01 | -1.04e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 37 | 9.13e-01 | 1.04e-02 | 9.91e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 49 | 9.00e-01 | -1.04e-02 | 9.88e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 88 | 8.67e-01 | -1.04e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 90 | 8.65e-01 | 1.04e-02 | 9.83e-01 |
| GOBP CIRCADIAN RHYTHM | 127 | 8.42e-01 | -1.03e-02 | 9.78e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 54 | 8.96e-01 | -1.03e-02 | 9.88e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 192 | 8.08e-01 | -1.02e-02 | 9.74e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 51 | 9.00e-01 | -1.02e-02 | 9.88e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 8 | 9.60e-01 | -1.02e-02 | 9.96e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 39 | 9.13e-01 | -1.01e-02 | 9.91e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 22 | 9.35e-01 | -1.01e-02 | 9.94e-01 |
| GOCC U2AF COMPLEX | 5 | 9.69e-01 | 1.01e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 12 | 9.52e-01 | -1.01e-02 | 9.96e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1074 | 5.85e-01 | 1.01e-02 | 9.49e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 9.54e-01 | 1.01e-02 | 9.96e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 7 | 9.63e-01 | 1.00e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 194 | 8.10e-01 | -1.00e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 9.69e-01 | 1.00e-02 | 9.96e-01 |
| GOBP CHROMOSOME SEGREGATION | 314 | 7.61e-01 | 1.00e-02 | 9.72e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 100 | 8.63e-01 | 1.00e-02 | 9.82e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 573 | 6.85e-01 | -1.00e-02 | 9.64e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 9.55e-01 | -9.94e-03 | 9.96e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 23 | 9.34e-01 | 9.94e-03 | 9.94e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 9.33e-01 | 9.92e-03 | 9.94e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 30 | 9.25e-01 | -9.91e-03 | 9.94e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 23 | 9.35e-01 | -9.87e-03 | 9.94e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 9.67e-01 | -9.86e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 118 | 8.54e-01 | -9.85e-03 | 9.81e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 47 | 9.07e-01 | -9.85e-03 | 9.90e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 90 | 8.72e-01 | -9.83e-03 | 9.83e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 9.64e-01 | 9.82e-03 | 9.96e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 242 | 7.94e-01 | -9.80e-03 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 27 | 9.30e-01 | -9.80e-03 | 9.94e-01 |
| GOMF NUCLEASE ACTIVITY | 171 | 8.26e-01 | 9.78e-03 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 189 | 8.17e-01 | 9.77e-03 | 9.76e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 9.51e-01 | -9.77e-03 | 9.96e-01 |
| GOMF AMP BINDING | 12 | 9.53e-01 | -9.76e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 197 | 8.14e-01 | -9.75e-03 | 9.76e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 6 | 9.67e-01 | -9.73e-03 | 9.96e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 478 | 7.18e-01 | -9.72e-03 | 9.69e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 49 | 9.07e-01 | -9.71e-03 | 9.90e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 60 | 8.97e-01 | -9.70e-03 | 9.88e-01 |
| GOMF LEUCINE BINDING | 6 | 9.67e-01 | 9.63e-03 | 9.96e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 166 | 8.31e-01 | 9.62e-03 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 9.70e-01 | -9.61e-03 | 9.96e-01 |
| GOBP SIGNAL RELEASE | 240 | 7.99e-01 | -9.60e-03 | 9.73e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 9 | 9.60e-01 | -9.55e-03 | 9.96e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 58 | 9.01e-01 | 9.50e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 39 | 9.19e-01 | -9.47e-03 | 9.92e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 60 | 8.99e-01 | 9.47e-03 | 9.88e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 9.65e-01 | -9.46e-03 | 9.96e-01 |
| GOBP RESPONSE TO ALKALOID | 52 | 9.06e-01 | -9.44e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 9.57e-01 | -9.44e-03 | 9.96e-01 |
| GOCC RECEPTOR COMPLEX | 187 | 8.25e-01 | -9.42e-03 | 9.76e-01 |
| GOBP CELL DIVISION | 440 | 7.37e-01 | 9.40e-03 | 9.70e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 28 | 9.31e-01 | 9.40e-03 | 9.94e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 9.68e-01 | 9.39e-03 | 9.96e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 16 | 9.48e-01 | 9.38e-03 | 9.95e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 9.63e-01 | -9.37e-03 | 9.96e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 203 | 8.19e-01 | 9.36e-03 | 9.76e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1201 | 5.94e-01 | 9.33e-03 | 9.51e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 90 | 8.79e-01 | 9.33e-03 | 9.84e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 10 | 9.59e-01 | 9.30e-03 | 9.96e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.71e-01 | 9.30e-03 | 9.96e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 56 | 9.04e-01 | 9.30e-03 | 9.89e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 35 | 9.25e-01 | 9.25e-03 | 9.93e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 343 | 7.71e-01 | 9.21e-03 | 9.73e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 21 | 9.42e-01 | -9.20e-03 | 9.95e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 235 | 8.10e-01 | 9.14e-03 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 9.72e-01 | -9.14e-03 | 9.96e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 9 | 9.62e-01 | -9.13e-03 | 9.96e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 129 | 8.58e-01 | 9.12e-03 | 9.81e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 12 | 9.56e-01 | -9.12e-03 | 9.96e-01 |
| GOBP POTASSIUM ION TRANSPORT | 77 | 8.90e-01 | -9.11e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 9.42e-01 | -9.11e-03 | 9.95e-01 |
| GOBP REGULATION OF NEUROGENESIS | 196 | 8.27e-01 | -9.10e-03 | 9.76e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 487 | 7.34e-01 | -9.08e-03 | 9.70e-01 |
| GOCC I BAND | 68 | 8.97e-01 | -9.06e-03 | 9.88e-01 |
| GOCC MEDIATOR COMPLEX | 37 | 9.24e-01 | -9.05e-03 | 9.93e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 6 | 9.69e-01 | 9.05e-03 | 9.96e-01 |
| GOBP NAD METABOLIC PROCESS | 27 | 9.35e-01 | 9.05e-03 | 9.94e-01 |
| GOBP INTERFERON BETA PRODUCTION | 52 | 9.10e-01 | -9.03e-03 | 9.91e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 27 | 9.36e-01 | 8.99e-03 | 9.94e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 9.67e-01 | 8.97e-03 | 9.96e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 19 | 9.46e-01 | -8.96e-03 | 9.95e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 9.42e-01 | -8.95e-03 | 9.95e-01 |
| GOBP ORGANELLE LOCALIZATION | 449 | 7.47e-01 | 8.94e-03 | 9.71e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 756 | 6.80e-01 | -8.94e-03 | 9.64e-01 |
| GOBP AXONAL TRANSPORT | 49 | 9.14e-01 | -8.93e-03 | 9.91e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 110 | 8.72e-01 | -8.93e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 45 | 9.18e-01 | 8.93e-03 | 9.92e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 225 | 8.18e-01 | 8.92e-03 | 9.76e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 23 | 9.41e-01 | 8.88e-03 | 9.95e-01 |
| GOBP RESPONSE TO ATP | 18 | 9.48e-01 | -8.87e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 39 | 9.24e-01 | -8.85e-03 | 9.93e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 53 | 9.12e-01 | -8.83e-03 | 9.91e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 24 | 9.41e-01 | 8.80e-03 | 9.95e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 27 | 9.37e-01 | 8.79e-03 | 9.95e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 5 | 9.73e-01 | -8.77e-03 | 9.96e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 29 | 9.35e-01 | -8.72e-03 | 9.94e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 14 | 9.55e-01 | 8.72e-03 | 9.96e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 9.66e-01 | -8.71e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 30 | 9.34e-01 | 8.70e-03 | 9.94e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 24 | 9.41e-01 | 8.69e-03 | 9.95e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 214 | 8.29e-01 | 8.58e-03 | 9.76e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 8 | 9.67e-01 | -8.57e-03 | 9.96e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 19 | 9.49e-01 | -8.55e-03 | 9.95e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 5 | 9.74e-01 | 8.55e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 788 | 6.88e-01 | -8.53e-03 | 9.64e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 8 | 9.67e-01 | 8.47e-03 | 9.96e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 9.52e-01 | -8.46e-03 | 9.96e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 5 | 9.74e-01 | 8.45e-03 | 9.96e-01 |
| GOMF SULFUR COMPOUND BINDING | 111 | 8.78e-01 | 8.45e-03 | 9.84e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 9.20e-01 | -8.43e-03 | 9.92e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 9.65e-01 | -8.42e-03 | 9.96e-01 |
| GOMF LIPOPEPTIDE BINDING | 6 | 9.72e-01 | 8.37e-03 | 9.96e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 33 | 9.34e-01 | -8.36e-03 | 9.94e-01 |
| GOBP GLYCOSYLATION | 149 | 8.62e-01 | -8.28e-03 | 9.82e-01 |
| GOBP MICROTUBULE SEVERING | 6 | 9.72e-01 | 8.27e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 6 | 9.72e-01 | -8.27e-03 | 9.96e-01 |
| GOCC CONDENSIN COMPLEX | 6 | 9.72e-01 | -8.27e-03 | 9.96e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 560 | 7.41e-01 | 8.24e-03 | 9.70e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 16 | 9.54e-01 | 8.24e-03 | 9.96e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 91 | 8.93e-01 | 8.20e-03 | 9.87e-01 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 9.55e-01 | -8.19e-03 | 9.96e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 93 | 8.92e-01 | 8.19e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 57 | 9.15e-01 | -8.18e-03 | 9.92e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 38 | 9.31e-01 | 8.17e-03 | 9.94e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 61 | 9.12e-01 | 8.16e-03 | 9.91e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 9.43e-01 | 8.15e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 879 | 6.87e-01 | -8.13e-03 | 9.64e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 22 | 9.48e-01 | 8.09e-03 | 9.95e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 88 | 8.96e-01 | 8.09e-03 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 23 | 9.47e-01 | 8.08e-03 | 9.95e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 24 | 9.45e-01 | 8.07e-03 | 9.95e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 207 | 8.42e-01 | 8.06e-03 | 9.78e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 59 | 9.15e-01 | 8.05e-03 | 9.92e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 15 | 9.57e-01 | 8.04e-03 | 9.96e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 149 | 8.66e-01 | -8.04e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 10 | 9.65e-01 | 8.03e-03 | 9.96e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 351 | 7.98e-01 | 8.02e-03 | 9.73e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 9.57e-01 | 8.00e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 216 | 8.40e-01 | 7.98e-03 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 85 | 8.99e-01 | -7.95e-03 | 9.88e-01 |
| GOCC ENDOSOME LUMEN | 23 | 9.47e-01 | 7.95e-03 | 9.95e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1273 | 6.41e-01 | -7.94e-03 | 9.59e-01 |
| GOCC PHAGOCYTIC CUP | 24 | 9.46e-01 | -7.94e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 833 | 7.02e-01 | -7.91e-03 | 9.65e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 19 | 9.53e-01 | 7.88e-03 | 9.96e-01 |
| GOBP RESPONSE TO IRON ION | 20 | 9.52e-01 | 7.86e-03 | 9.96e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 12 | 9.63e-01 | -7.82e-03 | 9.96e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 228 | 8.40e-01 | -7.80e-03 | 9.77e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 547 | 7.58e-01 | -7.78e-03 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1050 | 6.76e-01 | -7.77e-03 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 13 | 9.62e-01 | 7.72e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 245 | 8.36e-01 | 7.71e-03 | 9.76e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 5 | 9.76e-01 | -7.70e-03 | 9.96e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 176 | 8.61e-01 | -7.69e-03 | 9.82e-01 |
| GOMF CYCLASE ACTIVITY | 10 | 9.66e-01 | 7.67e-03 | 9.96e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 36 | 9.37e-01 | 7.66e-03 | 9.95e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 79 | 9.07e-01 | -7.63e-03 | 9.90e-01 |
| GOBP PHAGOSOME MATURATION | 23 | 9.50e-01 | 7.60e-03 | 9.96e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 9.67e-01 | 7.56e-03 | 9.96e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 10 | 9.67e-01 | -7.53e-03 | 9.96e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 13 | 9.63e-01 | 7.53e-03 | 9.96e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 9 | 9.69e-01 | -7.50e-03 | 9.96e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 26 | 9.47e-01 | -7.50e-03 | 9.95e-01 |
| GOMF LAMIN BINDING | 12 | 9.64e-01 | 7.49e-03 | 9.96e-01 |
| GOCC CKM COMPLEX | 5 | 9.77e-01 | 7.48e-03 | 9.96e-01 |
| GOBP CELL CELL ADHESION | 476 | 7.82e-01 | -7.46e-03 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 168 | 8.68e-01 | -7.46e-03 | 9.83e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 9.53e-01 | -7.38e-03 | 9.96e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 145 | 8.78e-01 | 7.38e-03 | 9.84e-01 |
| GOCC ANCHORING JUNCTION | 525 | 7.75e-01 | -7.35e-03 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 858 | 7.20e-01 | 7.31e-03 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 10 | 9.68e-01 | 7.30e-03 | 9.96e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 131 | 8.86e-01 | 7.24e-03 | 9.86e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 23 | 9.52e-01 | 7.24e-03 | 9.96e-01 |
| GOCC TRANSFERASE COMPLEX | 717 | 7.45e-01 | -7.23e-03 | 9.70e-01 |
| GOCC MITOCHONDRION | 1328 | 6.66e-01 | -7.22e-03 | 9.63e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 11 | 9.67e-01 | 7.22e-03 | 9.96e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 193 | 8.63e-01 | 7.21e-03 | 9.83e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 87 | 9.08e-01 | 7.19e-03 | 9.90e-01 |
| GOMF ALCOHOL BINDING | 49 | 9.31e-01 | 7.18e-03 | 9.94e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 23 | 9.53e-01 | 7.16e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 9.78e-01 | -7.11e-03 | 9.96e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 9.78e-01 | -7.11e-03 | 9.96e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 173 | 8.72e-01 | -7.10e-03 | 9.83e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 266 | 8.43e-01 | -7.08e-03 | 9.78e-01 |
| GOCC CILIARY TRANSITION FIBER | 6 | 9.76e-01 | -7.07e-03 | 9.96e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 15 | 9.62e-01 | 7.06e-03 | 9.96e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 9.09e-01 | -7.05e-03 | 9.90e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 9 | 9.71e-01 | 7.01e-03 | 9.96e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 51 | 9.31e-01 | 7.01e-03 | 9.94e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 7 | 9.74e-01 | -7.00e-03 | 9.96e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 710 | 7.54e-01 | 7.00e-03 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 52 | 9.31e-01 | 6.98e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 54 | 9.29e-01 | -6.98e-03 | 9.94e-01 |
| GOBP ESTROUS CYCLE | 10 | 9.70e-01 | 6.95e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 120 | 8.96e-01 | 6.92e-03 | 9.88e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 6 | 9.77e-01 | -6.91e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 8 | 9.73e-01 | 6.91e-03 | 9.96e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 9.62e-01 | -6.90e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 53 | 9.31e-01 | 6.85e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 30 | 9.49e-01 | -6.81e-03 | 9.95e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 24 | 9.54e-01 | -6.80e-03 | 9.96e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 100 | 9.07e-01 | 6.77e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 5 | 9.79e-01 | 6.76e-03 | 9.96e-01 |
| GOBP STABILIZATION OF MEMBRANE POTENTIAL | 5 | 9.79e-01 | 6.76e-03 | 9.96e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 36 | 9.44e-01 | -6.72e-03 | 9.95e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 119 | 9.00e-01 | -6.70e-03 | 9.88e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 663 | 7.72e-01 | -6.67e-03 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 80 | 9.19e-01 | 6.61e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 76 | 9.21e-01 | 6.61e-03 | 9.92e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 5 | 9.80e-01 | 6.61e-03 | 9.96e-01 |
| GOBP SELECTIVE AUTOPHAGY | 86 | 9.16e-01 | -6.60e-03 | 9.92e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 170 | 8.82e-01 | -6.60e-03 | 9.86e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 9.62e-01 | -6.60e-03 | 9.96e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 142 | 8.93e-01 | 6.53e-03 | 9.87e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 9.76e-01 | -6.53e-03 | 9.96e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 9.62e-01 | -6.51e-03 | 9.96e-01 |
| GOMF SULFATIDE BINDING | 5 | 9.80e-01 | -6.48e-03 | 9.96e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 384 | 8.29e-01 | 6.47e-03 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 15 | 9.66e-01 | -6.42e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 176 | 8.83e-01 | -6.42e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 9.63e-01 | 6.36e-03 | 9.96e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 43 | 9.43e-01 | 6.33e-03 | 9.95e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 391 | 8.31e-01 | 6.32e-03 | 9.76e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 323 | 8.46e-01 | 6.32e-03 | 9.79e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 8 | 9.76e-01 | 6.26e-03 | 9.96e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 16 | 9.66e-01 | 6.25e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 183 | 8.85e-01 | -6.23e-03 | 9.86e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 313 | 8.51e-01 | -6.22e-03 | 9.81e-01 |
| GOCC VACUOLAR LUMEN | 120 | 9.07e-01 | -6.20e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 9.81e-01 | -6.20e-03 | 9.96e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 37 | 9.48e-01 | -6.20e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 323 | 8.49e-01 | -6.19e-03 | 9.80e-01 |
| GOBP FEEDING BEHAVIOR | 33 | 9.51e-01 | 6.16e-03 | 9.96e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 64 | 9.32e-01 | -6.16e-03 | 9.94e-01 |
| GOBP HISTAMINE SECRETION | 11 | 9.72e-01 | -6.14e-03 | 9.96e-01 |
| GOBP HISTAMINE TRANSPORT | 11 | 9.72e-01 | -6.14e-03 | 9.96e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 9.50e-01 | 6.13e-03 | 9.96e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 9.68e-01 | 6.11e-03 | 9.96e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 75 | 9.27e-01 | 6.09e-03 | 9.94e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 70 | 9.30e-01 | 6.09e-03 | 9.94e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 90 | 9.21e-01 | -6.09e-03 | 9.92e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 15 | 9.68e-01 | 6.08e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 18 | 9.64e-01 | -6.08e-03 | 9.96e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 63 | 9.34e-01 | 6.06e-03 | 9.94e-01 |
| GOBP REGULATION OF LOCOMOTION | 574 | 8.06e-01 | 6.05e-03 | 9.74e-01 |
| GOBP EXOCYTOSIS | 224 | 8.77e-01 | -6.04e-03 | 9.84e-01 |
| GOBP PROTEIN DEACETYLATION | 48 | 9.42e-01 | 6.03e-03 | 9.95e-01 |
| GOBP MATURATION OF SSU RRNA | 49 | 9.42e-01 | 6.00e-03 | 9.95e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 582 | 8.07e-01 | 5.99e-03 | 9.74e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 9.82e-01 | 5.98e-03 | 9.96e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 26 | 9.58e-01 | -5.97e-03 | 9.96e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 13 | 9.70e-01 | 5.95e-03 | 9.96e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 185 | 8.89e-01 | -5.94e-03 | 9.87e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 76 | 9.29e-01 | 5.91e-03 | 9.94e-01 |
| GOBP BONE MINERALIZATION | 60 | 9.37e-01 | -5.88e-03 | 9.95e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 77 | 9.29e-01 | -5.86e-03 | 9.94e-01 |
| GOCC PRESYNAPSE | 288 | 8.65e-01 | 5.85e-03 | 9.83e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 15 | 9.69e-01 | 5.85e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 21 | 9.63e-01 | 5.84e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 259 | 8.72e-01 | -5.84e-03 | 9.83e-01 |
| GOBP COGNITION | 149 | 9.03e-01 | -5.80e-03 | 9.89e-01 |
| GOMF SH3 DOMAIN BINDING | 80 | 9.29e-01 | 5.75e-03 | 9.94e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 513 | 8.26e-01 | 5.72e-03 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 90 | 9.26e-01 | -5.70e-03 | 9.94e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 266 | 8.75e-01 | 5.61e-03 | 9.84e-01 |
| GOCC SPINDLE POLE CENTROSOME | 10 | 9.76e-01 | -5.59e-03 | 9.96e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 22 | 9.64e-01 | -5.59e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 9 | 9.77e-01 | 5.58e-03 | 9.96e-01 |
| GOBP MRNA METABOLIC PROCESS | 635 | 8.12e-01 | -5.58e-03 | 9.75e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 131 | 9.13e-01 | -5.56e-03 | 9.91e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 28 | 9.60e-01 | -5.50e-03 | 9.96e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 35 | 9.55e-01 | 5.49e-03 | 9.96e-01 |
| GOBP OVULATION CYCLE | 32 | 9.57e-01 | 5.47e-03 | 9.96e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 145 | 9.10e-01 | -5.47e-03 | 9.91e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 13 | 9.73e-01 | 5.41e-03 | 9.96e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 10 | 9.76e-01 | 5.40e-03 | 9.96e-01 |
| GOCC LATE ENDOSOME | 236 | 8.87e-01 | -5.38e-03 | 9.86e-01 |
| GOBP TOXIN METABOLIC PROCESS | 6 | 9.82e-01 | 5.35e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 9.78e-01 | 5.29e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 10 | 9.77e-01 | 5.28e-03 | 9.96e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 93 | 9.30e-01 | 5.27e-03 | 9.94e-01 |
| GOBP REGULATION OF MYELINATION | 29 | 9.61e-01 | 5.27e-03 | 9.96e-01 |
| GOCC CELL LEADING EDGE | 283 | 8.79e-01 | 5.26e-03 | 9.84e-01 |
| GOBP RELAXATION OF MUSCLE | 21 | 9.67e-01 | 5.26e-03 | 9.96e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 715 | 8.13e-01 | 5.26e-03 | 9.76e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 13 | 9.74e-01 | -5.23e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 9.82e-01 | 5.22e-03 | 9.96e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 415 | 8.57e-01 | -5.20e-03 | 9.81e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 8 | 9.80e-01 | -5.17e-03 | 9.96e-01 |
| GOBP SECRETION | 523 | 8.42e-01 | -5.13e-03 | 9.78e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 9.80e-01 | 5.13e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 22 | 9.67e-01 | -5.09e-03 | 9.96e-01 |
| GOCC MEMBRANE MICRODOMAIN | 172 | 9.09e-01 | 5.06e-03 | 9.91e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 197 | 9.03e-01 | -5.06e-03 | 9.89e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 9.75e-01 | 5.02e-03 | 9.96e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 17 | 9.71e-01 | -5.02e-03 | 9.96e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 9.80e-01 | -5.01e-03 | 9.96e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 58 | 9.47e-01 | -5.01e-03 | 9.95e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 85 | 9.37e-01 | 4.99e-03 | 9.95e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 84 | 9.37e-01 | 4.99e-03 | 9.95e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 9.62e-01 | -4.99e-03 | 9.96e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 9.72e-01 | -4.98e-03 | 9.96e-01 |
| GOBP DNA METHYLATION | 38 | 9.58e-01 | -4.98e-03 | 9.96e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 62 | 9.46e-01 | 4.95e-03 | 9.95e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 72 | 9.42e-01 | 4.93e-03 | 9.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 10 | 9.78e-01 | 4.93e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 231 | 8.98e-01 | -4.93e-03 | 9.88e-01 |
| GOBP B CELL HOMEOSTASIS | 31 | 9.62e-01 | 4.89e-03 | 9.96e-01 |
| GOCC NUCLEAR BODY | 695 | 8.29e-01 | -4.88e-03 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 9.80e-01 | -4.87e-03 | 9.96e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 85 | 9.38e-01 | 4.87e-03 | 9.95e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 501 | 8.53e-01 | 4.86e-03 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 7 | 9.82e-01 | -4.85e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 331 | 8.81e-01 | 4.81e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 56 | 9.50e-01 | 4.80e-03 | 9.96e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 9.78e-01 | -4.80e-03 | 9.96e-01 |
| GOBP AMIDE TRANSPORT | 179 | 9.12e-01 | -4.79e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 23 | 9.68e-01 | -4.78e-03 | 9.96e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 108 | 9.32e-01 | 4.78e-03 | 9.94e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 8 | 9.81e-01 | 4.76e-03 | 9.96e-01 |
| GOBP HEMOPOIESIS | 659 | 8.38e-01 | 4.73e-03 | 9.77e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 5 | 9.85e-01 | -4.73e-03 | 9.97e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 27 | 9.66e-01 | -4.71e-03 | 9.96e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 9.85e-01 | -4.70e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 30 | 9.65e-01 | -4.69e-03 | 9.96e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 26 | 9.67e-01 | -4.69e-03 | 9.96e-01 |
| GOBP MITOTIC CYTOKINESIS | 67 | 9.47e-01 | -4.67e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 16 | 9.74e-01 | -4.67e-03 | 9.96e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 9.84e-01 | -4.67e-03 | 9.97e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 64 | 9.49e-01 | 4.64e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 10 | 9.80e-01 | -4.63e-03 | 9.96e-01 |
| GOCC GATOR2 COMPLEX | 5 | 9.86e-01 | 4.63e-03 | 9.97e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 172 | 9.18e-01 | 4.59e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 15 | 9.76e-01 | 4.57e-03 | 9.96e-01 |
| GOBP MEMORY | 50 | 9.56e-01 | -4.53e-03 | 9.96e-01 |
| GOBP CALCIUM ION TRANSPORT | 207 | 9.12e-01 | -4.48e-03 | 9.91e-01 |
| GOBP VIRAL LIFE CYCLE | 232 | 9.07e-01 | -4.45e-03 | 9.90e-01 |
| GOMF POLY A BINDING | 20 | 9.73e-01 | -4.43e-03 | 9.96e-01 |
| GOMF MICROTUBULE BINDING | 179 | 9.19e-01 | -4.42e-03 | 9.92e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 21 | 9.72e-01 | 4.39e-03 | 9.96e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 249 | 9.06e-01 | 4.37e-03 | 9.90e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 354 | 8.88e-01 | 4.37e-03 | 9.86e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 37 | 9.64e-01 | 4.33e-03 | 9.96e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 11 | 9.80e-01 | -4.31e-03 | 9.96e-01 |
| GOBP PANCREAS DEVELOPMENT | 32 | 9.66e-01 | -4.31e-03 | 9.96e-01 |
| GOCC VESICLE MEMBRANE | 840 | 8.34e-01 | -4.31e-03 | 9.76e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 50 | 9.58e-01 | -4.30e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 178 | 9.22e-01 | 4.29e-03 | 9.92e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1151 | 8.10e-01 | 4.29e-03 | 9.75e-01 |
| GOCC SPINDLE | 327 | 8.95e-01 | 4.28e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 9.70e-01 | -4.24e-03 | 9.96e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 9.82e-01 | 4.23e-03 | 9.96e-01 |
| GOBP VIRION ASSEMBLY | 30 | 9.68e-01 | -4.22e-03 | 9.96e-01 |
| GOBP PYROPTOSIS | 29 | 9.69e-01 | 4.22e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 182 | 9.22e-01 | 4.22e-03 | 9.92e-01 |
| GOBP SKIN DEVELOPMENT | 116 | 9.38e-01 | 4.22e-03 | 9.95e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 242 | 9.10e-01 | 4.21e-03 | 9.91e-01 |
| GOBP PLACENTA DEVELOPMENT | 88 | 9.46e-01 | 4.20e-03 | 9.95e-01 |
| GOBP MITOTIC CELL CYCLE | 658 | 8.56e-01 | -4.19e-03 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 18 | 9.76e-01 | -4.18e-03 | 9.96e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 284 | 9.04e-01 | 4.17e-03 | 9.89e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 15 | 9.78e-01 | 4.16e-03 | 9.96e-01 |
| GOBP GERM CELL DEVELOPMENT | 156 | 9.29e-01 | 4.15e-03 | 9.94e-01 |
| GOBP EXPORT FROM CELL | 496 | 8.75e-01 | -4.15e-03 | 9.84e-01 |
| GOBP LIPID CATABOLIC PROCESS | 199 | 9.21e-01 | 4.07e-03 | 9.92e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 9.85e-01 | -4.07e-03 | 9.97e-01 |
| GOMF AMINO ACID BINDING | 20 | 9.75e-01 | 4.04e-03 | 9.96e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 13 | 9.80e-01 | 4.02e-03 | 9.96e-01 |
| GOBP MONOCYTE EXTRAVASATION | 8 | 9.84e-01 | -4.01e-03 | 9.97e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 53 | 9.60e-01 | -3.98e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 79 | 9.51e-01 | 3.98e-03 | 9.96e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 6 | 9.87e-01 | -3.97e-03 | 9.97e-01 |
| GOBP CELLULAR HOMEOSTASIS | 466 | 8.84e-01 | 3.96e-03 | 9.86e-01 |
| GOBP HOMEOSTATIC PROCESS | 982 | 8.38e-01 | -3.91e-03 | 9.77e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 89 | 9.49e-01 | -3.91e-03 | 9.95e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1146 | 8.27e-01 | 3.90e-03 | 9.76e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1267 | 8.20e-01 | -3.89e-03 | 9.76e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 8 | 9.85e-01 | 3.87e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 60 | 9.59e-01 | 3.82e-03 | 9.96e-01 |
| GOBP RETICULOPHAGY | 16 | 9.79e-01 | 3.81e-03 | 9.96e-01 |
| GOBP LOCOMOTION | 668 | 8.68e-01 | 3.81e-03 | 9.83e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 9.86e-01 | -3.80e-03 | 9.97e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 181 | 9.30e-01 | -3.78e-03 | 9.94e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 219 | 9.24e-01 | -3.73e-03 | 9.93e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 53 | 9.63e-01 | 3.70e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 67 | 9.58e-01 | 3.68e-03 | 9.96e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 125 | 9.44e-01 | -3.66e-03 | 9.95e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 137 | 9.42e-01 | 3.63e-03 | 9.95e-01 |
| GOBP FIBROBLAST PROLIFERATION | 62 | 9.61e-01 | -3.61e-03 | 9.96e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 39 | 9.69e-01 | 3.59e-03 | 9.96e-01 |
| GOBP T CELL ACTIVATION | 409 | 9.02e-01 | 3.56e-03 | 9.89e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 131 | 9.44e-01 | -3.55e-03 | 9.95e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 40 | 9.69e-01 | -3.55e-03 | 9.96e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 9.65e-01 | 3.54e-03 | 9.96e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 9.85e-01 | -3.54e-03 | 9.97e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 154 | 9.40e-01 | 3.54e-03 | 9.95e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 11 | 9.84e-01 | 3.53e-03 | 9.97e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 9.85e-01 | 3.52e-03 | 9.97e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 9.88e-01 | 3.52e-03 | 9.97e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 56 | 9.64e-01 | 3.50e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 482 | 8.96e-01 | 3.50e-03 | 9.88e-01 |
| GOBP TONGUE DEVELOPMENT | 6 | 9.88e-01 | -3.47e-03 | 9.97e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 16 | 9.81e-01 | 3.46e-03 | 9.96e-01 |
| GOBP CELL CELL RECOGNITION | 34 | 9.73e-01 | -3.39e-03 | 9.96e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 113 | 9.51e-01 | -3.35e-03 | 9.96e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 145 | 9.45e-01 | 3.33e-03 | 9.95e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 19 | 9.80e-01 | -3.31e-03 | 9.96e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 42 | 9.70e-01 | 3.30e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 42 | 9.71e-01 | 3.30e-03 | 9.96e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 47 | 9.69e-01 | -3.28e-03 | 9.96e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 215 | 9.35e-01 | -3.22e-03 | 9.94e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 215 | 9.36e-01 | 3.21e-03 | 9.94e-01 |
| GOCC TRANSPORT VESICLE | 271 | 9.28e-01 | 3.21e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1009 | 8.66e-01 | 3.20e-03 | 9.83e-01 |
| GOBP LYSOSOMAL TRANSPORT | 111 | 9.54e-01 | -3.18e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 16 | 9.82e-01 | 3.17e-03 | 9.96e-01 |
| GOBP EMBRYO DEVELOPMENT | 599 | 8.98e-01 | -3.10e-03 | 9.88e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 59 | 9.67e-01 | 3.09e-03 | 9.96e-01 |
| GOBP RESPONSE TO CYTOKINE | 596 | 8.99e-01 | 3.08e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 9.91e-01 | 3.07e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1247 | 8.59e-01 | 3.07e-03 | 9.81e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 6 | 9.90e-01 | 3.05e-03 | 9.98e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 9.86e-01 | 3.05e-03 | 9.97e-01 |
| GOBP GLIOGENESIS | 172 | 9.45e-01 | -3.04e-03 | 9.95e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 15 | 9.84e-01 | 3.03e-03 | 9.97e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 477 | 9.12e-01 | -2.99e-03 | 9.91e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 78 | 9.64e-01 | -2.98e-03 | 9.96e-01 |
| GOCC GOLGI MEMBRANE | 484 | 9.11e-01 | 2.98e-03 | 9.91e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 218 | 9.40e-01 | 2.97e-03 | 9.95e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 301 | 9.30e-01 | 2.96e-03 | 9.94e-01 |
| GOBP REGULATION OF CELL SIZE | 111 | 9.57e-01 | 2.95e-03 | 9.96e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 195 | 9.44e-01 | -2.94e-03 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 9 | 9.88e-01 | -2.92e-03 | 9.97e-01 |
| GOBP ENERGY HOMEOSTASIS | 43 | 9.74e-01 | -2.91e-03 | 9.96e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 91 | 9.62e-01 | -2.91e-03 | 9.96e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 51 | 9.72e-01 | 2.89e-03 | 9.96e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1089 | 8.77e-01 | 2.84e-03 | 9.84e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 11 | 9.87e-01 | 2.80e-03 | 9.97e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 268 | 9.38e-01 | -2.77e-03 | 9.95e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 15 | 9.85e-01 | 2.77e-03 | 9.97e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 457 | 9.20e-01 | -2.76e-03 | 9.92e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 9.88e-01 | 2.76e-03 | 9.97e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 10 | 9.88e-01 | 2.76e-03 | 9.97e-01 |
| GOBP ORGANELLE ASSEMBLY | 714 | 9.01e-01 | 2.76e-03 | 9.88e-01 |
| GOBP CYTOKINE PRODUCTION | 530 | 9.15e-01 | 2.74e-03 | 9.92e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 9.89e-01 | 2.71e-03 | 9.97e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 512 | 9.17e-01 | 2.70e-03 | 9.92e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1188 | 8.78e-01 | 2.70e-03 | 9.84e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 50 | 9.74e-01 | -2.70e-03 | 9.96e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 199 | 9.48e-01 | -2.69e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 337 | 9.33e-01 | 2.66e-03 | 9.94e-01 |
| GOCC CILIARY PLASM | 65 | 9.71e-01 | 2.63e-03 | 9.96e-01 |
| GOBP VIRAL PROCESS | 330 | 9.35e-01 | 2.62e-03 | 9.94e-01 |
| GOBP RESPONSE TO BACTERIUM | 360 | 9.33e-01 | -2.61e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 133 | 9.59e-01 | 2.60e-03 | 9.96e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 184 | 9.53e-01 | 2.50e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 78 | 9.70e-01 | 2.49e-03 | 9.96e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 92 | 9.67e-01 | -2.49e-03 | 9.96e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 80 | 9.69e-01 | -2.49e-03 | 9.96e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 52 | 9.75e-01 | -2.48e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 73 | 9.71e-01 | -2.48e-03 | 9.96e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 57 | 9.74e-01 | 2.46e-03 | 9.96e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 42 | 9.78e-01 | 2.42e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 52 | 9.76e-01 | 2.42e-03 | 9.96e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 18 | 9.86e-01 | 2.42e-03 | 9.97e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 9.86e-01 | 2.41e-03 | 9.97e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 9.92e-01 | 2.40e-03 | 9.98e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 9.92e-01 | 2.40e-03 | 9.98e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 286 | 9.45e-01 | 2.39e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 418 | 9.34e-01 | 2.37e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 189 | 9.56e-01 | -2.36e-03 | 9.96e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 224 | 9.53e-01 | -2.32e-03 | 9.96e-01 |
| GOBP SINGLE FERTILIZATION | 54 | 9.77e-01 | -2.30e-03 | 9.96e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 9.91e-01 | 2.27e-03 | 9.98e-01 |
| GOBP WOUND HEALING | 232 | 9.53e-01 | 2.25e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 314 | 9.46e-01 | 2.24e-03 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 7 | 9.92e-01 | 2.24e-03 | 9.98e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 17 | 9.87e-01 | 2.21e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 9.90e-01 | -2.21e-03 | 9.98e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 445 | 9.38e-01 | 2.18e-03 | 9.95e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 71 | 9.75e-01 | -2.16e-03 | 9.96e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 9 | 9.91e-01 | -2.16e-03 | 9.98e-01 |
| GOBP PROTEIN ACYLATION | 116 | 9.68e-01 | 2.14e-03 | 9.96e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 285 | 9.51e-01 | -2.12e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 305 | 9.50e-01 | -2.09e-03 | 9.96e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 58 | 9.78e-01 | -2.08e-03 | 9.96e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 15 | 9.89e-01 | 2.04e-03 | 9.97e-01 |
| GOCC CLEAVAGE FURROW | 41 | 9.82e-01 | -2.03e-03 | 9.96e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 24 | 9.86e-01 | 2.02e-03 | 9.97e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 52 | 9.80e-01 | 1.97e-03 | 9.96e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 9.91e-01 | 1.94e-03 | 9.98e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 9.94e-01 | -1.91e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 32 | 9.85e-01 | 1.91e-03 | 9.97e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 136 | 9.70e-01 | -1.90e-03 | 9.96e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 519 | 9.42e-01 | 1.89e-03 | 9.95e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 71 | 9.78e-01 | -1.88e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 11 | 9.91e-01 | -1.88e-03 | 9.98e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 53 | 9.81e-01 | -1.87e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 13 | 9.91e-01 | 1.84e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 57 | 9.81e-01 | -1.83e-03 | 9.96e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 158 | 9.69e-01 | -1.82e-03 | 9.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 5 | 9.94e-01 | -1.82e-03 | 9.98e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 55 | 9.81e-01 | -1.81e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 9.91e-01 | -1.79e-03 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 37 | 9.85e-01 | 1.76e-03 | 9.97e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 104 | 9.75e-01 | 1.76e-03 | 9.96e-01 |
| GOBP CYTOSOLIC TRANSPORT | 158 | 9.70e-01 | 1.72e-03 | 9.96e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 45 | 9.84e-01 | -1.72e-03 | 9.97e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 6 | 9.94e-01 | 1.72e-03 | 9.98e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 112 | 9.75e-01 | -1.72e-03 | 9.96e-01 |
| GOCC MITOCHONDRIAL MATRIX | 414 | 9.53e-01 | 1.71e-03 | 9.96e-01 |
| GOBP LIPOPHAGY | 7 | 9.94e-01 | 1.70e-03 | 9.98e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 90 | 9.78e-01 | 1.69e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 9.93e-01 | 1.69e-03 | 9.98e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 39 | 9.85e-01 | 1.69e-03 | 9.97e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 80 | 9.79e-01 | 1.67e-03 | 9.96e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 9 | 9.93e-01 | 1.67e-03 | 9.98e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 117 | 9.76e-01 | 1.63e-03 | 9.96e-01 |
| GOBP ORGANELLE FISSION | 314 | 9.61e-01 | -1.62e-03 | 9.96e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 381 | 9.57e-01 | -1.61e-03 | 9.96e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 31 | 9.88e-01 | 1.57e-03 | 9.97e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 49 | 9.85e-01 | 1.56e-03 | 9.97e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 30 | 9.88e-01 | -1.56e-03 | 9.97e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 78 | 9.81e-01 | -1.55e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 34 | 9.88e-01 | -1.55e-03 | 9.97e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 165 | 9.73e-01 | -1.52e-03 | 9.96e-01 |
| GOBP LIPID METABOLIC PROCESS | 826 | 9.42e-01 | -1.52e-03 | 9.95e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 209 | 9.71e-01 | -1.47e-03 | 9.96e-01 |
| GOBP MAPK CASCADE | 436 | 9.58e-01 | 1.47e-03 | 9.96e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 39 | 9.88e-01 | -1.43e-03 | 9.97e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 18 | 9.92e-01 | -1.41e-03 | 9.98e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 46 | 9.87e-01 | -1.35e-03 | 9.97e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 39 | 9.88e-01 | 1.35e-03 | 9.97e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 29 | 9.90e-01 | -1.34e-03 | 9.98e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 9.90e-01 | -1.33e-03 | 9.98e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 7 | 9.95e-01 | -1.32e-03 | 9.98e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 149 | 9.78e-01 | -1.31e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 74 | 9.85e-01 | -1.30e-03 | 9.97e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 347 | 9.67e-01 | -1.29e-03 | 9.96e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 9.96e-01 | 1.28e-03 | 9.99e-01 |
| GOMF PHOSPHATASE BINDING | 147 | 9.79e-01 | 1.28e-03 | 9.96e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 176 | 9.77e-01 | 1.28e-03 | 9.96e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 18 | 9.93e-01 | 1.24e-03 | 9.98e-01 |
| GOMF MYOSIN V BINDING | 10 | 9.95e-01 | -1.22e-03 | 9.98e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 42 | 9.89e-01 | 1.21e-03 | 9.97e-01 |
| GOBP MEMBRANE FISSION | 40 | 9.90e-01 | 1.11e-03 | 9.98e-01 |
| GOBP RESPONSE TO LECTIN | 21 | 9.93e-01 | -1.10e-03 | 9.98e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 485 | 9.69e-01 | -1.05e-03 | 9.96e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 350 | 9.74e-01 | -1.00e-03 | 9.96e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 9.97e-01 | 9.91e-04 | 9.99e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 23 | 9.93e-01 | 9.88e-04 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 92 | 9.88e-01 | 9.30e-04 | 9.97e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 16 | 9.95e-01 | -9.30e-04 | 9.98e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 11 | 9.96e-01 | -9.25e-04 | 9.98e-01 |
| GOBP PODOSOME ASSEMBLY | 16 | 9.95e-01 | -9.20e-04 | 9.98e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 101 | 9.87e-01 | -9.09e-04 | 9.97e-01 |
| GOCC NURD COMPLEX | 15 | 9.95e-01 | -8.88e-04 | 9.98e-01 |
| GOBP REGULATION OF HEART RATE | 39 | 9.93e-01 | 8.65e-04 | 9.98e-01 |
| GOCC EARLY ENDOSOME | 305 | 9.80e-01 | -8.45e-04 | 9.96e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 532 | 9.74e-01 | 8.36e-04 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 9.95e-01 | 7.99e-04 | 9.98e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 221 | 9.85e-01 | 7.55e-04 | 9.97e-01 |
| GOCC CAJAL BODY | 56 | 9.92e-01 | -7.52e-04 | 9.98e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 287 | 9.83e-01 | -7.27e-04 | 9.97e-01 |
| GOBP NEUROMUSCULAR PROCESS | 71 | 9.92e-01 | -7.05e-04 | 9.98e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 9.95e-01 | -6.98e-04 | 9.98e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 9.98e-01 | 6.89e-04 | 9.99e-01 |
| GOBP HEART PROCESS | 107 | 9.91e-01 | -6.40e-04 | 9.98e-01 |
| GOBP MEIOTIC CELL CYCLE | 151 | 9.89e-01 | -6.30e-04 | 9.97e-01 |
| GOBP TRNA CATABOLIC PROCESS | 14 | 9.97e-01 | 6.04e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 27 | 9.96e-01 | -6.04e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 49 | 9.95e-01 | 5.64e-04 | 9.98e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 440 | 9.85e-01 | -5.20e-04 | 9.97e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 7 | 9.98e-01 | -5.14e-04 | 9.99e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 25 | 9.97e-01 | 4.64e-04 | 9.99e-01 |
| GOBP ORGANELLE FUSION | 125 | 9.93e-01 | 4.55e-04 | 9.98e-01 |
| GOMF EXONUCLEASE ACTIVITY | 73 | 9.95e-01 | 3.88e-04 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 185 | 9.94e-01 | 3.44e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 119 | 9.95e-01 | -3.17e-04 | 9.98e-01 |
| GOCC PROTEIN DNA COMPLEX | 806 | 9.89e-01 | 2.92e-04 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 9.98e-01 | -2.90e-04 | 9.99e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 22 | 9.98e-01 | 2.56e-04 | 9.99e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 201 | 9.95e-01 | 2.48e-04 | 9.98e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 80 | 9.97e-01 | 2.15e-04 | 9.99e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 52 | 9.98e-01 | 2.02e-04 | 9.99e-01 |
| GOBP RESPONSE TO PH | 16 | 9.99e-01 | 1.86e-04 | 1.00e+00 |
| GOBP CELLULAR EXTRAVASATION | 46 | 9.98e-01 | -1.71e-04 | 9.99e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 258 | 9.97e-01 | 1.57e-04 | 9.99e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 9 | 9.99e-01 | 1.57e-04 | 1.00e+00 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 9.99e-01 | 1.57e-04 | 1.00e+00 |
| GOMF TUBULIN BINDING | 255 | 9.97e-01 | -1.48e-04 | 9.99e-01 |
| GOBP REGULATION OF OSSIFICATION | 61 | 9.99e-01 | 1.39e-04 | 9.99e-01 |
| GOMF ACTIN FILAMENT BINDING | 127 | 9.98e-01 | -1.34e-04 | 9.99e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 8 | 1.00e+00 | 5.87e-05 | 1.00e+00 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 16 | 1.00e+00 | 4.90e-05 | 1.00e+00 |
| GOCC EARLY ENDOSOME MEMBRANE | 134 | 9.99e-01 | -4.60e-05 | 1.00e+00 |
| GOBP ORGANELLE DISASSEMBLY | 126 | 1.00e+00 | -6.27e-06 | 1.00e+00 |
Detailed Gene set reports
GOBP SEQUESTERING OF IRON ION
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION
Top enriched genes
Click HERE to show all gene set members
GOBP RESPONSE TO ZINC ION STARVATION
Top enriched genes
Click HERE to show all gene set members
GOBP HEMATOPOIETIC STEM CELL MIGRATION
Top enriched genes
Click HERE to show all gene set members
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF MAST CELL CHEMOTAXIS
Top enriched genes
Click HERE to show all gene set members
GOBP SEX DETERMINATION
Top enriched genes
Click HERE to show all gene set members
GOBP L SERINE TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL
Top enriched genes
Click HERE to show all gene set members
GOCC CELL POLE
Top enriched genes
Click HERE to show all gene set members
GOMF ACID PHOSPHATASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF FERTILIZATION
Top enriched genes
Click HERE to show all gene set members
GOMF OXO ACID LYASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP CILIUM DISASSEMBLY
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
Top enriched genes
Click HERE to show all gene set members
GOBP COCHLEA MORPHOGENESIS
Top enriched genes
Click HERE to show all gene set members
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE
Top enriched genes
Click HERE to show all gene set members
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOCC MHC CLASS I PROTEIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS
Top enriched genes
Click HERE to show all gene set members
GOMF TAP BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL
Top enriched genes
Click HERE to show all gene set members
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
Top enriched genes
Click HERE to show all gene set members
GOBP HEPARIN BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP FOLIC ACID TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOBP GAS TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOBP MHC CLASS I BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE
Top enriched genes
Click HERE to show all gene set members
GOCC TORC1 COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF TRANSMITTER GATED CHANNEL ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Top enriched genes
Click HERE to show all gene set members
GOBP MAINTENANCE OF SISTER CHROMATID COHESION
Top enriched genes
Click HERE to show all gene set members
GOBP VITAMIN TRANSMEMBRANE TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOBP LIPID IMPORT INTO CELL
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL
Top enriched genes
Click HERE to show all gene set members
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION
Top enriched genes
Click HERE to show all gene set members
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.3.3 (2024-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4 GGally_2.2.1
## [3] ggplot2_3.5.0 reshape2_1.4.4
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] gplots_3.1.3.1 kableExtra_1.4.0
## [11] limma_3.58.1 mitch_1.15.0
## [13] DESeq2_1.42.0 muscat_1.16.0
## [15] beeswarm_0.4.0 stringi_1.8.3
## [17] SingleCellExperiment_1.24.0 SummarizedExperiment_1.32.0
## [19] Biobase_2.62.0 GenomicRanges_1.54.1
## [21] GenomeInfoDb_1.38.6 IRanges_2.36.0
## [23] S4Vectors_0.40.2 BiocGenerics_0.48.1
## [25] MatrixGenerics_1.14.0 matrixStats_1.2.0
## [27] hdf5r_1.3.9 Seurat_5.0.1
## [29] SeuratObject_5.0.1 sp_2.1-3
## [31] plyr_1.8.9
##
## loaded via a namespace (and not attached):
## [1] spatstat.sparse_3.0-3 bitops_1.0-7
## [3] httr_1.4.7 RColorBrewer_1.1-3
## [5] doParallel_1.0.17 numDeriv_2016.8-1.1
## [7] backports_1.4.1 tools_4.3.3
## [9] sctransform_0.4.1 utf8_1.2.4
## [11] R6_2.5.1 lazyeval_0.2.2
## [13] uwot_0.1.16 mgcv_1.9-1
## [15] GetoptLong_1.0.5 withr_3.0.0
## [17] prettyunits_1.2.0 gridExtra_2.3
## [19] progressr_0.14.0 cli_3.6.2
## [21] spatstat.explore_3.2-6 fastDummies_1.7.3
## [23] labeling_0.4.3 sass_0.4.8
## [25] mvtnorm_1.2-4 spatstat.data_3.0-4
## [27] blme_1.0-5 ggridges_0.5.6
## [29] pbapply_1.7-2 systemfonts_1.0.5
## [31] svglite_2.1.3 scater_1.30.1
## [33] parallelly_1.37.0 rstudioapi_0.15.0
## [35] generics_0.1.3 shape_1.4.6
## [37] ica_1.0-3 spatstat.random_3.2-2
## [39] Matrix_1.6-5 ggbeeswarm_0.7.2
## [41] fansi_1.0.6 abind_1.4-5
## [43] lifecycle_1.0.4 yaml_2.3.8
## [45] edgeR_4.0.15 SparseArray_1.2.4
## [47] Rtsne_0.17 grid_4.3.3
## [49] promises_1.2.1 crayon_1.5.2
## [51] miniUI_0.1.1.1 lattice_0.22-5
## [53] beachmat_2.18.1 cowplot_1.1.3
## [55] pillar_1.9.0 knitr_1.45
## [57] ComplexHeatmap_2.18.0 rjson_0.2.21
## [59] boot_1.3-28.1 corpcor_1.6.10
## [61] future.apply_1.11.1 codetools_0.2-19
## [63] leiden_0.4.3.1 glue_1.7.0
## [65] data.table_1.15.2 vctrs_0.6.5
## [67] png_0.1-8 spam_2.10-0
## [69] Rdpack_2.6 gtable_0.3.4
## [71] cachem_1.0.8 xfun_0.42
## [73] rbibutils_2.2.16 S4Arrays_1.2.0
## [75] mime_0.12 survival_3.5-8
## [77] iterators_1.0.14 statmod_1.5.0
## [79] ellipsis_0.3.2 fitdistrplus_1.1-11
## [81] ROCR_1.0-11 nlme_3.1-164
## [83] pbkrtest_0.5.2 bit64_4.0.5
## [85] EnvStats_2.8.1 progress_1.2.3
## [87] RcppAnnoy_0.0.22 bslib_0.6.1
## [89] TMB_1.9.10 irlba_2.3.5.1
## [91] vipor_0.4.7 KernSmooth_2.23-22
## [93] colorspace_2.1-0 ggrastr_1.0.2
## [95] tidyselect_1.2.0 bit_4.0.5
## [97] compiler_4.3.3 BiocNeighbors_1.20.2
## [99] xml2_1.3.6 DelayedArray_0.28.0
## [101] plotly_4.10.4 scales_1.3.0
## [103] caTools_1.18.2 remaCor_0.0.18
## [105] lmtest_0.9-40 stringr_1.5.1
## [107] digest_0.6.34 goftest_1.2-3
## [109] spatstat.utils_3.0-4 minqa_1.2.6
## [111] variancePartition_1.32.5 rmarkdown_2.25
## [113] aod_1.3.3 XVector_0.42.0
## [115] RhpcBLASctl_0.23-42 htmltools_0.5.7
## [117] pkgconfig_2.0.3 lme4_1.1-35.1
## [119] sparseMatrixStats_1.14.0 highr_0.10
## [121] fastmap_1.1.1 rlang_1.1.3
## [123] GlobalOptions_0.1.2 htmlwidgets_1.6.4
## [125] shiny_1.8.0 DelayedMatrixStats_1.24.0
## [127] farver_2.1.1 jquerylib_0.1.4
## [129] zoo_1.8-12 jsonlite_1.8.8
## [131] BiocParallel_1.36.0 BiocSingular_1.18.0
## [133] RCurl_1.98-1.14 magrittr_2.0.3
## [135] scuttle_1.12.0 GenomeInfoDbData_1.2.11
## [137] dotCall64_1.1-1 patchwork_1.2.0
## [139] munsell_0.5.0 Rcpp_1.0.12
## [141] viridis_0.6.5 reticulate_1.35.0
## [143] zlibbioc_1.48.0 MASS_7.3-60.0.1
## [145] ggstats_0.5.1 listenv_0.9.1
## [147] ggrepel_0.9.5 deldir_2.0-2
## [149] splines_4.3.3 tensor_1.5
## [151] hms_1.1.3 circlize_0.4.15
## [153] locfit_1.5-9.8 igraph_2.0.2
## [155] spatstat.geom_3.2-8 RcppHNSW_0.6.0
## [157] ScaledMatrix_1.10.0 evaluate_0.23
## [159] nloptr_2.0.3 foreach_1.5.2
## [161] httpuv_1.6.14 RANN_2.6.1
## [163] tidyr_1.3.1 purrr_1.0.2
## [165] polyclip_1.10-6 future_1.33.1
## [167] clue_0.3-65 scattermore_1.2
## [169] rsvd_1.0.5 broom_1.0.5
## [171] xtable_1.8-4 fANCOVA_0.6-1
## [173] RSpectra_0.16-1 later_1.3.2
## [175] viridisLite_0.4.2 lmerTest_3.1-3
## [177] glmmTMB_1.1.9 cluster_2.1.6
## [179] globals_0.16.2END of report